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Preface 
The evaluation of the exposure of workers to dangerous agents is one of the measures 
insuring a better health protection. This evaluation is called monitoring. 
Two approaches are available for the monitoring : 
- ambient monitoring already in use for many years and 
- biological monitoring of more recent development. 
The  need  for clear definitions and for establishing the  respective roles of these two 
types  of monitoring  has  become necessary recently.  In  1980 in  Luxembourg  at  an 
international seminar organized jointly by the CEC and the  United States authorities 
(Occupational  SafetY  and  Health  Administration  and  the  National  Institute  for 
Occupational Safety and Health) on the Assessment of Toxic Agents at the Workplace, 
the following definitions were agreed : 
- ambient  monitoring  is  the  measurement  and  assessment  of  agents  at  the 
workplace  and  evaluates  ambient  exposure  and  health  risk  compared  to  an 
appropriate reference; 
- biological monitoring is the measurement and assessment of workplace agents 
or  their  metabolites  either  in  tissues,  secreta,  excreta,  expired  air  or  any 
combination  of  these  to  evaluate  exposure  and  health  risk  compared  to  an 
appropriate reference.  -
In addition, the term "Health Surveillance" was also defined as the periodic medico-
physiological examinations of exposed workers with the objective of protecting health 
and preventing occupational related disease. The detection of established disease is 
outside the scope of this definition. 
The definitions of biological monitoring and health surveillance separate components 
of a continuum which can range from the measurements of agents in the body through 
measurements of  metabolites,  to signs  of early disease.  A problem  left unresolved 
concerns the precise place within these definitions of certain biochemical tests such 
as  zinc  protoporphyrin  (ZPP),  delta  aminolaevulinic  acid  dehydrase  (ALA-D),  delta 
aminolaevulinic acid (ALA) in the blood and urine, etc., which are, in fact, indicators of 
metabolic effects which have occurred as a consequence of exposure. 
Ambient monitoring is carried out for different reasons, for example : 
a.  determining ambient concentrations in  relation to an established legal standard or 
consensus guideline; 
b.  determining the relationship,  if any,  between the concentrations of agents at the 
workplace and the health of the workers; 
c.  ensuring the effectiveness of control measures; 
d.  evaluating the need for controls in the vicinity of specific emission sources; 
e.  indicating trends in relation to an improvement or determination at the workplace; 
f.  providing an historical record. 
Biological monitoring measures ·or evaluates exposure from all  routes.  It  sometimes 
allows a better evaluation of health risk than ambient monitoring especially in  cases 
where exposure through different routes has to be considered. 
Biological  monitoring takes  into account individual variability,  the  impact of factors 
such as personal activity, biological characteristics and life styles of the individuctl. VI 
The  two  types  of  monitoring  are  complementary  in  increasing  the  protection  of 
workers'  health.  If  both  are  carried  out  simultaneously,  information  should  be 
produced on  the relationships existing between external exposure and concentration 
of  the  substance  in  biological  samples,  and  between  this  concentration  and  early 
effects. 
Detailed knowledge of the metabolism of the toxic agent in the human organism and of 
the alterations that occur in the critical organ is essential in selecting the parameter to 
be used as indicator. 
Unfortunately,  however,  such  knowledge  is  usually  insufficient and  thus  limitations 
exist in most biological monitoring programmes. 
The conditions necessary for successful biological monitoring are : 
- existence of indicators, 
- existence of analytical methods that will guarantee technical reliability in the use of 
these indicators, 
- possibility of measuring the indicators on readily accessible biological specimens, 
- existence and knowledge of dose-effect and dose-response relationships. 
In carrying out a biological monitoring programme, it is indispensable to know exactly 
what the characteristics and behaviour of the indicators under study are in relationship 
to  length  of  exposure,  time  elapsed  since  beginning  and  end  of  exposure,  and  all 
physiological  and  pathological  factors  other  than  exposure  that  could  give  a  false 
interpretation of the results obtained. 
Conditions for biological monitoring application include adoption of analytical methods 
yielding values comparable throughout the different laboratories. 
This long time adopted approach has already permitted the CEC to standardize in 1972 
a  method  for  erythrocyte  ALAD  determination  and  develop  programmes  for  inter-
laboratory comparisons for lead and cadmium determination in biological media. 
The  Council of Ministers of the European Communities in  adopting  in  1978 the  First 
Action  Programme  on  Safety  and  Health  at  Work  proposed  by  the  Commission 
stressed  the  need  to  increase  protection  against  dangerous  substances;  it 
emphasized  the  need  to  promote  new  monitoring  and  measuring  methods  for  the 
assessment of individual exposure,  in  particular through the application of sensitive 
biological indicators. 
In August 1982 the Council adopted a directive on the protection of workers exposed to 
lead. The monitoring of blood lead levels as well as the determination of ALAU, ALAD 
and  ZPP  are  among the tools to  be  used for monitoring worker exposure to  lead.  A 
comparison of the results with action levels and limit values allows appropriate action 
to be taken. 
Considerable  data  concerning  the  biological  monitoring  of  a  number  of  industrial 
chemicals has been published in the international literature. 
Nevertheless,  the  difference  in  approaches  used  in  the  research,  the  variety  of 
analytical  methods  and  the  frequent  discordances  in  the  results,  usually  make  it 
difficult to formulate a conclusive synthesis permitting the transfer of literature data 
into practice. 
The ai.m of this series dedicated to human biological monitoring of industrial chemicals 
in  occupational  health  is  based  on  the  considerable  experience  acquired  by  the 
authors in the specific topics. 
For the draft of the monographs, the following outline, suggested by R.L. Zielhuis and 
R.  Lauwerys, has been used : 
- a review of metabolism and/or mechanism of action; 
potentially  useful  biological  parameters  for  evaluation  of  exposure  and/or  body 
burden and/or early reversible effects; 
- a critical evaluation of each parameter : 
predictive validity in regard to exposure; 
quantitative  relationship  between  levels  of  external  exposure  and  internal 
exposure, and between exposure and effects; 
limitations of the test; 
- a proposal for one or several tests for biological monitoring. 
· Because of the considerable gaps in  scientific knowledge it has not been possible to VII 
follow this outline strictly in  every single one  of the  monographies.  It  is  hoped  that 
future research will fill these gaps. 
It  must be  recognized that the biological monitoring approach for other toxic agents 
must still be developed and that considerable research is still necessary. 
The Council in the above mentioned action programme and  in  the directives recently 
adopted in this field stressed the need to provide adequate information at all levels. It 
is  considered  that  these  monographs  will  be  of  benefit  to  the  occupational  health 
physicians,  the  industrial  hygienists,  the  employers  and  the  trade-union 
representatives,  by  giving  the  scientific  rationale  on  which  a number  of  biological 
monitoring programmes are based. Human biological monitoring of
industrial chemicals series
Benzene
R. Lauwerys3 
Summary 
This document reviews the liquid benzene as related to occupational exposure and the 
possibilities of the biological monitoring of exposure. 
Absorption  of  benze  occurs  mainly  through  inhalation  of  vapours  and  secondarily 
through  skin  contact  with  the  liquid  form.  Benzene  can  cause  aplastic  anaemia, 
leukemia and erythroleukemia. 
Benzene gives rise to phenol in vivo and therefore the measurement of urinary phenol 
excretion has some practical application for evaluating current exposure to benzene. 
A phenol  concentration exceeding 20  mg/1  at the  end of a work shift suggests that 
workers have been exposed to benzene if the analytical method used was sufficiently 
sensitive and  if other circumstances which might cause increased phenol excretion 
have been excluded. 
Determination of benzene in exhaled air is a valuable method of confirming exposure 
to benzene.  It  is  highly sensitive and  more specific than  phenol  determination.  Not 
enough data exists, however, to correlate benzene concentration in  exhaled air with 
integrated exposure.  A benzene concentration  in  breath of 0.12 ppm,  measured  16 
hours  after  the  end  of  exposure,  is  proposed  as  a  tentative  biological  threshold 
resulting from an 8 hour exposure to 1  0 ppm benzene. 
Further investigations are required to define the usefulness of the various biological 
parameters in the routine control of workers exposed to benzene. 5 
Benzene 
Chemical and Physical Properties 
Benzene  is  a colourless liquid at  normal  temperatures.  Several  of  its chemical  and 
physical properties are given in Table 1. 
Table I -Chemical and physical properties of benzene 
Boiling point (760 mm Hg) 
Vapour pressure (20 °C) 
Vapour density 
Molecular formula 
Structural formu  Ia 
1 ppm 
1 mq/m
3 
80.1  °C 
74.66 mm Hg 
2.77 
C6H6 
3.247 mg/m
3 
0."308 ppm 
Biological Changes Related to Chronic Benzene Toxicity 
Benzene can cause aplastic anaemia, leukemia and erythroleukemia. 
In its initial stages, benzene toxicity can manifest itself as a paradoxial alteration of the 
blood  picture.  Polycythemia  and  aneamia,  leucocytosis  and  leucopenia, 
thrombocytosis  and  thrombocytopenia  have  all  been  reported  in  exposed  workers. 
With continued exposure, however, the trend is toward decreased levels of circulating 
erythrocytes,  leucocytes  and  thrombocytes.  As  the  disease  intensifies,  circulating 
blood  cell  levels  decrease further and  pancytopenia develops  (Kocsis  and  Snyder, 
1975). 
Aksoy  et  al.  (1972)  found  that  workers  exposed  to  benzene  and  suffering  from 
pancytopenia displayed increased levels of HbF.  Depression of leucocytes is usually 
apparent prior ro the onset of anaemia (Hunter, 1939; Mitnik and Genkin, 1931 ). 
However,  Kocsis  and  Snyder  (1975)  have  rightly  stressed that despite the  general 
agreement that benzene toxicity r~sults in leukopenia, effective screening for benzene 
toxicity should not be restricted to the determination of leucocyte levels alone. 
It has also been suggested that thrombocytopenia may be among the earliest signs of 
benzolism (Goldwater, 1941; Nikulina and Titowa, 1934) and that the ability of platelets 
to aggregrate is also depressed by benzene (Saita and Sbertoli, 1954). Lee at al. (1973, 
1974)  have  demonstrated,  based  on  cell  counting  techniques  in  animals,  that  a 
reduction in the incorporation of 59Fe into haemoglobin of maturing red cells can occur 
even through no inhibition of white cell production is apparent. 6 
Thus,  the  effects  of  benzene  on  erythrocyte  production  occur  quite  soon  after 
exposure.  Detection of the  earliest stages of reduced  haemopoiesis is  not possible 
with classical cell counting techniques, however, due to the long life span of the red 
cells. 
Earlier  studies  performed  by  Truhaut  et  al.  (1959)  on  rabbits  suggested  that  the 
response of the erythropoietic system was quite variable, depending on the routes and 
the intensity of exposure. 
Hypofunction  of  one  system,  however,  may  be  associated  with  hyperfunction  of 
another system, and therefore no valid judgement can be  made as to whether or not 
hypofunction is  invariably seen  in  advance of hyperfunction (Deutsche Forschungs-
gemeinschaft,  197 4  ).  Since  these  changes  in  peripheral  blood  are  not  necessarily 
reversible,  they  cannot  be  regarded  as  sufficiently  sensitive  for  the  biological 
monitoring of workers exposed  to benzene.  Furthermore, their  lack of specificity is 
well known and does not require further comment. 
Cytogenetic studies have revealed that chromosomal aberrations can be found in bone 
marrow and peripheralleucocytes of humans exposed to benzene (Berlin et al., 1975; 
Forni and Moree, 1969; Forni et al.,  1971 a,b; Hartwich and Schwanitz, 1972; Prost et 
al., 1976; Tough and Court Brown, 1965; Tough et al., 1970; Vigliani e Forni, 1969). 
No  dose-effect  relationship  has  so  far  been  demonstrated  for  benzene-induced 
chromosome  aberration  and  the  implication  of  this  findiQg  for  the  occurrence  of 
benzene leukemia is still not clear (Truhaut and Murray, 1978). 
Metabolism 
Metabolic Pathways 
Absorption of benzene occurs mainly through inhalation of vapours and  secondarily 
through skin contact with the liquid form. 
According to Hanke et al.  (1961) the rate of human skin absorption of liquid benzene 
applied under a closed cup is 0.4 mg/cm2/h. 
Srbova et al. (1965) exposed human vlunteers to 47-110 ppm benzene vapours for 2 
hours and found that about 50°/o of the inhaled benzene was absorbed. 
Hunter (1966) found that at a benzene concentration of 35 ppm, the amount of benzene 
reached a relatively steady state in approximately 5-7 minutes and amounted to about 
47% of the benzene in the inhaled air. 
Docter and Zielhuis (1967) have pointed out that it is not the proportional retention as 
such  which  is  the  relevant  parameter but  the amount of  benzene  absorbed,  which 
includes not only the proportional retention but also the ventilation parameters. The 
amount  of  benzene  absorbed  has  been  estimated  at  about  0.4  mg/min  when  the 
subject is exposed to 1  0 ppm with a ventilation of 25 1/min (Docter and Zielhuis, 1967). 
Since  benzene  is  highly  lipophilic,  highest  levels are found  in  fat and  bone  marrow 
(Truhaut and Murray, 1978). 
A fraction of the absorbed benzene is excreted unchanged in the exhaled air. Several 
authors found that in man, the fraction eliminated in the exhaled air varies between 10 
and 50°/o,  depending on the metabolic activities and the quantity of the fat (Srbova et 
al., 1956; Teisinger et al., 1952). The  remaining fraction is metabolised (Hasegawa et 
al., 1967; Parkes and Wjlliams, 1953a, b; Porteous and Williams, 1964a, b). 
The  first  reaction  catalysed  by  the  microsomal  mixed  function  oxidase  system  of 
various tissues is the transformation of benzene into benzene epoxide (Harper et al., 
1973).  This  compound  is  a very  reactive  intermediate that  either  binds  directly to 
cellular constituents (e.g. DNA, proteins), or is further transformed into other benzene 
derivatives.  Benzene  epoxide  is  suspected of  being  responsible  for the  myelotoxic 
action of benzene (Daly et al., 1972; Jerina et al., 1968). 
Benzene  epoxide  may be  transformed non-enzymatically into phenol,  which  is  then 
conjugated with glucuronic acid or sulphate. The glucurono and sulphoconjugates of 
phenol are then excreted in the urine (Porteous and Williams, 1949a, b; Snyder, 197  4). 
Phenol (free or conjugated) constitutes the main urinary metabolite of benzene. 
The  epoxide  may  also  react  with  glutathion  and  the  product formed  will  be  S(1 ,2-
dihydro-2-hydroxyphenyl) glutathione. The subsequent action of a glutathionase in the 
presence  of  a glutamine  acceptor,  a  peptidase  and  acetyl  GoA  acetyltransferase, 
results  in  the  formation  of premercapturic acid,  i.e.  S(1 ,2-dihydro-2-hydroxyphenyl) 7 
acetyi-L-cysteine premercapturic acid, which is excreted as  such  in the urine. When 
urine is treated with mineral acids, the premercupturic acid is transformed into mer-
capturic acid. 
Trans-1 ,2-dihydroxybenzene  is  formed  under  the  action  of  the  enzyme  epoxide 
hydrase, and is quickly transformed into catechol (Jerina et al., 1968). An enzyme (cis-
benzene glycol dehydrogenase), which catalyses the conversion of cis-benzene glycol 
into catechol  in  the presence of NAD•,  has  been  isolated from bacteria (Axcell  and 
Geary,  1973).  Very  slight amounts of hydroquinol and  1  ,2,4-trihydroxybenzene have 
also been identified in urine. 
After a ring scission, catechol is transformed into trans-trans muconic acid, which is 
excreted in urine, and carbon dioxide, which is excreted with the exhaled air (see Fig. 
1  ). 
This metabolic pathway was first unravelled in animals but has also been confirmed in 
man.  Teisinger  et  al.  (1952)  repeatedly  exposed  15  volunteers  to  about  100  ppm 
benzene for 5 hours a day.  They  observed that 33  to 65°/o  of inhaled benzene was 
absorbed. Of the total quantity absorbed, an  average of 12.1 °/o  (3.8 to 27.8  %) was 
eliminated  by  the  pulmonary  route.  In  urine,  phenol  (averaging  28.8°/o),  catechol 
(2.9°/o)  and  hydroquinol  (1.1 °/o)  were  found,  as  well  as  a very  small  proportion  of 
unchanged benzene (0.1  to 0.2°/o of the quantity absorbed). On the other hand, Hunter 
and Blair (1972) exposed 5 volunteers to 22 ppm for 6 hours, and found that 7  4 to 87°/o 
of  the  benzene  absorbed  is  excreted  as  phenol  and  about  12°/o  is  eliminated 
unchanged in the exhaled air. Sherwood (1976) has also estimated that about 80°/o  of 
absorbed  benzene  is  biotransformed  into  phenol.  All  the  investigations  agree, 
however,  that phenylmercapturic acid,  catechol,  hydroquinol  and  muconic acid are 
minor metabolites of benzene. 
It has  been demonstrated that benzene metabolism occurs not only  in  the liver, but 
also in other tissues like the bone marrow (Snyder et al., 1977). This observation may 
have some bearing on benzene toxicity. It should be recalled that as for the majority of 
voltatile organic substances, the elimination of benzene and  its metabolites is  rapid. 
Excretion of  the  metabolites is  usually completed within  24-48  hours  after a single 
exposure which represents a biological half life of less than  12 hours (Sherwood and 
Carter,  1970).  However, tissues with high  fat content may retain a slight quantity of 
benzene for several days after the end of exposure. 
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Figure 1 -Metabolic biotransformation of benzene in vivo 8 
Factors Influencing Benzene Metabolism 
Animal  experiments  suggest  that  benzene  metabolism  can  be  stimulated  by 
microsomal enzyme inducers such as phenobarbital (Ikeda and Ohtsuji, 1971; Snyder 
et al.,  1967) and that benzene can stimulate its own metabolism. On the other hand, 
Sato et al.  (1967) have observed that in  vitro some metabolites of benzene (phenol, 
catechol and hydroquinol) can inhibit benzene hydroxylation. 
Ikeda et  al.  (1972)  have also found  that  in  rats,  conversion of benzene to phenol  is 
suppressed  by  the  simultaneous  administration  of  toluene.  Phenobarbital  pre-
treatment,  which  stimulates benzene metabolism,  reduces  the  leukopenic action of 
benzene in rats (Ikeda and Ohtsuji, 1971 ). 
Biological Indicators 
Background Information 
Information  about  the  fate  of  benzene  in  vivo  has  given  rise  to  several  biological 
exposure tests : 
- the determination of the ratio between inorganic and organic sulphates in urine; 
- the measurement of total (free and conjugated) phenol in urine; and 
- the measurement of benzene in blood and exhaled air (Lauwerys, 1975). 
Pheripheral  blood  examination  and  cytogenetic  techniques  are  also  suggested  for 
detecting early biological manifestations of benzene. 
It  should  be  stressed  that  since  the  biological  half-life  of  benzene  metabolites  is 
usually short (less than 12 hours), the time of sampling of biological material in relation 
to  exposure  is  very  important.  When  biological  monitoring  involves  sampling  and 
analysing  urine,  the  collection  methods  and  the  means  of  expressing  the  results 
should be standardised. 
Several methods of urine collection can be considered : 
Collection of urine for 24 hours and expression of the results in  amount excreted 
per 24 hours. This procedure is the most accurate, but it is also impractical for the 
routine monitoring of workers. 
2  Collection of urine during a well-defined period of time (e.g.  for two to four hours 
during  the  second  part  of  the  work  shift)  and  expression  of  the  results  in 
quantity/unit time.  This  method is  more accurate than  spot sample analysis, but 
often too elaborate for routine control of workers. 
3  Spot  specimen  collection  at  a  well-defined  time  after  the  beginning  or  end  of 
exposure (at the end of work shift or 16 hours after the end of exposure, i.e. before 
starting a new work period). This seems to be  the most widely used method. It is 
advisable  to  correct  the  results  for  the  dilution  of  the  urine.  Two  methods  of 
correction have been  used : a)  expression of the results per gram of creatine; b) 
adjustment to a constant specific gravity. 
Although  creatine  adjustment is  not superior to  specific gravity adjustment,  the 
former is better for very concentrated and very dilute samples (Elkins et al., 1974). 
Furthermore,  in  the  case  of  glucosuria  and  probably  proteinuria,  the  specific 
gravity adjustment may give inaccurate results. Whatever the method of collection, 
analyses  performed  on  very  dilute  urine  specimens  (specific  gravity  less  than 
1  .01 O) are not reliable. The results of urine analyses can only be interpreted if renal 
excretion is not impaired (no evidence of kidney disfunction). 
4  When  a large  interindividual  variability and/or  a high  "background" level  of  the 
biological parameter selected makes the  interpretation of a single measurement 
difficult, it is sometimes useful to analyse biological material collection before and 
after the exposure period. 
If there is no important circadian rythm in the urinary excretion of the substance, 
the  change  in  the  biological parameter due  especially to exposure can  then  be 
better assessed. 
When comparing results on benzene metabolite excretion as reported in the literature, 
it must be kept in mind that since different methods of urine collection may have been 
used, results may not be comparable. Furthermore, the different degree of specificity 
and the sensitivity of the analytical method selected for urine analysis must also be 
taken into consideration. 9 
When  one  attempts  to  correlate  the  changes  of  a  biological  parameter  with  the 
intensity of benzene exposure, one must also realise that in several investigations the 
determination of the exposure was  necessarily inaccurate due to semi-quantitative 
determination with detector tubes, a limited number of spot samples and the failure to 
take  skin  contamination  into  consideration.  Exposure  has  rarely  been  well-
characterized in the terms proposed by Sherwood (1971 ). 
Ratio between Inorganic and Organic Sulphates In Urine 
The ratio between inorganic and total sulphates in urine is normally more than 85°/o. In 
59  non-exposed  individuals, Teisinger  and  Bergerova-Fiserova (1955)  have  found  a 
mean  ratio  of  92.5°/o  with  a  standard  deviation  of  4.6°/o.  Exposure  to  benzene 
produces a decrease in this ratio, since some metabolites of benzene are eliminated 
as sulphoconjugates (Yant et al., 1936a, b). 
A  tabulation  of  rather  "old"  data  from  the  literature  on  the  relationship  between 
benzene exposure and inorganic-total sulphate ratio has been prepared by the German 
Working Group for the Establishment of MAK-values, of the Senate Commission for the 
Examination of  Hazardous  Industrial  Materials (Deutsche Forschungsgemeinschaft, 
1974). It is partially reproduced in Table 2. 
Table II- Urinary inorganic sulphate after exposure to benzene (8 hours daily) 
Number of  Concentration of 
Average inorganic 
subjects exposed  benzene (ppm) 
sulphate (%  of total  Reference 
sulphate) 
14  13-23  85  Yantetal., 
8  19-50  70  1936b 
22  123- 132  72 
13  158-372  55 
40-45  71  (67- 79)  Hardy and  Elkins, 
55-70  54  1948 
50-70  68 
80  67 
8  0  86  Bowditch and  Elkins, 
6  40  81  1939 
11  <40- 75  61 
11  75- 100  42 
9  100- 125  34 
4  10.5- 31.5  >so  Teisinger and 
Bergerova-F iserova, 
1955 
It is clearly evident that on a group basis, a significant decrease in the ratio, i.e. below 
70°/o, is only observed when benzene exposure exceeds 40 ppm. 
The sensitivity of this test is thus too low as an exposure on the order of 10 ppm, the 
time-weighted average exposure recommended in  1974 by  the National  Institute for 
Occupational Safety and Health (NIOSH, U.S.A.), and in 1976 by an international group 
of experts  (Truhaut  and  Murray,  1978),  would  not  significantly  influence  this  ratio 
(Teisinger and Bergerova-Fiserova, 1955; NIOSH, 1974). The specificity of this test is 
also limited since numerous hydroxylated organic chemicals are also excreted in urine 
as sulphoconjugates. This test can no longer be recommended for evaluating benzene 
exposure. 
Concentrations of Total Phenol in Urine 
Contrary to substituted benzene derivatives, e.g. toluene and xylene, which are mainly 
metabolised on the side chain, benzene gives rise to phenol in vivo and therefore the 
measurement of urinary phenol excretion has been proposed as an  exposure index. 
The half-life of phenol lies in the range of 4-8 hours (Sherwood and Carter, 1970). 
Assuming that 30°/o  of the retained benzene is oxidized into phenol (Teisinger et al., 
1952), about 60 mg phenol should be produced in workers exposed to 1  0 ppm benzene 
for 8 hours with a ventilation of 25 1/min. Individual variability in pulmonary ventilation 10 
and  in  the  proportion  of  benzene  biotransformed  into  phenol  (80°/o  according  to 
Sherwood. 1976) makes the preceding estimation valid only on a group basis. 
Several methods have been developed for the analysis of free and conjugated phenol 
in biological material. As  indicated above, interpretation of the reported results must 
take the specificity of these methods into consideration. Briefly, in order of increasing 
specificity,  these  include : the  colorimetric method of Theis-Benedict (diazotised  p-
nitroaniline as  reagent)  and  the  colorimetric method,  using  4-aminoantipyrine as  a 
reagent, the colorimetric method of Gibbs (2,6-dichloroquinone chlorimide as reagent) 
and the various gas liquid chromatographic methods. 
The  4-aminoantipyrine  method  determines  many  phenol  derivatives  (Gottlieb  and 
Marsh. 1946). 
The method of Theis-Benedict, which measures not only the phenol but also the ortho-, 
meta- and paracresol and other hydroxy compounds (Muting at al., 1970), gives values 
for phenol cntent in urine about 30°/o  greater than those obtained with the method of 
Table Ill -Phenol concentration in urine of persons non-occupationally exposed to benzene 
Number of  Phenol 
subjects  concentration 
X =25 mg/24 H 
(range:  11  - 42 mg/24 h 
X = 30 mg/1  (S.G.  1  024) 
(range:  15 - 50 mg/1) 
X= 17.8 mg/1 
(range:  3.2-41.3 mg/1) 
X= 7 mg/1 
12  X= 17 mg/1  {S.G.  1016) 
(range.  9.3- 34.4) 
(range·  5 - 1  0 mg/1) 
328  X= 8.2 mg/24 h {S.D. 5.9) 
97.5th percentile= 20 mg/1 
54  X= 7.8 mg/1  {S.G.  1024) 
(S.D. 3.7) 97 .5th percentile= 
=  16 mg/1 
20  I X= 7.5 mg/1  {S.G.  1024) 
I (range.  2- 18 mg/1) 
10 
I_ 
f  X= 10.4 mg/24 h 
(Male)  95th percentile= 12.4 unit 
10  X = 11 .3 mg/24 h 
(Female)  95th percentile= 14.8 unit 
20  X = 4 7 mg/G creatinine 
9.4 mg/1  (Uf1COrrected) 
97.5th percentile= 14.7 mg/G 
I 
creatinine 
9  X= 1.8 mg/1 
(all<  3.5 mg/1) 
13  X  =7.6 mg/1  (S.G.  106) 
(range: 3.2- 14.7 mg/1) 
+=See methods 
Methods 
1.  Colorimetric method of Theis-Benedict 
2.  Amino-antipyrine method 
3.  Modified Theis-Bened ict method 
4.  Colorimetric method of Gibbs 
5  Gas chromatographic method 
Method 
for phenol  Reference 
determination 
1 +  Deichmann and Schafer, 1942 
1  Walkley et al., 1961; 
Pagnotta et al., 1961 
1  Teisinger and 
Bergerova-F iserova, 1952 
2  Bardodej et al., 1962 
3  Buchwald, 1966 
4  Porteous and Williams, 1949b 
4  Teisinger and 
Bergerova-F iserova, 1952 
4  Docter and Zielhuis, 1967 
5  Van Haaften and Sie, 1965 
5  Lebbe et al., 1966 
Lebbe et al., 1966 
5  Buchet et al., 1972 
5  Sherwood, 1972b 
5  Dirmikis and Darbre, 1974 11 
Gibbs (Rainsford and Davies, 1965). With the latter method, ortho- and metacresol can 
also interfere (Docter and Zielhuis, 1967; Sherwood and Carter, 1970), but since, of the 
three cresol isomers, only p-cresol is normally present in significant quantity in urine 
(Sherwood  and  Carter,  1970),  the  interference of  the  other  two  isomers  is  usually 
minimal.  Buchwald  (1966)  has  proposed  a  modification  of  the  method  of  Theis-
Benedict  using  a stabilized diazonium  salt  of  p-nitroaniline.  The  author claims that 
although ortho- and metacresol interfere with this technique, paracresol does so only 
slightly. 
Gas chromatographic methods (Bakke and Sheline, 1969; Buchet et al., 1972; Dirmikis 
and Darbre,  1974; Lebbe et al.,  1966; Sherwood and Carter,  1970; Van  Haaften and 
Sie, 1965) are certainly superior in specificity to colorimetric methods, though not that 
superior to Gibbs' method (Van Haaften and Sie, 1965). Gas chromatographic methods 
are not only very specific, but also very precise when used with an internal standard 
(Buchet et al.,  1972). Whatever the method used,  it is  necessary to control that the 
hydrolysis of conjugated phenol is complete before extraction. Enzymatic hydrolysis 
seems to be the method of choice. 
A summary of control values reported in the literature for phenol concentration in urine 
by  persons who  have  not been  occupationally exposed  to benzene  is  presented  in 
Table 3. 
It is obvious that the Theis-Benedict method gives results which are too high due to p-
cresol interference. It is known that p-cresol, which is not a metabolite of benzene, can 
amount to up  to 58°/o  of  "total phenols" in  urine (Van  Haaften and  Sie,  1965).  One 
must conclude that the colorimetric method of Theis and  Benedict cannot be  relied 
upon for detecting slight exposure to benzene. Since phenolic compounds other than 
p-cresol are only found in minute quantities in normal urine, the results obtained with 
Gibbs' method are rather close to those obtained by gas chromatography. 
Considering only the results obtained with the last two techniques, it can be concluded 
that in persons non-occupationally exposed to benzene, phenol concentration in urine 
does not exceed 20 mg/1. 
The  results  of  studies  which  have  attempted  to  correlate  benzene  exposure  with 
urinary phenol excretion are presented in graph form in  Fig.  2,  where the regression 
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Figure 2- Relationship between the phenol concentration in post shift urine samples and benzene 
exposure. Each point represents the mean value found in a group of workers. See Table 
4.  Phenol was determined by the method of Gibbs (X) or by gas chromatography(*) 12 
Table IV - Relationship between benzene exposure and phenol in urine (Colorimetric 
method of Gibbs and gas chromatography technique) 
Total 
Concentration  Concentration 
Number of  Benzene  Duration  phenol-urine  phenol-urine 
subjects  cone. (ppm)  expos. (hrs.) 
expos. 
before exposure  after exposure 
(C.t.) 
(mg/1)  (A)  (mg/1)  (B) 
43  <10  8  - 28 (12- 44)  33 ( 19- 74) 
10  7- 15  8  ::::::as  52 (24- 144)  87 (14- 176) 
8  12- 15  8  ::::::108  55 (37- 98)  100 (60- 195) 
8  7.5-50 (24)  8  ::::::192  37 (25- 46)  74 (52- 124) 
7  40-60  8  ::::::400  60 (41  - 91)  126 (61- 310) 
6  10-70  8  ::::::320  37 (21  -56)  129 (50- 254) 
5  10-70  6  ::::::240  79 (59- 177)  140 (107- 210) 
5  20-80  8  ::::::400  68 (52- 111)  140 (87 - 224) 
14  25-150  5-6  ::=::::480  39 (19- 69)  177 (113- 278) 
3  >500  1  >500  - 132 (82- 188) 
10  0.55  5. 1 ( 1. 5 - 14.4)  5.1  (2.1  -14.7) 
10  1.31  4.9 (0.3- 12.5)  6.5 ( 1.6 - 23.4) 
10  10.20  8.5 (2.2- 32)  15.4 (5.9 - 39.2) 
1  25  4 1/2  115  ±6  50 
5  0.52  5.3  2.8  2.8 (1- 5)  9.8 (5- 18) 
2  2.15  3  6.45  1.5 ( 1 - 2)  5.5 (5-6) 
2  2.0  9.4  ±5  12.0 (9- 15) 
1  20.0  114.0  ±a  71.0 
1  100  50 
20 
Table IV (cont.d) -Relationship between benzene exposure and phenol  in urine (Colorimetric) 
method of Gibbs and gas chromatography technique) 
Time of urine  (B)- (A) 
Methods 
for phenol  Remarks  Reference 
sampling  (mg/1) 
determination 
5  Gibbs  Atmoshperic benzene  Rainsford and 
35  Gibbs  concentration determined  Davies,  1965 
45  Gibbs  by spot samples during 
Immediately 
37  Gibbs  the shift 
66  Gibbs 
after 
92  Gibbs 
exposure 
61  Gibbs 
72  Gibbs 
138  Gibbs 
- Gibbs 
0  Chromatog.  Personal sampler  Berlin et al., 1975 
1.6  Chromatog.  Personal sampler 
6.9  Chromatog.  Personal sampler 
End of  ±44  Chromatog.  Sedentary subject (lab  Sherwood and 
exposure  Chromatog.  exposure)  Carter. 1970 
End of  7 (4- 15)  Chromatog.  Personal  sampler  Parkinson, 1975 
exposure  4  Chromatog.  Personal sampler 
End of  7  Chromatog.  Personal sampler  Sherwood, 1972b 
exposure  63  Chromatog.  Personal sampler 
End expos.  Chromatog.  Personal sampler  Sherwood. 1976 
16h after 
exposure 13 
line  proposed  by  Teisinger  and  Bergerova-Fiserova  (1955)  has  been  reproduced. 
These  results  are also  summarized  in  Table  4.  Only  the  results  obtained  with  the 
colorimetric technique of Gibbs or by gas chromatography have been presented in this 
table, since, as we have indicated above, they are comparable. The results have also 
been  presented  in  graph  form,  i.e.  Fig.  2 and  Fig.  3.  Fig.  3 shows  the  relationship 
between the change in urine phenol concentration during exposure to benzene and the 
concentration  of  benzene  in  air.  Although  the  data  are  derived  from  different 
investigations, they clearly indicate that on a group basis there is a highly significant 
correlation (r  = 0.93; p less than 0.001) between exposure to benzene (C.t.) and the 
concentration of phenol found in a urine sample collected at the end of exposure. 
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Figure 3- Relationship between change in urine phenol concentration during exposure to benzene 
and concentration of benzene in air.  Each point represents the mean value found in a 
group of workers. See Table 3.  Phenol was determined by the method of Gibbs (X) or 
by gas chromatography ( * l 
These results suggest for a 6 hour exposure to a benzene level of approximately the 
current ACGIH (American Conference of Governmental Industrial Hygienists) TLV (10 
ppm),  the  average  phenol  concentration  in  the  postshift  urine  samples  would  be 
around 40 mg/1 (corrected for a specific gravity of 1.016), provided a specific method 
of  analysis  were  used  (Gibbs,  chromatography).  When  the  average  phenol 
concentration exceeds 20 mg/1, exposure to benzene has occurred. 
However,  in  using  20  mg/1  as  the  threshold,  very  slight  exposure  to  benzene  (e.g. 
exposure  to  1  ppm  benzene  which  is  the  time-weighted  average  concentration 
recently proposed by  the American Occupational Safety and  Health Administration) 
may be  overlooked,  since the pre-exposure  level  may be  much  lower.  In  that case, 
comparison  of phenol  concentrations between  pre- and  post-shift samples  may be 
useful, since it seems that in  control individuals there is  no significant difference in 
phenol concentration between morning and afternoon urine samples (Van Haaften and 
Sie, 1965). 
Data  published  by  Bethlehem  Steel  Corporation  (NIOSH,  1974),  Pagnotto  (NIOSH, 
197  4),  Pagnotto  et  al.  (1961)  and  Walkley  et  al.  (1961)  also  indicate  that  urinary 
excretion  of  phenol  has  a  linear  relationship  to  the  atmospheric  concentration  of 
benzene to which workers are exposed. However, these results were obtained with the 
method of Theis and Benedict and the interference of cresol makes interpretation of 
the data for a moderate benzene exposure (less  than  10 ppm) difficult. The  data of 14 
Pagnotto and  Bethlehem  Steel  Corporation  are  published  in  NIOSH  (1974)  and are 
summarized in Table 5. The data published by Walkley et al. (1961) are reproduced in 
Fig. 4. It is evident that below an exposure level of 10 ppm (C.t. less than 60 ppm x h) no 
clear change  in  urinary metabolite excretion can  be  demonstrated when  using  the 
Theis-Benedict technique, probably because of p-cresol interference. 
Table V- Summary of data published by Pagnotta and Bethlehem Steel Corporation 
Sampling (hr)  4-5 
ppm  100  200 
Uncorrected  Mean  3-09  8- 19 
(mg/ml)  SD  0-70  2-62 
Corrected  Mean  2-81  5-85 
(mg/ml)  SD  0-66  1-24 
Rate  Mean  3- 10  4-61 
(mg/min)  SD  0-84  0-80 
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Figure 4- Relationship between phenol concentration in  post-shift urine sample and benzene 
exposure. Phenol was determined by the method of Theis-Benedict. Data are from 
Walkley et al., (1961) 
The  ingestion of  phenacetin,  caffein,  saccharin, aspirin and salicylic acid does not 
affect the excretion of phenol (Docter and Zielhuis, 1967; Walkley et al., 1961 ). 
It  has  been  stated that  in  non-exposed subjects there is  no difference in  excretion 
between the sexes, not between smokers and non-smokers; the concentrations in the 
morning and afternoon do not differ significantly (Van Haaften and Sie, 1965). 
There are, however, several factors which influence phenol excretion. 15 
Dermal application of phenol-containing preparations, exposure to phenol itself, some 
gastrointestinal  disorders  favouring  the  bacterial  degradation  of  tyrosine  and 
phenylalanine (Duran et al.,  1973) and ingestion of phenylsalicylate containing drugs 
(Fishbeck  et al.,  1975);  Kociba. et  al.,  1976)  increase urinary phenol  concentration 
(Lauwerys, 1975). 
The proportion of benzene eliminated as phenol increases after ethanol consumption 
(Sherwood, 1976). 
In  summary, on  a group basis the following  relationship between benzene exposure 
and  phenol  excretion  can  be  proposed  if  a  specific  method  is  used  for  phenol 
determination in urine. 
A phenol concentration exceeding 20 mg/1  at the end of the working period suggests 
that  workers  have  been  exposed  to  benzene,  at  least  if  Gibbs'  method  or  a  gas 
chromatographic method is  used  for phenol  determination and  if the other circum-
stances causing increased phenol excretion (see above) have been excluded. 
Table VI - Relationship between benzene exposure and phenol excretion 
Benzene exposure (C.t.)  (ppm x h) 
0 
40++ 
80 
100 
200 
+  Corrected for a S.G.:  1016 
++ 10ppmfor4hours 
Phenol concentration in urine collected at 
the end of the working day {mg/1) + 
<2o 
30-35 
45-50 
50-55 
85-90 
Concentrations of Benzene in Exhaled Air 
The  usefulness  of  this  biological  method  was  primarily  investigated  by  Sherwood. 
Elimination  curves  for  benzene  in  exhaled  air,  initially  obtained  by  Sherwood  and 
Carter (1970) and Sherwood (1972a), demonstrated a two or more phase elimination 
process comprising a rapid phase with a half-time in  the vicinity of 1 hour and a low 
phase  with  a  half-time  of  1  day  or  more.  However,  results  recently  obtained  by 
Sherwood (1976) showed three distinct phases of elimination : a very  rapidly falling 
rate during the first one or two hours after exposure, a less rapid fall over the next few 
hours and then a steady decline to natural background levels over a period of as much 
as 70 hours. 
During the first period, the concentration/time relationship is not logarithmically linear, 
and according to Sherwood (1976),  it is likely that several compartments of the body 
contribute during  this  period.  The  second  period,  which  may define the  release  of 
benzene from lean tissues, is generally marked by a half-life of 3 to 4 hours. The third 
period, which may indicate loss of benzene from fatty tissues,  has  a characteristic 
half-life of between 20 and 30 hours. 
As  in  the  case  of  many  volatile  solvents,  it  is  to be  expected  that  the  content  of 
benzene in exhaled air on the morning following exposure best reflects the integrated 
exposure, i.e. exposure-dose (ppm x h), during the preceding day. The last parameter 
may therefore be a good index of the risk of chronic disease (Sherwood, 1972a). Two 
methods have been developed for sampling exhaled air: breath sampling tubes, and 
breath sampling respirator (Sherwood and Carter, 1970). Sherwood (1972a) has briefly 
listed the advantages and disadvantages of both methods. 
ccThe  former (sampling  tube)  has  the  advantage of instantaneous  collection, 
complete absence of chemical pre-treatment before gas chromatography and 16 
ready collection of duplicate samples. Although the latter requires a 10 minute 
sampling period for each  operator,  it provides a more consistent measure of 
elimination, as all exhaled breath over the period is sampled and it reduces the 
risk of interference from ambient benzene vapour.» 
The  results obtained by several authors who measured benzene in  exhaled air have 
been tabulated (see Table 7).  Results found 16 hours after the end of exposure (pre-
shift sample) are plotted in Fig. 5. Although the results do not allow any firm conclusion 
to be drawn (sometimes only 1 subject per experiment) they suggest that an  8 hour 
exposure to  10 ppm benzene produces a benzene concentration in  breath of around 
0.12 ppm 16 hours after the end of exposure. 
Table VII - Benzene in exhaled air 
Benzene in exhaled air (ppm) 
Number  Benzene  DuratiOn  Total  During  After 
of  cone.  of expos.  expos.  exposure  exposure  Remarks  References 
subjects  (ppm)  (h)  (ppm x h)  Cone.  T1me  Cone. 
8  - - Control  0 013  - 0013  Field study on workers  Berlin et al  . 1975 
10  - - 1 31  - Vanable  0 04  (phys1cal activity) 
16 h  003 
10  - - 10.20  - End expos  043 
16 h  0.11 
10  - - 05  - End expos  0.08 
16 h  0.04 
1  25  45  115  - End expos.  2.0  Sedentary subject  Sherwood and 
16 h  02  Carter, 1970 
- - - 200  - 16 h  03  - Barretta + 
- - - 182  - 16 h  013  Bla1r +  -
10  1 44  07  1  - End of  0 41  F 1eld  study  Park1nson, 1975 
expos 
2  20  - 94  - End of  0.16  F1eld  study  Sherwood, 1972b 
expos. 
1  200  - 114  - End expos  0 84  F 1eld  study  Sherwood, 1972b 
16 h  019 
3  26 5-28 5  6  159-171  - 17 h  0 06-0 34  Volunteer study  Hunter and Bla1r, 
1972 
1  24 6  3-4  73 8-98 4  - End of  12 3-13 5  Volunteer study  Hunter and Blair. 
expos  1972 
1  - - 100  - 16 h  0  15  Sedentary subject  Sherwood, 1976 
+ = C1ted  by Sherwood and Carter, 1970 
For routine monitoring, Sherwood (1971)  has proposed taking samples at the end of 
the work shift and analysing them promptly. Any follow-up samples needed can then 
be taken before the next shift commences, which will allow a better estimation of the 
integrated exposure during the preceding day. 
Sherwood and Carter (1970) have also indicated that if the longer half-life of one day 
(slow phase of elimination) is  confirmed, some accumulation of benzene may occur 
over a working week when exposure is repeated. According to their data, after 5 days 
sedentary exposure to 115 ppm x h/day, concentration in breath on the morning of the 
sixth day would be twice that of the second morning, that is, about 0.4-0.3 ppm. 
Sherwood  (1976)  has. also  reported  that  ethyl  alcohol  could  accelerate  benzene 
elimination in  exhaled air and as  phenol  in  urine. The  same author has also found a 
good correlation (0.75 to 0.94} between phenol in  urine and benzene in breath for the 
period of 20 hours following the end of the exposure. 
In summary, determination of benzene in exhaled air is certainly a valuable method of 
confirming exposure to benzene.  It is  highly sensitive and more specific than phenol 
determination. It may, however, be  relevant to stress that benzene is present in very 
high  concentrations  in  cigarette smoke (47  to  64  ppm)  (Egle  and  Gochberg,  1976; 
Newsone et al., 1965}. Therefore, although determination of benzene in exhaled air is 
specific, its detection does not necessarily imply exposure to chemicals containing 
benzene.  This  may explain  the  results of Berlin et al.  (1975},  who found benzene  in 
exhaled air of control workers (although the authors suggest that it mainly derives from 
motor fuel). 
More  experimental  work  is  required  to validate  the  correlation  between  integrated 
exposure to benzene (ppm  x h)  and  its concentration in  exhaled air on  the  morning 
following exposure. 17 
Concentration of Benzene in Blood 
The  measurement  of  benzene  in  blood  has  rarely  been  studied  as  a  method  of 
evaluating exposure (Truhaut, 1968). It is likely, however, that benzene in blood follows 
the same pattern of change as that in breath, with which it is in equilibrium. 
Sate et al.  (1975) exposed three volunteers to 25 ppm benzene for two hours. At the 
end  of  the  exposure  period  benzene  in  blood  was  approximately  200  /Lg/1  and 
decreased up to about 10 /Lg/1  5 hours after the end of exposure. Gas chromatography 
techniques have been reported for detecting benzene concentration in blood (Angerer 
et al., 1973; Sate et al., 1975; Snyder et al., 1975; Szadkowski et al., 1971; Withey and 
Martin, 1974). 
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Figure 5- Relationship between benzene exposure and benzene concentration in exaled air  16 
hr after the end of exposure 
Cytogenetic Studies 
Several cytogenetic studies have confirmed the mutagenicity of benzene. Berlin et al. 
(1975)  have  recently  investigated  the  frequency  of  chromosome  aberrations  in 
peripheral  lymphocytes  of  workers  currently exposed  to benzene.  Their  results are 
summarized in Table 8. 
The  road  tanker drivers (current  exposure  1.31  ppm)  show  a greater proportion  of 
chromosome damage than do individuals from the other two occupational groups. Ship 
tanker crews who sustain the highest current exposure do  not,  however, have such 
high levels of chromosome damages. The authors stress the point that these workers 
are young and the labour turnover in  these coastal tankers is  high. According to the 
authors, the highest long term integrated exposure is to be found among  road tanker 
drivers.  The  authors  recognize  that  they  cannot  conclude  with  certainty  that  the 
chromosome damage was caused by benzene exposure, since petrol contains many 
other  components  that  could  conceivably  give  rise  to  such  damage.  Previous 
cytogenetic  studies  have  demonstrated  that  benzene  can  cause  chromosomal 
aberrations in man, but the integrated exposure of the workers could not be estimated 
in any of them. The results of these cytogenetic studies are summarized in Table 9. 
At present, cytogenetic studies are possibly useful in confirming previous exposure to 
benzene if the  influence of other physical and chemical agents on  chromosomes is 
also  taken  into  account.  It  would  be  interesting  to  know  whether  chromosomal 
aberrations  are  precursor signs  of  haematological  changes  and  whether  individual 18 
susceptibility plays a role in  the development of these chromosomal changes.  In the 
latter case,  such  tests  would  have  a place  in  the  routine  screening  of  workers  to 
benzene. 
Table V Ill - Frequency of chromosome aberrations in peripheral lymphocytes 
Estimation of  % of cells with  %of cells with 
Group  No.  Mean age  current exposure  chromosome and  chromosome type  to benzene  chromatid-type 
(C.t.) (ppm)  aberrations  aberrations 
Road  11  45.1  1.31  11.5 +  2.2 + 
tanker 
drivers 
Ship  9  30.7  10.20  5.3  1.0 
tanker 
crews 
Petrol  9  42.5  0.5  6.1  0.4 
station 
I 
staff 
+  .  . .  .  =  stgntftcantly dtfferent from the two other groups 
From Berlin et al  , 1975 
Table IX- Cytogenetic studies 
I  % of cells woth  % of cells with 
chromosome and 
Group  !  No.  Age range (yr)  chromosome  chromatid  References 
j 
aberrations  aberrations 
Workers examoned  2 yr after exposure  20  25-64  25  Though et al , 1970 
to benzene for 1 - 20 yr  I 
On sote controls  5  1.0 
Other controls  38  1 4 
I 
I 
Workers examoned  14- 15 yr after  10  I  36-54  2.28  Forn1 et al  , 1971a 
exposure to benzene tor 1 · 22 yr 
Controls  34 
i  0.7 
Workers studoed  1 · 18 yr after  !  25  21.61 
I 
311  Forno et al .. 1971b 
recovery from benzene pooson1ng 
Controls  25  0 53 
Refonery workers exposed to benzene  9  104  Hartwich and 
for 3 to 7 yr  Schwanotz, 1972 
Controls (blood donors)  51 
i 
Road tanker drovers  I  11  27 -64 
I 
2.2  11  5  Berlin et al., 1975 
I 
Shop tanker crews  !  9  17 . 62  0.2  53 
Petrol statoon staff  j 9  I  26 -65  0.2  6  1 
Peripheral Blood Examination and Other Biological Tests 
It  is  known  that  periodic  haematologic  testing  may  fail  to  reveal  chronic  benzene 
poisoning  at  a stage when  the  damage done  to  the  blood producing  organs  is  still 
reversible  (Van  Haaften  and  Sie,  1965).  Furthermore,  there  is  no  quantitative 
relationship between intensity of exposure and response. Thus these tests can only be 
used  to detect a lesion  in  exposed  workers,  but cannot be  considered  as  sensitive 
enough for the early detection of excessive exposure. 
Girard  et  al.  (1970)  have  reported  that  benzene  and  toluene  exposure  reduces 
leukocyte  alkaline  phosphatase  activity.  A  reduction  of  the  plasma  levels  of  the 
immunoglobulins lgG and lgA and an increase in the level of lgM have also been found 
in workers exposed to benzene (Lange et al., 1973). The specificity and the sensitivity 
of  these  tests  are,  however,  unknown.  Presently  they  cannot  be  proposed  for 
screening workers potentially exposed to benzene. 19 
Conclusions 
Among  the  tests  which  have  been  proposed  for  evaluating  current  exposure  to 
benzene,  two appear to have  some  practical application: determination of  the  total 
phenol  concentration  in  urine  and  measurement  of  the  benzene  concentration  in 
exhaled air. 
The  limitations  of  these  tests  must,  however,  be  kept  in  mind.  When  phenol  is 
measured with a specific method, any value exceeding 20 mg/1,  for example in urine 
collected at the end of the work shift, indicates exposure to benzene. That is, if other 
causes of increased phenol excretion have been excluded. 
In workers with normally low urinary phenol excretion, slight exposure to benzene (C.t. 
less than  10 ppm  x h)  may not be detected by measuring phenol  in  a postshift urine 
sample alone.  Increased sensitivity can be obtained by comparing the concentration 
of phenol in pre- and postshift urine samples. 
When benzene exposure is very low (C.t.  less than  1 ppm, i.e. 0.15 ppm for 8 hours), 
this  technique  is  not  sensitive  enough  for  confirming  exposure.  For  integrated 
exposure exceeding 10 ppm  x h (C.t.), the correlation between phenol excretion and 
benzene exposure is only valid on a group basis. It has been estimated that in a group 
of workers exposed to 10 ppm benzene for 8 hours, the mean phenol concentration in 
urine samples collected at the end of the exposure period would amount to 45-50 mg/1 
(S.G. 1  .016). 
The  determination  of  benzene  in  exhaled  breath  is  a  very  specific  and  sensitive 
method  for  confirming  exposure  to  benzene.  However,  not  enough  data  exists  to 
correlate benzene concentration in exhaled air with integrated exposure. It must also 
be  kept  in  mind  that  since benzene  is  present  in  cigarette smoke,  its  detection  in 
exhaled breath does not necessarily imply occupational exposure to benzene. 
Nevertheless, a benzene concentration in breath around 0.12 ppm, detected 16 hours 
after the end of exposure, is proposed as a tentative biological threshold resulting from 
an 8 hour exposure to 10 ppm benzene. 
Peripheral  blood analysis  of workers exposed to benzene  is  not  useful  as  a test  of 
exposure, but can be used to detect those who might be particularly susceptible to the 
myelotoxic action of benzene. 
Further  investigations  are  required  to  define  the  usefulness  of  cytogenetic 
investigations in the rq.utine control of workers exposed to benzene. 
Research Needs 
The following are recommendations for further research : 
Further  investigation  of  the  possibility of  determining  benzene  concentration  in 
exhaled air for evaluating the intensity of exposure; 
Epidemiological studies to determine the  level  of long-term exposure to benzene 
not associated with chromosomal aberration and  evaluation of these changes as 
possible precursor signs of haematological disorders; 
- Study of individual variability in  susceptibility to benzene to help identify subjects 
potentially more at risk when exposed; 
Investigation of the potential action of benzene on  the immunological defences of 
the  organism  with  a  view  to  the  development  of  biological  tests  for  the  early 
detection of the toxic action of benzene; 
Basic investigation of the interaction of benzene metabolites with critical cellular 
sites as relevant for the detection of excessive exposure. 20 
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Summary 
Cadmium is  a metal widely used in industry.  In  human exposure the two main target 
organs are the kidney and the lung. Still uncertain is the carcinogenic effect. 
The  main  route  of  absorption  in  occupational  exposure  is  the  respiratory  tract. 
Cadmium  is  retained  in  the  body,  having  a calculated  half-life  of  10-20 years.  It  is 
principally excreted with urine. 
For the biological monitoring of cadmium-exposed subjects both indicators of internal 
dose and indicators of effect are available. 
Cadmium  concentration  in  urine  mainly  reflects  body  burden  at  low  exposure 
conditions and in absence of renal damage. Cadmium concentration in  blood mainly 
reflects  recent  exposure.  The  most  sensitive  indicators of  effect are  urinary beta2-
microglobulin  and  retinol-binding  protein,  which  enable  detection  of  early  tubular 
proteinuria.  Electrophoresis  of  urinary  proteins  is  also  useful,  because  it  permits 
distinguishing between proteinuria of tubular and  of glomerular type,  the  latter has 
been  also described  in  cadmium-exposed  subjects.  Therefore  also the  quantitative 
determination of high molecular weight proteins, such as albumin and transferrin, may 
be  useful.  It is  uncertain if the above mentioned indicators of effect are sufficient to 
detect a renal damage, which is still reversible. 
As  an  "operative limit value" for CdU  10 p.g/g  creat. has been suggested in  order to 
prevent reaching critical concentration in kidney cortex. 
No sufficient data are at present available for setting limit values for CdB and for the 
various indicators of effect. 
Abbreviations 
CdU 
CdB 
CdA 
TCA 
SSA 
beta2-MG 
RBP 
MT 
cadmium concentration in urine 
cadmium concentration in blood 
cadmium concentration in air 
trichloroacetic acid 
sulphosalicilic acid 
beta2 microglobulin 
retinol-binding protein 
metallothionein 27 
Cadmium 
Chemical and physical properties 
Cadmium  is  a silver-white, soft metal, symbol Cd,  atomic number 48,  atomic weight 
112.4, specific gravity 8.6, melting point 320.9°C, boiling point 765°C. 
Starting from temperatures of 400-500°C there are considerable vapour losses with 
the  consequent  formation  of  cadmium  oxide.  Cadmium  has  a valence  + 2.  Of  the 
many  inorganic cadmium compounds, several are quite soluble in water, e.g. fluoride, 
chloride, acetate and sulphate, whereas oxide, sulphide and carbonate are insoluble. 
Cadmium  also  forms  organic  compounds,  but  these  are  rather  unstable  in 
environmental conditions. 
Cadmium is found in nature mainly together with zinc in the form of sulphide deposits 
(greenockite); cadmium-zinc ratio in these minerals ranges from 1:100 to 1:1000. 
Cadmium production is constantly growing; in Europe it has risen from 216,900 tons in 
1966  to  585,000  tons  in  1977;  and  consumption  also,  though  considering  trade 
fluctuations, has an increasing trend (Stubbs, 1979). 
The framework Directive of EEC (November 1980) considers cadmium as a toxic agent 
from  the  workplace  view  point,  and  the  Commission  will  prepare  an  individual 
directive. 
Chronic effects in humans 
The lungs and kidneys are the two target organs after long-term exposure to cadmium 
(Friberg, 1950). 
However,  data concerning  occupationally exposed  workers,  as  well  as  the  general 
population of cadmium polluted areas suggest that the kidney is the "critical organ" 
(Nordberg, 1976). 
Kidney damage is  classically characterized by  a tubular proteinuria (Friberg,  1948). 
There is an increased urinary excretion of low molecular weight proteins, coming from 
the  plasma,  due  to  an  impaired  reabsorption  (Piscator,  1961 ).  More  recent 
investigations  indicate  that  the  cadmium  proteinuria  may  consist  not  only  in  the 
tubular proteinuria, but also in a proteinuria of glomerular type (Bernard et al., 1976). 
The  literature  mainly  reports  cadmium  toxicity  as  follows:  cadmium  bound  with 
metallothionein is filtered through the glomeruli. Protein is normally reabsorbed in the 
proximal tubules and metabolized, and the absorbed metal is bound in the tubular cells 
with other metallothionein. When more cadmium accumulates in the kidney than can 
be bound by metallothionein, cadmium then exchanges with zinc in enzymes involved 
in the reabsorption and catabolism of proteins; this may cause tubular proteinuria and 
tubular damage (Nordberg, 1972; Friberg et al., 197  4). 
In  intense and  prolonged  exposure conditions,  lung  disturbances may  occur.  Early 
investigations reported  emphysema (Baader,  1951;  Kazantzis  et al.,  1963);  in  more 
recent studies only a mild obstructive syndrome has been found (Materne et al., 1975; 
Stanescu et al., 1977). 
Cadmium can provoke bone lesions which are similar to osteomalacia; it is yet to be 
demonstrated whether they are directly caused by the action of the metal on the bone 
tissue, or secondary to the renal  damage possibly associated with a disturbance of 
vitamin-D metabolism (Lauwerys, 1978). 28 
The  renal disturbances may also affect the handling of calcium and phosphorus with 
possible formations of stones (Way-Yee Chan and Rennert, 1981 ). 
In  workers excessively exposed  to cadmium,  slight hypochromic anemia (Tsushiya, 
1967), modest functional liver disturbances (Friberg, 1950), and anosmia (Adams and 
Crabtree, 1966) have been described. Actually the hypertensive action of cadmium in 
humans is still controversial, and further studies are required (Friberg, 1979). 
A carcinogenic effect of cadmium was  first suspected  in  1965 after the  report of 5 
cancer cases in 7  4 cadmium exposed workers; 3 were prostate cancers (Potts, 1965). 
On  the  basis  of  the  few available  data,  IARC  (1978)  concluded  that  "occupational 
exposure to cadmium in some form (possibly the oxide) increases the risk of prostate 
cancer in  man.  In  addition, one of these studies suggests an  increase of respiratory 
tract cancer''. 
According to Piscator (1981 a) the role of cadmium in the development of cancer of the 
prostate  is  still  controversial,  also  with  regard  to  the  complex  ethiology  of  this 
neoplasm, and further investigations are necessary, however. 
Metabolism 
Absorption 
The  respiratory and  gastrointestinal tracts are the  two main  routes of absorption of 
cadmium in man. Percutaneous absorption is practically negligible. 
For the respiratory route in test animals, an  absorption ranging from 1  0°/o  to 40% of 
the inhaled cadmium dose has been observed. The variation depends upon the particle 
size and the chemical form of cadmium.  For example, cadmium oxide and cadmium 
chloride are more readily absorbed than cadmium sulphide (Poots et al.,  1950; Princi 
and Geever, 1950). 
There  are  no  human  data  for  the  respiratory  absorption  of  cadmium  in  working 
conditions. Considering the cadmium concentration in cigarettes and autopsy data of 
smokers, an  absorption  rate of 25% - 50% has been  calculated (Lewis et  al.,  1972; 
Friberg et al., 1974; Elinder et al., 1976). 
Gastrointestinal absorption in test animals is lower than 1  0°/o  of the oral dose, and is 
about  2% in  many  cases.  The  absorption  is  considerably  increased  when  there  is 
calcium, protein,  iron  or  zinc  deficiency (Suzuki  et al.,  1969;  Hamilton and  Valberg, 
197  4; Spivey Fox et al., 1979). 
The absorption is higher in young rats and mice than in adults (Nordberg, 1975; Kostial 
et al., 1979). 
In  humans the gastrointestinal absorption rate varies from 1.5% to 29% (Nomiyama, 
1980), and is also influenced by the amount of the iron depots (Flanagan et al., 1978). 
Distribution 
Blood 
After  absorption  cadmium  is  transported  through  the  organism  by  the  blood 
circulation. 
In  rats,  after  a  single  injection,  cadmium  is  found  mainly  in  the  plasma  and  it 
undergoes  a rapid  clearance (Shaikh  and  Lucis,  1972). After  repeated  injections in 
rabbits the level of cadmium in blood increases progressively until a ceiling is reached 
(Friberg, 1955); in this situation cadmium is contained prevalently in the erythrocytes 
(Truhaut and Boudene, 1954). 
In man blood cadmium is found mainly in the erythrocytes (Szadkowsky, 1972; Wilden, 
1973). However, the ratio between cadmium in plasma and cadmium in red blood cells 
decreases with the  rising  of the  concentration in  whole blood;  in  cadmium exposed 
workers Bernard et al.  (1977) have found 13°/o  of the circulating cadmium in  plasma 
agai.nst 31% in the control group. 
Most  of  the  erythrocytic  cadmium  is  probably  bound  to  metallothionein  (Nordberg, 
1972). 
More  details  on  the  significance  of cadmium  in  blood  in  man  will  be  given  in  the 
paragraph "Indicators of Internal Dose". 29 
Tissues 
Cadmium  accumulates  in  the  body,  and  the  body  burden  in  non-occupationally 
exposed subjects in Europe anq North America has been estimated as 9.5 mg- 40 mg 
(Lauwerys, 1978). 
Cadmium deposit increases with age and is greater in smokers (Lauwerys, 1979). 
The  newborn  tissues  are  almost  free  of  cadmium,  due  to  the  barrier  role  of  the 
placenta (Roels et al.,  1978). However, in blood and urine the metal is always present 
(Baglan  et al., 1974; Odone et al., 1982). 
a)  Liver and kidneys 
In  chronic  exposure  experiments  in  animals  about  75%  of  cadmium  injected  or 
absorbed by the intestine is found in liver and kidney (Friberg, 1979). 
ln  humans,  after  long-term  low-level  exposure,  about  40%  - 80°/o  of  the  retained 
cadmium is  found  in  the  liver and kidneys,  and about one  third in  the  kidney alone 
(Friberg, 1974). In these organs, cadmium is mainly bound to metallothionein. 
Metallothionein is a low molecular weight protein (PM 1  0,000- 12.000) with high cystetne restdues 
content and deficient in  aromatic amino acids (Kagt  and  Vallee.  1961;  Margoshes and  Vallee. 
1957). 
In  man,  metallothionein has  been found  not only  tn  ltver.  ktdneys  and  erythrocytes. but  also  m 
heart, brain, testis and skin epithelial cells (Lucis et al..  1970).  In  antmals. the protem  has  been 
detected also  in  placenta,  spleen.  and  in  intestinal  mucosa  (Wolkowsky.  1974.  Amacher  and 
Ewing,  1975).  Not  only  cadmium  but  other  metals,  m particular  Zn.  Cu.  Hg.  Ag.  Sn  can  bmd 
metallothionein  in  vivo  (Sabbioni  and  Marafante,  1975a).  Cadmtum  can  induce  synthesis  of 
metallothionein in  kidneys,  liver, and intestine (Piotrowsky et al..  1974; Sabbiont and  Marafante. 
1975b; Sugawara, 1975; Bryan et al., 1979). In lungs and kidneys of rats metallothionem synthests 
is stimulated also by zinc (Oberdoerster and Ktirdel, 1981 ).  Metallothionein is filtered through the 
glomeruli and then reabsorbed in the proximal tubules. 
After a single injection of CdCI2 in mice, the greatest concentration is found in the ltver and a small 
amount  in  the  kidney.  On  the  contrary,  after  administration  of  cadmium-thtonem  a  htgher 
concentration is measured in the kidney than in the liver (Nordberg et al., 1975) 
Cadmium  level  in  the  kidney  and  in  particular  in  the  renal  cortex  increases 
progressively with age (Friberg et al., 1974). This depends not only from the amount of 
the metal chronically absorbed, but also from the probable transfer of cadmium from 
other tissues to the kidney (Friberg, 1979). 
It has been observed that in non occupationally exposed subjects when they reach 50-
60 years, the level of cadmium in the kidneys tends to diminish (Schroeder et al., 1967; 
Piscator and Lind, 1972; Miller et al., 1976; Kowal et al., 1  979). Many factors may have 
contributed  in  determining  this  situation,  in  particular,  the  occurrence  of  age-
dependent renal changes (Travis and Maddock, 1980) and the increased exposure of 
the population to cadmium over the last 50 years (Friberg et al., 197  4). 
Smoking significantly increases the level of cadmium in  kidney tissue (Hammer et al., 
1973; Elinder et al., 1976; Ellis et al., 1979). 
Once renal damage has occurred cadmium excretion rises markedly and the level in 
the kidney diminishes (Friberg et al., 1971 ). 
b)  Lungs 
In  non-occupationally exposed subjects, the lungs contain about 2°/o  of the cadmium 
body burden (Schroeder et al., 1967; Sumino et al., 1975). 
The concentration of cadmium in  this organ appears to increase with age (Tipton and 
Shafer, 1964; Friberg et al., 1971) and is also affected by smoking (Lewis et al., 1972). 
c)  Other organs 
Cadmium has been found in various other human organs: muscle, testicles, pancreas, 
etc. (Sumino et al., 1975). In exposed persons the cadmium pancreatic concentration 
is also increased. 
In  bone,  cadmium  concentrations  are  usually  very  low.  Animal  and  human 
observations sul"}qest that cadmium does not easily penetrate into the brain (Sumino et 
al., 1975). 30 
Excretion 
Urinary 
The urinary system is the main route of excretion for cadmium. In non-occupationally 
exposed subjects, daily excretion corresponds to approximately 0.004°/o- 0.015°/o of 
the total body burden (Friberg et al., 1974). 
In animals, after a single dose of cadmium, only a small part of the metal is found in the 
urine  (Miller  et  al.,  1969;  Lucis  et  al.,  1969).  Long-term  experiments  in  rats  have 
demonstrated  a  good  correlation  between  urinary  excretion  and  body  burden  of 
cadmium during the accumulation phase. This phase is followed by a sharp increase in 
cadmium urinary excretion which corresponds to the onset of proteinuria, indicating 
tubular damage (Nordberg, 1972). 
The significance of urinary cadmium excretion in humans will also be discussed in the 
paragraph "Indicators of Internal Dose". 
Fecal 
In  animals the gastrointestinal tract is  an  important route of elimination of absorbed 
cadmium.  In  rabbits  and  rats  before  proteinuria  occurs,  fecal  excretion  is  usually 
higher than urinary excretion (Axelsson and Piscator, 1966). 
No correlation exists between body burden of cadmium and fecal cadmium (Nordberg, 
1972). 
In humans, fecal excretion of cadmium is suggested as being less than 0.1% (Rahola 
et al., 1972); it mainly indicates the amount of ingested cadmium. 
Other routes 
Other  routes  of  excretion  are  less  important  than  urinary  and  fecal  (CEC,  1977). 
Cadmium in hair is hardly useful because of the difficulty of distinguishing endogenous 
cadmium from that deposited on the surface (Nishiyama and Nordberg, 1972). 
A recent  study .reports  markedly higher concentrations of  cadmium  in  the saliva of 
exposed workers as against that of unexposed subjects (Gervais et al., 1981 ). 
Biological half-life 
Mathematical models have been developed for evaluating the metabolism of cadmium 
in  man.  According  to  a  one-compartment  model,  which  considers  only  the  renal 
cortex, a half-life of 20 years has been  calculated (Friberg,  1979). A more elaborate 
eight-compartment model gives shorter half-times (8-14 years) for each compartment 
(Kjellstroem and Nordberg, 1978). 
Critical Organ Concentration 
The  kidney  is  the  criti~al  organ  for  cadmium,  i.e.  the organ which first reaches the 
critical concentration. 
Many  efforts  have  been  undertaken  to  determine  the  critical  concentration  of 
cadmium in renal cortex. 
Friberg et al. (197 4), when relating cadmium concentrations measured in kidney tissue 
obtained  from  autopsies and biopsies of cadmium  exposed  subjects with clinical 
findings  of  tubular  disturbances,  indicate  200  /J.g/g  wet  weight  as  the  critical 
concentration in kidney. 
Experiments  in  rats  and  rabbits  have  shown  functional  and  morphological  kidney 
changes  occurring  at  kidney cortex concentrations of 200-400  /J.g/g  (Bonnell  et  al., 
1960; Axelsson et  al.,  1968; Stowe et al.,  1972).  In  larger animals,  i.e.  monkeys,  a 
critical concentration of 380-470 /J.g/g has been found (Nomiyama, 1980). 
Considering the available data, a WHO group (1977) concluded that in man the critical 
level may be between 100 and 300 /J.g/g, with 200 /J.g/g as the most likely estimate. 
Neutron  activation  analysis  permits in  vivo  measurement of  cadmium  in  liver and 
kidney (Mclellan et  al.,  1975). The  application  of  this  technique  has  been  recently 31 
enabled the construction of a transportable equipment (Vartsky et al., 1977). Until now, 
only a few studies on cadmium workers have been carried out. 
Roels  et  al.  (1979)  have  reported  their conclusion  of  a critical  concentration  lying 
between 200 and 250 p.g/g.  In this study no difference was observed in the cumulative 
frequency distribution of kidney cadmium between normal subjects and subjects with 
kidney  lesions.  This  fact  may  be  explained  with  the  fall  in  kidney  cadmium 
concentration· after  the onset of proteinuria. Moreover in workers with renal damage 
cadmium concentrations in  the liver are markedly higher as against subjects without 
renal damage. These results have been substantially confirmed by the same authors in 
a more recent study (Aoels et al., 1981 ). 
Much the same observations have been reached by Ellis et al. (1981 ),  but on the basis 
of their measurements they have indicated a critical level of 300-400 p.g/g. 
Biological Indicators 
Indicators of internal dose 
Concentration of cadmium in urine 
In  non-occupationally  exposed  subjects,  the  mean  urinary  excretion  - though  with 
some fluctuations- generally does not exceed 1 p.g/g creat. when the analysis is made 
by  atomic absorption spectroscopy (Table  1  ).  In  the  past,  when  the  analyses  were 
conducted  with  less  accurate  methods,  higher  values  were  reported  (Smith  and 
Kench, 1957; lmbus et al., 1963). 
Table I -Some examples of urinary cadmium concentration, determined by AAS, in not 
occupationally exposed subjects 
Country  No.  Mean 
BDR  10  0.98 
s  10  0.39 
U.S.A.  189  0.64 
{Chicago) 
U.S.A.  86  0.59 
{Dallas) 
J  30  4.8 ± 2.9 
{Nagasaki) 
J  30  6.1  ±4.2 
{Akita) 
B  88  0.88 
GB  542  0.52 ±0.46 
NL  34  0.48 00 
I  268  0.75 °
0 
0.56 °
0 
0 
Quoted by Fribergetal., 1971 
00 
Geometric mean 
000 
67% range 
Range  Unit  Reference 
0.34- 1.57  J.J,g/24  h  Lehnert et a  I.. 1  968 
0.05-0.77  J.J,g/24  h  Linman and Lind 
0 
0.02-2.06  J.J,Q/1  Kowal et al., 1979 
0.11  - 2.14  J.J,g/1  Kowal et al.. 1979 
J.J,g/1  Tsushiya et al., 1979 
J.J,g/1  Tsushiya et al., 1979 
0.77- 1.93  J.J,g/g  creat  Buchet et al., 1980 
J.J,g/1  {24 h)  Strehlow and Baltrop, 
1981 
0.21  - 1.06 °
00 
J.J,g/g creat  Wibowo et al., 1982 
0.10-4.50  J.J,g/1  Alessio et al., 1982 
0.08-4.54  J.J,g/g  creat 
Values referred for the general population of Japan are higher, probably due to a more 
intense environmental exposure (Tsushiya, 1978). The urinary excretion of cadmium is 
affected by tobacco smoke. Higher CdU  values are reported in smokers than in  non-
smokers (Eiinder et al., 1978; Kowal et al., 1979; Cohn et al. 1979). 
Age also influences the urinary excretion of cadmium. It has been demonstrated that, 
on  a group basis, CdU  increases with ag·e  (Lauwerys et.  al.,  1976; Tsushiya,  1978; 
Elinder et al., 1978; Kowal et al., 1979; Alessio et al., 1982). 32 
Starting from the sixties CdU  seems  to decrease (Tati  et  al.,  1976).  This  fact is  in 
accordance with the diminution of cadmium  kidney tissue concentration  mentioned 
before (see "Distribution-Tissues"). 
No  statistically  significant  differences  by  sex  have  been  reported  when  urinary 
cadmium  concentration  is  expressed  in  ~tgll.  Adjusting  CdU  per  gram  creatinine 
females present higher values; this is probably due to a difference in urinary creatinine 
excretion in the two sexes (Kowal et al., 1979; Alessio et al., 1982). 
In  occupationally exposed  subjects,  cadmium  excretion varies widely  in  relation  to 
different exposure conditions. 
Smith et al. (1980) analysing 27 workers chronically exposed to cadmium have found a 
significant  correlation  between  the  time-weighted  cumulative  exposure  and  CdU 
(Fig. 1  ). 
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Figure 1 -Association between CdU and Time-Weighted Cumulative Exposure in 3 groups of 
subjects exposed to increasing cadmium concentrations (from Smith et al., 1980) 
Harada (1976)  reports that in  male and  female workers of a battery producing plant, 
average CdU  values  tend  to  increase with  the  airborne concentration of cadmium. 
Increase in CdU  is more marked among workers with more than 6 months exposure, 
although  increases  in  CdU  are  not  infrequent  even  during  the  first  6  months  of 
exposure (Fig.  2). These discrepancies may be explained by different exposure levels. 
Lauwerys  et  al.  (1979a)  have  followed  the  behaviour  of  CdU  in  11  cadmium  salts 
factory workers for about a year after the start of an excessive exposure (CdA values 
110-2125 JLg/m3). They observed three phases in cadmium excretion, i.e. first phase (0-
15 days) with a rapid increase of  up to about 15 JLg/g  creat., a second phase (15-120 
days) of  slower increase followed  by  another phase of  rapid  increase.  It  should  be 
noted that of the examined workers only 4 were newly exposed to cadmium. 
The  same  research  group  has  made a study on  about  200  workers,  subdivided as 
subjects with  "low  expo~ure" and  those  with  "high exposure".  On  the  whole,  the 
airborne cadmium concentration was usually below 90 ~tlm
3 •  In the first group CdU and 
duration of employment were significantly correlated,  and no correlation was found 
between CdU  and CdB.  In  the second group, CdU  and duration of employment were 
not correlated, while a significant correlation was present between CdU and CdB. The 
workers of both  groups all  had  a normal  electrophoretic pattern of urinary proteins 
(Lauwerys et al., 1976). 
They  also  report a slower decrease of CdU  than CdB  in  relation  to the decrease of 
expos)Jre. 
In  retired workers the persistence of rather high CdU  levels has been observed and a 
correlation between CdU levels and length of past cadmium exposure has been found 
(Odone et al., 1982b)). 
Neutron activation has permitted to couple the  in  vivo measurement of cadmium in 
kidney with CdU. In 221  workers without signs of kidney disfunction and with cadmium 
kidney cortex concentrations below the indicated critical level of 200-250 JLglg, a good 
correlation was found between CdU and cadmium in kidney cortex (Fig. 3). The critical 90 
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Figure 2- Relationship between cadmium concentration in air and CdU  in workers with up to 6 
months and more than 6 months of exposure (from Harada, 1976) 
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Figure 3- Relationship between CdU. and Cadmium in  kidney cortex in subjects without kidney 
disfunction (from Lauwerys et al., 1979 b) 
33 
250 34 
level of 200-250 p.g/g in kidney cortex corresponds to a CdU  level of 1  0-15 p.g/g creat. 
(Roels et al., 1979). 
Considering  the  data  reported  above,  it  can  be  concluded  that,  in  low  exposure 
conditions,  with  kidney  cadmium  concentrations  below  the  critical  level,  and  in 
general in absence of signs of kidney impairment, CdU mainly reflects cadmium body 
burden. On the other hand, in high exposure conditions CdU  is prevalently influenced 
by current exposure. 
Concentration of  cadmium in blood 
In non occupationally exposed subjects mean cadmium blood concentrations usually 
do not exceed 0.5 p.g/1 00 ml (Table II). The wide range among the reported values is 
probably mainly determined by the presence of smokers in  the considered groups. It 
has been widely demonstrated that smokers have significantly higher CdB values than 
non smokers (Uiander and Axelsson, 1974; Beevers et al.,  1976; Kowal et al.,  1979; 
Gervais et al.,  1981; Morgan et al.,  1981 ).  CdB  values increase with the number of 
cigarettes smoked (Zielhuis et al., 1977). Smoking less than 10 cigarettes is enough for 
a' significant rise in CdB concentration (Alessio et al.,  1982). Kowal et al. (1979) have 
also observed  that CdB  values  are significantly higher in  present  smokers  than  in 
former smokers. 
Table II -Some examples of blood cadmium concentration, determined by AAS, in not 
occupationally exposed subjects 
Country  No. 
Mean 
pg/100 ml 
U.S.A.  243  0.5 
BDR  18  0.35 
s  150  0.2 
BDR  >500  0.15 
U.S.A.  105  0.12 
(Colorado) 
U.S.A.  168  0.11 
(Chicago) 
B  88  0.23 
NL  34  0.26 
00 
I  268  0.07 
00 
0 
Quoted by Friberg et al., 1971 
00 
Geometric mean 
000 
67% range 
Range  References 
0.5- 14.2  Kubota et al., 1968 
Lehnert 
0 
Piscator 
0 
0.03-0.8  Stoeppler and Brandt, 1978 
0.04-0.69  Wysowsk i et al., 1978 
0.02-0.33  Kowal et al., 1979 
0.02- 1.16  Buchet et al., 1980 
1.81  - 3.95 °
00 
Wibowo et al., 1982 
0.01  -0.32  Alessio et al., 1982 
In smokers a modest but significant correlation has been found between CdB and CdU, 
no correlation in non smokers (Alessio et al., 1982). 
Cadmium blood concentrations are not influenced by age.  No differences have been 
reported by sex (Kowal et al., 1979; Alessio et al., 1982). 
In occupationally exposed subjects cadmium levels in blood are considerably higher 
than in the general population (Lauwerys, 1978). Higher CdB values have been found in 
workers with  elevated  exposure  against  to workers with  lower exposure (Piscator, 
197  4;  Lauwerys  et  al.,  1976).  According  to Harada et al.  (1979)  CdB  undergoes  a 
relatively linear increase in proportion to the airborne cadmium concentration. 
After the start of cadmium exposure CdB increases straight up to. 120 days and then 
levels off (Lauwerys et al.,  1979a). Kjellstroem (1979),  following  17 newly employed 
workers for 1 year, exposed to an average Cd concentration of 50 p.g/m3, found nearly 
the same behaviour for CdB,  but no significant increase of CdU  was noticed. This is 
shown for one worker in Fig. 4; also all the other workers had a similar pattern. 
No correlation has been found between CdB and length of exposure, independently of 
the exposure degree (Friberg et al., 1974; Lauwerys et al., 1976). 
After cessation of exposure,  CdB - though diminishing - may  remain  above  normal 
values  for  a  long  period  (Tsushiya,  1969;  Friberg  et  al.,  1971).  But  as  previously 
referred, it has a more rapid decrease than CdU (Harada et al., 1979).  · 35 
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Figure 4- Cadmium concentration in air (o), blood (e), and  urine ( 6.) of a worker during the 
first year of exposure (from Kjellstroem, 1979) 
The observation that in  currently exposed workers CdB appears to be  unrelated with 
the level of cadmium in the organs (Friberg et al., 1971; Nordberg, 1976) seems to be 
supported  by  recent  results  obtained  with  the  new  atomic  absorption  technique; 
examining 72  cadmium exposed workers, a rather weak correlation has  been  found 
between CdB and cadmium concentration in kidney cortex (Lauwerys et al., 1979b). 
Finally, according to Piscator (1979) it can  be  suggested that CdB  should be  mainly 
considered as an indicator of recent exposure. 
Indicators of effect  ·Proteinuria 
As previously mentioned, the most typical feature of long-term exposure to cadmium is 
proteinuria (Friberg, 1950). 
Proteinuria  is  mainly  represented  by  low  molecular  weight  proteins  and  therefore 
called "tubular proteinuria" (Butler and Flynn, 1958; Piscator, 1962). 
Qualitative-quantitative determinations 
Because of the prevalence of low molecular weight proteins, tubular proteinuria is not 
detected with  the  classic  boiling  or  citric  acid  tests  (Baader,  1951 ).  A  qualitative 
determination is possible using the TCA test or the SSA test, but these methods are not 
sensitive  enough  and  permit  only  the  detection  of  a  fully  developed  proteinuria 
(Friberg, 1979). 
Also, the quantitative determination of urinary proteins with turbidimetric tests or with 
the  Tsushiya-biuret  test  is  not  always  sufficient,  since  the  excretion  of  some  low 
molecular weight proteins might be increased considerably, while the total proteinuria 
is still within the normal range (Piscator, 1972). 
Using the above methods, a correlation between proteinuria and  length of exposure 
has been reported (Tsushiya, 1967). 
Once established, proteinuria persists after cessation of exposure (Piscator, 1962); it 
can also appear many years after exposure has ceased (Bonnell et al., 1959; Friberg et 
al., 1971). On the other hand, it has been reported that proteinuria can be reversible in 
workers no longer exposed to cadmium (Tsushiya, 1976). 
The  onset  of  proteinuria  depends  on  the  degree  of  exposure.  Kjellstroem  (1976) 
analysing the studies on  proteinuria among cadmium exposed subjects published up 
to  1976,  has  concluded  that  tubular  proteinuria  may  develop after  10-20 years  of 
exposure to less than 50 ~tglm
3 CdA. 36 
Low molecular weight proteins- tubular proteinuria 
Quantitative determinations of low molecular weight proteins have been performed in 
cadmium exposed subjects. 
For  routine controls of cadmium exposed subjects beta2-microglobulin, among the 
urinary low modular weight proteins, is at present the most widely used. 
Beta2-MG (PM 11 ,800) was first isolated in urine by Berggard and Bearn in 1968. 
The urinary excretion increases markedly in cases of tubular disfunction, i.e. not only 
in  cadmium  poisoning,  but  also  in  Franconi's  syndrome,  Wilson's  disease,  Balkan 
nephropathy, and  in  general  in  any disease  involving the  immunitary system.  In  the 
past, beta2-MG was determined with immunodiffusion, recently a more sensitive radio-
immunoassay has  been  developed (Evrin  et  al.,  1971 ).  As  to  analysis,  it  has  to  be 
noticed, that if urine pH  is  below 5.5,  beta2-MG  may be degraded (Evrin  and  Wibell, 
1972). 
Average values of beta2-MG  in  urine in  non-exposed subjects are usually below 100 
J.LQ/1,  but discrepancies exist between the reported "upper normal values" (Table Ill). 
This  indicates an  opportunity of establishing preliminarly a reference group,  before 
st~dying exposed subjects. 
Table Ill -Some examples of urinary beta
2 microglobulin concentration, determined by R lA, 
in not occupationally exposed subjects 
"UPPER LIMIT" 
Country  No.  Age  Geometric mean  95% tolerance  Reference 
interval 
s  87 0  44.1 °  841Jg/1  290  Kjellstroem et al., 
p.s.  1023  1977a 
j  40 <?  51-60  61.9 IJQ/g creat  690  Kjellstroem et al., 
1977b 
j  93  50-69  86/Jg/1  700  Kojima et al., 1977 
35 0 58<? 
B  87 0  20-65  71  /JQ/g creat 
00 
200  Buchet et al., 1980 
GB  542 o+ <?  Adults  57 iJQ/1 °
0 
167  Strehlow and Baltrop, 
1981 
GB  203 0  18-55  76 /JQ/1  441  Stewart et al.',  1981 
NL  34 0  20-60  79 iJQ/g creat  161  000  Wibowo et al., 1982 
I  102 o+ <?  38.3 °
0 
67 iJQ/g creat  250  Alessio et al., 1982 
86.21Jg/l  300 
0 
Geometric mean 
00 
Arithmetic mean 
000 
Upper 67% range 
In non occupationally exposed subjects the increase of beta2-MG in urine is associated 
with age (Kitamura,  1976; Tsushiya et al.,  1979).  Data are too scarcely available to 
draw  any  conclusion  on  the  influence  of  sex  and  tobacco  smoke  on  the  urinary 
excretion of beta2-MG in non-exposed individuals. Elevated levels have been reported 
after physical exercise (Kitamura, 1979). 
In cadmium exposed subjects urinary beta2-MG have a higher sensitivity for detecting 
tubular proteinuria in comparison to the qualitative and quantitative methods for total 
proteinuria  and  even  to  some  electrophoretic  techniques  (Shirohishi  et  al.,  1977). 
Cadmium exposed workers, as well as ltai-ltai disease patients, often have 100 to 1000 
times  .higher  urinary  beta2-MG  levels  above  the  normal  range  (Kjellstroem  et  al., 
1977a). 
Kjellstroem et al. (1977b) have  found that in 186 workers of a battery factory, exposed 
to an average CdA concentration of 50 p.g/m3, beta2-MG in urine increase with length of 37 
employment (Fig.  5).  In  these  subjects  after  only  6-12  years  employment  a  major 
prevalence (19%) of increased urinary beta2-MG, referred to an upper limit of 290 #Lg/1, 
was present as against the reference group (3.4°/o). Smokers had a higher prevalence 
rate than non smokers. 
Similarly, in  subjects living in  a cadmium polluted area, an  increasing prevalence of 
high  urinary  beta2-MG  levels  has  been  found  with  increasing  residence  time 
(Kjellstroem et al., 1977a; Kojima et al., 1977). 
Analysing  a  group  of  cadmium  workers  Smith  et  al.  (1980)  have  reported  an 
association between time-weighted cumulative exposure and beta2-Hg in urine . 
Group Cd+ F  • 
100 000  Group X  •  •  Group 0 
50000  •  F  •  •  • 
••  • 
F  ~F 
• •  •  10 000  •  F  •  •  • •  • 
(V)  5000  •  +  F•  N 
0  •  •  F  ••  ••  •  •  • 
Ol 
F 
</)  +  •  8  •  • 
'0  1000  •  •  .l  + 
(l) 
* 
u  +  F  F  ++ 
~  500  • •  • 
0  •  F+ 
290  +  B  u  •  (l)  •  •  •  •  ++•  +  c  ••  ..__  +  .,.  + 
::J 
100  •  • 
.:::::::  e+•  t•  •  A  Ol  84  ••  +  :::t.  •  * 
+  •  F 
50  •  •  c  •  +  •  + 
::J  •  •  ..0  +  e+  !;2  •  •  +  Ol  •  * •  2  • 
~  10  fi:  •  •  en  5  • 
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Figure 5- Relationship between urinary beta2 -microglobul in  concentrations and employment 
time 
A  geom. aver.  in the reference group 
8  =  upper 95% tolerance level  in the reference group (from Kjellstroem et al., 1977 b) 
In  non  occupationally exposed subjects urinary beta2-MG  is  significantly correlated 
with both CdU and CdB (Kjellstroem et al., 1977a). 
Japanese authors are  of the  opinion  that,  in  cadmium  exposure  the  rise  of urinary 
beta2-MG may be not due to tubular impairment, but to an increase of serum beta2-MG 
stimulated by cadmium (Tsushiya et al.  1979; Harada et al., 1979). 
On the other hand, Swedish authors affirmed that the increase of beta2-MG in serum is 
determined by a reduction of the glomerular filtration rate (Kjellstroem and Piscator, 
1979; Piscator, 1981 ). 
In workers who have been retired for many years from cadmium exposure, high urinary 
beta2-MG  levels have still been  reported (Stewart and  Hughes,  1981 ).  Also Tsushiya 
(1976)  referred  the  persistence of moderately increased urinary beta2-MG  levels in 
workers with past exposure to cadmium, though accompanied by the disappearance 
of proteinuria. However, more data are required concerning the behaviour of urinary 
beta2-MG in subjects with past cadmium exposure. 
Also the urinary excretion of another low molecular weight protein, the retinol-binding 
protein (PM  21 ,000), increases in cadmium exposure (Kanai et al., 1971 ).  RBP follows 
the same pattern of excretion than beta2-MG, but offers the advantage of being stable 
in acid urine (Bernard and Lauwerys, 1981 ). The development of a simple non isotopic 
latex immunoassay for the analysis of RBP  in  urine will probably permit in  future a 
greater diffusion of this test (Bernard et al., 1982). 38 
The main question concerning both beta2-MG as well as RBP is to see if they enable 
detection of a still  reversible  renal  disfunction.  More  information in  this  regard  will 
probably  come  by  coupling  the  determinations of beta2-MG  and  RBP  with  neutron 
activation measurements of cadmium in the kidney. 
Also lysozyme (PM  14,400) and  ribonuclease (PM  13, 700) undergo a marked urinary 
excretion in  workers with chronic cadmium exposure (Piscator,  1966;  Adams et al., 
1969). 
The  appearance of aminoaciduria is  considered a late effect of long-term cadmium 
exposure together with glycosuria and phosphaturia (Piscator, 1966). 
As mentioned before, metallothionein is the main binding protein for cadmium, and 
therefore has a role in cadmium toxicity. However, until some years ago no reasonably 
sensitive techniques  were  available for  its determination.  Recently a radioimmuno-
assay with a sufficiently low detection limit has been developed for the analysis of MT 
in human biological fluids (Chang et al., 1980). Only a few studies have been performed 
using  this  test.  In  40  subjects with  occupational  exposure  to  cadmium  of  different 
degree, urinary excretion of MT was augmented in the subjects with higher exposure 
levels. A good correlation was found both between urinary MT and CdU,  urinary MT 
and CdB.  MT concentration in  urine was similar in individuals with and without renal 
damage (Chang et al., 1980). 
In  subjects with  ltai-ltai  disease  higher  urinary MT  levels  have  been  found  than  in 
control subjects (Tohyama et al., 1981 ). 
The  same authors report a significant correlation between urinary MT and  liver and 
kidney  cadmium  levels determined by  neutron  activation  in  workers  of  a cadmium 
producing plant. 
These data seem to indicate that urinary MT has rather to be considered an indicator 
of dose than an indicator of effect. But for a correct interpretation of MT in urine more 
information is necessary, especially in regard to different exposure conditions. 
High molecular weight proteins-glomerular proteinuria 
Electrophoresis  of  urinary proteins has  to  be  considered  a useful  test  in  cadmium 
subjects first, because it enables detecting of early renal disturbances, and  second, 
because it permits distinguishing between tubular and glomerular disfunctions. 
The most frequent electrophoretic pattern in chronic cadmium poisoning is of tubular 
type  (Piscator,  1962;  Adams  et  al.,  1969).  However,  Belgian  authors  have  found 
patterns  of  both  tubular  and  glomerular  type;  quantitative  determinations  have 
demonstrated a significant increase in the urinary excretion of single high  molecular 
weight proteins like albumin and transferrin  (Bernard et al., 1976). The tubular and the 
glomerular  alterations  can  appear  associated  or  independently,  but  without 
chronological order (Bernard et al., 1979). 
Conclusions 
From the foregoing,  it is possible to draw some considerations on the significance of 
the  tests  at  present  available  for  the  biological  monitoring  of  cadmium-exposed 
workers. 
The indicators of internal dose - CdU and CdB- are influenced to a different degree 
by exposure and body burden. 
CdU m_ainly reflects body burden in low exposure conditions and in absence of signs of 
renal damage. At high exposures CdU is principally affected by current exposure. 
CdB may be considered mainly as an indicator of recent exposure than of body burden. 
However, more information in  this regard would derive from the distinction between 
erythrocyte and serum cadmium. 
Considering  the  indicators  of  effect,  qualitative and  quantitative determinations of 
total  proteinuria  permit  only  the  demonstration  of  an  already  developed  renal 
disfunction. 
The determinations of urinary beta2-microglobulin and retinol-binding protein seem to 
be,, until now the  most sensitive test for the detection of  an  early tubular damage. 
However,  uncertainties  exist  concerning  their  specificity  and  their  capability  of 
detecting renal impairment in a reversible stage. 
The  glomerular component of cadmium  proteinuria,  revealed  by  electrophoresis of 
urinary proteins,  can  be  quantified  by  the  determination  of  single  high  molecular 
weight proteins like albumin and transferrin. 
The few available data on the urinary excretion of metallothionein in cadmium-exposed 
subjects seem to indicate that urinary MT has to be regarded as an indicator of dose, 
but more data are needed. 39 
Considering the relationship between CdU and the critical concentration in the kidney 
cortex - generally regarded as 200 p.g/g - a "limit value" for CdU of 10 p.g/g creat. 
can be suggested. For CdB and the different indicators of effect sufficient information 
is not yet available to permit the indication of "limit values". 
Finally it has to be  remarked, that the persistent uncertainty regarding carcinogenic 
activity of cadmium  in  man,  represents  a considerable  limitation  in  the proposal  of 
biological monitoring criteria. 
Research Needs 
Though much progress has been achieved in  the last years, especially performing in 
vivo  measurements  of  cadmium  contents  in  liver  and  kidneys,  many  topics  need 
further investigation for a correct approach to the problem of biological monitoring, 
namely: 
- standardization of analytical techniques for both internal dose and effect indicators 
- relationships  between  external  exposure  and  indicators  of  dose  and  effect  in 
different exposure conditions 
- relationship between CdB and CdU 
- relation~hip between indicators of internal dose and indicators of effect 
- relationship between cadmium concentration in liver and kidneys and indicators of 
dose and effect in order to establish critical levels for the biological indicators 
- research  on  the  reversibility of  the  proteinuria detected with  currently available 
indicators of effect, especially urinary beta2-MG and urinary RBP 
- more information concerning the critical level of cadmium in kidney cortex 
- studies on the mec~anism  of cadmium toxicity in the kidney 
- studies defining the tubular or glomerular pattern of cadmium induced proteinuria 
- information on absorption, distribution.  retention and excretion of cadmium in man 
- investigations  on  the  role  of  metallothionein  in  cadmium  toxicity,  and  on  the 
possible use of urinary metallothionein as a biological indicator 
- finally, studies to answer the most important question concerning the carcinogenic 
effect of cadmium in man. 40 
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Introduction 
This monograph is based upon a review submitted by the Coronel Laboratory, Faculty 
of  Medicine,  University  of  Amsterdam,  The  Netherlands,  to  CEC  in  1976;  this  has 
recently  been  updated  to  the  state  of  the  art  of  early  1982. 
The  monograph  reviews  biological  monitoring  in  occupational  exposure  to  volatile 
halogenated hydrocarbons,  i.e.  several  widely  used  chlorinated  solvents  and  a few 
agents  applied  as  refrigerant  and  blowing  agent,  pesticide,  anaesthetic  or  plastic 
monomer.  In  this respect this monograph differs from  most other monographs in this 
series  which  usually  review  biological  monitoring  methods  for  one  agent  only.  Only 
those agents for which at least a few tentative data are available,_have been reviewed. 
Each  review  is  built  up  as  follows,  if  feasible: 
1  .  Chemical  and  physical  properties 
2.  Effects  on  humans 
3.  Metabolism 
4.  Biological  indicators 
5.  Conclusions 
6.  Research  needs 
As far as possible the quantitative data on  biological monitoring have been presented 
for  three  points  of  time,  which  are  most  feasible  in  practice: 
- at 
1
/2-1  h  after  exposure:  at  the  end  of  the  working day 
- at  16-20  h  after  exposure:  at  the  following  morning  before  exposure  starts 
- at  60-64  h after exposure:  after a weekend  at  Monday morning  before  exposure 
starts. 
These  points  of time  are  particularly feasible  for  biological  monitoring  of fat-soluble 
volatile agents.  It will be shown that the points of time are crucial for the estimation of 
total  exposure. 
This review does not contain all  specified information, which  is  required for adequate 
biological monitoring.  Even  for widely studied compounds definite conclusions cannot 
yet  be  drawn,  particularly  because  of the  following  reasons: 
- various  human  volunteer  studies  applied  different  designs,  measured  different 
parameters,  and  this  again  at  different  points  of  time 
- various industrial studies only measured a few parameters; they often were deficient 
in  exposure  data 
- differences in  analytical techniques lead  to  different results;  particularly the  recent 
application of gaschromatographic methods resulted  in  more sensitive and  reliable 
data  than  older  analytical  methods 
- in  previous  years  biological  monitoring  almost  exclusively  relied  upon  analysis  of 
metabolites in  urine,  whereas  levels of agent and/or metabolites in  exhaled  air or 
blood  may  present  more  reliable  biological  indicators. 
To a large extent there exists a great comparability in  analytical gaschromatographic 
methods for  measuring  agents  or metabolites  in  biological  specimen.  Moreover,  the 
same  metabolites may occur in  exposure  to  different chlorinated  hydrocarbons,  e.g. 
trichloroethanol  and  trichloroacetic  acid,  in  blood  and/or  urine  in  exposure  to 
trichloroethane, tetrachloroethane and  1,1, 1-trichloroethane. On the other hand these 
agents  widely  differ  in  the  percentage  metabolized,  e.g.  a  large  procentual 
biotransformation in  the case of trichloroethane and  a minor biotransformation in  the 
case of the other two.  Dichloromethane (methylene chloride) even is metabolized into 
the  previously  unexpected  metabolite  carbon  monoxide.  Therefore,  in  the  case  of 50 
dichloromethane  also  the  forthcoming  monograph  on  carbon  monoxide  should  be 
consulted.  In the case of monochloromethane a minority of subjects appear to have a 
poor  capability  for  biotransformation,  which  may  increase  their  susceptibility. 
All agents reviewed act on the nervous system as a narcotic; some solvents have even 
been  widely  applied  as  anaesthetic  (particularly  trichloroethane).  Some  agents  are 
exclusively  applied  as  such  (halothane,  methoxyflurane).  Moreover,  all  liquid 
compounds  have  a defattening  effect  on  the  skin. 
Some  agents  also  exert  specific  effects.  The  saturated  chlorinated  hydrocarbons 
trichloromethane  and  tetrachloromethane  may  exert  severe  hepatotoxic  and 
nephrotoxic effects. Chloromethane and bromomethane may lead to severely disabling 
neurologic sequelae.  Because  of  its  specific  biotransformation  dichloromethane acts 
both as narcotic agent and as precurser of carbonmonoxide (decreased transport and 
utilisation  of  oxygen:  hypoxia). 
A  few  agents  have  proved  to  be  an  animal  carcinogen:  trichloromethane  and 
tetrachloromethane, and even a human carcinogen: monochloroethene (vinylchloride). 
The  gaps  in  knowledge  sometimes  are  serious;  there  still  is  need  for  research  to 
establish  even  tentative data.  Moreover,  in  most cases the  data available only allow 
'application of the biological exposure data as group average values.  There is a great 
need to  establish individual biological exposure data which reliably estimate individual 
total exposure through  respiration and/or dermal absorption, and  which also take into 
account individual variability particularly in  fatty mass.  In  obese subjects the  levels of 
the  agent  in  blood  may increase less  and  more  slowly than  in  lean  subjects  during 
exposure;  the  total  amount taken  up  however,  will  be  larger and  consequently  after 
exposure  the  levels  in  exhaled  air  and  blood  will  be  higher  than  in  lean  subjects, 
particularly  when  measured  at  16-20  h  or  at  60-64  h  after  the  end  of  exposure. 
Because females  usually have  twice the  relative fatty  mass than  males,  females  will 
follow the trends of obese males.  However, data from  exposed workers,  according to 
sex  and  to  obesity,  are  hardly  available. 51 
Summary 
This  monograph  reviews  data on  biological  assessment of occupational exposure to 
the following volatile halogenated hydrocarbons: monochloromethane (methylchloride), 
monobromomethane  (methylbromide),  dichloromethane  (methylene  chloride), 
trichloromethane  (chloroform),  tetrachloromethane  (carbon  tetrachloride), 
1  ,2-dichloroethane  (ethylene  dichloride),  1,1, 1-trichloroethane  (methylchloroform), 
trichloroethane  (trichloroethylene),  tetrachloroethane  (perchloroethylene), 
monochloroethene  (vinylchloride)  and  two  anaesthetics  (halothane  and 
methoxyflurane).  Most  agents  are  widely  used  as  solvents. 
All  agents exert non-specific narcotic effects and  are defattening the skin; irritation of 
mucosae is usually weak. Some agents also exert specific hepatotoxic, nephrotoxic or 
neurotoxic effects. A few agents are established animal carcinogens, and vinylchloride 
is  even  an  established  human  carcinogen. 
All  agents  are  liposoluble,  and  most  of  them  undergo  biotransformation  into 
metabolites; this allows biological assessment of exposure by  measurement of agent 
and/or metabolites in  exhaled  air,  blood  and/or urine.  The  points of time of sampling 
are  critical  for  quantitative  assessment  of  total  exposure. 
Although  for  the  above  mentional  agents  many  data  are  available  for  only  a  few 
substances it is  possible to suggest practicable methods for biological assessment of 
occupational exposure,  and only for group average levels. This is particularly true for 
trichloroethane.  For  dichloromethane,  1,1, 1-trichloroethane  and  tetrachloroethane 
tentative  group  average  biological  exposure  data  in  relation  to  exposure  levels  as 
occur in occupational practice are suggested. For the other agents too little information 
is available to suggest more than a possible biological monitoring approach. There is a 
great need for more  human  volunteer studies  and  occupational exposure studies to 
improve  biological  assessment  of  occupational  exposure. 
Abbreviations 
MC 
TAl 
PERC 
TCE 
TCA 
TIC 
vc 
COHb 
Ci 
Ce 
A 
LC 
ppm 
bw 
h 
BSP 
CPK 
y-GT 
LDH 
SGOT 
SGPT 
methylchloroform  (1, 1, 1-trichloroethane) 
trichloroethylene  (trichloroethane) 
perchloroethylene  (tetrachloroethane) 
trichloroethanol 
trichloroacetic  acid 
total  trichlorocompounds  (TCE + TCA) 
vinylchloride  (monochloro  ethene) 
carboxyhaemoglobin 
concentration  in  inhaled  air 
concentration  in  exhaled  (alveolar)  air 
.  [  Ci-Ce)  retent1on  \--cl 
lungclearance: volume  of inspired  air cleared  from  vapour in  one minute 
(minute  volume  x  retention) 
parts  per  million  (1 o-s) volume/volume 
body  weight 
hour 
bromsulphtalein  test 
creatinephosphokinase 
y-glutamyl-transpeptidase 
lactic  dehydrogenase 
serum  glutamic-oxalacetic  transaminase  (aspartate  aminotransferase) 
serum  glutamic-pyruvate  transaminase  (alanine  aminotransferase) 1.  Monochloromethane  (Methylchloride) 
Chemical  and  physical  properties 
physical  state 
molecular  weight 
melting  point 
boiling  point 
vapour  density 
molecular  formula 
structural  formula 
colorless  gas 
50.49 
-97.7 oc 
-23.7°C 
1.78 
CH3CI 
H  H 
c 
H  Cl 
1 mg/m3 = 0.48  ppm;  1 ppm = 2.09  mg/m3  at  20 oc  and  760  mm  Hg. 
Effects  on  humans 
53 
Methylchloride  has  three physical  properties that  increase  its  potential  for  hazard  to 
workers'  health:  it  is  a  gas  at  roomtemperature,  it  is  colorless,  and  its  odor  is 
undetectable  at  conc~ntrations in  air  that  may  already  be  injurious  to  health.  The 
nervous  system  appears  to  be  the  critical  target  system.  Symptoms  observed  are 
ataxis, staggering gait, weakness, tremor and vertigo; these symptoms may occur after 
a  latency  time  of  2 to  3  h. 
Repko et al  (1976)  studied the  behavioral and  neurological effects in  122 workers in 
several  industrial  plants  of a company  using  methylchloride  as  a blowing  agent  for 
foam  manufacture;  49  non-exposed  subjects  served  as  controls.  The  overall  mean 
concentration  was  34  ppm,  between  departments  ranging  from  mean  8 to  60  ppm. 
Exposure  to  methylchloride  adversely  affected  performance  in  cognitive timesharing 
tasks  and  it  increased  the  finger  tremor.  No  relationship  was  established  between 
exposure  and  various  psychological  effects  and  personality  tests  employed;  no 
exposure  related  neurological  effects  were  observed. 
Stewart et al (1977) and Hake et al (1977) exposed 10 adult males and 9 adult females 
to  20,  100  and  150  ppm  for  periods  of  1,  3  and  7.5  h.  Physical,  neurological, 
behavioral,  clinical  and  medical  studies  revealed  no  deleterious  effects  of 
methylchloride  exposure. 
Putz-Anderson  et  al  (1981)  exposed  male  or  female  adults  to  100  (n = 8)  or 200 
(n = 24)  ppm  for  3  h;  in  addition  they  received  a  diazepam  dose  or  a  placebo. 
Diazepam produced  a significant  1  0%  impairment in  task performance,  whereas the 
effect of 200 ppm methylchloride was only rqarginally significant (average impairment 
of  4.5%). 
Metabolism 
Inhaled methylchloride is easily absorbed and  rapidly metabolized. After exposure of 
volunteers to concentrations up to  150 ppm the mean breath concentrations dropped 
very rapidly (Stewart et al 1977); methanol was not found in the urine of the volunteers. 
In  urine  samples  obtained  from  persons  occupationally  exposed  to  methylchloride 54 
(30-90  ppm)  Van  Doorn  et  al  (1980)  identified  S-methylcysteine  as  a metabolite  of 
methylchloride. No significant increase was found for thioethers. The excretion patterns 
of S-methylcysteine indicated a relatively long biological half-life for this metabolite (or 
its percursors). The authors calculated that almost all the retained methylchloride was 
excreted in  urine as  S-n1ethylcysteine  in  4 of 6 workers; the other two excreted  less 
than  10%. 
Stewart et al  (1977) and  Putz-Anderson et al  (1981) also distinguished two groups in 
exposure  of  human  volunteers  to  methylchloride  (see  3.2.0.).  A  majority  had 
methylchloride blood and breath concentrations which were two to six times lower than 
in  three  of ten  males and  one of nine females  (Stewart et al  1977),  and  in  three of 
twentyfour subject,  respectively  (Putz-Anderson  et al  1981 ).  These  findings  strongly 
suggest the existence of two populations: a minority of cc  poor converters ,  with a high 
body burden of methylchloride and a low excretion of S-methylcysteine and a majority 
of  cc  converters, with  a lower methylchloride body burden  and  a high  percentage of 
methylchloride excreted as  S-methylcysteine.  It is not clear whether this difference in 
metabolism  indicates  a  difference  in  susceptibility  to  methylchloride. 
Biological  indicators  of  exposure 
In  order  to  develop  a  practical  cc  biologic,  test  to  estimate  the  magnitude  of  an 
industrial exposure volunteers of both sexes were exposed repetitively on a daily basis 
to methylchloride in concentrations of 20,  1  00 and 150 ppm for periods of 1  , 3 and 7.5 
h.  (Stewart et al  1977). Blood and  breath analysis revealed that the subjects could be 
divided  into two groups:  a minority of subjects  (type  B)  with  two to  six times  higher 
concentration in  blood and  exhaled air than the majority of the subjects (type A)  (see 
section  3.3.0.).  This  phenomenon  should  encourage  the  use  of  breath  monitoring. 
In  table  1 the  result of the  breath  analysis are summarized for type A subjects.  The 
alveolar concentrations  in  type  B subjects  were  60  to  11 0%  higher than  the  mean 
values in type A subjects at zero time, and were three to six fold higher at one h post 
exposure.  For  type  A  subjects  one  cannot  differentiate  between  1,  3  and/or  7.5  h 
exposure from  post exposure decay curves. The breath concentrations of the B type 
subjects  were  much  higher  and  did  not  overlap  with  the  values  from  the  type  A 
subjects  at  15,  30  and  60  min  after  exposure. 
TABLE  1 
Mean concentrations of methylchloride in  alveolar air (Ce)  after exposure as  percentage of the 
inhaled  concentration  (Ci)  (calculated  from  Stewart  et  al  1977). 
exposure  condition  mean  Ce  as  %  of  Ci 
Ci  time  time  after  exposure 
ppm  h  number of times  1 /2  h  1  h  2h 
20  71/2  4x  1.8  1.0  0.60 
100  71 /2  5x  male  2.0  1.2  0.50 
100  71/2  5x  female  2.8  1.4  0.55 
100 ± 40  71/2  5x  fluct.,  male  1.4  0.8  0.45 
150  71 /2  2x  male  2.0  0.9  0.50 
The blood concentrations at the end of exposure in type B subjects were about 5 times 
higher than in type A subjects (about 1  0 mg/1 methylchloride compared to about 2 mg/1 
after to  3 h exposure to  100 ppm). The results indicate that the higher post exposure 
breath  levels  of type  B subjects  are  direct  results  of  higher  blood  levels. 
Repko et al  (1976) also measured the concentration of methylchloride in the breath of 
the exposed workers immediately prior to the termination of the exposure. The mean 
concentration in  breath was  13 ppm,  while the mean exposure concentration was 34 
ppm. 
Use  of  urinary  excretion  of  S-methylcysteine  for  assessment  of  the  exposure 
magnitude is subject to the same problem of  cc  converters>>  and  cc  poor converters». 55 
Conclusions 
Possibilities for biological monitoring of exposure to methylchloride exist: measurement 
of methylchloride in exhaled air or in blood, or its metabolite S-methylcysteine in urine. 
However, a minority of subjects is not or only poorly capable to convert methylchloride. 
This  results  in  a  high  body  burden  of  methylchloride  in  these  subjects. 
Which  of the type of subjects is  more susceptable to  the toxic effect of exposure to 
methylchloride,  is  not  clear.  Additional  studies  should  be  carried  out  to  solve  this 
problem. 
Research  needs 
More  studies  have  to  be  carried  out  in  exposed  workers to  establish  a relationship 
between  respiratory  exposure  (concentration  and  duration),  biological  indicators  of 
exposure  and  health  effects. 
2.  Monobromomethane  (methylbromide) 
Chemical  and  physical  properties 
physical  state 
molecular  weight 
specific  gravity 
melting  point 
boiling  point 
vapour  density 
molecular formule 
structural  formula 
colorless  gas 
94.95 
1.73 0°/0°C 
-93.6°C 
4.6°C 
3.27  (air  = 1) 
CH3Br 
/·H 
Br-C-H 
""-H 
1 mg/m3  = 0.257  ppm;  1 ppm = 3.89  mg/m3  at  25 oc  and  760  mm  Hg. 
Effects  on  humans 
Toxis  effects  mainly  refer  to  the  central  nervous  system.  Van  den  Oever  (1979) 
reviewed  the  clinical  symptoms:  in  intensive  exposure  coma  and  convulsions  may 
occur,  followed  by  neurological  sequelae  and  pulmonary  oedema.  In  less  intensive 
exposure  there  usually  exists  a  latency  period  of  one  to  several  hours,  before 
prodromal symptoms develop: headache, nausea, vomiting, drunkenness, drowsiness. 
This may develop into a neurological syndrome: myoclonic contractions (particularly in 
hands  and  face  muscles)  followed  by  convulsions,  disorientation  and  maybe  coma. 
Typical cerebellar disturbances may cause adiodochokeinesis, myoclonic contractions. 
In  acute  intoxications  also  hyperthermia,  pulmonary  oedema  and  sometimes 
hepatorenal damage may occur.  Dermal contact may cause dermatitis and  blistering; 
exposure of the eyes causes conjunctivitis and  keratitis.  In  intensive exposure death 
may occur within 24 to 48 h;  in survival neurological sequelae may persist. In two fatal 
cases 92 and 83 mg bromide/1  blood have been reported; one case that survived had 
69  mg/1  (Clarke et al  1945), but 400 mg/1  has also been  reported: Rathus and Landy, 
1961  (survived)  and  Hine,  1969  (fatal).  In  1  0  of  33  workers  Verberk  et  al  (1979) 
observed  slight  disturbances  of  the  encephalogram  and  a  small  increase  of 
serumtransaminases; the bromide in blood levels (neutronactivation) were 4 to 23 mg/1; 
in those with eeg-disturbances the geom.  average (-SO geom. to+ SO geom.) was 
10.9  mg/1  (6.2-19.2),  in  the  others  8.2  mg/1  (5.6-12.0). 
Metabolism  and  biological  indicators 
Exposure mainly occurs by inhalation; limited dermal absorption may also take place. 
The whole molecule as  such and  not Br seems to  be the causative agent for health 
effects;  it  interferes  with  energy  metabolism  and  inhibits  triosephosphate 
dehydrogenase;  methylbromide  also  methylates  SH-,  amino- and  carboxylgroups. 
Shapovalov  (1974)  observed  in  exposed  workers  a  decreased  concentration  of 56 
SH-groups in  blood  and  increased  levels of protein, decreased levels of albumin and 
increased levels of globulins, although Verberk et al  (1979) did not observe any effect 
on  the  albumin/globulin  quotient. 
In  the  body  methylbromide  is  metabolized  into  bromide;  this  results  in  increased 
bromide levels in blood.  ~n non-exposed workers Hine (1969) found 0.5-2 mg bromide/1 
blood; in the Netherlands in  1300 non-exposed males (av.  19 yr) 0.2-1.5 mg  bromide/1 
blood was  measured (neutronactivation); Bowen  (1974) reported  1.3-10 mg/1  in  blood 
and  1-14  mg/1  in  bloodserum.  According  to  Gay  (1962)  the  maximal  acceptable 
bromide in blood level was 50 mg/1.  Although a relationship between bromide in blood 
levels and the health hazard probably exists, the relationship is not yet clear,  probably 
also due to  analytical problems (see 4.4.0.) and  different times of sampling; often the 
analytical  methods  have  even  not  been  reported. 
The  reported  bromide  in  blood  levels  have  not  been  corrected  for  exposure  to 
inorganic bromide and, therefore, are as such not per sea good measure for exposure 
to  methylbromide.  Methylbromide  levels  in  blood  have  not  been  measured. 
Bromide  levels  in  urine  in  non-exposed  subjects  have  been  reported  to  be  3-5  mg/1 
(Hauck 1968); there are no data on  urinary levels in methyl bromide exposed workers. 
Analytical  methods 
Various  methods  exist  for  measurement  of  bromide  in  blood  (Hessing  1980): 
- goldchloride  method;  not  accurate  at  levels  below  100  mg/1  (Rathus  and  Landy 
1961;  Greenberg  1971) 
- Conway  microdiffusion;  applicable  for  levels  below  50  mg/1  (Rathus  and  Landy 
1961) 
- rbntgenfluorescence;  detection  level  in  urine  0.2  mg/1  (Hauck  1968) 
- neutronactivation; coefficient of variation 6-12%, low detection level (De Goeiy et al 
1976) 
- spectrophotometry; its coefficient of variation is considerable at levels below 20 mg 
bromide/1  (Hessing  1980) 
- Heuser  (1970)  described  a  gaschromatographic  method  for  simultaneous 
determination  of  bromide  and  methylbromide  in  vegetation. 
Conclusion 
Measurement of bromide,  possibly  methylbromide,  in  blood  very  probably offers the 
method  of  choice  in  biological  monitoring.  There  is  need  to  improve  the  quality  of 
analytical  methods  for  bromide  and  methylbromide  in  blood.  Because  insufficient 
knowledge exists on the relation between methylbromide in blood and health effects, it 
is  not  possible  to  propose  a  routine  biological  monitoring  program.  Simultaneous 
exposure  to  other  Br-containing  compounds,  interalia  drugs,  may  confuse 
interpretation  of  bromide  in  blood  levels. 
It  may  be  prudent  to  keep  levels  below  about  15  mg  bromide/1  blood. 
Research  needs 
There  is  need  to  study 
- methods  to  measure  bromide  and  methylbromide  in  blood 
- the  halftime  of  bromide  and  methylbromide  in  blood 
- the  relation  between  bromide  and  methylbromide  in  blood  and  external  exposure 
- the  relation  between  bromide  and  methylbromide  in  blood  and  health  effects. 3.  Dichloromethane  (methylene  chloride) 
Chemical and physical properties 
physical  state 
molecular weight 
specific  gravity 
melting  point 
boiling  point 
vapour  density 
vapour  pressure 
molecular formule 
structural  formule 
colorless  liquid 
84.94 
1.32 20°/4°C 
-96.7°C 
+ 40.1°C 
2.93  (air= 1) 
440  mm  Hg  at  25°C 
CH2CI2 
Cl'- /H  c· 
c1/ ""'-H 
1  mg/m3  =  0.288  ppm;  1 ppm= 3.48  mg/m3  at  25°C  and  760  mm  Hg. 
Effects  on  humans 
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Methylene chloride has the wellknown narcotic effects and is slightly irritative for mu-
cous membranes and  skin.  Particularly in  exposure for more than 3 to  4 h endoge-
neously (from methylene chloride) produced carbon monoxide (CO) may exert in own 
effects. In a human volunteer study (12 males) Putz et al  (1978) studied psychomotor 
performance in exposure to 76 ppm CO - 4 h in rest or to 195 ppm methylene chloride-
4 h in  rest; the %  COHb increased from  1.4 to 4.85 respectively 5.1 : in  various tests 
performance decreased, in one of these more in exposure to methylene chloride than 
in  exposure to CO.  This suggests a synergistic effect of methylene chloride and  CO 
together. In tests with exposure to methylene chloride for less than 4 h this extra effect 
of CO is  not observed  (Stewart et al.  1972,  Winneke  1974,  Gamberale et al  1975). 
In  animal tests  (mice 5000 ppm,  24 h per day,  1 to 7 days)  moderate degenerative 
changes were observed in  liver and kidney; however, much less than in exposure to 
e.g. carbon tetrachloride. Combined exposure to ethanol had a potentiating effect. No 
teratogenic  and/or  reproductive  effects  have  been  observed. 
In  epidemiological studies in  workers with exposure to 50-150 ppm (Friedlander et al 
1978) no increased mortality (e.g.  cardiovascular disease,  cancer)  was observed.  In 
exposure of male (and  not of female)  rats  (3500 ppm - 6 h/d- 5 d/wk - 24 mths)  an 
increased  incidence  of sarcomata  in  and  next to  the  parotid  gland were observed;. 
however, there appears to be no reason to consider this as indicating human carcino:. 
genicity.  In  mutagenicity  tests  methylene  chloride  is  weakly  positive. 
In  industry combined exposure to other solvents (e.g.  dichloroethane, dichloroethene) 
often  occurs;  this  makes  it  difficult to  ascribe observed  health  effects to  methylene 
chloride  itself. 
Metabolism 
Methylene choride is readily taken up through inhalation, and is also absorbed consi-
derably through the skin. The agent itself does not accumulate significantly in repeated 
exposure over 5 days (Stewart et al 1976). The partition coefficient of methylene chlori-
de between blood and air at 37° C is about 8-10 (Sato and Nakajima 1979, Lindqvist 
1978) and between fat/air about 150-160 (Droz and Fernandez 1977, Sato and Nakaji-
ma  1979). 
Production  of carbon  monoxide (CO)  after exposure to methylene chloride was first 
observed by Stewart et al  (1972). Evidence that CO is a biotransformation product of 
methylene chloride has been obtained by  use of isotope tagged  methylene chloride 
(Carlsson and Hultengren 1975). About 25% of the methylene chloride absorbed was 
ultimately excreted as CO and the post exposure excretion of methylene chloride by 
exhalation was less than 5% of the amount absorbed (DiVincenzo and Kaplan 1981a). 
In  animal  experiments  it  has been  shown that increased COHb-levels only occur in 
exposure to di- and  trjhalogen-methyl  compounds;  production  of CO increases with 
atomic weight of the halogen (CI--+ Br--+ J) (Fodor et al  1973). Ciuchta et al.  (1979) 
observed inhibition of biotransformation into CO in combined exposure to various alco-
hols  or toluene. 58 
The biological half life of COHb after exposure to  halogenated hydrocarbons is about 
10-12 h,  i.e. double the T1/2 of COHb-levels after CO-exposure. This can be explained 
by  the  still  continueing  formation  of  CO  from  methylene  chloride  after  exposure. 
Biological  indicators 
Human volunteer studies 
Concentrations of methylene chloride in exhaled air (Ce) 
Table 2 presents data from  human  volunteer studies.  The following conclusions may 
be  drawn: 
- the  retention  (R)  seems  to  decrease  with  increasing  exposure  concentration  (Ci) 
and  with  increasing  duration  of  exposure  (T); 
- for similar T the decay curves of Ce for different Ci's run  parallel; Ce  itselft increa-
ses  with  a  larger factor  than  Ci; 
- for Similar Ci-levels the early post exposure Ce-levels are about the same,  but the 
Ce-levels  decrease  faster  as  T  becomes  shorter;  after  about  4  h post  exposure 
Ce-levels  are  more  or  less  proportional  to  T; 
- fluctuation  of  Ci  does  not  or  hardly  affect  Ce; 
- determination of  Ce  at  1-2 h after exposure presents the  best means to  estimate 
previous exposure;  measurement of a series  of samples  over a few  hours  highly 
increases  the  predictive  power  (Stewart  et  al  1976); 
- female subjects have about the same Ce-levels as males quring the first hours after 
exposure; at 16 h females tend to have higher Ce-levels (Stewart et al.  1976); this 
difference could  be due to  a higher amount of fatty tissues in women. This is  also 
found  by  Engstrom  and  Bjurstrom  (1977).  During  the  first  2 h after exposure the 
concentration in alveolar air tended to be lower and declined more rapidly in obese 
subjects than  in  slim  ones.  Thereafter concentrations dropped more slowly in  the 
obese  group.  During  the  later phase of elimination,  the  obese subjects tended  to 
have  a  higher  concentration  in  alveolar  air; 
- there  is  no  cumulation  in  the  body  in  repeated  exposure  (Stewart  et  al  1976,  Di 
Vincenzo  et  al  1981 a); 
- physical  workload  increases  Ce-levels  over  the  whole  post  exposure  period. 
Astrand  et  al  1975  studied  also  the  effect  of  physical  exercise  (50-150  W)  on  the 
uptake; the total duration of exposure was always 2 h, but broken up in 4 periods of 30 
min.  with difference in  Ci  and  in  physical activity. The  results may be  summarized as 
follows: 
- at  rest  about  55%  of  the  amount  inhaled  is  taken  up 
- physical  exercise  (50  Watt)  increases  uptake  with  about  a factor  2  (45%  of  the 
amount inhaled; with continuous 50 Watt workload the percentage ultimately beco-
mes  somewhat  smaller:  30-35%) 
- with  increasing workload  (100-150  Watt)  the  alveolar ventilation  increases 5 to  7 
fold of the rest value,  but the uptake is not considerably higher than  in  the case of 
50  Watt  workload. 
Di  Vincenzo et al  (1981 b)  reported similar results: the percentage of methylene chlori-
de absorbed at  rest,  light,  moderate,  and  heavy work  intensities was  72,  58,  53 and 
47% respectively. Exercise was accompanied by an increased pulmonary excretion of 
CO during exposure which undoubtedly contributed to the lower than expected COHb 
values  encountered  during  heavy  workloads. 
Stewart  and  Dodd  (1964)  examined  absorption  through  the  skin  of  4  subjects,  by 
thumb immersion for 30  min;  mean  alveolar Ce  after exposure was 3.1  ppm,  at 2 h 
0.69 ppm; these levels were considerably higher than for tri-, tetrachloroethylene, car-
bon tetrachloride and  1,1 ,  1-trichloroethane and  are comparable with a respiratory ex-
posure  to  50-1 00  ppm  methylene  chloride  for  1  h,  see  table  1. 59 
TABLE 2: Mean concentration of methylene chloride in alveolar air (C8) after exposure as 
percentage of the inhaled concentration (Ci), the retention (R) at the end of exposure and COHb 
concentration. 
cone. Ci  time  R alv.  mean Ce as % of Ci  mu 
reference  (ppm)  (h)  end  time after exposure  COHb 
exp.  1/2h  1 h  2h  1~20h 
Stewart et al (1976)  50  3.6  2.0  0.8 
50  5X1  0.76  2.8  12  0.6 
100  1  3.7  2.0  0.9 
100  5X1  0.64  5.0  3.0  0.9 
250  1  4.8  2.7  0.7 
250  5x1  0.66  6.1  3.7  1.0  ..11 
250  fl  1  2.0  0.7  0.08 
250  fl  5x1  4.9  2.7  1.0  0.40 
250  fem  1  7.2  4.3  1.1  1.10 
250fem  5x1  7.2  4.5  1.3  0.76 
500  1  0.57  7.6  4.0  0.9  0.08 
500  2x1  7.9  4.3  1.6  0.08 
EngstrOm et al (19n)  750  1  wl  15  7.7  3.8 
100  2  16  11  2.7 
Riley et al (1966)  100  2  16  13  11  2.7 
90  5.2  3.7  1.8 
DiVincenzo et al (1971)  210  2  5.8  3.2  2.2 
DiVincenzo et al (1972)  100  2  5.4  4.0  1.3 
200  2  6.7  3.4  1.5 
100  2  wl  10.8  6.1  3.4 
Astrand et al (1975)  2501500  2  wl  16  9  4.4  0.15  4.5 
250  2  wl  17  8.8  4.3  0.03  3.2 
Stewart et al (1976)  500  2  wl  20  13  4.6  0.17  4.0 
50  3  4.2  1.8  (2.0) 
50  5x3  0.72  3.8  2.2  1.8 
100  5.0  3.7  - 1.6 
100  5x3  0.63  6.1  3.8  1.9 
250  3  6.6  3.8  1.5  0.16 
250  5x3  0.59  8.9  4.3  1.9  0.20  ..13 
250  fl  3  5.4  3.7  1.8  0.20 
250  fl  5x3  8.2  4.6  2.0  0.16 
250  fem  3  7.0  5.5  0.5  0.60 
250  fem  5X3  7.6  5.9  1.4  0.72 
500  3  16  8.9  3.9  0.10 
500  2X3  0.50  17.7  9.5  3.4  0.08 
Di Vincenzo et al (1972)  100  4  5  3  2 
Putz et al. (1978)  195  4  5.1 
Stewart et al (1976)  1/2  7.2  2.8  1.8 
50  5x71 /2  0.70  7.2- 3.6  2.2  ..11.8 
100  71/2  6.1  4.0  3.7 
100  5a71/2  0.67  7.9  4.5  3.2  ..13.5 
250  71 /2  13.2  5.9  2.3  0.16 
250  5a71 /2  0.52  8.7  5.1  3.6  0.32  ..17 
250  fl  71 /2  12.9  7.8  3.5  0.28 
250  fl  5x71/2  9.7  6.8  3.7  0.40 
250  fem  71 /2  12.3  8.8  2.8  1.40 
250  fem  5x71 /2  13.3  9.3  2.8  0.92 
500  71 /2  0.45  17.8  12.1  5.0  0.26 
500  2x71 /2  21.2  13.2  5.1  0.28  ..110 
DiVincenzo et al (1981a)  50  71 /2  -0.70  5  4  1.9 
100  71 /2  -0.60  8  5  3.4 
150  71 /2  -0.65  7  4  5.3 
200  71 /2  -0.60  9  5  6.8 
fl  = fluctuating 
fem  = female 
wl  = workload 
~  = increase during exposure 
Concentration of methylene chloride in blood 
Di Vincenzo et al (1971  and 1972) exposed 11  subjects to 100 and 200 ppm for 2 and 
4 h; venous blood was taken at different points of time.  In  exposure to 200 ppm the 
blood level was twice that in exposure to 100 ppm, but doubling of exposure time from 
2 to 4 h did not double the blood level. Two hour exposure to 200  ppm  resulted  in 
about 2.2 mg/1 blood at the end of exposure. Serial breath and blood die-away curves 
were very similar in form in the post exposure phase; however during and after expo-
sure blood concentrations did  not show such  a  rapid  increase and decrease as  the 
concentration in exhaled air. In 1981  Di Vincenzo et al  (1981 a)  reported similar results 
with exposure of 14 subjects to 50,  100, 150, or 290 ppm methylene chloride for 7.5 h. 60 
Astrand  et  al.  (1975)  measured  in  subjects  exposed  to  250  or 500  ppm  methylene 
chloride  in  arterial  and  (peripheral)  venous  blood.  The  relationship  between 
concentrations  in  arterial  blood  and  in  alveolar  air  was  linear  at  the  end  of  each 
exposure period: [concentration in blood (mg/kg)]  = -1.059 + 0.0124 [concentration 
in  alveolar air (mg/m
3
)]. The venous concentration followed the arterial concentration; 
at  higher  levels  of  uptake  (physical  activity)  the  arterio-venous  difference  increased 
considerably.  The  correlation  between  the  arterial  blood  levels  and  amount  of 
methylene  chloride  taken  up  was  rather  poor. 
Concentrations of methylene chloride in adipose tissue 
Engstrom and Bjurstrom (1977) exposed 12 subjects to a concentration of 750 ppm for 
1 h while performing work at an  intensity of 50 W.  The amount of methylene chloride 
absorbed  was  highly  correlated  with  the  degree  of  obesity  and  with  body  weight. 
Needle biopsy specimens of subcutaneous adipose tissue were taken before exposure 
and 0,1.2.3 and 4 h after exposure. The mean concentration in the adipose tissue was 
10.2 mg kg  at  1 h after exposure  and  8.4  mg/kg  after 4  h.  In  six  slim  subjects the 
concentration in adipose tissue at 4 h after exposure was on the average twice that in 
six  more  obese  subjects.  On  the  other hand,  in  spite of the  lower concentration  the 
obese subjects had  a greater calculated amount of methylene chloride in the total fat 
depots  of  the  body.  Two  subjects  were  studied  about  22  h  after  exposure,  the 
concentrations in  subcutaneous adipose tissue were  1.6 and  1.7 mg/kg  respectively. 
More studies have to be carried out to provide data on concentrations in adipose tissue 
in  relation  to  various  exposure  levels. 
Concentration of methylene chloride in urine 
The  overall  excretion  with  urine  is  negligible  in  comparison  with  elimination  through 
exhalation  (Di  Vincenzo et al  1971,  1972,  1981 b);  it  did  not appear to  be  related  to 
work  intensity  (Di  Vincenzo  et  al  1981b).  There  is  no  reason  to  propose  biological 
monitoring  based  upon  urine  sampling. 
Concentrations of carboxyhemoglobine in  blood 
Table 1 also presents data on  % COHb.  In short-terms exposure to< 250 ppm for 3 h, 
the % COHb probably does not exceed 5%, but it may do so in repeated exposure for 
7 to 8 h'day. The% COHb can be indirectly estimated by measuring CO in exhaled air 
(see  document  on  Carbon  Monoxide). 
It should be emphasized that monitoring for CO  in  exhaled air or COHb in  blood can 
only  be  applied  for  biological  monitoring  of  exposure  to  methylene  chloride  in 
non-smoking  subjects.  Moreover,  during  monitoring  the  concentration  in  inhaled  air 
(environment)  should  not  exceed  9 ppm  CO. 
Astrand  et  al  (1975)  also  measured  COHb  levels  in  blood.  In  sharp  contrast  with 
methylene chloride levels, COHb levels increased in the postexposure phase, even up 
to  2-4 h.  The venous COHb did  not differ systematically from  the  arterial  levels.  The 
COHb exceeded 5% when subjects were exposed to 500 ppm for 2 h with workload. In 
the case of 8 h exposure to <  100 ppm total COHb levels (inclusive pre-exposure level 
of 1-1.5%)  will  probably  not  exceed  5%  in  non-smokers. 
In  human  volunteers  (10  males,  9 females)  exposed  to  50-500  ppm  for  1,  3 or  7.5 
hiday  at  rest  for  up  to  five  successive  days  Peterson  (1978)  derived  the  following 
equation: 
A  o/c  COHb =  0.0842(D.Ci)o.72 
o  (T + 220)o.ns 
D  =  exposure duration in  minutes 
Ci =  concentration methylene chloride in ppm 
T  =  time after the end of exposure in min 
, in which 
This equation is only valid for exposure to 50-500 forD= 1-7.5 h,  in rest. 
Di  Vincenzo and  Kaplan  (1981 a)  observed  in  a human volunteer study (see table 2) 
that exposure for 7.5  h 5 days to  50,  100,  150 or 200 ppm  resulted  in  peak COHb-
levels of 1.9, 3.4, 5.3 or 6.8%. Alveolar air and blood levels of CO were directly propor-
tional  to  the  magnitude of exposure;  at  100 ppm  8 h a COHb-level  of 3%  could  be 
expected. In a second study by Di Vincenzo and Kaplan (1981 b),  in which the effect of 
exercise and of smoking was examined in 3 volunteers exposed for 7
1
/2 h to 100 ppm, 
it was observed that exercise did  not increase COHb-levels, probably because of the 
increased respiratory excretion of CO; when smoking during or after exposure to met-
hylene chloride there appeared to be an additive effect on % COHb. 61 
Concentration of carbon monoxide in exhaled air 
In  the  human volunteer study carried out by  Stewart et al  (1976) CO was present in 
alveolar air at all conditions; the CO level in alveolar air reached its maximum at 1-2 h 
after exposure,  and was directly related to magnitude of exposure. The portion of CO 
due  to  methylene  chloride  in  combined  exposure  can  be  calculated  by  taking  into 
account the difference in biological half life of COHb due to methylene chloride and of 
COHb due to  e.g.  smoking.  It should  be  noted that  simultaneous exposure to  other 
solvents may increase biological half life of COHb (triple in  case of methanol).  In  the 
experiments of Di Vincenzo and Kaplan (1981 a) the concentration of CO in expired air 
was  also directly proportional to the magnitude of the exposure both during and after 
the  exposure. 
Industrial exposure studies 
Ratney  et  al  (1974)  examined  a group  of  non-smoking  workers  (n = 7)  exposed  to 
160-200 ppm  (mean  180 ppm)  at  day of sampling,  but already exposed  for several 
years;  in  addition there was  exposure to  25-36 ppm  (mean  31  ppm) chloroform.  The 
pre-exposure  average  CO  level  in  alveolar air was  29  ppm,  which  increased  during 
exposure to  about  50  ppm;  before  next exposure  the  CO  level  was  23  ppm;  these 
levels  correspond  to  COHb  (calculated)  4.9%  (3.3-5.3),  8.3%  (5.7-12.0)  and  3.9% 
(3.6-4.9). The biological half life of COHb was  13 h.  From these data it became clear 
that- although  methylene chloride  itself is  not cumulative  in  repeated exposure-
HbCO-Ievels  are;  the  «morning  after>>  pre-exposure  levels  were  almost  5%. 
Benzon et al  (1978) examined  a worker after he  had  accidentally been  overcome by 
methylene  chloride  vapours;  the  COHb-levels  had  increased  up  to  19%;  another 
worker with  a history of ischemic heart disease  had  been  exposed concurrently with 
the  other  patient;  the  following  day  his  COHb  level  was  6%. 
Perbellini et al  (1977) examined methylene chloride levels in  alveolar air and in blood 
of  shoe  sole  factory  workers.  At  21  ± 8  ppm  methylene  chloride  the  alveolar 
concentration was average 14 ppm and in blood average 40.41  mg/1;  at 35 ± 12 ppm 
the  average  levels  were  20  ppm  and  0.99  mg/1;  at  96 ± 75  ppm  the  levels  were 
average 65 ppm and 3.07 mg/1  (groups of 4 or 5 workers). In this factory the methylene 
chloride  exposure  was  rather variable  (high  S.D.).  The  data are  too  limited  to  allow 
valid  extrapolation. 
Conclusions 
Biological  monitoring  of methylene chloride exposure can  be  based  upon  measuring 
the  agent  itself in  exhaled  air or blood,  however,  because  methylene chloride  is  not 
cumulative, and because in exposure for more than 3 to 4 h per day production of CO 
appears to  be  the  limiting factor as  regards  health  risk  and  the  half life of COHb  is 
longer than  in  the  case of exposure  to  CO,  biological  monitoring  based  upon  either 
exhaled air analysis of CO or blood analysis of COHb is to be preferred. However, this 
can  only be  applied  in  non-smoking workers.  Sampling  should  be  done at  about 2 h 
post exposure, or after 16 h (following morning).  Post exposure COHb levels (at 2 h) 
are  not  expected  to  exceed  2-3%  and  at  16  h  post-exposure  1%  in  the  case  of 
exposure  for  8  h to < 100  ppm  methylene  chloride  in  non-smokers. 
Methods  for  analysis  of  methylene  chloride  in  exhaled  air  and  blood  have  been 
described by Di Vincenzo et al.  (1971 ),  Stewart et al  (1976) and Astrand et al.  (1975). 
For methods of  analysis of COHb and  CO  see document on  biological monitoring of 
CO-exposure. 
Research  needs 
There particularly is need of studies of workers: measurement of methylene chloride in 
inhaled  air by  means  of  personal  sampling,  and  of  methylene  chloride  and  carbon 
monoxide levels in exhaled air and in blood, at the end of a work day at 1 to 2 h, at 16 
h (following  morning)  and  at  64  h after exposure  (Monday  morning),  separately for 
non-smoking  and  for smoking  workers.  Such  studies  should  lead  to  valid  biological 
monitoring  indices,  which  allow to  estimate  individual  uptake  of methylene chloride. 62 
4.  Trichloromethane  (chloroform) 
Chemical  and  physical  properties 
physical  state 
molecular  weight 
specific  gravity 
freezing  point 
boiling  point 
vapour  density 
vapour  pressure 
molecular formula 
structural  formula 
1 mg/m3 =  10.206 ppm; 
colorless  liquid 
119.39 
1.49  15°/4°C 
-63.5°C 
61.2 oc 
5.3  (air= 1) 
200  mm  Hg  at  25°C 
CHCI3 
/CI 
H-C-CI 
""'cl 
1 ppm =  4.89 mg/m3 at 25°C and 760 mm  Hg. 
Effects  on  humans 
Chloroform exerts non-specific narcotic effects and specific effects on liver and kidney; 
this  determines  the  permissible  level  of  exposure.  In  animal  experiments  liver 
hepatomata  have  been  observed,  with  possible  carcinogenity,  however  at  high 
dosages.  According  to  IARC  (1979)  chloroform  produced  hepatomas  and 
hepatocellular carcinomas in mice, malignant kidney tumours in male rats and tumours 
of the thyreoid in female rats.  In humans no case reports or epidemiological studies are 
available  which  point  to  human  carcinogenicity.  However,  IARC concluded  that  it  is 
reasonable for practical purposes to regard chloroform as if it presented a carcinogenic 
risk  in  humans. 
According to Challen et  al  (1958) the following tentative relationships for occupational 
exposure could be given: in average exposure to 77-237 ppm there were complaints of 
nausea, loss of appetite, frequent and burning micturition, lack of mental concentration, 
depression, irritability; no evidence of liver injury was observed 3-4 yr after exposure. 
Among workers exposed for 1  0-24 months to 22-71  ppm  (with  a few short term  peak 
concentrations)  dryness  of  mucosae  and  lassitude  were  observed;  no  evidence  of 
liverfunction impairment. Bomski et al  (1967) studied workers exposed to 2-205 ppm; 
there was an increased incidence of viral hepatitis, enlarged liver and spleen. Gambini 
and Farina (1973) observed an enlarged liver without evidence of disturbed function in 
29%  of 64 workers exposed to  17-28 ppm  (peaks  up to 360 ppm)  in  12-37 months. 
Alcohol  intake  increases  the  hepatotoxicity. 
Metabolism 
Hardly no data exist on  metabolism  in  healthy workers;  most data refer to studies in 
anaesthesized patients.  Chloroform is  absorbed through inhalation and  eliminated by 
exhalation. Because of its liposolubility the agent will be deposited in fatty tissues (e.g. 
brain).  The partition  co~fficient of chloroform between blood  and  air at 37°C  is  about 
10-12  (Sato  and  Nakajima  1979,  and  Lindqvist  1978)  and  between  fat/air  about 
400-425 (Droz and Fernandez 1977, Sato and Nakajima 1979). No pertinent data are 
available  on  metabolism. 
Bergman  (1979)  studied  metabolism  by  means  of  autoradiography  after  respiratory 
exposure of mice.  Chloroform showed a high  affinity for nervous and  adipose tissue, 
with a specific long-time retention in the cerebellar cortex, meninges and spinal nerves. 
Biotransformation  particularly took place  in  liver and  kidney,  with  an  accumulation of 
non-volatile radioactivity;  metabolites were also found  in the bronchi, and  non-volatile 
metabolites in the testicular interstitium.  In  the nervous or fatty tissues no non-volatile 
metabolites were observed.  Metabolites were  excreted via urine  (9%) and  bile;  C02 
(30%)  ~as found  as  metabolite  in  exhaled  air  and  about  30%  was  exhaled  as 
chloroform  during  8  h  after  exposure. 
Lehmann et al  (1910)  found 60-70%  retention  in two subjects exposed for 20 min to 
4000-5000  ppm.  Fry  et  al.  (1972)  recovered  18-67%  of the  dose  in  expired  air as 
chloroform within 8 h after oral administration of 0.5 g chloroform to humans. The lower 63 
percentages were obtained with obese persons. Of a dose of 0.5 g 13C-chloroform 48 
and 51%  respectively was  recovered as 
13C02  in  expired air of two human subjects. 
There was a linear relationship between the rate of pulmonary excretion of chloroform 
and  its  concentration  in  blood.  With  smaller  dose  the  percentage  of  chloroform  in 
exhaled  air  was  also  smaller.  The  same  dose-dependency  has  also  been 
demonstrated  in  animal  experiments. 
Pohl  et  al  (1977)  observed  in  vitro  (rat  liver  microsomes)  biotransformation  to 
trichloromethanol,  which  spontaneously  dechlorinates  to  phosgene.  This  was 
confirmed  in  vivo  by  Pohl  et  al  (1979)  in  phenobarbital  pretreated  rats.  Reitz  et  al 
(1979) observed that after correction for metabolic activation in rats and mice a correct 
estimate for the cancer risk could be made, in contrast to estimation from the exposure 
levels as such. This, moreover, resulted in a much lower risk estimate for humans than 
when  extrapolated  from  the  inhaled  concentrations. 
Biological indicators 
According to NIOSH (1974b) only Lehmann et al (1910) studied levels of chloroform in 
exhaled  air after exposure to concentrations  in  air,  however not relevant for present 
day practice (4400 ppm  (21500 mg/m3)  - 30 min; 7200 ppm  (35300 mg/m3)  - 15 min); 
at about 20  min  after exposure the concentrations in  exhaled air were 970 and  1  040 
mg/m
3  respectively.  Other  authors  measured  the  agent  in  blood  in  anaesthesized 
patients. These data are inadequate for proposing an appropriate method for biological 
monitoring  in  workers. 
Conclusions 
At  the  present state  of  the  art  not  even  tentative  conclusions  can  be  presented  for 
biological  monitoring  methods  in  case  of  occupational  exposure. 
Research  needs 
There hardly exist any valid data on biological assessment of exposure. There is need 
for  studies  in  human  volunteers  and  in  workers,  particularly  on  the  relationship 
between  chloroform  poncentrations  in  inhaled  air  and  in  exhaled  air  and/or  blood. 
5.  Tetrachloromethane  (Carbon  tetrachloride) 
Chemical  and  physical  properties 
physical  state 
molecular  weight 
specific  gravity 
freezing  point 
boiling  point 
vapour  density 
vapour  pressure 
molecular formule 
structural  formule 
1mg/m3  = 0.159  ppm;  1 ppm 
Effects on humans 
colorless  liquid 
153.8 
1.59  25°/4°C 
-22.6°C 
76.8°C 
5.3  (air  =  1) 
91  m  Hg  at.  20°C 
CCI4 
Cl "'-.  /CI 
c 
c1/ 'c1 
=  6.29  mg/m3  at  25°C  and  760  mm  Hg 
In  addition to non-specific narcotic effects on the central nervous system (the narcotic 
properties  are  weaker  than  for  trichloroethylene  and  chloroform)  mild  to  moderate 
irritative  effects  on  skin  and  mucous  membranes,  non-specific effects  (e.g.  nausea, 
colic, diarrhoea) on the gastro-intestinal tract may occur. The most important more or 
less specific effects are those on  liver and  kidney function.  Liver damage may result 64 
from either short term high level or longterm low level exposure: necrosis and cirrhosis. 
Renal  impairment is  a common  feature;  it  may exist in  the  absence of demonstrated 
liver effects. The liver and kidney impairment is enhanced by ingestion of ethanol and 
other  aliphatic  alcohols. 
Liver  and  renal  function  tests  are  regarded  to  be  the  most  sensitive  and  practical 
methods to  detect early  health  impairment.  In  acute  exposure  both  liver and  kidney 
function  may  be  most  critical,  in  chronic  exposure  liver  effects  are  predominant. 
Stewart  and  Witts  (1944,  quoted  by  WHO  1979)  noted  a  high  incidence  of 
gastro-intestinal  symptoms  in  workers  exposed  under  wartime  conditions:  severe 
nausea, vomiting, colic, diarrhoea, with  relief during brief episodes of absence. Similar 
findings were reported by Kazantkis et al  (1960) in workers exposed to concentrations 
ranging  from  48  to  about  1  00  ppm. 
According to  WHO  (1979)  measurement of serum enzym  activities provides the most 
useful  practical  indicator  of  early  changes  in  liver  function,  although  according  to 
Stewart et  al  (1961)  urinary urobilinogen  and  serum  iron  might  be  a more  sensitive 
indicator. Ornithine carbamyl transferase  (OCT)  is considered to  be the most specific 
enzyme  for  the  liver,  but  in  practice  application  meets  difficulties.  Lactic 
dehydrogenase  isoenzymes  (LDH4  and  LDH5)  and  sorbitol  dehydrogenase  (SOH) 
appear to  be  also  reasonably specific.  The  less  specific cytoplasmic enzymes  SGPT 
and SGOT have also shown a good sensitivity for liver changes; SGPT appears to be 
preferred for monitoring early effects  in  long term  low-level exposure; SGOT is  more 
transient  because  of  a  shorter  half  life  (WHO  1979). 
IARC  (1979)  reviewed  the  carcinogenic properties of carbon  tetrachloride.  In  several 
animal  experiments  liver  tumours,  including  hepatocellular  carcinomas  have  been 
induced.  There  exists sufficient evidence that carbon  tetrachloride  is  carcinogenic in 
experimental  animals.  No  epidemiological  studies  are  available  to  assess  human 
carcinogenicity;  however,  a few  case  reports  described  appearance of liver tumours 
associated with cirrhosis,  following  rather short term exposure to carbontetrachloride. 
IARC concluded that it is reasonable to regard carbon tetrachloride as if it presented a 
carcinogenic  risk  to  humans. 
Metabolism 
There only exist few studies on  metabolism. Carbon tetrachloride is readily absorbed 
by the lungs and the gastro-intestinal tract. The blood/air and fat/air partition coefficient 
at  37°C  are  about  1  0-12  (Sato  and  Nakajima  1979;  Lindqvist  1978)  and  about  400 
(Sato and  Nakajima, 1979; Droz and  Fernandez 1977) respectively. 
Stewart and  Dodd  (1964)  detected  carbon  tetrachloride  in  exhaled  air of  3 subjects 
within  1  0 min following immersion of the thumb for 30 min  in the solvent; the concen-
tration  in  exhaled  air increased during exposure,  continuing  to  rise  in  the  10-30 min 
interval following exposure. The concentration was followed till 5 h after exposure. The 
concentration in exhaled air would be equivalent to a 30 min vapour exposure to 2.5-12 
ppm. The uptake through topical application to both hands for 30 min was estimated to 
be equivalent to respiratory exposure to about 10 ppm for 3 h. 
Studies with  repeated  respiratory or dermal exposure in  volunteer studies or in worke 
have  not  been  carried  out. 
When  carbontetrachloride  is  administered  together with  fat,  the  intestinal  absorption 
and  pulmonary  elimination  increase,  ethanol  also  increases  slightly  absorption. 
Bergman (1979) studied the distribution and elimination of carbon tetrachloride in mice 
by means of whole body autoradiography. Carbon tetrachloride had a high  affinity for 
nervous and  adipose tissues; carbon tetrachloride was retained for a longer period of 
time  than  any  other  chlorinated  solvent  studied  (methylene  chloride,  chloroform, 
carbon  tetrachloride).  Biotransformation  mainly  takes  place  in  liver  and  kidney; 
accumulation of nonvolatile radioactivity takes place in these organs. Metabolites were 
also  localized  in  the  bronchi,  non-volatile  metabolites  were  noted  in  testicular 
interstium; 
14C02  was identified as a metabolite in exhaled air. Within 8 after exposure 
about  70%  of  the  dose  was  unchanged  in  exhaled  air  and  about  4.5%  as  C02. 
Monkeys breathing a concentration of 46 ppm carbontetrachloride for 139-349 minutes 
retained  30.9%  of  the  inhaled  amount.  One  monkey  inhaling  46  ppm  14C-carbon 
tetrachloride  for  344  minutes  exhaled  40%  and  11 %  of  the  absorbed  amount  as 
unchanged 
14C-carbon  tetrachloride  and 
14C02  respectively  during  1800  hrs  after 
exposure  (McCollister  et  al  1951 ). 
Metabolism  of  carbon  tetrachloride  is  almost  unknown.  The  formation  of  CCI3  -
radicals  is  assumed  to  be  the  initial  step  in  the  biotransformation,  the  radicals 65 
subsequently  bind  irreversibly  to  cellular  macromoleculars  and  initiate  lipid 
peroxidation. This formation of the radicals is supported indirectly by the appearance of 
small  amounts  of  chloroform  and  hexachloroethane  (a  dimerization  product  of 
CCI3-radicals)  in  tissue of rabbits  after administration of carbon tetrachloride (Fouler, 
1969). 
Biological indicators of exposure 
In exposure of 6 healthy subjects to two times 10 ppm for 3 h (Stewart et al  1961) the 
concentration in mixed exhaled air was 2-3 ppm at the end of exposure, 0.7 ppm at 1 h 
and about 0.25-0.3 ppm at 5 h after exposure. In a group of 6 subjects exposed to 49 
ppm for 70 min the levels in mixed exhaled air were 14 ppm at o h,  1. 7 ppm at 1 h and 
0.3 ppm  at 5 h after exposure.  In both conditions the  limit of detection (0.2 ppm) was 
achieved at 6 h after exposure. The agent was not detected in blood or urine (detection 
limit  5  mg/1). 
Stewart  et  al  (1963)  examined  a  case  of  ingestion  of  carbon  tetrachloride  and 
methanol; in exhaled air about 300 ppm was found 3-5 h after ingestion, 21/2 week later 
the  concentration  was  about  0.3  ppm. 
Very probably measurement of carbon tetrachloride in exhaled air will be the method of 
choice.  However,  the  data  available  do  not  allow  to  propose  a  reliable  relationship 
between  concentration  and  duration  of exposure  and  the  level  in  exhaled  air.  There 
does  not  seem  to  be  any  possibility to  base  biological  assessment of  exposure  by 
measurement  of  metabolites  in  urine  or  carbon  tetrachloride  in  blood. 
Methods of measurement carbon tetrachloride are presented by Stewart et  al_ (1961 ). 
Because  of the  rather  slow elimination  in  exhaled  air one  shouJd  not  take  samples 
immediately  after  exposure;  serial  analysis  over  a  period  of  time  will  be  most 
promising. 
Conclusions 
At  the  present state  of knowledge,  no  reliable  indicators for  biological  monitoring  of 
workers  exposed  to  carbon  tetrachloride  can  be  proposed.  Very  probably  serial 
analysis  of the  concentration  in  exhaled  air will  prove  to  be  the  method  of choice. 
Research  needs 
There  is  need  to  study: 
- the  relationship  between  concentrations  in  air/duration  of  exposure  and  serial 
concentrations  in  exhaled  air;  , 
- rather  specific  early  indicators  of  impairment  of  liver- and  kidney  functions; 
- the  effect of factors  not related  to  carbon  tetrachloride exposure on  the  biological 
indicators,  e.g.  intake  of  ethanol  and  drugs,  sex,  age. 
6.  1  ,2-Dichloroethane  (ethylene  chloride,  ethylene 
dichloride) 
Chemical  and  physical  properties 
physical  state 
molecular  weight 
specific  gravity 
melting  point 
boiling  point 
vapour  density 
molecular  formula 
structural formule 
colorless  oily  liquid 
98.9 
1.25  (20°C) 
-35.4°C 
83.5°C 
3.42  (air  =  1) 
C2H4CI2 
~  f;i 
CI-C-C-CI 
H  R 
1 mg/r:n3  =  0.24 ppm; 1 ppm  = 4.11  mg/m3 at 26°C and 760 mm Hg. 66 
Effects  on  humans 
Only few quantitative data on effects on  humans are available. Reviews are published 
by  NIOSH  (1976)  and  IARC  (1979). 
1  ,2-Dichloroethane  may  exert  a  variety  of  effects;  a  specific  critical  effector  organ 
cannot be given. Exposure may affect the circulatory, respiratory and nervous systems, 
liver,  kidney,  skin  and  mucous  membranes.  Acute  exposure  has  often  resulted  in 
death;  in  fatal  cases the signs and  symptoms usually start with  headache,  dizziness, 
nausea, vomiting, anorexia, tenderness or pain in the epigastrium, tachycardia, leading 
to cyanosis and coma, and finally to respiratory, circulatory or kidney failure.  In autopsy 
pulmonary oedema, congestion of visceral organs and haemorrhages into most organs 
were  observed.  Fatalities  have  also  occurred  without  preceding  narcosis. 
Ac~ording to  Byers  (1943,  quoted  by  NOISH  1976)  the  worst symptoms  may  occur 
with a certain delay in the evening after a day's work in case of exposure to about 1  00 
ppm.  Rosenbaum  (1947,  quoted  by  NIOSH  1976)  did  not  observe  any  changes  in 
blood  or  internal organs,  but increased lability of the vegetative nervous system,  and 
frequent symptoms of fatigability,  irritability and sleeplenessness were reported in  100 
workers  exposed  for  6  months  to  5  years  to  levels  below  25  ppm. 
Shchepotin and  Bondarenko (1978) examined 248 patients with acute poisoning; they 
distinguished  four  different  clinical  syndromes:  toxis  encephalopathy  (63. 7%)  acute 
gastro-enteritis  (84.6%),  hepatopathy  (35.4%)  and  acute  circulatory  insufficiency 
(57.7%).  Akimov  et  al  (1978)  described  in  14  fatal  cases  cerebral  oedema, 
haemorrhagy,  ischemia  and  myeline  degeneration. 
IARC  (1979)  concluded  that  sufficient  evidence  exists  that  1  ,2-dichloroethane  is 
carcinogenic  in  mice  and  rats  (oral  administration  by  gavage):  malignant  tumour  in 
lung,  liver,  mamma,  uterus,  stomach  and  haemangiosarcoma.  In  the  absence  of 
adequate  data  in  humans,  it  appeared  to  be  reasonable,  for  practical  purposes,  to 
regard  1  ,2-dichloroethane as  if it  presented a carcinogenic risk to  humans.  However, 
IARC did  not yet take into account negative findings in  rats  and  mice with  respiratory 
exposure for 2 years to 5,  10, 50 or 250 ppm, reported by Maltoni (1977) and absence 
of skin tumours after topical application for over one year in mice by Goldsmidt (1978). 
Metabolism 
In  rats exposed to 220 or 800 ppm  Sopikov and Gorshunova (1979) measured after 3 
h  20  and  56  mg  dichloroethane/L  in  blood  respectively.  The  pulmonary  retention 
decreased during exposure from  70% at 15 min to 10% at 3 h.  According to Sato and 
Nakajima  (1979)  the  partition  coefficient of dichloroethane between  blood-air is  19.5 
and  between blood-fat 447.  Sopikov and  Gorshunova (1979)  found  a similar partition 
coefficient  for  blood-air.  They  also  studied  the  procentic  relationship  between  the 
concentrations in  blood (as  100%) and that in  various organs, e.g.  liver 80%, kindney 
44%,  spinal  nervous system 70%,  medulla 57%,  brain  15-20%. After oral dosage in 
rats  the  biological  half-life  of  the  dichloroethane  level  in  blood  was  88  min  and  in 
exhaled  air  76  min. 
Hofmann et al  (1971) and  Yllner (1971) established that biotransformation takes place 
in  liver  microsomes  as  follows:  1  ,2-dichloroethane  ~ chloroethanol  ~ 
chloroacetaldehyde ~  monochloroacetic acid  ~  glycolic avid ~  oxalic  acid.  In  mice 
receiving  i.p.  50-170  mg/kg  b.w.  labelled  dichloroethane,  10-42%  was  exhaled 
unchanged and  12-4.2% as C02, depending upon the dosage; most of the  remainder 
was  excreted  as  chloroacetic  acid,  S-carboxymethylcysteine  and  thiodiacetic  acid 
(YIIner,  1971 ). 
In two cows, which received  1.75-17.5 mg/kg b.w.  in their food for 22 days Sykes and 
Klein  (1957,  quoted by NIOSH  1976) detected the agent in  the  milk (0.13-0.35 mg/1); 
there  was  no  clear  gradient  with  dosage  or  duration  of  exposure. 
Urusova (1953, quotes by NIOSH 1976) analysed the 1  ,2-dichloroethane concentration 
in  milk  and  in  exhaled  air  of  women  occupationally  exposed  to  15.5  ppm  for  an 
unspecified period of time; near to the end of the workday the concentration in exhaled 
air was reported to be 14.5 ppm, and in milk 5.4.-6.4. mg/1, at 18 h after work the levels 
were  respectively  2-4  ppm  and  1.95-6.3  mg/1. 67 
Biological  indicators  of  exposure 
Very  few  studies  have  been  performed  in  humans.  On  the  basis  of  limited  animal 
experiments  one  may  expect  that  measurement  of  1  ,2-dichloroethane  and/or  its 
metabolites  in  exhaled  air,  blood  and/or  urine  offer  possibilities  for  biological 
monitoring. 
Conclusions 
Possibilities  for  biological  monitoring  of  exposure  to  1  ,2-dichloroethane  exist: 
measurement of the agent in  exhaled air or in blood,  or of its metabolites in  blood or 
urine.  However,  reliable  studies  in  humans  do  not  exist. 
Research  needs 
There is need to study the toxicokinetics in  humans, with the objective to evaluate the 
relationships  between  concentrations  in  air/duration  of  exposure  and  biological 
indicators  of  exposure,  and  this  for  exposure  up  to  about  20  ppm. 
7.  1,1,1-Trichloroethane (methylchloroform,  MC) 
Chemical  and  physical  properties 
physical  state 
molecular  weight 
specific  gravity 
freezing  point 
boiling  point 
vapour  density 
vapour  pressure 
molecular formula 
structural formule 
mg/m3  =  0.183 ppm;  1 ppm  = 
Effects  on  humans 
colourless  liquid 
133.4 
1.34  25°/4°C 
-30.4°C 
74.1°C 
4.6.  (air  =  1) 
127  mm  Hg  at  25°C 
CH3CCI3 
H........  PI 
H-C-C-CI 
H .- Cl 
5.46 mg/m3 at 25°C and 760 mm Hg 
1,1, 1-Trichloroethane  has  non-specific  narcotic,  irritative  and  degreasing  porperties, 
common  to  all  chlorinated  hydrocarbon-solvents. 
Stewart et al (1961) exposed groups of 6 to 7 subjects to 500 ppm -78  min: only sight 
transient irritation of eyes was  observed; to  496 ppm- 186 min:  no effect on  well-
being,  equilibrium,  coordination;  to 900-955  ppm  for 73  min  (3  subjects),  35  min  (2 
subjects), 20 min (2 subjects): evidence of disturbed equilibrium was present in a few 
subjects.  Salvini et al  (1971) exposed 6 subjects to 400-500 ppm for 8 h (1.5 h inter-
ruption): only in the first 30 min a few complaints of dizziness and slight excitation were 
mentioned;  in  various performance tests only a decreased tachistoscopic perception 
carried out under mental stress was observed; in exposure to 350 ppm no effects were 
seen. Gamberale and Hultengren (1973) exposed 12 subjects to subsequently (30 min 
periods)  250,  350,  450  and  550  ppm,  total  120 min;  they  examined  reaction  time, 
perception speed and manual dexterity. At 350 ppm (at 1/2-1  h) a transient decrease in 
performance was observed, but not at 250 ppm (at 0-1/2 h). Stewart et al (1975) expo-
sed 10 male subjects in an extensive testing programme: 0 100 350 and 500 ppm for 
1  ,3 and 75 h 5 d/wk; and  10 females only to 0 and 350 ppm for 1  ,3 and 7.5 h, 5 d/wk. 
Only in exposure to 500 ppm, 5 d/wk, changes in the EEG were observed at day 5.  In 
exposure to  ~ 350 ppm  a moderate to  strong  odour was  noted,  decreasing during 
exposure.  There were no effects on  haematological and  biochemical parameters,  no 
neurological effects,  no  effects on  lungfuncion  (only slight decrease in  diffusion),  no 
effects in various performance tests, and only slight increase in some subjective symp-
toms was observed. The authors concluded that in exposure of males to 500 ppm, 7.5 68 
h/day,  5 d/wk in  rest no evidence of health  impairment was observed,  except some 
changes in the EEG. 
In various studies hardly any effects on liver- and kidney functions were observed. 
In  studies in  workers Saki et al  (1975),  Maroni et al  (1977) and  Kramer et al  (1978) 
observed no exposure. dependent effects on liver function. 
There is no evidence of carcinogenicity. IARC (1979) concluded that the available data 
did not permit an evaluation of the carcinogenicity of 1, 1,1-trichloroethane to be made. 
Metabolism 
Up~ke 
By the lungs. The retention and the uptake (lungclearance, LC) decrease quickly in the 
course of exposure at rest (Table 3). Because the solubility in blood of MC is small, the 
uptake decreases quickly; the release to metabolism is small.  The uptake during the 
first exposure hour was twice as high as during the fourth exposure hour (Monster et al 
1979b). 
TABLE 3: Uptake by the lungs of MC at rest 
time after start of exposure 
min  h 
Reference  0  10  30  60  4  8 
Humbert and 
Fernandez 1977  alveolar retention (R)  0.42  0.37  0.28  0.24 
Monster et al  1979b  alveolar retention (R)  0.75  0.51  0.47  0.39  0.30 
Monster et al  1979b  lungclearance (LC,I/min)  6.0  3.7  3.0  2.5  1.9 
The  blood/air  and  fat/air  partitioncoefficients  at  37°C  are  3-6  and  about  360, 
respectively (Astrand 1975,  Lindqvist 1978, Monster 1979, Sato and  Nakajima 1979, 
Droz  and  Fernandez  1977). 
Workload during exposure increases the uptake (Table 4); the retention decreases, but 
the minute volume increases faster.  The uptake during 100 Watt workload was 2-2.5 
times that at rest,  but during the first workload  (after 1 h exposure)  the  uptake was 
30% higher than the uptake during the second workload (after 3 h exposure): LC was 
6.0  and  4.5  1/min,  respectively  (Monster  et  al  1979b). 
TABLE 4: Uptake by the lungs of MC during workload (Astrand et al1973) 
workload (30 min exposure) 
test  rest  sow  100W  150W 
alveolar retention (R)  0.80  0.62  0.50  0.40 
alveolar minute volume (1/min)  6.6  22.  36  55 
lungclearance (LC, 1/min)  5.3  13.6  18  22 
Through  the  skin.  Immersion  of  one  hand  in  liquid  MC  over 
1
/2  h  resulted  in  a 
concentration  of  MC  in  alveolar  air,  comparable  with  the  concentration  after  a 
respiratory  exposure  to  50-250  ppm  (275-1365  mg/m
3
)  for 
1
/2  h.  Immersion  of  one 
thumb in  liquid MC  resulted in  1/20 of the concentration of alveolar air obtained after 
immersion  of one  hand  in  liquid  MC.  About  the  same concentrations  in  alveolar air 
were obtained after repeated immersions of one hand in liquid MC for 60 time in 
1
/2 h 
(Stewart and  Dodd  1964).  On  the  basis of the alveolar concentration  Fukabori et al 
(1976,  1977) came to the conclusion that application of liquid MC over 2 h to 12.5 cm
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of forearm skin or immersion of both hands in liquid MC  11  times for 1  0 min would be 
equivalent to a 2 h exposure to 10-20 ppm (55-11 0 mg/m3)  MC of vapour. Despite the 
large  range  in  absorption  rate  between  the  experiments,  we  can  conclude  that 
absorption  through  the  skin  during  normal  industrial  work  will  be  small  compared  to 
that  in  respiratory  exposure. 
When  subjects,  dressed  in  pyjamas,  socks  and  a full  face  piece  respiratory,  were 
exposed to  MC vapor the amount of MC expired postexposure was only 0.1% of the 
amount  that  should  be  expired  in  exposure  to  the  same  concentration  without  a 
respirator  (Riihimaki  and  Pfaffli  1978). 
Biotransformation 
We  assume that a small  amount of MC  absorbed into the  body is biotransformed by 
hydroxylation  to  trichloroethanol  (TCE);  subsequently,  partial  oxidation  of  TCE  to 
trichloroacetic  acid  (TCA)  will  take  place. 
The half-life of MC in blood and expired air depends on the length of exposure and on 
the  time  of  sampling  after  exposure.  The  concentration  follows  a  multi-exponential 
curve.  The  toxicokinetic  behavior  of  TCE  and  TCA  is  similar  after  exposure  to 
trichloroethylene,  although  the  concentrations  are  much  lower.  TCE  reaches  the 
maximum  concentration  in  blood  and  urine  almost  directly  after  exposure  and 
decreases with  a half-life of about  10-15  h.  The  concentration  of TCA  in  blood  and 
urine  increases  up  to  20-40  h  after  single  exposure.  Thereafter  the  concentration 
decreases  with  a  half-life  of  about  70-100  h (Monster  et  al  1979b). 
Recovery 
The percentage of the uptake, excreted as  MC  in expired air and-as TCE and TCA in 
urine are presented in Table 5.  We may conclude that MC is almost totally exerted by 
expiration; only small  amounts  were  excreted  in  urine as TCE  (2%  to  5%) and  TCA 
(1%  to  2%). 
TABLE 5 : Percentage of the amount taken up excreted as MC in  expired air and as 
trichloroethanol (TCE) and trichloroacetic acid (TCA)  in  urine 
Reference 
Humbert  and  Fernandez  1977 
Monster  et  al  1979b 
Biological indicators 
Human volunteer studies 
expired  air  (%) 
MC 
97  (88  - 106) 
60-80 
Concentrations of trichloroethane in exhaled air 
urine  (%) 
TCE  TCA 
4.6  1.7 
2  1 .5 
Table 6 summarizes data from  various studies; the concentrations after exposure in 
alveolar air (Ce) are expressed as a percentage of the inhaled concentration (Ci) and 
arranged  according  to  the  length  of  exposure. 
The  following  conclusions  may  be  drawn  from  this  table: 
I 
- The concentration in  alveolar air decreases quickly in the first  1/2  h after exposure 
from  60%  to  80%  (end  of  exposure,  Table  3)  to  10%  to  20%  of  Ci. 
- As  duration  of  exposure  increases,  the  relative  concentration  in  alveolar  air  is 
higher,  more  pronounced  when  the  sampling  after  exposure  occurs  later.  After 
exposure at rest for 6-8 h the mean concentration in alveolar air is about 19% C  /2 
h),  15%  (1  h),  2.4%  (16  h)  and  0.6%  (64  h),  respectively.  After exposure while 
resting for 6-8 h, over 5 days, the mean concentration is about 30% C/2 h), 20%  (1 
h),  4  (16  h),  and  1 (64  h)  of  Ci,  respectively. 
- Workload  during  exposure  increases  the  concentrations  in  alveolar  air over  the 
whole  postexposure  period. 70 
TABLE 6:  Concentration of MC  in  alveolar air (Ce)  after exposure as  percentage of the inhaled 
concentration  (Ci) 
Reference  Number  Mean  Ce  as  %  of  Ci 
of  Ci  Time 
subjects (ppm)  (h)  1 /2 h  1 h  2  h  16  h  64h  120 h 
Stewart  et  al  (1975)  4  350  5x1  9  6  3  0.4  0.2 
Fukabori  (1970)  4  195  2  11  5  3.5 
4  376  2  9  6  3.2 
4  558  2  12  7  4.8 
4  831  2  9  5  3.3 
Astrand  et  al.  (1973)  4  250+WL
8  2  16  12  6  0.8 
5  250/350+  WL  b  2  17  13  3  0.6 
Salvini  et al  (1971a)  6  600  3  13  10  1.5  0.25  0.08 
Stewact  et  al  (1969)  11  507  3  10  0.8 
Stewart  et  al  (1961b)  3  496  3  13  6  4.4  0.7 
Stewart  et  al  (1975)  4  350  5x3  17  11  7  1.0  0.4 
Monster  et  al  (1979b)  6  70  4  15  10  7  0.58  0.07  0.03 
6  140  4  14  11  6  0.58  0.10  0.03 
6  140+Wlc  4  16  12  8  0.66  0.09  0.03 
Stewart  et  al  (1969)  6  482  61/2-7  14.5  2.1  0.40 
Humbert and  Fernandez  (1977)  3  72  8  22  14  11  2.8  0.63  0.17 
2  213  8  20  16  12  2.8  0.66  0.16 
Stewart  et  al.  (1969)  5  507  5x61 /2-7  20  4.5  1.2  0.55 
Rowe  et al.  (1963)  4  370  5x7  15  3.8  2.2 
Stewart et al.  (1975)  4  100  5x71 /2  35  28  20  4.5  0.7 
4  350  5x1 /2  26  20  13  3  0.6 
4  350fem.  5x71 /2  23  14  7  2  1.0 
4  350 flue.  5x71 /2  29  23  16  3  0.9 
4  500  5x71 /2  40  30  17  2.4 
a1 /2 h rest, 1 /2 h 50 Watt, 1/2  h 100 Watt, 1/2  h 150 Watt 
b1 /2 h 250 ppm, 1/2  h 350 ppm,  1/2  h 250 ppm+ 50 Watt, 1 /2 h 350 ppm+ 50 Watt 
e During exposure 2x1 /2  h 100 Watt workload 
tern= female 
flue= wide fluctuation(± 150). 
Trichloroethanol in  expired air 
As in exposure to trichloroethylene, TCE can be measured in expired air (Monster et al 
1979b);  the  concentration  of  TCE,  however,  is  much  smaller  than  in  exposure  to 
trichloroethylene  under comparable  conditions  of  exposure. 
Excretion of metabolites (trichloroethanol and trichloroacetic acid) in urine 
In two investigations (Humbert and Fernandez 1977, Monster et al 1979b) the amounts 
of TCE and TCA excreted in urine after a single exposure were measured. The authors 
came  to  the  same  conclusion:  about  75%  of TCE  was  excreted  within  48  h,  while 
about 75%  of TCA was excreted  within 5 days,  in  concordance to  the differences in 
half-life.  The  amounts  of  TCE  and  TCA,  however,  were  much  smaller  than  after 
exposure  to  trichloroethylene. 
With repeated exposures (n=5) to 500 ppm (2730 mg/m3) of MC, 7 h/day, over 5 days, 
a slow increase was found in the amounts of TCE excreted in 24 h urine: the first day 
about 20 mg, the fourth day about 50 mg, and 5 days after the last exposure still about 
7 mg was found (Stewart et al  1969). There was hardly an increase in the TCA excre-
tion; the amount of TCA excreted in urine before exposure, however, was high: 15 mg 
in 24 h. With repeated exposures (n =2) to 420 ppm (2300 mg/m3) of MC 2 h/day, over 
3 days, a maximum excretion of 7 mg TCA per 24 h was found on the fifth day after the 
start  of  the  exposure  (Tada  1969). 
Concentrations of MC,  trichloroethanol and trichloroacetic acid in blood 
In  a serie of experiments in  which volunteers were exposed  subsequently to various 
conditions (250 or 350 ppm  (1365-1900 mg/m3)) at rest or with  physical activity of 50, 
1  00 or 150 Watt the arterial  and  venous blood concentrations of MC were measured 
(Astran·d et al  1973). During exposure there was a linear relation between the concen-
tration  in  alveolar air and  in  arterial  blood.  The concentration  in  blood  was  about 5 
times the concentration in alveolar air. The concentration in venous blood was somew-
hat lower than  in  arterial  blood.  The difference in  concentration between arterial and 
venous  blood  was  the  smallest  at  the  highest  physical  activity  (150  Watt). 
In a serie of experiments in which volunteers were exposed to 70 or 140 ppm (380-764 
mg/m3)  of MC for 4 h,  the concentrations in blood of MC, TCE and TCA were measu-71 
red  (Monster et al  1979b). The blood concentrations of MC in the postexposure period 
(up to 64 h) ran parallel to those in alveolar air. The concentration in blood was 5 times 
higher than  in  alveolar air.  The kinetic behaviour of TCE  and  TCA in  blood  was  the 
same  as  in  exposure  to  trichloroethylene;  the  concentrations,  however,  were  much 
lower. 
In the experiments in which volunteers were exposed to 100, 350 or 500 ppm of MC for 
1  ,3 or 7
1
/2  h. Stewart et al (1975) measured concentrations of MC in blood. In exposu-
re  to  350 ppm  for 71/2  h/day,  5 days/week the  blood  concentrations  were 0.27 mg/1 
(before next exposure),  6.06 mg/2 (4  h),  6.44 mg/2 (pre exit)  and  5.06  mg/1  (15  min 
post  exposure)  respectively. 
Conclusions from experiments 
MC in alveolar air and blood in the first hours after exposure indicate recent exposure 
concentrations;  the concentrations  next  morning  indicate the  time  weighted  average 
(TWA)  concentration  over the  preceding  day(s)  and  the concentrations after a wee-
kend probably indicate the TWA over the preceding week.  TCE in  exhaled air,  blood, 
and urine in the first hours after exposure and the next morning indicate the TWA over 
the preceding day(s). For TCA in blood and urine the time of sampling is not so impor-
tant;  it  indicates  the  TWA  over  the  preceding  week. 
Extrapolation from human volunteer studies to Industrial exposure 
As in exposure to trichloroethylene the results of the volunteer studies can be used for 
extrapolation to concentrations to be expected in occupational (weekly) exposure. 
The results of the single exposure experiment - 70 ppm (380 mg/m3)  exposure to 50 
ppm  (275  mg/m3)or MC  4 h (Monster et a I 1979 b)  were  used f9r extrapolation to  a 
TWA, 8 h/day, 5 days/week. The estimation of TCE  and TCA urine concentrations at 
the end of the workshift (at the  latter part of the week)  is  shown  in Table 7,  together 
with the concentrations in  urine extrapolated from the repeated exposure experiments 
to  500  ppm  (2750  mg/m3)  of  MC,  7  h,  5  days  (Stewart  et  al  1969). 
The MC concentrations in alveolar air to be expected in exposure to a TWA exposure 
to 50 ppm (275 mg/m3)  can  be estimated from the mean concentrations measured in 
the volunteer studies after exposure at rest for 6-8 h,  5 days (Table 6),  and are about 
15 ppm (80 mg/m
3
)  at 
1
/2 h after exposure, about 2 ppm (11  mg/m
3
) at 16 h, and about 
0.5  ppm  (3  mg/m3
)  at  64  h  after  exposure. 
Caperos et al  (1982) simulated absorption and excretion of MC as well  as the forma-
tion and elimination of TCE and  TCA by a mathematical model.  They concluded that 
theoretically the  most suitable method to  estimate the exposure is by two determina-
tions, before and after a work shift. Following this procedure, analysis of TCE in  urine 
is more sensitive than determination of MC  in breath. TCA is  not sensitive enough to 
provide  an  estimate  for  the  average  exposure  during  one  day. 
TABLE 7: Estimated trichloroethanol (TCE) and trichloroacetic acid (TCA) concentrations in urine 
at the end of the workday in subjects exposed to 50 ppm (275 mg/m3) of MC 8 h/day, 5 
days/week 
TCE  TCA 
Reference  mg/g creatinine  mg/g creatinine 
From experiments 
Monster et al 1979b  -6  -2 
Stewart et al  1969  -4  -1.3 
From industrial studies 
Seki et al 1979  9.9  3.6 
Tada 1969  5  mg/1 
Industrial  expo~ure studies 
Seki et al  (1975)  measured the urinary metabolites (in  mg/1)  in  the latter part of the 
workweek in workers from 3 printing plants. 72 
The  workers  were  exposed to  MC  for  51/2  days/week,  8 h/day.  There  was  a  linear 
relationship between the mean MC concentration in air and the mean metabolite con-
centration in  urine.  Although the concentrations of TCE  and  TCA were given in  mg/1, 
almost  the  same  values  are  to  be  expected  in  mg/g  creatinine,  because  for 
TCE  +  TCA the values in mg/1 and in mg/g creatinine were almost the same. In Table 
7 the concentrations in  urine are shown for 1  0 workers exposed to  53 ppm  (290 mg/ 
m 3)  of MC. 
Tada (1969) collected  urine  from  15 workers  in  a printing  plant exposed to 37 ppm 
(200 mg/m3)  of MC, 7 h/day. The mean TCA exretion was 3.4 mg/1;  recalculation to an 
exposure to 50 ppm (275 mg/m3) of MC resulted in an excretion of about 5 mg/1 (Table 
7). 
Nakaaki et al  (1978) descibed an  investigation in a printing plant. They compared du-
ring  exposure the inhaled MC concentration with the expired concentration.  After 3 h 
exposure the MC concentration in expired air was about half the inhaled concentration. 
After  6  h exposure  the  expired  MC  concentration  was  almost  equal  to  the  inhaled 
concentration. 
Recently Monster et al (in press) investigated exposure to MC in 4 workshops. About 8 
workers were followed up in each workshop. During a whole normal workweek exposu-
re to MC was measured with personal air samplers. The average exposure during the 
whole week per subject was between 2 and 70 ppm  (11-380 mg/m3). The day to day 
variation was large: in one third of the subjects the highest daily average was 5 times 
or more  greater than  the  lowest  daily  average. 
During  that  week biological  specimens were collected  (blood,  alveolar air,  urine)  on 
Monday morning, Wednesday morning and evening, Friday morning and evening, and 
again  on  Monday morning.  From  the relations between the exposure magnitude  (as 
TWA concentration) and the concentrations in biological specimens, the mean concen-
trations in  the biological specimens can be estimated for a TWA exposure to 50 ppm 
(275  mg/m3)  of  MC  8  h/day,  5  days/week  (Table  8). 
TABLE 8: Mean concentrations of MC, trichloroethanol (TCE) and trichloroacetic acid (TCA) in 
blood, alveolar air and urine in subjects exposed to a TWA concentration of 50 ppm (275 mg/m
3
) 
of MC, 8 h/day, 5 days/week 
Time  of sampli[lg  after exposure 
Test  end  of  5-15 min  16 h  64h 
exposure 
Blood  (mg/1) 
- MC  0.9  0.07 
- TCE  0.16 
- TCA  2.3  1.6 
Alveolar  air 
- MC,  mg/m3  (ppm)  210(39)  13(2.4)  8(1.5) 
- TCE  mg/m3  0.014  0.007 
Urine  (mg/g  creatinine) 
- TCE  4.9  2.5  0.9 
- TCA  2.5  1.8  1.4 
The results indicate that on Monday morning TCA and MC in blood and TCE in  urine 
seem  to  be  relatively good parameters for estimation of the mean weekly exposure. 
TCA in blood on Friday evening also seems to be a reasonable parameter for estima-
tion of the mean weekly exposure. TCE in  urine, blood and alveolar air at the end of 
the workday and the next morning are usable for estimation of the TWA exposure of 
the preceding day. The variation between individuals became much smaller when the 
TWA exposure was estimated over the preceding 2 days. MC in blood and alveolar air 
at the  end  of the  workday and  the  next  morning  seems to  represent  only  a  rough 
estimation of the exposure (large variation  between individuals with  about the same 
TWA exposure). The concentrations of TCE and TCA in urine at the end of exposure 
are somewhat lower than those found by Seki et al (1975) and Tada (1969). This can 
partly be  explained by differences in analysis: Monster et al  used a specific gaschro-
matographic method, while Seki et al and Tada used a nonspecific spectrophotometric 
method  (Fujiwara  reaction). 73 
The mean  concentration of  MC  in  alveolar air 5-15 min  after exposure was only so-
mewhat lower than th·e mean inhaled concentration. The concentrations 16 h and 64 h 
after exposure were somewhat higher those  measured in  the volunteer studies after 
exposure for 6-8 h over 5 days. This difference probably can be explained by a higher 
accumulation of MC  in  (adipose)  tissue with  weekly exposure compared to that with 
only 5  days  exposure. 
Analytical  methods 
Methods for measuring MC in  air and blood have been given by Astrand et al  1973, 
Fukabori et al 1976, Aiihimaki and  Phaffli 1978. 
Methods for measuring TCE and TCA in blood and urine are discussed in the subchap-
ter trichloroethylene. 
Conclusions 
The existing information on MC exposures is limited.  Tentative group average levels of 
1  ,  1, 1-trichloroethane, trichloroethanol and trichloroacetic acid in blood, alveolar air and/ 
or urine  in  occupational  exposure  to  50  ppm,  however,  could  be  presented. 
Research  needs 
More data,  particularly from  repeated  exposure studies  and  from  studies  in  industry 
should be available before an  adequate proposal for biological monitoring can be pre-
sented. 
8.  Trichloroethene  (trichloroethylene,  TRI) 
Chemical  and  physical  properties 
physical  state 
molecular  weight 
specific  gravity 
melting  point 
boiling  point 
vapour density 
vapour  pressure 
molecular formule 
structural  formule 
1  mg/m3  =  0.186  ppm;  1 
Effects  on  humans 
colourless  liquid 
131.4 
1  .45  25°/4°C 
-86.8°C 
+86°C 
4.54  (air  =  1) 
77 'mm Hg  (25°C) 
CICH=CCI2 
H,  /CI 
c  = c 
c1/  'c1 
ppm  =  5.38  mg/m3  at  25°C  and  760  mm  Hg 
The  principal  effects  of TAl are  on  the central  nervous system:  narcotic effects,  as 
induced by organic solvents as such.  In  addition there exists slight to  moderate irrita-
tion  of mucosae of eyes and  airways.  There probably are  no  or hardly any· specific 
effects. When TAl exposure is followed by alcohol consumption,  « degreasers'flush » 
may occur: red blotchs on face, neck, shoulders, due to vasodilatation of skin vessels. 
Overexposure leads to confusion, headache, vertigo, dizziness, tremor,  nausea, slee-
plessness or insomnia, feeling of drunkenness etc. Cardiac failure may occur, particu-
larly in association with mild exercise following exposure to high concentrations. Epide-
miological studies in workers have in general not found functional changes of liver and 
kidney, except in case of preexistent pathology. The odour threshold is above 19 ppm. 
Many research groups have studied early effects on psychophysiological performance. 
Stewart et al  (1970) exposed five human subjects to 200 ppm- 7 h for 5 consecutive 74 
days; this induced in 2 subjects a slightly positive Romberg test, and feelings of fatigue 
at  day 4 and  5.  Salvini  et  al  (1971)  observed  in  6 volunteers  and  in  6 TAl-workers, 
exposed for 8 h to about 100 ppm, transient irritation of the eyes and decreased perfor-
mance;  other studies  at  these  exposure levels  did  not  show  effects on  the  nervous 
system at exposure for 2 to 3 h,  but in exposure of 15 volunteers to  about 300 ppm -
2
1
/4  h there was a trend to decreased performance in the Bourdon-Wiersma test (Ette-
ma et al  1975). In surveys in industry (NIOSH 1978) vague complaints were registered 
from  workers exposed to average 25  ppm  (15-50 ppm).  WHO  (1981)  suggested that 
subjective symptoms were not expected to occur at exposures not exceeding 25 ppm 
as  TWA. 
In  animal  experiments  some  evidence  of carcinogenicity  has  been  observed  (Weis-
sburger 1977); per oral (gavage) administration of 500 or 1000 mg/kg b.w. (TRI in corn 
oil)  in  rats,  1200 or 2400  mg/kg  b.w.  in  male  mice  and  900  or  1800 mg/kg  b.w.  in 
female  mice 5 d/wk for 78  wk  induced hepatocellular carcinomata in  mice,  but not in 
rats (only a slightly increased incidence in female rats). Henscher et al. (1980) exposed 
mice,  rats  and  Syrian  hamsters to  100 or 500  ppm  pure  (not:  technical)  TRI-6 h/d-5 
d/wk-18 months: only in female mice an increased incidence of tumors was observed; 
there was no dose-response relationship. TRI  has weakly mutagenic properties in va-
rious  tests.  Page  (1979)  concluded  that  TRI  should  be  regarded  at  most as  a weak 
carcinogen because of: only liver tumors in one species, weak mutagenicity, only after 
metabolic activation (into an  epoxide),  no evidence of human carcinogenicity.  In  wor-
kers  Axelson  et  al  (1978),  Tola  et  al  (1980)  could  not find  any  evidence of human 
carcinogenicity;  Novotna  et  al  (1979)  did  not  find  an  increased  prevalence  of  TAl-
exposure  amongst  63  cases  of  liver  carcinoma. 
Metabolism 
Uptake 
By the lungs. The influence of the duration of exposure on the uptake is small. After an 
initial decrease in  retention  in  5-15 min the retention remains at the same level  (Mon-
ster et  al  1976,  1979a,  Fernandez et al  1975),  due  to  release  of TRI  from  blood  by 
metabolic processes.  In alveolar air the retention is about 0.75 (Fernandez et al1975), 
but  in  total  (mixed)  exhaled  air  (including  physiological  deadspace)  only  about 0.45 
(Monster et al  1976,  1979a). The resulting lung clearance (LC)  however, is the same: 
4.5.  1/min. The LC,  suggested by Van  Rees (1974), indicates which volume of inspired 
air/min  is  cleaned  from  vapour:  it  is  the  retention  multiplied  with  the  minute volume. 
This product should be preferred as an  indicator of the uptake instead of the retention 
as  such.  · 
Workload  during  exposure  increases the  uptake  (Monster et  al.  1976,  As~rand et  al 
1976); the  retention decreases, but the minute volume increases faster (Table 9).  Du-
ring  1  00  Watt  workload  the  uptake was  2.5-3.0 times the comparable uptake at  rest 
(Monster et al.  1976), but during the first workload (after 1 h exposure) the uptake was 
15%  higher than  during the second workload  (after 3 h exposure):  LC  11.5 and  10.0 
respectively. 
TABLE  9:  Uptake  of TRI  by  the  lungs  during  workload  (calculated  from  Astrand  et al  1976) 
Test 
Alveolar  retention  (R) 
Alveolar  minute  volume,  1/min 
Lungclearance  (LC),  1/min 
rest 
0.80 
6.6 
5.3 
Condition  (after  30  min) 
50 w  100 w  150 w 
0.62  0.50  0.40 
22  36  55 
13.6  18  22 
Through the skin. Immersion of a thumb in liquid TRI during 1/2 h resulted in concentra-
tions of TRI  in  alveolar air comparable with those in  respiratory exposure to about 20 
ppm  (110 mg/m
3
)  for 
1
/2  h (Stewart and Dodd,  1964). There was,  however, a conside-
rable  individual variation in  the  rate  at which  TRI  penetrated the skin.  The amount of 
metabolites excreted after immersion of one hand during  1/2  h in  liquid TRI  was about 76 
one third of the amounts excreted after respiratory exposure to 1  00 ppm C 535 mg/m3) 
during 4 h (Sato et al  1978). The uptake of vapour through the skin is not known,  but 
this  will  probably  be  small. 
The blood/air and fat/air partition coefficients of trichloroethylene at 37°C are 9-15 and 
about 750, respectively (Astrand 1975, Sherwood 1976, Lindqvist 1978, Sato and Na-
kajima  1979,  Monster  1979,  Droz  and  Fernandez  1977). 
Biotransformation 
Figure 1 illustrates the metabolic pathway. The first reaction product is trichloroethyle-
ne oxide.  This  is  transformed  into chloralhydrate.  Chloralhydrate is  partly reduced to 
trichloroethanol (TCE) and partly oxidized to trichloroacetic acid (TCA). After oral admi-
nistration TCE is partly metabolized into TCA (Marshall and Owens 1954, Muller et al 
1974).  TCE  is  most often  conjugated  with  glucuronic  acid  before  being  excreted  in 
urine.  Only  small  amounts  of free  TCE  are  excreted  in  urine  and  in  exhaled  air. 
The half-life of TAl in exhaled air and blood depends upon the length of exposure and 
upon the time of sampling after exposure: the concentration follows a multi-exponential 
curve. After single exposure to TAl, TCE reaches its maximum concentration in blood 
and urine almost directly after exposure. Thereafter the concentration decreases with a 
half-life of about 10-.15 h (Monster et al  1976,  1979a, Muller et al  1974, Vesterberg et 
al  1976).  After single exposure to  TAl the  concentration  of TCA in  blood  and  urine 
increases up to 20-40 h after exposure. Thereafter the concentration decreases with a 
half-life  of about  70-100  h  (Monster  et  al  1979a,  Muller  et  al  1974). 
TCA as such (in oral administration) has a smaller half-life: about 50 h. The half-life is 
somewhat larger in oral administration of TCE and of chloralhydrate and about 85-99 h 
after repeated exposure to TAl, due to  delayed formation of TCA from  TAl and TCE 
still  available  from  the  tissues  (Muller  et  al  1974). 
Cl,  pH 
CI-C-C-H 
Cl
1  H 
l 
TeE-glucuronide 
Cl,  PI 
C  =  C  (TRI) 
c(  'H 
(TCE)  .. 
Figure  1.  Biotransformation  of trichloroethylene  (TAl) 
Recovery 
(chloral hydrate) 
Cl,  jJ 
CI-C-C  (TCA) 
c(  'bH 
After respiratory exposure about 1  0% of the amount taken up is expired unchanged, 
about 30% to 50% is excreted as TCE in urine, and about 10% to 30% as TCA also in 
urine (Table 10). Additional pathways of metabolism and elimination may be operative 
since  in  these experiments the total  recovery accounts for only 50%  to 75% of the 
amount  absorbed. 76 
TABLE 1  0: Percentage of the amount taken up excreted as TRI in expired air and as TCE and 
TCA in urine 
Reference 
Monster  et  al  1976 
Monster  et  al  1979a 
Soul:ek  and  Vlachova  1960 
Bartonil:ek 
Biological  indicators 
Human volunteer studies 
Expired  air 
% 
TRI 
10 
8 
Concentrations  of trichloroethylene  in  exhaled air 
urine 
% 
TCE  TCA 
28-51  7-27 
29-37  10-21 
32-59  10-30 
38-49  27-35 
Table  11  summarizes data from  various studies; the concentrations after exposure in 
alveolar air (Ce) are expressed as a percentage of the inhaled concentration (Ci)  and 
arranged according to the length of exposure. The following conclusions may be drawn 
from  Table  11: 
- The concentration in alveolar air decreases fast in the first half hour after exposure: 
from  about  25%  at  the  end  of  exposure  to  about  5%  of  Ci. 
- As  the duration of exposure increases, the  relative concentration  in  exhaled air is 
higher,  more pronounced when the sampling after exposure occurs later. After ex-
posure at rest for 6-8 h the average concentration in alveolar air is about 6% to 7% 
of Ci  at  1/2  h,  about 4% at 1 h,  about 0.6% to 0.7% at 16 h,  and about 0.15% after 
64  h. 
- Fluctuating  concentrations  influence the  early postexposure concentrations; these 
reflect  the  concentrations  at  the  end  of  exposure. 
At  16  h postexposure  the  alveolar  air concentrations  are  generally in  agreement 
with  the  TWA  exposure  (Stewart  et  al  1974). 
- Workload  during  exposure  increases  the  concentrations  in  alveolar  air  over  the 
whole  postexposure  period. 
- Alcohol  consumption  during  exposure  increases the  concentration  in  alveolar air. 
- The concentration in  alveolar air appears to be somewhat lower in  women than in 
men,  probably  due  to  higher  fatty  mass  in  women. 
- In exposure for 5 days compared to  1 day the results are conflicting. The results of 
Kimmerle and Eben (1973b) show a slight increase of TRI in the early postexposure 
period at consecutive days compared to the first day.  In  the study of Monster et al 
(1979a) only an  increase of the alveolar concentration was found in the concentra-
tion  16  h after each  exposure  at  consecutive  days,  higher in  subjects  with  more 
adipose tissue. The results of Stewart et al  (1974) do not show an  accumulation at 
all  in  alveolar  air  during  the  exposure  week. 77 
TABLE  11  : Mean concentration of TRI  in  alveolar air (Ce) after exposure as percentage 
of the inhaled concentration (CI) 
Number  Average  Mean  Ce  as  %  of  Ci 
of  Ci  Time 
subjects
8  (ppm)  (h)  1/2  h  1 h  2  h  16  h  64h 
Astrand et al 1976  5m  1  00/200+  WL  b  2  6.5  3.7  2.9  0.2 
Astrand et al  1976  Sm  100+Wlc  2  9.4  5.2  3.0  0.4 
Astrand et al  1976  5m  200+Wld  2  9.7  6.4  4.2  0.4 
Nomiyama et al  1971  5m  320  2%  8.1  6.9  4.8 
Nomiyama et al  1971  Sf  320  ~/3  5.1  5.2  3.6 
Stewart et al 197  4  3m  20  5x3  3.5  2.5  1.3  0.35 
Stewart et al 197  4  3m  100  5x3  3.5  2.0  0.9  0.3 
Stewart et al  197  4  3m  100 fluct.  5x3  1.9  2.2  1.2  0.34 
last. c.  200 
Stewart et al  197  4  3f  100  5x3  3.0  1.2  1.1  0.28 
Stewart et al  197  4  3m  200  5x3  3.1  2.1  1.2  0.4 
Stewart et al  1970  2m  200  31 /4  2.0  0.45 
Kimmerle et al 1973b  4  m  42  4  4.3  2.9  1.6 
Kimmerle et al  1973b  4f  42  4  3.6  2.1  1.2 
Kimmerle et al  1973b  4  48 1st day  4  2.9  1.4  0.6 
(3m+1f)  48 5th day  5x4  2.9  1.7  0.9 
Monster et al 1976  4m  70  4  4.5  3.4  2.2  0.27  0.033 
Monster et al 1976  4m  70+WL
8  4  6.0  4.7  3.4  0.34  0.044 
Monster et al 1979a  5m  70 1st day  4  5.2  3.0  2.1  0.17 
Monster et al 1979a  5m  70 5th day  5x4  4.3  3.4  2.5  0.26  0.039 
Stewart et al  197  4  2m  100  4  3.6  0.4 
Stewart et al  197  4  100 fluct.  4  5  0.3 
last. c.200 
Stewart et al  197  4  100 fluct.  4  2  0.45 
last. c.50 
Schacke et al 1973  12  106  4  30- 16  1.3 
(10m+2f) 
Monster et al  1976  4m  140  4  3.1  2.3  1.7  0.18  0.021 
Monster et al  1976  4m  140+WL
8  4  4.8  4.6  2.5  0.30  0.030 
Stewart et al 197  4  2m  200  4  3.5  0.35 
Sato et al 1978  4m  100  4  4.8  3.0  1.8 
Nomiyama et al 1977  3m  201  4  5.0  4.0  2.5 
Nomiyama et al  1977  3m  81  4  4.0  4.0  3.7 
Nomiyama et al  1977  3m  27  4  4.4  4.8  4.4 
Muller et al  1974  Sm  100  6  4.0  0.20  0.05 
Stewart et al  1970  6m  200  5x7  5.0  4.1  3.5  0.8  0.15 
Stewart et al  197  4  4m  20  5x1/2  6.5  3.5  2.2  0.85 
Stewart et al  197  4  4m  100  5x71 !2  7.1  3.9  2.7  0.7 
Stewart et al  197  4  4m  100 fluct.  5x71 /2  7.2  4.0  2.5  0.92 
last c.100 
Stewart et al  197  4  4f  100  5x71 /2  5.3  4.0  2.7  0.38 
Stewart et al  197  4  4m  200  5x71 /2  7.1  5.0  2.7  0.8  0.23 
Stewart et al 197  4  4m  200+alc.  71 /2  15  6.8  3.2  0.9 
Fernandez et al 1977  160/135/  8  5.0  4.0  0.6  0.20 
97/56/54 
a male (m) or female (f) 
b 1/2 h 100 ppm,  1/2 h 200 ppm,  1/2 h 100 ppm+50 W,  1 /2 h 200 ppm+50 W. 
c 1/2 h rest,  11/2 h  +  50 W. 
d 1 /2 h rest,  1/2 h 50 W,  1 /2 h 100 W,  1 /2 h 150 W. 
8  during exposure 2x1 /2 h 100 W. 
Trichloroethanol in exhaled air 
Trichloroethanol (TCE) can also be  measured  in  exhaled  air with exposure to TRI.  A 
close  relation  (r = 0.98)  was  found  over a wide  range  between  the  concentration  of 
TCE in blood and  in exhaled air (Monster et al  1975, 1976, 1979a). The concentration 
of TCE in alveolar air is about 1  0,000 times lower than in blood, but it permits predic-
tion  of the  concentration  in  blood  without  blood  sampling  and  does not  require  the 
absence  of TRI  in  inhaled  air. 
Excretion of metabolites in urine 
Single  exposure.  In  most  investigations  the  amounts  of  trichloroethanol  (TCE)  and 
trichloroacetic acid (TCA) excreted are expressed in amount par 24 h.  In Table 12 the 
amount excreted in  urine in the experiments are arranged according to  the exposure 
magnitude  (timex concentration).  This  enables  the  following  conclusions: 
- The  major  portion  of TCE  is  excreted  in  the  first  24  h  after  start  of  exposure. 
- The major portion of TCA is excreted in the second and third 24 h after exposure. 78 
The excretion of TCA continues a long time,  according the half-life of about 70-100 
h.  Note that  some  of the  experiments  (Stewart  et  al  1970)  seem  to  have  started 
before  the  excretion  of  TCA  of  preceding  exposure  was  minimal. 
- Alcohol  consumption  during  exposure  decreases  the  excretion  of  TCE  and  TCA 
(Muller  et  al  1975). 
- Workload  during  exposure  increases  the  excretion  of  TCE  and  of  TCA. 
- Males seem to excrete more TCE  in the first 24 h after exposure than females but, 
females  seem  to  excrete  more  TCA  than  males;  however,  the  ranges  are  large. 
- The  results  are  not consistent  between  the  experiments.  This  is  probably due to 
individual differences  in  metabolism,  missing  of voidings during daily urine collec-
tions,  differences  in  alcohol  consumption,  and  so  on. 
TABLE 12: Mean amounts of trichloroethanol (TCE) and trichloroacetic acid (TCA) excreted in 
urine per 24 h after single exposure to TRI 
TCE  TCA 
(mg/24 h)  (mg/24 h) 
sub  Ci  Time 
Reference  jects
8  (ppm)  (h)  Citime  1st  2nd  3rd  1st  2nd  3rd 
Kimmerle et al1973b  4m  42  4  168  60  12  5  5  7  10 
Kimmerle et al  1973b  41  42  4  168  55  22  10  10  13  13 
Monster et al 1976  4m  70  4  280  126  40  12  7  14  12 
Monster et al 1976  4m  70+WLb  4  280  162  55  20  9  19  13 
Schacke et al  1973  12(10 m+ 2f)  1{)6  4  424  130  00  50  4  10  12 
Stewart et al 1970  2m  100  4  400  163  25  4  69  49  66 
Stewart et al  1970  2m  100  4  400  101  13  9  52  57  42 
Ogata et al  1973  4m  170  3  510  max 22 mg/h  max 4 mg/h 
70 h after 
exposure 
Ogata et al  1973  5m  170  7  1190  max 40 mglh  max 8 mg/h 
50 h after 
exposure 
Muller et  al1974  5m  100  5  500  250  50  20  40  40  40 
Muller et al  1975  5m  100  6  600  max 17 mg/h  max 2.0 mglh 
2-4 h after  4 h after 
exposure  exposure 
Muller et al 1975  5m  100+alc.  6  600  max 7 mg/h  max 0.2 mg/h 
Monster et al  1976  4m  140  4  560  242  84  17  11  25  20 
Monster et al  1976  4m  140+WLb  4  560  272  93  20  16  36  28 
Nomiyama et al  1971  5m  320  2_2t3  854  220  85  50  21  60  55 
Nomiyama et al1971  51  320  2_2t3  854  140  90  50  55  80  70 
Stewart et al  1970  2m  200  3
1
/2  700  135  57  21  72  63  54 
Stewart et al  1970  5m  200  7  1400  147  71  94  31  48  33 
Stewart et al.  1970  2m  200  7  1400  219  143  100  43  62  104 
a male (m) or female (f) 
b during exposure 2x1/2  h 100 W workload 
Repeated exposure. In table 13 the amounts of TCE and TCA excreted per 24 h on the 
first and last day of exposure in the experiments are arranged according to the exposu-
re  magnitude  (timex concentration). 
The  following  conclusions  may  be  drawn  from  this  table: 
- Cumulation  of  TCE  during  the  week  seems  to  be  small,  about  50%  to  80%. 
- Amounts of TCA excreted  in  urine  per 24  h at  the  fifth  day of exposure are 5-10 
times  higher  than  at  the  first  day. 
- Fluctuating concentrations in air seem to have only small influences on the amounts 
excreted  per  24  h.' 
- Alcohol consumption during exposure decreases the amounts of TCE and TCA ex-
creted  in  urine. 
- Differences  in  metabolite  excretion  between  males  and  females  are  not  marked; 
there  is  a  tendency  towards  higher  excretion  of  TCE  in  male  subjects. 
- After exposure to 50 ppm (270 mg/m3)  for 8 h,  each day, the amounts excreted per 
24 h on the fifth day can be calculated from the regression lines: TCE: 220 mg/24 h; 
TCA:  130  mg/24  h. 79 
TABLE 13: Mean excretion of trichloroethanol (TCE) and trichloroacetic acid (TCA) in urine after 
repeated exposure to TAl on the first and fifth day of exposure 
TCE  TCA 
(mg/24 h)  (mg/24 h) 
Reference  sub- Ci  time 
jects•  (ppm)  (h)  Citime  day 1  day 5  day 1  day 5 
Stewart et al  197  4  3m  20  3  60  24  26  <33  <  31 
Stewart et al  197  4  4m  20  7
1
/2  150  37  43  <  22  <40 
Kimmerle et al 1973b  3m+1f  48  4  200  75  100  5  70 
Monster et al 1979a  Sm  70  4  280  140  220  10  83 
Muller et al 1975  Sm  50  6  300  100  160  20  90 
Muller et al 1975  Sm  50+alc.  6  300  70  110  5  65 
Ertle et al  1972  Sm  50  6  300  120  220  20  100 
Ertle et al  1972  5m  50 flue  6  300  130  210  10  110 
Stewart et al 197  4  3m  100  3  300  105  174  <  29  111 
Stewart et al 197  4  3m  100 flue  3  300  159  298  64b  110 
Stewart et al 197  4  3f  100  3  300  118  113  <  25  84 
Ertle et al 1972  5m  100  6  600  180  260  20  250 
Stewart et al  197  4  3m  200  3  600  362  429  gab  180 
Triebig et al1976  4m+3f  100  6  600  135  155  32  230 
Stewart et al 197  4  4m  100  7
1
/2  750  135  523  52  253 
Stewart et al 197  4  4m  100fluc  71/2  750  198  220  165b  197 
Stewart et al 197  4  4f  100  7
1
/2  750  211  296  28  241 
Stewart et al 1970  Sm  200  7  1400  308  405  51  391 
Stewart et al 1970  4m  200  71/2  1500  450  895  175b  390 
a male (m) or female (f) 
b carryover from preceding exposure 
Note.  The regression lines of all data on the 5th day of exposure for TCE and TCA  _are: 
TCE  (mg/24  h)  = 0.45  (h x ppm)  +  39,  r  = 0.85; 
TCA  (mg/24  h)  = 0.27  (h x ppm)  +  20,  r  = 0.97. 
Concentrations in blood of trichloroethylene, trich/oroethanol and trichloroacetic acid 
Single  exposure.  In  table  14  the  concentrations  of  TRI,  TCE  and  TCA  in  blood  in 
experiments with human volunteers are arranged according to the exposure magnitude 
(timex concentration). 
TABLE 14: Mean concentrations of trichloroethylene (TAl) trichloroethanol (TCE) and 
trichloroacetic acid (TCA) in blood after single exposure to TAl 
Blood leYels 
1lll  TCE 
(mg/1)  (mg/1) 
......._.  IUb- Cl  .....  ..  ..  .. 
TCA 
(mg/1) 
Jectl'  (ppm)  (h)  ~h  11h  aperlnwlt11 h  aperlnwlt11 h 
Kimmerle et al 1973b  4f  40  4  0.30  0.1  1.4 
Kimmerle et al 1973b  4m  40  4  0.27  0.09  1.0 
Vesterbeg et al1976  Sm  100  2+Wib 2.2  0.4  2.8 
Vesterberg et al 1976  Sm  100+2002+Wlc3.3  0.5  3.0 
Vesterberg et al1976  5m  200  2+Wld7.4  0.9  3.9 
Monster et al 1976  4m  70  4  1.3  0.16  0.011  3.2 
Monster et al 1976  4m  70  4+WL
8
- 0.21  0.020  4.0 
Konietzko et al 1975  20m  95  4  3.0 
Sato et al 1978  4m  100  4  1.7  0.17 
Muller et al  1974  Sm  100  5(5
1
/2)  1.2  0.34  0.07  6.01 
Monster et al 1976  4m  140  4  0.27  0.020  5.2 
Monster et al 1975  4m  140  4+WL
8
- 0.38  0.036  5.8 
Muller et al 1975  Sm  100  6  1.3  0.4  (0.1)  4.51 
Muller et al 1975  Sm  100  6+alc  2.7  0.9  (0.2)  2.01 
:,male (m) or
1 
female (f)  . 
1 2 h, rest, 1 /2 h 50 Watt Workload 
c1/2 h 100 PRm,  1/2 h 200 r,pm.  1/2 h 100 ~pm +  50 Watt,  1/2 h 200 ppm +  50 Watt 
d1/2  h rest,  /2  h 50 Watt,  /2 h 100 Watt,  /2 h 150 Watt 
• during exposure 2 x 1/2 h 100 Watt workload 
1 nonglucouronidized fraction of TCE 
g TCA in plasma 
0.53 
0.4 
0.8(20h)  3.0  13 
1.0(20h)  2.8  13.5 
1.6(20h)  3.9  18 
0.67  3.3  9.0 
1.2  3.6  9.7 
1.7'  2()11  50(20h)g 
1.8  4.0  12 
2.2  4.5  16 
1.21  1~  28g 
1.01  ~  4g 80 
The  following  conclusions  may  be  drawn  from  this  table: 
- TRI concentration in blood rises sharply after the start of exposure, but thereafter it 
levels off; at the end of exposure TRI concentration in blood decreases sharply, but 
not  as  sharply  as  in  exhaled  air  (Astrand  et  al  1976). 
- TCE concentration in  blood rises sharply during exposure and reaches a maximum 
in  the  first  hour after exposure;  thereafter the  concentration  declines  rapidly  and 
exponentially  with  a  half-life  of  10-15  h. 
- TCA concentration in  blood  continues to  rise  even  after the end  of exposure; the 
increase persists up to 20-40 h after exposure; thereafter the concentration decrea-
ses  exponentially  with  a  half-life  of  70-1 00  h. 
- In blood two fractions of TCE exist: free TCE and TCE comjugated with  glucuronic 
acid. 
- Concentrations  of TCA  in  plasma are  higher by  about  a factor of 2 than  in  total 
blood,  due  to  the  high  binding  of  TCA  to  plasma  proteins. 
- Workload  during  exposure increases the  concentrations of TRI,  TCE  and  TCA in 
blood. 
- Alcohol  consumption  during exposure  increases the concentration of TRI  and  de-
creases  the  concentrations  of  TCE  and  TCA  in  blood. 
- Differences  in  absolute  values  between  comparable  experiments  may  be  due  to 
differences  in  analysis  or  to  interindividual  differences. 
Repeated exposure.  In  table 15 the concentrations of TRI,  TCE,  and TCA in blood in 
repeated  exposure  experiments  are  arranged  according  to  the  exposure  magnitude 
(timex concentration). 
The  following  conclusions  may  be  drawn: 
With each further exposure the values of TRI  in blood recorded before starting the 
next exposure show a progressive daily increase (after the fifth day 2 x higher than 
at  second  day). 
With each further exposure both the maximum value of TCE (end exposure) and the 
minimum value  (before starting  next exposure)  show a progressive daily increase 
(after the fifth exposure day 20% to 50%  higher than after the first exposure day). 
TCA cumulates progressively from day to day and  reaches a maximum concentra-
tion  at  the  end  of  the  fifth  exposure  day. 
Alcohol consumption during exposure decreases both TCE and TCA concentrations 
in  blood. 
Fluctuating concentrations hardly affect the TCE  and  TCA concentration  in  blood. 
- Differences  in  absolute  values  between  comparable  experiments  may  be  due  to 
differences  in  analysis  or  to  interindividual  differences. 
TABLE 15: Mean concentrations of trichloroethylene (TRI), trichloroethanol (TCE) and trichloroa-
cetic  acid  (TCA)  in  blood  after  repeated  exposure  to  TRI 
TRi  (mg/i)  TCE  (mgli)  TCA (mg/i) 
Reference  Ci  time  end  end  end 
subjects (ppm)  (h)  dey  experiment  2 h  16  h  experiment  16  h  experiment  16 h 
experiment  16 h 
Kimmerle et al 1973b4  48  4(x5)  1  0.3  0.18  2.0  1.0 
5  0.7  2.4  0.9 
Monster  et  al  1976 5  70  4(x5)  1  1.30  0.22  0.009  3.4  0.9  3  8 
5  1.32  0.22  0.018  4.2  1.2  31  30 
Muller  et  al  1972  5  50  6(x5)  1  1.6  0.4  15  18 
5  2.2  0.7  52  49 
Muller  et  al  1975  5  50  6(x5)  1  1.5  0.45  15  18 
5  2.2  0.6  52  49 
Muller  et  al  1975  5  50  6(x5)  1  1.2  0.4  4  6 
+ale  5  1.5  0.5  25  31 
Ertle  et  al  1972  5  50  6(x5)  1  1.7  0.5 
5  2.0  0.8 
Ertle  et  al  1972  5  50b  6(x5)  1  1.6  0.5 
5  2.3  0.7 
Ertle  et al  1972  5  100  6(x5)  1  3.2  1.0 
5  4.9  1.5 
Triebig  et  al  1976  7  100  6(x5)  1  1.3  1.2  6.5  4  11  32 
5  1.5  10  (6)  66 
a nonglucuronidized  fraction  of TCE  and  TCA  in  plasma 
b mean  50  ppm,  fluct.  250  ppm  12  min/h 81 
Conclusions from  volunteer experiments 
TAl levels in  alveolar air and  in  blood in the first hours after exposure indicate recent 
exposure concentrations.  The concentration  next morning  before exposure indicates 
the TWA concentration over the preceding day(s) and the concentration after a wee-
kend probably indicates the TWA over the preceding week. TCE levels in exhaled air, 
blood,  and  urine  in  the first  hours  after exposure and  the  next morning  indicate the 
TWA over the preceding day(s). For TCA in blood and urine the time of sampling is not 
so  important;  it  indicates  the  TWA  over  the  preceding  week. 
Industrial exposure studies 
Several researchers (Ogata et al 1971, Tanaka and Ikeda 1968, Ikeda et al 1972) have 
recommended measuring both metabolites (TIC  =  TCA  + TCE) to estimate TAl ex-
posure. This approach may also take into account individual differences in metabolism. 
However, since the biological half-lives of both metabolites are different, the time and 
duration  of  urine  sampling  is  quite  critical.  Furthermore,  during  industrial  operation 
where the magnitude of the exposure fluctuates during the day and from day to day, it 
is difficult to correlate the TIC value with the exposure on the preceding day in view of 
the fact that the major portion of TCE formed appears the same day in urine, whereas 
only a  comparatively small  portion  of the  TCA  is  excreted  during the  same  period. 
Ogata et al (1971) examined 10 men exposed to 10-40 ppm (54-214 mg/m3) daily. The 
concentration was determined with Kitagawa tubes near the nose of each worker every 
20  min.  The  average  was  taken  as  environmental  concentration.  The time  of  urine 
sampling was from  12.00-17.00 h on Wednesday. The concentrations were corrected 
to a urine density of 1.024. Ikeda et al  (1972)  examined 51  male workers in  10 work-
shops, in which the atmospheric concentrations of the solvent were relatively constant. 
The concentration  in  each  workshop was determined  at  least 5 times with  Kitagawa 
tubes. The average, 3-175 ppm  (16-940 mg/m3), was taken to represent the environ-
mental  concentration.  Urine  samples  were  collected  in  the  latter  half  of  the  week 
around 15.00 h after urine was excreted at about 13.00 h.  From the relations given by 
these authors the concentrations of TCE and TCA per gram creatinine can be calcula-
ted for an  exposure to 50 ppm  (270 mg/m3)  TAl (Table 16). Thus an  exposure to 50 
ppm (270 mg/m3)  TAl would correspond to an excretion of about 180 mg TCE/g creati-
nine and to  100 mg TCA/g creatinine in urine collected at the end of the work period. 
Only a few data exist on the blood concentrations during occupational exposure. Pfaffli 
and Backman (1972) measured TAl concentrations in blood and expired air during and 
after exposure. Particularly in mixed exposure 1,1, 1-trichloroethane seems to delay the 
excretion of TAl. Lindner (1973) measured the TCE  conc~ntration in  blood before the 
exposure (0.5-2.7 mg/1) and in the middle of the worktime (1.2-4.0 mg/L). The exposure 
concentration  was  about  40  ppm  (215  mg/m3)  TAl. 
TABLE  16:  Estimated  concentrations  of  trichloroethanol  (TCE)  and  trichloracetic acid  (TCA)  in 
urine  at  the  end  of  the  workday  in  subjects  exposed  to  50  ppm  (270  mg/m3
)  TRI,  8 h/day,  5 
day/week 
Reference 
From  industrial  studies: 
Ogata  et  al  (1971) 
Ikeda  et  al  (1972) 
From  experiments 
Repeated  exposure  experiments 
(Table  13) 
Monster  et  al  (1979a) 
Guberan  (1977) 
TCE  TCA 
(mg/g creatinine)(mg/g creatinine) 
~150 
~215 
160 
220 
155 
~ 90 
~105 
100 
100 
100 
Extrapolation from human volunteer studies to Industrial exposure 
The results of the volunteer studies can be used for extrapolation to concentrations to 
be expected in occupational (weekly) exposure. The amounts of TCE and TCA in 24 h 
urine can be recalculate to amounts per gram creatinine assuming an excretion of 1.8 
g  creatinine/day.  One  has  to  keep  in  mind  that  at  the  end  of the  work  period  the 82 
excretion rates of the metabolites are maximal. The excretion rate of TCE at the end of 
exposure is about 20% to 40% higher than over the whole 24 h. The excretion rate of 
TCA during the daytime is about 1  0% higher than over the whole 24 h and for TCA 
there  is  also  a  carryover of 20%  to  30%  from  the  preceding  exposure  week. 
In  the repeated exposure experiments the mean amounts excreted in  urine per 24 h 
(220 mg TCE, 130 mg TCA) in  exposure to 50 ppm (270 mg/m3), 8 h,  5 days can be 
calculated. These amounts were used for the estimation of the urine concentrations at 
the end of the workshift (in the latter part of the week) and are presented in Table 16. 
The amounts excreted in  urine in the repeated exposure experiment of Monster et al 
(1979a) were also used for extrapolation. Guberan (1977), using a mathematical model 
for the simulation of the pharmacokinetics of inhaled TRI, calculated biological values 
in  exposure to  1  00 ppm  (535 mg/m3)  TRI.  Their values recalculated to 50 ppm (270 
mg/m3)  and  to  mg/g  creatinine  are  also  presented  in  Table  16. 
The concentrations in alveolar air to be expected in exposure to 50 ppm (270 mg/m3) 
can  be  estimated  from  the  mean  concentrations  measured  in  the  volunteer studies 
after exposure at rest for 6-8 h, 5 days (Table II) and are about 3-4 ppm (16-21  mg/m3) 
at 
1
/2  h after exposure, about 0.3-0.4 ppm (1.6-2.1  mg/m3)  at 16 h and about 0.1  ppm 
(0.54  mg/m3)  at  64  h  after  exposure. 
Droz and Fernandez (1978) used a mathematical model to study the influence of hour-
ly variations and daily variations in exposure concentration on the alveolar TRI concen-
trations and on the excretion of TCE and TCA in urine. They calculated that two analy-
ses, one before and one after exposure (morning urine), theoretically are sufficient to 
estimate the degree of exposure whatever day of the week is considered and whatever 
the daily variations are in exposure concentrations. Theoretically the analysis of TCE in 
urine appears to be better than analysis of TRI in exhaled air with regard to sensitivity. 
The excretion of TCA is not directly and simply connected with the degree of exposure; 
it can be used for qualitative evaluation of the preceding day's exposure. The authors 
note that blood analyses could in  practice be preferable to analysis of urine, because 
of the smaller individual variations generally observed with the former. Indeed in expe-
riments with repeated exposure to constant concentrations the smallest interindividual 
variation  was  found  for the  concentrations  in  blood  (Monster et  al  1979a). 
Analytical  methods 
Exhaled air 
Various methods have been described for the determination of TRI in exhaled air. Most 
of them are based on collecting exhaled air (alveolar or mixed exhaled air) into glass 
tubes or bags (Saran, Tedlar). The determination can be done by infrared (Stewart et 
al1970, Schacke et al1973) or by gaschromatography (Muller et al1974, Stewart et al 
1974, Monster and Boersma 1975, Kimmerle and Eben 1973a). Monster and Boersma 
(1975)  also  determined  TCE  in  exhaled  air. 
Urine 
Spectrophotometric methods have been described for the determination of TCA and 
TCE  in  urine  (Tanaka  and  Ikeda  1968,  Ogata  et al  1970,  Weichardt and  Bardodej 
1970, Ogata et al1974). Basically these methods involve the hydrolysis of the glucuro-
nide of TCE in urine, followed by its oxidation to TCA. TCA is then determined colori-
metrically by the Fujiwara reaction. This reaction is not specific, and the natural pre-
sence of chromophore substances in biological fluids may interfere. Very sensitive and 
specific gaschromatographic techniques are also available for TCE and TCA in  urine 
(Stewart et al  1974, Buchet et al  1974, Humbert and Fernandez 1976, Breimer et al 
1974, Ogata and Saeki 1974). 
BI()Od 
Various  gaschromatographic methods  have been  described for the determination of 
TRI, TCE and TCA in blood (serum). Determinations of TRI are based on extraction or 
headspace analysis.  Determinations of TCE  are  based  on  extraction  or headspace 
analysis of free TCE and total TCE. Determinations of TCA are based on decarboxyla-
·tion to chloroform or esterification to TCA-methyl ester. The methods are descibed for 
TRI,  free  TCE,  and  chloralhydrate  (Kimmerle  and  Eben  1973a); for TCA in  plasma 
(Muller et al 1972), for total TCE in plasma (Muner et al 1975); for TRI, TCA, free TCE, 83 
and alcohol (Herboltsheimer and Funk,  1974; for chloralhydrate, free TCE, total TCE, 
TCA,  and  monochloroacetic acid  (Ogata and  Saeki,  1974); for free  TCE,  total  TCE, 
chloralhydrate, and TCA (Breimer et al.  1974); for TAl, total TCE,  and TCA (Monster 
and Boersma 1975); for TCE, chloralhydrate, and TCA (Garret and Lambert, 1966); for 
free TCE, total TCE,  and TCA (Vesterberg et al.  1975). Most of these determinations 
are based on separate analysis of TAl, TCE and TCA and use time-consuming extrac-
tions and hydrolysis. Only Monster and Brersma (1975) described a method for simul-
taneous  determination  of TAl,  total  TCE  and  TCA. 
Conclusions 
Among the chlorinated hydrocarbon solvents TAl has been studied most fully.  Nevert-
heless  only  suggestions  can  be  made  for  average  group  parameters  in  relation  to 
exposure. 
In table 17 the concentrations to be expected in a TWA exposure to 50 ppm are sum-
marized.  These  data  are  only  approximate. 
Research  needs 
There still is a need for well designed epidemiological studies. Moreover, these studies 
should also pay attention to interindividual differences in toxicokinetics, and to the fac-
tors responsible for these: anthropometric measures, sex, genetic make up, and use of 
alcohol  and  drugs.  This  will  make  it  possible  to  estimate  individual  exposure. 
TABLE 17: Estimated concentrations of trichloroethylene (TRI), trichloroethanol (TCE) and trichlo-
roacetic acid (TCA) in alveolar air,  blood, and urine in subjects exposed to 50 ppm (270 mg/m
3
) 
TRI, 8 h/days, 5 days/week 
Time  (h) 
medium  End 
exposure  1/2  16  64 
Alveolar  air 
TRI  (ppm)  10-15  3-4  0.3-0.4  0.1 
TRI  (mg/m3)  50-80  16-21  1.6-2.1  0.5 
TCE  (mg/m
3
)  0.4-0.6 
Blood  (mg/1) 
TRI  0.9  0.2  0.02  0.006 
TCE  4-6  1-2  ? 
TCA  60-70  60-70  35-50? 
Urine  (mg/g  creatinine) 
TCE  180  120  15? 
TCA  100  80  50? 
?  = uncertain,  doubtful 84 
9.  Tetrachloroethene (tetrachloroethylene,  perchlo-
roethylene, perc.) 
Chemical  and  physical  properties 
physical  state 
molecular weight 
specific  gravity 
melting  point 
boiling  point 
vapour  density 
vapour  pressure 
molecular formula 
structural formula 
colorless  liquid 
165.9 
1.62  24°/4°C 
-23.3°C 
121.2°C 
5.7  (air  =  1) 
19  mm  Hg  at  25°C 
CCI2  =  CCI2 
c1,  c1 
c- r/ 
c1/  '-'c1 
1 mg/m3  = 0.147 ppm; 1 ppm = 6. 78 mg/m
3  at 25°C and 760 mm Hg 
Effects  on  humans 
Tetrachloroethylene  has  narcotica and  irritative properties  and  is  degreasing for the 
skin:  these  non-specific effects  are  comparable to  those from  the  other chlorinated-
hydrocarbon-solvents.  In  addition it may exert toxic effects in  liver and  kidneys,  more 
so  than  trichloroethylene. 
Tetrachloroethylene  has  had  a wide  spread  use  in  the  tropics  as  a drug  in  case  of 
ancylostomiasis (dosage 11-206 mg/kg b.w.); only in a few cases serious effects have 
been  observed  with  a  dosage  of  26  mg/kg  b. w. 
In  exposure of 6 subjects for 2 h to 200 ppm  irritation of mucosae,  drowsiness and 
dizzeness occurred (Stewart et al1961); in exposure of 16 subjects 1 to 5 days for 7 h 
to 1  00 ppm again slight irritation, disturbed equilibrium and  light headed ness was ob-
served (Stewart et al 1970). In 32 subjects 20 to 54 times exposed to 25-50 100 or 150 
ppm for 1, 3,  5
1
/2 or 7
1
/2 h/day performance in various tests altered, no potentiation of 
effects in additional intake of diazepam or ethanol was observed (Stewart et al 1976a). 
Chmielewski  et  al  (1976)  examined 9 workers  (A)  exposed to  levels in  air below 30 
ppm  and  16 workers  (B)  exposed to  60-440 ppm  for 2 months to 27 years.  A slight 
increase of albumin and decrease of a-globulin fractions in serum and slight excretion 
of  homovalic  acid  was  observed  in  group  A;  in  group  B  4  workers  showed  EEG-
abnormalities,  increased  activity  of alanine-and  aspartate-aminotransferase,  decrea-
sed  activity of acetylcholinesterase and  increased a-lipoprotein-fraction in  serum.  Es-
sing (1973 and 1975) examined 112 workers exposed for average 11.5 year to tetrach-
loroethylene:  74%  of air samples  were  0-61  ppm,  11%  61-116  ppm,  14%  116-190 
ppm;  120  subjects  served  as  controls.  Drowsiness,  nausea,  anorexia,  perspiration, 
impotence,  tremor and  decreased sensibility in  the fingers were reported;  the serum 
levels of SGOT, SGPT, bilirubin and alkalic phosphatase were lower than in the control 
group, i.e. no evidence of live dysfunction. The serum-creatinine level was increased in 
the exposed group; no increased levels of ureum in urine, specific weight or decreased 
phenolred-excretion  was  observed,  i.e.  no  evidence  of  renal  dysfunction. 
Blair et al (1979)  report~d in the USA an increased proportional mortality for malignant 
tumours  in  drycleaning  workers,  exposed  to  tetrachloroethylene  and  also to  carbon 
tetrachloride, trichloroethylene and petroleumsolvents. These preliminary findings were 
based upon a limited study.  Katz and Jowett (1981) studied the proportional mortality 
pattern of 671  female laudry and drycleaning workers for the period 1963-1977 in Wi-
sconsin, USA; they could not find any overall increase in  malignant tumours, although 
indications for an elevated risk was observed for cancers of kidney  .. and genitals, along 
with smaller excess of bladder and skin cancer and lymphosarcoma. This study could 
not find any specific relation with exposure to tetrachloroethylene, but it might serve as 
a  signal  for  further  study. 
According  to  IARC  (1979)  there  is  only  limited  evidence  that  tetrachloroethylene  is 
carcinogenic in  mice. The epidemiological data discussed above were not yet evalua-
ted  by  IARC. 85 
Metabolism 
Uptake 
By the lungs. The retention and the uptake (lung clearance, LC) decrease in the course 
of exposure at rest  (Table 18), but not as fast as  in  exposure to  1,1, 1-trichloroethane 
(methylchloroform, MC).  The solubility of PERC in  blood and  adipose tissue is  higher 
than of MC (higher partition coefficients for blood/air and fat/air); therefore the capacity 
of the body to  ab~orb PERC is  higher than for MG.  The blood/air and fat/air partition 
coefficients of PERC at 37°C are about 15 and 2000 respectively (Sato and Nakajima 
1979,  Monster  1979,  Droz  and  Fernandez  1977). 
Workload during exposure increases the uptake. The uptake during 100 Watt workload 
was 2.5-3.5 times the comparable uptake at rest, but during the first workload (after 1 h 
exposure)  the  uptake  was  about  20%  higher than  the  uptake the  second  workload 
(after 3  h exposure):  lungclearance  12.6 and  10.3  1/min  respectively  (Monster et  al 
1979c). 
Through the skin.  Immersion of one thumb in  liquid PERC during 40 min resulted in a 
concentration of PERC in alveolar air comparable with the concentrations after a respi-
ratory exposure to  10-15 ppm  (70-105 mg/m3)  for 40 min  (Stewart and  Dodd  1964). 
Subjects, dressed in  pyjamas,  socks and a full  facepiece respirator, were exposed to 
PERC vapour (Riihimaki and Pfaffli 1978). The amount of PERC exhaled after exposu-
re  was  about  1%  of  the  amount  that  should  be  exhaled  in  exposure  to  the  same 
concentration  without  a  respirator. 
Biotransformation 
A small amount of PERC absorbed in the body is probably transformed by oxidation to 
perchloroethylene oxide and subsequently, by rearrangement, to trichloroacetyl chlori-
de,  which  is  hydrolyzed  into  trichloroacetic  acid  (TCA)  (YIIner  1961,  Daniel  1963). 
The half-life of PERC in  blood and expired air depends on the length of exposure and 
on  the time of sampling after exposure. The concentration follows a multiexponential 
curve. 
The toxicokinetic behavior of TCA after exposure to  PERC  is similar to  its  behaviour 
after  exposure  to  tri?hloroethylene  and  to  1,1, 1-trichloroethane. 
The concentration of TCA in blood increases up to 20 h after single exposure; thereaf-
ter the  concentration decreases with  a half-life of about 80  h (Monster et  al  1979c). 
Tetrachloroethylene is almost totally (80% to 100%) excreted by exhalation; only small 
amounts  are  excreted  in  urine  as  TCA  (2%)  (Fernandez  et  al  1976,  Monster et  al 
1979c). 
TABLE  18:  Uptake  by  the  lungs  of  PERC  at  rest 
time  after  start  of  exposure 
Reference  minutes  hours 
0  10  30  60  4  8 
Fernandez  et  al.  (1976)  alveolar  retention  0.75  0.70  0.60  0.47 
Monster et  al.  (1979c)  alveolar  retention  -0.90  0.80  0.74  0.69  0.60 
----------
Monster et  al.  (1979c)  lungclearance  (LC)  (1/min)  6.7  5.0  4.5  4.2  3.8 
Biological  indicators 
Human volunteers 
Concentrations of tetrachloroethylene in exhaled air 
Table 19 summarizes data from various studies. The concentrations after exposure in 
alveolar air (Ce) are expressed as a percentage of the inhaled concentrations (Ci) and 
arranged  according  to  the  length  of  exposure. 86 
The  following  conclusions  may  be  drawn  from  this  table: 
The  concentration  in  alveolar air decreases  in  the  first  1/2  h after exposure from 
40%  - 50%  (end  exposure,  Table  18)  to  15%  - 30%  of  Ci. 
As  the duration of exposure  increases, the relative concentration in  alveolar air is 
higher, more pronounced when the sampling after exposure occurs later. After ex-
posure at rest for 6-8 h,  the  mean concentration  is about 23%  e/2 h),  18%  (1  h), 
4%  (16  h),  and  2%  (64  h),  respectively. 
After exposure at rest for 6-8 h,  5 days, the mean concentration is about 35% e/2 
h),  30%  (1  h),  8%  (16  h),  and  5%  (64  h),  respectively. 
Workload  during  exposure  increases  the  concentrations  in  alveolar  air over  the 
whole  postexposure  period. 
Excretion of the metabolite trichloroacetic acid in urine 
In table 20 the amounts of trichloroacetic acid (TCA) excreted per 24 h in the volunteer 
studies with  single  exposure  are  arranged  according  to  the  exposure magnitude  (ti-
mex concentration). 
TABLE 19: Mean concentrations of PERC in alveolar air (Ce) after exposure as percentage of the 
inhaled concentration (Ci) 
number  mean Ce as % of Ci 
of  Ci  time 
Reference  subjects  (ppm)  (h)  ,,2 h  1 h  2h  16 h  64h  120 h 
Stewart et al  1961  6  194  3  13  9  6  1.1  0.44  0.26 
6  101  3  12  8.5  6  1.0 
Essing et al  1972  5  69  3  7.2  1.2 
Stewart et al1961  1  395  3.5  23  17  13  4.3  1.5  0.88 
Fernandez et al  1976  1  100  4  18  12  9 
1  150  4  17  12  7 
1  200  4  19  13  8 
Monster et al 1979c  6  70  4  16  14  12  2.1  0.65  0.30 
6  140  4  16  14  13  1.9  0.65  0.32 
6  140+WL
8  4  20  17  15  2.5  0.78  0.39 
Hake and Stewart 19n  25+Wlb  5.5  26 
100+Wlb  5.5  18 
Fernandez et al 1976  1  150  6  19  15'  10 
5  100  8  20  15  12  4  2 
4  150  8  27  21  16  4  2 
3  200  8  25  19  14  4  2 
Stewart et al  15  100  7  20  3.5  2.0  1.3 
1970 
5  100  5x7  30  8  5  3.0 
Guberan and Fernandez 197  4  Model  100  5x8  35  31  25  7.5  5.0 
Hake and Stewart 19n  Model  100  5x7.5  25  8  4.5 
• during exposure 2 x 0.5 h 100 W workload 
b during exposure 0.5 h 50 W'workload 
TABLE 20: Mean amounts of trichloroacetic acid (TCA) excreted in urine per 24 h after single 
exposure to PERC 
number  Ci  TCA (mg) 
of  Ci  time  X 
Reference  subjects  (ppm)  (h)  time  0-24 h  24-48 h  48-72 h 
Ogata et al 1971  4  87  3  261  2.4  0.7 
Bolanowska and  5  58  5  290  2-4 
Golacka 1972 
Monster et al 1979c  6  70  4  280  4.0  1.0  0.9 
6  140  4  560  6.8  2.3  2.1 
6  140+WL
8  4  560  8.3  2.8  1.8 
Fernandez et al 1976  2  150  8  1200  11-12  9-10  3.5-4 
• 2 x 0.5 h 100 W workload. 87 
In  contrast  to  exposure  to  trichloroethylene  and  to  1,1, 1-trichloroethane  (MC)  the 
amounts of TCA excreted in  the first 24  h after start of exposure were higher than  in 
the following 24  h.  This difference can  be  explained by the difference in  metabolism. 
The formation  of TCA  in  exposure to  PERC  is  mainly determined  by  the amount of 
PERC in the body, whereas in exposure to MC the formation is mainly determined by 
the amount of trichloroethanol (TCE).  In exposure to trichloroethylene the formation of 
TCA has an intermediate position: a direct formation from chloralhydrate and indirectly 
from TCE (Monster et al  1979c).  In  repeated exposure experiments with exposure up 
to 150 ppm (1035 mg/m
3
)  for 7
1
/2 h/day only traces of TCA and no TCE could be found 
(Hake  and  Stewart  1977). 
Concentrations of tetrachloroethylene and trichloroacetic acid in blood 
Only few data on blOod levels exist in volunteers exposed for at least 3-4 h.  In a series 
of experiments in which volunteers were exposed to 70 or 140 ppm (480,  965 mg/m
3
) 
for 4 h the concentrations in  blood of PERC  and TCA were  measured (Monster et al 
1979c).  The  concentrations  of  PERC  in  the  postexposure  period  (up  to  150  h)  ran 
parallel to  those in  alveolar air.  The concentration in  blood was  16 times  higher than 
the  concentration  in  alveolar  air  (Monster  1979,  Monster  et  al  1979c). 
Hake  and  Stewart  (1977)  mentioned that the  exposure  concentration  had  a greater 
effect on the blood level than the length of exposure. The blood levels did not seem to 
increase much  after 3 h of exposure; however, 30  min  of moderate exercise (50  W) 
during exposure  increased the  venous  blood  levels about three  to  fourfold  over that 
expected after an equivalent time of sedentary exposure. Alcohol consumption had no 
effect  on  the  concentration  of  PERC  in  blood  or  in  exhaled  air  during  exposure. 
Conclusions from experiments 
The  repeated  exposure  experiments  indicate  that  PERC  accumulates  in  the  body; 
therefore,  PERC  in alveolar air and  in  blood  in the first hours after exposure probably 
indicates  more  a time  weighted  average  (TWA)  exposure  than  the  recent  exposure 
concentration;  the  concentration  next  morning  and  after  the  weekend  probably 
indicates the TWA exposure over the preceding days or weeks.  For TCA in blood and 
urine the time of sampling is not so important; it indicates the TWA exposure over the 
preceding  week. 
Extrapolation from human volunteers studies to industrial exposure 
The  results  of  the  single  exposure  experiments  - 70  ppm  (480  mg/m3),  4  h  -
(Monster et al  1979c) were used for extrapolation to a TWA exposure of 50  ppm (345 
mg/m
3
)  8  h/day,  5 days/week. 
The estimation of TCA in urine at the end of the workshift (at the latter part of the week) 
is shown in Table 21.  The concentrations of PERC- in  alveolar air to be expected in  a 
TWA exposure to 50 ppm (345 mg/m3) can be estimated from the mean concentrations 
measured in the volunteer studies after exposure at rest for 6-8  h,  5 days (Table 19); 
they are about 18 ppm (120 mg/m
3
)  ~t 
1
/2 h after exposure, about 4 ppm (28 mg/m
3
)  at 
16  h,  and  about  2.5  ppm  (17  mg/m3)  at  about  64  h  after  exposure. 
TABLE  21 
Estimated concentrations of trichloroacetic acid (TCA) and trichloroethanol (TCE) in urine at the 
end of the workday in subjects exposed to 50 ppm (345 mg/m
3
)  PERC, 8 h/day 5, days/week 
Reference  TCA  TCE 
From experiment 
Monster et al 1979c  3.9 mg/g creatinine  0 
From industrial studies 
Ikeda et al  1972a  45  mg/1  30  mg/1 
Weichart et al  1975  - 3  mg/1  - 0.7 mg/1 88 
Industrial exposure studies 
Ikeda et al  (1972a)  measured TCA and TCE  excretion in  34 workers during 6 days/ 
week in 2 h samples at the end of the workday. They found about 45 mg TCA/1 and 30 
mg TCE/1  at exposure levels of 50 ppm (345 mg/m3), and about 50 mg TCA/1  and 30 
mg TCE/1 at 100 ppm (690 mg/m3). Despite the large variation they concluded that the 
urinary concentrations increased until the atmospheric concentrations reached 50-1 00 
ppm,  but little increase occurred at higher concentrations. In another study they mea-
sured  4-35  mg  TCA/1  in  4  workers  exposed  daily to  maximal  20-70  ppm  (140-180 
mg/m
3
)  and 32-97 mg  TCA/1  in  66  workers exposed to maximal 200-400 ppm  (1380-
2760  mg/m3).  The  TCE  concentrations  were  at  the  same  order of magnitude. 
In urine of workers the same authors (Ikeda and Imamura 1973) measured a half-life 
for total trichlorocompounds (TCE  + TCA)  of about 144 h.  The urine samples were 
obtained  on  Saturday,  Sunday,  and  Monday  morning. 
Ikeda et al  (1972a.b 1973) used a modification of the Fujiwara reaction. The Fujiwara 
reaction,  however,  is  not  specific  for  TCE  and  TCA.  An  increase was  observed  in 
coloration when the urine samples from tetrachloroethylene-exposed workers were oxi-
dized  before the  Fujiwara  reaction.  This  increase was  tentatively attributed to  TCE. 
Weichart and Lindne (1975) examined workers in drycleaning shops; the average con-
centration  was  about  15  ppm  (1 05  mg/m
3
).  They  measured  with  a  gas-
chromatographic  method  PERC  and  TCA in  blood,  and  TCA and  small  amounts of 
TCE in  urine: The authors did not present any information on the time of sampling of 
blood and urine, so the data only provide limited information. The mean concentrations 
in  uri~e extrapolated  to  50  ppm  (345  mg/m3)  are  presented  in  Table  21. 
Recently Monster et al  (in  press 1982b) investigated exposure to PERC in 3 dryclea-
ning  shops.  About  8  persons  were  followed  up  in  each  workshop.  During  a  whole 
normal  workweek the  exposure to  PERC  was  measured  with  personal  air samplers. 
The average exposure over the workweek varied  from  1.5 ppm  (1 0.5 mg/m3)  to  160 
ppm (110 mg/m3). During that week biological specimens were collected (blood, alveo-
lar air, urine) on Monday morning, Wednesday and Friday evening, and again Monday 
morning. 
From the relations between the exposure magnitude (as TWA) and the concentrations 
in biological specimens, the mean concentration in blood, alveolar air, and urine can be 
estimated in  a TWA exposure to  50  ppm  (345 mg/m3),  8 h/day,  5 days/week (Table 
22). The results indicate that PERC in blood on  Friday after work seems to be a relati-
vely good parameter for estimation of the TWA-week exposure. For PERC in alveolar 
air and TCA in blood the spread in the results was somewhat larger. TCE in urine was 
more related to the TWA exposure over the (two) preceding day(s) than to the TWA-
week  exposure. 
TABLE 22:  Mean concentrations of PERC,  trichloroethanol (TCE) and  trichloroacetit acid (TCA) 
in  blood,  alveolar air and/or in  urine in  subjects exposed to a TWA exposure of 50 ppm  (345 
mg/m3)  PERC  8  h/day,  5  days/week 
Time of sampling after exposure 
Test  end of exposure  5-15 min  64h 
Blood (mg/1) 
PERC  2.3  0.82 
TCE 
TCA  5.8  3.8 
Alveolar air (PERC) 
mg/m3  160  53 
ppm  " 23  8 
Urine (mg/g creatinine) 
TCA  9.7  4.9 
TCE  0.5 
The concentration of PERC  in  alveolar air in  this study is higher (especially at 64 h 
after exposure)  than  estimated from  the repeated  exposure esperiments  (Table  19). 89 
The reason for this may be underestimation of the accumulation of PERC in the repea-
ted exposure experiments compared to weekly exposure (accumulation in adipose tis-
sue). 
The concentration of TCA in  urine in this study is also higher than estimated from the 
experiments, but much lower than measured by Ikeda et al (1972a). The last difference 
can partly be explained by differences in analysis: a specific gaschromatographic met-
hod  versus  an  a  specific  spectrophotometric  method. 
In the industrial studies TCE was measured in  urine, while no TCE could be detected 
in the experimental exposure studies. The reason for this difference may be that small 
amounts of other chlorinated  hydrocarbons are  present  in  PERC  used  in  industry or 
that the metabolism  of  PERC  changed  after a certain  period  of exposure  to  PERC. 
Analytical methods 
Methods for measuring PERC in air and blood have been given by Riihimaki and Pfaffli 
1978, Essing et al  1972, Stewart et al  1970. 
Methods for measuring TCE and TCA in  blood and  urine have been  discussed in the 
part trichloroethylene. 
Conclusions 
The data published  are  limited  in  scope  and  do not yet  allow to  propose sufficiently 
validated  quantitative  biological  monitoring  methods. 
In  Table  22  group average data on  levels of tetrachloroethylene trichloroethanol  and 
trichloroacetic  acid  in  blood,  alvelar air and/or urine  in  occupational  exposure to  50 
ppm  have  been  presented. 
Research  needs 
Because there apparently is a cumulation of PERC (and TCA) in the body when expo-
sed  for  days  and  weeks,  adequately  controlled  obs~rvations in  industry  in  workers 
exposed  for at least ·a few weeks are  needed to  establish valid  biological  monitoring 
parameters. 
10.  Monochloroethene (vinyl chloride, VC) 
, 
Chemical  and  physical  properties 
physical  state 
molecular weight 
melting  point 
boiling  point 
vapour  density 
vapour  pressure 
molecular formule 
structural  formule 
1 mg/m3  =  0.391  ppm;  .1 
Effects  on  humans 
colorless  gas 
62.5 
-153.rc 
-13.9°C 
2.15  (air  =  1) 
2580  mm  Hg  at  20°C  and  760  mm  Hg 
CH2  =  CHCI 
H,  /H 
c = c 
H/  'c1 
ppm  =  2.56  mg/m3  at  25°C  and  760  mm  Hg. 
According to  Rowe (1974) vinylchloride has a rather low acute toxicity; it is narcotic in 
action  (and  actually  used  as  such).  Spirtas  et  al  (1975)  performed  a questionnaire 
survey on a population of white vinylchloride polymerisation workers (n=298), compa-
red  with  rubber workers (n=212) (response  rate  67%  and  42%  respectively).  There 
was a clear exposure response relationship for dizziness or light-headedness, nausea 90 
or sickfeeling, headache,  cc  pins and needles», general fatigue. These symptoms were 
most  frequent  in  case  of  high  exposure;  most  readings  were  20-30  ppm, 
sometimes  >  50 ppm, but in the past often  >  200 ppm. Kramer et al (1972) studied 
98 workers exposed up to 25 yr in  a polymerisation plant; there was exposure to  1  0 
ppm vinylchloride (as TWA with considerable variability) and less than 5 ppm to vinyli-
dene chloride.  Six parameters correlated  significantly with  cumulative TWA and  with 
the product of TWA and time on the job (ppm-yr): systolic and diastolic blood pressure, 
BSP,  icterus  index,  Hb,  ~-protein level.  Most  relevant  probably  are  the  parameters 
indicating disturbed liverfunction. Wyatt et al  (1975) examined blood chemistry in  413 
exposed  workers  and  469  controls:  albumin  levels  (increased)  and  cholesterol  level 
trends with  age  (smaller increase)  were different;  no such  difference were found  for 
total protein, Ca,  P,  creatinine, uric acid,  bilirubin, alkaline phosphatase,  LDH,  SGOT, 
CPK.  Lange  et  al  (1976)  observed  increased  coproporphyrin,  sometimes  also  (). 
aminolaevulinic acid in urine in patients with signs of liver damage. Generally speaking, 
liver function tests - as far as practicable in workers - do not provide early indication 
of potential liver disease in vinylchloride exposed workers (Falk et al  1976). It appears 
that detection of structural rather than functional changes is likely to be more rewarding 
for detection of early effects: grey-scale ultrasonography may be a promising practica-
ble  method  for this  (Duck  1976,  Williams  et al  1976).  Lange  et  al  (1974)  observed 
decreased platelet counts.  Ward  (1976)  reported immune complex disorders in  21  of 
58 workers; the extent and severity of these abnormalities paralleled  c~inical features 
(Raynauds' disease) to a large extent,  but. in some individuals they were already pre-
sent when clinical features were minimal or absent. Several research groups (inter alia 
Purchase et al 1976, Hansteen et al 1978) have also observed chromosomal defects in 
vinychloride  workers. 
EG  (1978)  requires for preventive medical examination at  least in  addition to clinical 
investigation, rontgen examination of hand skelet and EG (1978) suggest the following 
laboratory test: SGOT, SGPT, yGT, alkaline phosphatase, total bilirubin, platelet count, 
urine  analysis,  blood  sedimentation  rate  and  cryoglobulin. 
These data are  presented  because they may offert the- as far as known  - only 
means to detect early effects or early indications of late (irreversible) effects (Raynaud, 
aero-osteolysis,  portal  fibrosis,  angiosarcoma,  sclerodermia) in  vinylchloride exposed 
workers. 
Many studies in  workers  have shown  that vinylchloride  is  also  a human carcinogen. 
Infante (1981)  recently  reviewed  various studies.  In  4 of 8 epidemiological studies a 
significant excess  of  liver  cancer among  VC- workers  was  demonstrated;  in  5  of 8 
studies a significant excess of cancer of the  central  nervous system  was  observed. 
Moreover, there also are indications for increased risk of lung cancer and for lymphatic 
and haemopoetic system cancer. Some studies did not demonstrate an increased can-
cer risk;  however,  this  may  have  been  due  to  an  insensitive  study  design. 
Recently Maltoni et al (1981) reviewed the experimental evidence of carcinogenicity of 
vinylchloride (VC). The conclusions, based upon studies of respiratory exposure over a 
wide range of concentrations and many animal species, were as follows: (1)  VC indu-
ces tumours in  all  animal systems tested; (2)  VC is a multipotential carcinogen: diffe-
rent types of tumour in different sites; (3)  liver angiosarcomas are observed in all ani-
mal  species  studied;  (4)  there  is  a clear-cut dose-respons relationship;  (5)  newborn 
animals are extremely responsive and  easily develop hepato-carcinomas and  angio-
sarcomas;· (6) VC is a transplacental carcinogen; (7) carcinomas occur at exposure to 
50 ppm VC and probably even at 10 ppm, but no carcinomas were observed in expo-
sure to  5 ppm  and  1 ppm.  Radike  et  al  (1981)  observed an  enhanced carcinogenic 
respons  in  combined  exposure  to  ethanol  and  VC. 
Metabolism 
The most important route of exposure is through inhalation. At least in monkeys, expo-
sed to 800 and 7000 ppm for 2.5 and 2.0 h (excluding the head) a small amount was 
absorbed through the skin: 0.02 to 0.03% of total vinylchloride avajlable for absorption; 
the  majority  of absorbed  agent  was  eliminated  by  the  lungs  (Hefner  et  al  1975). 
Up·to about 15 years ago vinylchloride was regarded as rather harmless, so little effort 
was devoted to study metaboJism. After the discovery of carcinogenic effects, particu-
larly liver angiosarcoma, much attention was directed to investigation of effects of long 
term low level exposure. After this discovery, there were ethical constraints in  perfor-
ming human volunteer studies. Older studies (quoted by Williams 1959) reported that 
vinylchloride is promptly exhaled; 82% is eliminated after discontinuation of exposure. 
The  agent apparently is  liposoluble,  and so is  readily taken up by the body,  but also 
quickly eliminated.  More  recent  data  on  humans  are  discussed  in  12.4.0. 91 
In rats (Stokinger 1976) two metabolites have been identified in the liver: N-acetyi-S-(2-
hydroxy ethyl) cysteine and thiodiglycolic acid; they are thought to represent free avai-
lable SH-groups that act as  <<scavengers,,  of the vinyl  free  radical,  so  removing  its 
oncogenic  properties.  Muller  et  al  (1975)  found  substances  corresponding  to  S-
carboxymethylcysteine  and  thiodiacetic  acid  in  urine  of  exposed  rats. 
In  1978 Vainio reviewed metabolism, mutagenicity and carcinogenicity of vinychloride. 
The  metabolism  can  be  described  as  follows: 
vinyl-
chloride 
chloro-ethylene 
oxide 
chloroacetal-
dehyde 
chloroacetic 
acid 
S-formylmethylglutathione 
Biotransformation  into  the  epoxide chloroethylene  oxide involves  microsomal  mixed-
function oxidase by a liver microsomal system; this epoxide rearranges with a half-life 
of 1  .6 min spontaneously into the aldehyde; both can react with glutathione. Mutageni-
city depends upon the metabolic activation to the epoxide, although also the aldehyde 
is mutagenic. Gehring et al (1978) demonstrated that in rats, exposed to 1.4-4600 ppm 
for  6  h the  logarithmic probability incidence  of  angiosarcoma versus  the  amount  of 
vinylchloride metabolized rather than the exposure concentration in air was linear. As-
suming no threshold extrapolation of the data below the range of doses causing experi-
mentally observable responses predicted an incidence of 0.01% hepatic angiosarcoma 
in  rats  exposed  to  4.6  ppm  vinylchloride.  Theoretical  extrapolation to  man,  exposed 
daily to 1 ppm sugges.ted an incidence of 1.5 per 1  00,000,000, which is less than that 
expected to occur spontaneously. Bolt et al  (1981) discussed the carcinogenic poten-
tial of peak exposure to vinylchloride in  man  on  the  basis of biotransformation in  ani-
mals (monkeys) and humans. The model calculation suggested that, regardless of the 
exposure profile, the amount of reactive metabolites formed would solely be a function 
of the mean atmospheric vinylchloride over time, also for very short exposure peaks up 
to 200-300 ppm. In man, in contrast to rats, the capacity for a direct detoxication of the 
epoxide  with  glutathione,  forming  t)l-acetyi-S-hydroxyethylcysteine,  is  limited;  this 
would  indicate  that  low  but  constant  exposure  levels  to  vinylchloride  could  be  less 
hazardous  than  marked  peak  exposures,  which  produce  just  the  same  integral 
amounts  of the  reactive  metabolite. 
Biological  indicators 
Human volunteer studies 
Baratta et al (1969) exposed 4-7 subjects (total13) to 50, 250 and 500 ppm vinylchlori-
de for  7.5  h;  mixed  exhaled  air  was  analysed  (Table  23). 
TABLE  23:  Relationship  between  concentration  in  inhaled  (Ci)  and  exhaled  (Ce)  air 
Ci  (ppm) 
50 
250 
500 
T  (h) 
7.5 
7.5 
7.5 
Ce  (ppm)  at  2  h  postexp. 
0.6 
4.8 
10.0 
0.9 
6.0 
15.0 
Ce  (ppm)  at  16  h  postexp. 
0.08 
0.45 
0.8 
0.12 
0.65 
1.3 92 
It  could  be  concluded  that: 
- the  concentration  in  exhaled  air  increases  about  linearly  with  that  in  inhaled  air 
- there occurs an  accumulation: vinylchloride still is detectable the following morning 
in  exhaled  air. 
It should be noted however, that these experiments investigated concentration levels, 
which  are  not regarded  acceptable any longer.  Vinylchloride concentrations  in  blood 
and  urine  were  not  measured.  Skin  absorption  has  not  been  studied  in  humans. 
Krajewski et al  (1980) exposed 5 male volunteers, aged 26-31  yr, for 6 h to 3,  6,  12 or 
24  ppm:  the retention  in  mixed  inhaled  air was  average 42%  from  15 min onwards. 
The concentration in  mixed exhaled air (Ce)  in  exposure to  6,  12 and  24 ppm  (15.0, 
30.0 and 60.0 mg/m3)  respectively was average 0.54,  1.30 and  2.84 mg/m3  as mean 
value 30 min after exposure, i.e. 3.60, 4.30 and 4.73% of the concentration in  inhaled 
air. 
Industrial exposure studies 
Baratta  et  al  (1969)  also  studied  on  the  job  exposures  in  10  workers  (Table  24). 
TABLE 24:  Relationship between concentrations in  inhaled (Ci)  and exhaled (Ce)  air in workers 
exposed  to  vinylchloride 
Ci  (ppm)  T  (h)  Ce  (ppm)  at  2  h  postexp.  Ce  (ppm)  at  16  h  postexp. 
25  8  0.32  0.60  0.02  0.05 
50  8  0.70  1.20  0.06  0.12 
100  8  1.60  2.50  0.15  0.28 
250  8  3.90  7.80  0.5  0.9 
These  data  agree  reasonably  with  those  observed  in  the  human  volunteer  study. 
Muller et al (1978) measured the excretion of thiodiglycolic acid in urine of 18 workers, 
exposed to 0.14 to 7.0 ppm (personal sampling) vinylchloride. The excretion of thiodi-
glycolic acid in 20 non-exposed workers was less than 1.5 mg/1;  in workers the increa-
se of metabolite excretion began shortly after starting exposure each day. The metabo-
lite excretion exceeded the normal range,  even  after a mean exposure level of about 
1.5 ppm, but not after exposure of less than 1.0 ppm. Muller et al (1979) described an 
analytical  GC-MS  method  for  thiodiglycolic  acid  in  urine;  in  34  non-exposed  males 
0.64  ±  0.32 mg/1 was found, In  14 non-exposed females 0.51  ±  0.20 mg/1.  Pharma-
ceutical drugs, other industrial agents and chloroacetylaldehyde precursors may also 
cause  increased urinary levels;  therefore,  this  method  of biological  monitoring  is  not 
wholly specific. The authors also suggested that measurement of hydroxyethylmercap-
turic acid might present possibilities for biological monitoring. Draminski and Trojanow-
ska (1981)  described another gaschromatographic method for masurement of thiodi-
glycolic  acid;  however,  the  detection  limit  was  10  mg/1. 
Conclusions 
There  does  not  yet  e),<ist  any  valid  routine  biological  monitoring  method  which  can 
evaluate vinylchloride exposure at present day accepted levels  <  1  0 ppm.  In view of 
the low Ce-levels at 2 hand 20 h after exposure to 25-50 ppm, a practicable technique 
still  has  to  be  developed. 
Myers et al (1975) described methods to measure vinylchloride at sub-ppm level using 
a personal monitor; limit of detection  <  20 ppb.  NIOSH (1974a) also described a ga-
schromatographic  method  after collection  on  charcoal  tubes. 
Particularly  recent  findings  of increased  urinary excretion  of  metabolites promise to 
become the method of choice, although more research is needed, and the metabolites 
are  not  fully  specific  for  exposure  to  vinylchloride. 
Research  needs 
Data on biological monitoring are still rather limited; there particularly is need to study 
the relationship between exposure to vinylchloride at concentrations below 1  0 ppm and 
the  excretion  of  metabolites,  on  individual  basis. 93 
11.  Anaesthetics 
Introduction 
In  the  past  several  of the  halogenated  hydrocarbons  reviewed  have  been  used  as 
anaesthetics;  trichloroethylene  may still  be  used  at  a small  scale.  At  present  a few 
other compounds are largely applied as anaesthetics; personnel of the operation room 
(anaesthesists, nurses and technicians) may become exposed. This type of occupatio-
nal exposure differs from that in industry: rather low level but irregularly shortterm peak 
exposures. The work may put heavy demands upon the central nervous functions and 
may involve emotional stress and irregular sometimes very prolonged working periods. 
Especially  two  agents  merit  discussion:  halothane= fluothane  (2-bromo-2-chloro-
1, 1, 1-trifluoroethane) and  methoxyflurane (2,2-dichloro-1, 1-difluoroethyl methyl ether). 
Effects  on  humans 
Reviews  on  health  effects  have  been  published  by  inter alia  NIOSH  (1977),  Chang 
(1977), Smith (1978), Ferstandig (1978),  Vessey and Nunn (1980) and  Edling (1980). 
Although reported suggestions on health effects in operation room personnel, including 
effects on  reproduction and  offspring, cannot always be maintained, the evidence can 
neither be  refuted.  There  exists suggestive evidence  of  increased  risk  of congenital 
abnormalities in  the offspring, spontaneous abortion,  liver and  kidney disease, decre-
ment in psychomotor performance, maybe of cancer.  However, there always is a pos-
sibility that the  health effects reported  may be  due to other work -related  factors,  e.g. 
work stress,  infections, radiation.  In  some studies there was an  indication for decrea-
sed  birth  weight and  in  one study for increased  infertility in  fermale  anaesthesists.  It 
has also been reported that an increased risk of abortions or congenital malformations 
exists in the family of male anaesthesists, but the evidence is dubious (Edling 1980). 
In  a study of delivery ward personnel (see 13.4.0) Dahlgren (1979a) observed a rela-
tionship (P < 0.001)  between exposure to  methoxyflurane (MTF)  and  increase in  se-
rum uric acid,  SGOT,  SGPT and  BUN  levels. A small part of the increase was due to 
simultaneous exposure to nitrous oxide. This suggested an effect on hepatic and renal 
functions.  In  animal studies hepato - and nephrotoxic effects have also been demon-
strated,  although  ustJally  in  high  exposure  intensity. · 
Gamberale et al (1974) studied effects of exposure to anaesthetic gases (halothane up 
to  1  0 ppm,  nitrous oxide up  to  3000  ppm,  ethanol  up to  94  ppm)  in  20  anaesthetic 
nurses and  in 20 intensive care nurses (controls); no measurable difference in impair-
ment was  observed  in  reaction  time  and  in  perceptical speed  between  both  groups; 
however, the individual variability of the responses in some reaction tests was greater 
in the anaesthetic nurses at the end of the work day. Korttila et al (1978) examined 19 
operation room (see 13.4.0.) nurses 'and  11  (younger) nurses working in the wards. No 
correlations  were  found  between  the  concentration  of  halothane  or  nitrous  oxide  in 
end-tidal  air and  psychomotor  or driving  performance. 
Metabolism 
The  anaesthetics  are  rapidly  absorbed  through  inhalation;  they  are  liposoluble  and 
parly metabolized into various compounds. The biological half life is considerable,  so 
accumulation probably takes place. The compounds and/or metabolites are measura-
ble  in  exhaled  air and/or urine.  Holaday (1977)  reviewed  the  metabolism  of various 
anaesthetics. The percentage of anaesthetics metabolized was calculated with a mo-
del and  were  as  follows  (at  4 h duration of anaesthesia):  enflurane 18%;  halothane 
26%; methoxyflurane 52%. The blood-gas  and  fat-gas  partition  coefficients were  re-
spectively for enflurane 1.9 and  70; for halothane 2.4 and  155; for methoxyflurane 11 
and 670 (according to Dahlgren  1979b,  13.0 and 825). The liposolubility and  the de-
gree of biotransformation increase in  the given order; this may explain the increasing 
drop of the concentrations in  exhaled air within the first 24  h after anaesthesia in  the 
reverse  order. 
According  to  Holaday  (1977)  excretion  of metabolites  occurs  almost exclusively  by 
urine; in  urine sampled  for up to  14 days 2.4%, 25%  and  44%  of the  total  amount 
taken  up of enflurane,  halothane and  methoxyflurane,  respectively was found.  In  the 94 
case of halothane exposure bromide is a principal metabolite; this is excreted with  a 
half life of 12-22 days.  The plasma bromide level  increases during 20-40 h after the 
end of anaesthesia. The biological half life of excretion of trifluoroacetic acid (another 
metabolite of halothane) in volunteers is 16 h; in patients longer half lites (39-61  h) are 
reported, probably because biotransformation still occurs the first 2 or 3 days following 
anaesthesia.  In  addition to the biotransformation into the fraction excreted measured 
as  fluoroacetic  acid,  bromide and  chloride,  a second  fraction  undergoes  irreversible 
binding to microsomal proteins. Hepatotoxicity may be related to a third fraction: relea-
se  of fluoride;  this  occurs  under anaerobic  conditions. 
Studies in volunteers and in occupational exposure 
Cascorbi et al  (1970)  performed studies with  labelled  halothane in  volunteers and  in 
exposed personnel; the agent was injected intraveneously. Exhaled air was measured 
over 5 min, urine collected up to 21  days. Urinary excretion of radioactivity was greater 
when the tracer was injected into unanesthesized subjects (n = 2) than when the same 
subjects  were  anaesthesized  (N20-halothane).  As  a  group  pharmacists  showed  a 
much  smaller  variation  in  urinary  metabolite  excretion  than  anaesthesists.  The 
amounts of  labelled  C exhaled  in  41/2  h ranged  from  10-45%  of the  injected  dose; 
measurable amounts were still recovered as late as 144 h after injection. Four of the 5 
anaesthesists excreted more radioactivity during the first 2 h after injection than the 4 
pharmacists. This suggests enzyme induction in the regularly exposed anaesthesists; 
however, this was not the case in one of them: he had been least exposed during the 
two  previous  years. 
In operating room personnel Hallen et al  (1970) measured exhaled air (rebreathed) at 
the end of one or more operations and venous blood at the end of a days' period. The 
halothane concentration was 7.0 ppm,  29.0 ppm  (median values) outside or within 25 
em of the outlet of gases; in expired air 4.0 ppm was found, in venous blood 0.13 mg/1 
(median  values)  (end  of  operation). 
After observing  methoxyflurane in  exhaled breath of an  anaesthesist up to 29 h after 
exposure to 2-10 ppm  in  his immediate work environment, Corbett (1973) studied le-
vels  in  end-expired  air  in  personnel  at  intervals  following  exposure:  halothane was 
detected up to 64 h,  and  methoxyflurane up to 29  h after exposure. Corbett and Ball 
(1973)  also measured breath decay curves in anaesthesists exposed to halothane tor 
70-390 min; the agent was detected in end-expired air for 26 h·(70 min exposure) to 64 
h (390 min exposure). Repeated exposure the next day increased the duration of exha-
lation. In surgeons with 70 min exposure (to lower levels than anaesthesists) halothane 
was detected for 9 h. The exposure concentrations were up to 1  0 ppm in the inhalation 
zone of anaesthesists,  0.14-0.25 ppm  in  the main  hallway leading to the room,  0.02-
0.04  ppm  in  the  anaesthesia  room,  and  0.10-0.22  ppm  in  the  recovery  room. 
Gostomzyk et al (1973) measured halothane levels in blood; the levels depended upon 
duration of exposure, size of operation room,  halothane index (indicator of exposure). 
They found  up to  about 1  000  1.:1g  halothane/! serum  at the end of exposure in  physi-
cians, and up to about 800  ~-tg/1 in nurses; with lower halothane index and larger room-
size the levels were much lower (up to 200 and 100  ~-tg/1 respectively). Even in the last 
case  halothane  was  still  present  in  blood  the  following  morning. 
Eichler et al  (1975)  examined  halothane levels in  exhaled air of anaesthesists at the 
end  of  an  operation;  they  compared  the  effects  of  three  narcosis-systems:  open 
(n = 23),  half  closed ·intubation  (n = 8)  and  half  closed  system,  mask  (n = 2).  The 
levels in  exhaled air were 1-243 ppm (duration narcosis 30-270 min), 2-14 ppm  (120-
270  min)  and  45  ppm  (180-240  min)  respectively. 
Gostomzyk et al (1975) measured halothane levels in blood in 17 anaesthesists and 17 
nurses at the end  of operation (3-4  h),  and  at  20  h after exposure.  The  levels were 
40-770  llg/1  serum  and  15.2  llg/1  respectively. 
Dalhgren (1979a, 1979b) particularly studied exposure to methoxyflurane (MTF) in ob-
stetrical analgesia.  Urinary fluoride levels were measured.  In  15 mothers exposed to 
MTF the concentration was 24.9 ± 19.6 mg/1 at 2-12 h after delivery and 6.8 ± 6.0 mg/1 
at 60-72 h;  in nitrous oxide (N20) analgesia the levels were 0.4 and 0.3 mg/1  respecti-
vely. In  addition 24 delivery ward  personnel were studied. It had been shown that the 
urinary F-concentrations were maximal about 12 h after exposure. Urinary fluoride con-
centrations were measured at the beginning of each workday during 5 separate three-
weeks  periods;  during  3  periods  MTF/N20  was  employed  as  anaesthetic,  during  2 
periods only N20. The duration (in  minutes) of exposure was  recorded for each sub-
ject; this was related to the fluoride (F) concentration (in mg/1) the day after this expo-
sure.  In  the  MTF/N20-periods  mean  exposure  time  was  72  min  (± 25),  mean 95 
F = 0.707  mg/1  (± 0.582);  in  the  N20-periods  respectively  73  min  (± 33)  and  0.352 
mg/1  (± 0.256).  In  the  general  population  the  F-concentrations were  0.28-0.62  mg/1. 
The data showed a clear difference (P < 0.001) between the F-concentrations in MTF/ 
N20-and N20-periods: the mean level was doubled, although the mean duration of ex-
posure was similar. Previously it had not been possible to detect even traces of MTF in 
exhaled  air  in  the  same  personnel  of  the  same  delivery  wards.  The  mean  MTF-
concentrations in  the delivery rooms were 0.5-0.8 ppm  MTF and  300-540 ppm  N20. 
Conclusions 
Occupational exposure of operation room personnel to halogenated hydrocarbons like 
halothane and  methoxyflurane offers  possibilities  for  biological  monitoring. 
Because. of the irregular working conditions in the operations theatre, no adequate data 
on exposure (level, duration, respiratory minute volume) are available; methods of bio-
logical  sampling  of exhaled air,  blood  or urine show a large variability.  Nevertheless 
these  studies  have  shown  that: 
- biological monitoring of exposure by means of sampling exhaled air and  blood for 
halothane  is  feasible; 
- metabolites can be found in blood and urine: bromide, trifluoroacetic acid in case of 
halothane,  fluoride  in  case  of  methoxyflurane; 
- the  biological  half life  may  be  rather  long;  cumulation  in  repeated  exposure  may 
take  place,  particulary  of  halothane; 
- adequate data on  relation  between  exposure (level,  duration)  and  biological para-
meters  are  not  yet  available. 
Research  needs 
Although various possibilities for biological monitoring have been demonstrated, there 
still is little insight in the relationship between exposure (concentrations-time weighted 
average, peaks; duration; irregualarity; repetitive exposure) and levels of the anaesthe-
tic and/or metabolites in blood, exhaled air and/or urine. There is need for more syste-
matic  studies,  and  for  comparative  studies  of  analytical  methods. 96 
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Summary 
This  document  reviews  inorganic lead  as  related  to occupational exposure and  the 
possibilities of the biological monitoring of exposure. 
The  main  route of absorption in occupational exposure is the respiratory apparatus. 
Derangement  in  heme  synthesis  is  currently  considered  the  first  adverse  effect 
associated with increasing concentration of lead in the soft tissues. 
A vaste number of tests which permit an evaluation of the degree of exposure, body 
burden, and toxic effect are available for monitoring lead workers. 
For periodic monitoring of workers exposed to lead it is recommended that two tests 
be  used  simultaneously;  one  test should  be  designed to indicate internal dose and 
another  to  indicate effect.  In  general  it  is  advisable  to  use  blood  lead  levels  as  a 
measure of internal dose, and erythrocyte protoporphyrin as an indicator of effect. 
For screening studies an inexpensive test which is easy to perform, sensitive, specific 
and  precise  should  be  used  to  indentify subjects  with  high  exposure.  Both  proto-
porphyrin and delta-aminolevulinic acid dehydratase comply with these requirements. 
For assessment on  a group analysis basis of the  environmental condition of a work 
place,  the  urinary tests may be  used; blood tests,  however, provide more accurate 
information. 
Individual blood lead  levels in  male workers should not exceed 60 /Lg/1 00 ml,  and  in 
women  workers  of  child-bearing  age  they  should  not  be  higher  than  40  /Lg/1 00  ml 
because of the potential adverse effect of lead on the foetus. 
Further investigations are required on the relationship between external and internal 
dose and standardization of the various biological tests. 
Abbreviations 
ALAD 
ALAU 
CPU 
EP 
PbA 
PbU 
PbUEDTA 
ZPP 
o-aminolevulinic acid dehydratase activity of erythrocytes 
o-aminolevulinic acid in  urine 
urinary coproporphyrin 
erythrocyte protoporphyrin 
lead in blood 
urinary lead 
amount of chelatable lead excreted with 24-h urine after administration of CaNa2 
EDTA (1  g intravenously) 
erythrocyte zinc protoporphyrin 109 
Lead 
Chemical and physical properties 
Lead is a chemical element represented by the symbol Pb and with an atomic number 
of 82,  atomic weight 207.21,  specific weight 11.342; melting point at 327°C; boiling 
point  at  about  1740°C.  Starting  from  temperatures  of  550  - 600°C,  there  is 
considerable production of vapours which combine with oxygen in the air to form lead 
oxide.  Lead  is  found  in the natural state in  mineral deposits. The  most common and 
most widely used mineral for extraction is galena (PbS).  The  lead content in directly 
mined mineral varies from 3 to 10%. 
Effects on humans 
Derangement  in  heme  synthesis  is  currently  considered  the  first  adverse  effect 
(critical effect) associated with increasing concentration of lead in the soft tissues; in 
fact, lead can inhibit some enzymatic activities of heme biosynthesis (Chisolm, 1971; 
De Bruin, 1971; Baloh, 1974; Waldron and Stoefen, 1974). See Fig. 1 (Chisolm, 1971 ). 
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Figure 1 -Biosynthesis of heme is inhibited by lead, resulting in accumulation of intermediates in 
the synthetic pathway. Lead  inhibits two steps (solid arrows) and may inhibit two 
others(broken arrows). 110 
The inhibition by lead of ALAD and heme synthetase, which are enzymes containing 
SH  groups,  is  well  documented.  Due  to  ALAD  inhibition,  an  accumulation  of ALA 
occurs in the serum and consequently in the urine; inhibition of heme synthase (iron 
chelatase) produces an  accumulation of protophorphyrin  IX  in  the erythrocytes. An 
increase in urinary coproporphyrins is an indirect evidence of coprogenase inhibition 
by lead. 
The  combination of decreased delta-aminolevulinic acid dehydratase activity in  red 
blood  cells,  increased  urinary  delta-aminolevulinic  acid,  increased  urinary 
coproporphyrin, and increased erythrocyte protoporphyrin is pathognomonic for lead, 
distinguishing it from all other disorders of pyrrole metabolism in man (Chisolm, 1975). 
Also  changes  in  nerve  conduction  velocity should  be  regarded  as  a critical  effect 
(Zielhuis,  1977). These  changes will not,  however,  be  considered here because the 
investigation  methods  are  rather  time-consuming,  difficult  to  perform  in  working 
environments, and are not always reliable since the alterations are unspecific. Such 
investigations can nevertheless be very useful for studies on groups of workers. 
Metabolism 
In working environments the main route of absorption is the respiratory apparatus. It is 
generally considered that 35-50°/o of the lead that reaches the lower respiration tract 
is absorbed into the blood stream. 
The potential increase in the body burden of lead can be expressed as: 
BB  = L x v  x R x o  x 1  o-3 
where BB  =  potential increase in body burden in  mg;  L =  air lead concentration in 
mg/m3; V =  pulmonary ventilation in m3/day; R =  fraction of inhaled lead retained; D 
= duration of exposure in days. R values vary according to the solubility and particle 
size of individual lead compounds. 
The uptake of lead by the gastro-intestinal tract is less complete than by the lung. Not 
more than 5-1 0°/o of ingested lead is generally absorbed, the balance being excreted in 
the feces. 
A potential gastro-intestinal absorption in industry should not be underestimated. Both 
because it can increase due to particular personal habits, e.g. smoking, eating in the 
workplace and because as much as 40°/o of inhaled lead of large diameter trapped in 
the  upper  respiratory tract may  be  swallowed  (Kehoe,  1961;  Knelson  et  al.,  1973; 
Hamilton and Hardy, 1974; Waldron and Stoefen, 1974). 
In a steady-state situation, lead intake equals output and the skeletal system contains 
about 80-90°/o of the total body burden of lead. 
Figure 2 (Baloh, 1974) gives a schematic representation of the dynamic interchange of 
the  body  lead  pool.  Blood  is  the  major  factor  in  determining  the  steady  state 
distribution of lead in  body tissues. There is  a dynamic equilibrium between red  cell 
lead and plasma lead on the one hand and between extracellular lead and intracellular 
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Figure 2- The dynamic interchange of the body lead pool 111 
lead  on  the  other.  It  is  likely to  be  the  ionic  fraction  of the  plasma  lead  which  is 
transferred  to  the  other  body  compartments.  The  equilibrium  constants  of  the 
reactions probably rank in  the following order: Kt  > K3  > K2  > K1.  However, since a 
state of equilibrium is  rarely reached,  the  rate constants  K, also become important. 
The  rate  constants  indicate  the  speed  with  which  the  state  of  equilibrium  can  be 
reached in any given reaction. 
The  rate  constants  in  Fig.  2  are  probably  in  the  reverse  order  of  the  equilibrium 
constants, i.e. K 11  > K 12  > K13  > K 14, indicating that the bone takes more time to reach 
its final  lead concentration than  erythrocytes or proteins (Baloh,  197  4;  Waldron and 
Stoefen, 197  4). 
According to Pietrovsky (1970) the total body burden of lead can  be  roughly divided 
into: 1) rapid exchange pool in blood and soft tissues; 2) intermediate exchange pool in 
skin and muscles; 3) exchange pool  in bone (intermediate exchange in bone marrow, 
trabeculae, and slow exchange in dense bone and teeth). 
Biological Indicators 
Indicators of internal lead dose 
Dose should, ideally, be defined as "the amount or concentration of a given chemical 
at  the  site of its action", i.e.  where  its presence  leads  to a given  effect. Since the 
determination of this amount is often impossible in practice, the dose may have to be 
estimated by various means and  in most cases one can speak only in terms of these 
dosage  estimates.  Metal  concentration  in  biological  media  can- often  be  used  as 
indicators (or indices) of exposure and of concentration in the critical organ (Nordberg, 
1976). 
Below  are  considered  the  biological  tests  which  may  be  used  as  indicators of  an 
internal lead dose. 
Concentration in blood 
The level of lead in blood (PbB) is a function of the quantity of lead absorbed from the 
environment minus the lead deposited in the bone cortex and soft tissues and the lead 
excreted with  urine  and  feces  (Waldron,  1971 ).  PbS  ts  about  2% of the  total  lead 
burden. Approximately 95% of blood lead is bound to erytt)rocytes and  is not readily 
diffusible;  plasma  lead (0.2%  of  the  total  burden)  is  made  up  of  two fractions:  the 
plasma protein bound fraction and the diffusible fraction, the latter being probably the 
metabolically active centre of the body lead pool (see Fig.  2) (Baloh, 197 4).  Diffusible 
plasma lead  probably gives the  best approximation of the  biologically effective lead 
burden,  although  at  present  it  is  not  possible  to  measure  it.  It  should  be  noted, 
however, that the plasmatic fraction of lead is not a constant function of the total blood 
lead  concentration  and  therefore  ~an  not  be  predicted  by  PbS  (Waldron,  197 4). 
However, for groups of subjects, PbS  is probably a reasonable indication of plasmatic 
levels (Zielhuis, 1975a). 
In  practice PbS  is  the  most  reliable  means of  measuring the extent of exposure:  it 
allows distinctions to be made between  normal subjects, subjects with permissible 
absorption  levels,  and  subjects  with  non-permissible  absorption  levels.  It  is, 
moreover,  particularly useful  in  epidemiological  studies.  In  fact,  a good  correlation 
exists between PbS and lead levels in the atmosphere (Williams et al., 1969). 
Interpretation of blood lead levels must take into account the fact that they reflect only 
one point in  time,  and  a dose which  is  steady,  increasing or  decreasing (Nordberg, 
1976).  However,  although  these  levels  allow  a  satisfactory  evaluation  of  current 
exposure, they are not  necessarily always correlated with  the  lead body burden.  In 
fact, after cessation of exposure, PbS may reach "normal" values while a body burden 
persists. This is demonstrated by a high urinary lead excretion after chelating therapy 
(Prerovska and Teisinger, 1970), or when disorders of heme synthesis are still evident 
(Selander  and  Cramer,  1970;  Alessio  et  al.,  1976c).  On  the  other  hand,  cases  are 
known  in  literature  of  adults  and  children  who  showed  clinical  symptoms  of 
intoxication  but  who  had  relatively  low  PbB  values  (Beritic,  1971;  Moncrieff et  al., 
1964). This apparent "paradox" could be due to the fact that measurement occurred 
some time after cessation of exposure (Kehoe, 1972). 
Studies on  volunteers who received different quantities of lead also showed that the 
PbS  levels  reach  a  given  ceiling  even  when  the  body  lead  burden  increases 112 
continuously during exposure (Kehoe,  1961 ).  This was also observed in occupational 
exposure (Benson et al., 1976). 
Factors exist which  can  influence  PbB  levels  independently of  exposure and  body 
burden.  For  example,  blood  levels  are  greatly affected by  the  red  blood  cell  mass 
(anemia,  polycythaemia).  There  has  been  much discussion of whether these  levels 
should  be  corrected  to  the  haematocrit  values,  but  there  is  disagreement  on  the 
biological validity of such correction (Lauwerys, 1975). 
Further,  the  measurement  of  lead  concentration  in  blood  also  presents  difficulties 
(Berlin et  al.,  1974;  WHO,  1977;  NIOSH,  1978).  A number of  interlaboratory control 
programmes have  revealed  high  rates of variation in  the results, which are probably 
due  to the fact that this parameter is  measured with  methods and  instruments that 
differ considerably one  from  the  other.  In  January  1978,  an  interlaboratory control 
programme  for  PbB  was  sponsored  by  the  EEC  (within  the  frame  of  the  activities 
provided for in  the EEC guidelines of 29.3.77). This programme is still under way and 
preliminary results indicate that the extractive methods followed by flame AAS always 
give  lower  results  than  the  other techniques with atomic absorption.  The  flameless 
methods  or  the  "Delves Cup"  give  similar  results  but  it  should  be  noted  that  the 
"Delves Cup" tends to overestimate the values. 
Concentrations in urine 
The  kidney  is  presumed  to  excrete  lead  by  two  routes:  glomerular  filtration  and 
transtubular flow or excretion (Vostal and Heller, 1968). 
The  relative  importance  of  the  two  routes  is  uncertain,  but  the  formation  of  lead 
containing  inclusion  bodies  suggests  that  in  subjects  with  heavy  lead  exposure 
transtubular flow may assume a greater importance (Cramer et al., 1974). 
Since  the  analysis  of  lead  in  urine  (PbU)  does  not  require  blood  withdrawal,  it  is 
sometimes  preferred  to  PbB  determination  (Lauwerys,  1975).  The  "normal"  PbU 
concentration in  adults usually oscillates between 10 and 80 p.g/1,  lower than 50 p.g/g 
creatinine (Baloh,  197 4;  Lauwerys,  1975).  In  subjects under continuous exposure,  a 
satisfactory  correlation  was  found  between  atmospheric  lead  levels  and  PbU  and 
between PbB and PbU (Williams et al., 1969). In the case of new lead exposure there is 
also a good correlation between PbB and  PbU,  but while PbB  increases without any 
demonstrable time lag, the increase in PbU  requires a latency period of about 2 weeks 
(Tola et al., 1973). 
Many factors other than lead absorption such as fluid intake and specific gravity of the 
urine may influence the excretion of lead (Ellis, 1966). Patients with chronic nephritis 
frequently have PbU levels within "normal" limits in spite of the existence of high lead 
stores  (Lilis  et  al.,  1968).  Prerovska  and  Teisinger  (1970)  have  demonstrated  that 
subjects with heavy lead exposure in the past can have normal urinary lead excretion 
even when excretion of chelatable lead remains high. 
Concentration in feces 
In  the non-occupationally exposed general population the quantity of lead eliminated 
with the feces is clearly higher than that eliminated with the urine. In fact, the greater 
part  of  the  metal  present  in  the  feces  consists of  ingested  lead  that  has  not been 
absorbed by the intestines (Kehoe, 1961 ). 
The  levels of lead in feces of "normal" subjects varies between 240 and 400 p.g/24 h 
(Kehoe, 1961; Barry, 1975). During occupational exposure the values increase to 760-
3800 JLg/24 h, according to the data of Saita and Moreo (1958). 
Measurement  of  lead  in  feces  can  be  used  to  determine  absorption  by  ingestion 
(accidental  or  intentional).  Fecal  lead  excretion  above  4  mg/1 OOg,  4  weeks  after 
occupational exposure has  ceased,  is  a sure indication of ingestion (Zielhuis,  1972). 
The analysis is valid only when performed during the period of ingestion or in the days 
immediately following (Vigliani and Debernardi, 1934). 
Chela table lead 
Chelatable  lead  is  strictly dependent  on  the active deposit of the  metal  in  the  soft 
tissues of the body,  including the  trabecular bone (Teisinger et al.,  1969),  and  as  a 
result it provides a more direct measurement of the rapid exchange pool. 
Chelatable lead can be measured by injections of CaNa2 EDTA or by penicillamine per 113 
os.  The  levels of PbU  EDTA (mean  +  2 SO)  in  26  inhabitants of Milan who were not 
occupationally exposed to lead, were 630 J.LQ/24  h (Alessio et al., 1976a). 
Limited data on  humans strongly suggest that the CaNa2 EDTA mobilization test may 
be a  better indication of the concentration of lead in affected organs of man (Nordberg, 
1976). 
Since CaNa2 EDTA is capable of binding only with extracellular lead (Teisinger et al., 
1958;  Castellino e Aloj,  1965),  it  is  likely that  measurement  of  metal  in  urine  after 
administration of this drug permits an indirect, though rough, evaluation of the levels of 
diffusible lead. 
After administration  of  CaNa2  EDTA,  the  reduction  in  levels  of  lead  in  the  plasma 
creates a cells/plasma gradient which slowly disappeares. After the first few days of 
treatment  in  fact,  urinary  lead  is  greatly  reduced  and  it  is  necessary  to  interrupt 
administration  for  a  few  days  so  that  an  equilibrium  may  be  established  in  the 
distribution of lead in the cellular and extracellular compartments and so that a high 
excretion of the metal may once again be obtained (Saita, 1962). 
In studies on children and adolescents (Chisolm et al., 1976), a statistically significant 
linear relationship was found between blood lead concentration and the logarithm of 
the  quantity  of  lead  excreted  in  the  24-hour  period  immediately  following 
administration of CaNa2 EDT  A.  In our laboratory, studies in progress have shown that a 
good correlation exists between  PbS  and  PbU  EDTA  in  adult  subjects with  current 
occupational  exposure  to  lead.  In  subjects  with  past  ocupational  exposure,  the 
correlation between the two parameters is definitely lower, although still statistically 
significant. Analysis of the regression curves shows that for corresponding values of 
chelatable  lead,  subjects  with  past  exposure  have  lower  blood  lead  levels  than 
currently  exposed  subjects.  The  slopes  of  the  regression  lines  are  statistically 
different (Fig. 3). 
120 
a)  •  b) 
n = 48  n =  45  r =  0 54 
100 
• 
E  80  •  • 
0 
0 
.......  •  • •  Ol 
:::l  60  y  en 
..0 
c._  .  ':/·  .. 
40  ./I  , .  ., 
20  ··:·· 
• 
• 
0  I  ' 
1  000  2000  3000  4000  1000  2000  3000  4000 
PbU- EDTA '-'g/24 h 
Figure 3- Relationship between chelatable lead  (PbU EDTA) and PbS  in male subjects with 
current (a)  and past exposure (b)  to lead 
Chelatable  lead  cannot be  used  in  epidemiological  studies because  it  necessitates 
administering a drug and also because 24-hour urine samples are difficult to obtain. 
The induced urinary lead test is capable of detecting and evaluating the existence of 
lead absorption which occurred in  the  past.  It  can  therefore  be  used  to  determine 
whether  former  acute  manifestations  or  current  chronic  manifestations  are 
attributable to lead intoxication, even when the other indicators of internal dose have 
returned to normal (Saita, 1962; Prerovska and Teisinger, 1970). 
Teisinger (1971) maintains that in subjects with past exposure, a urinary lead excretion 
above  1  mg/24 h  after  administration  of  CaNa2  EDTA  (2  g  i.v.)  is  indicative  of  a 
potentially dangerous body burden of the metal; for subjects still exposed,  however, 
the author sets critical level at 2 mg/24 h. 
Relationship b~tween external lead exposure and indicators of internal dose 
Many studies have demonstrated the existence of a correlation between PbS, PbU and 
the atmospheric lead levels in the working environment (PbA). 114 
The relationship between PbA and PbB has a similar profile both when the atmospheric 
lead levels are low and when  levels of 0.2 mg/m3 are  reached (See  Fig.  4) (Harada, 
1976). Williams et al. (1969) found a close correlation between PbA and PbB (r =  0.90) 
and  between  PbA  and  PbU  (r  = 0.82) with high statistical significance (p  <  0.01 ). 
Table I (Williams et al., 1969) gives the mean values and the 95°/o confidence limits of 
single determinations of PbB and PbU which correspond to 0.2 and 0.15 mg/m3 lead in 
air. The wide range of the confidence limits is evident from these data. 
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Figure 4- Relationships between lead concentration in air and  lead concentration in blood of 
lead workers. The curves are those obtained from a study of the PbA/PbB relation-
ship in newspaper industries (Harada, 1976), extended to plot also the values of Elkins 
( 1959). Harada et al.  ( 1960) and Tsuch iya and  Harash ima ( 1965) 
On  the basis of Williams' data, Zielhuis and Verberk (197  4)  examined the validity of 
various PbB and PbU levels as indicators of "unacceptable" exposure; they assumed 
PbA  =  0.12 mg/m3 to be the "acceptable" level (see Table II).  In this sample for the 
cut-offs considered, PbB levels have a higher validity than PbU levels as indicators of 
unacceptable exposure. PbB  > 40 has  maximum sensitivity (no false negatives : all 
individuals with PbA  >  0.12 have PbB  >  40);  however, specificity is moderate (also 
PbB  >  40 in subjects with PbA  <  0.12 : 44 °/o  of false positives). PbB  >  80 is highly 
specific -(no  individual with  PbA  <  0.12 has  PbB  >80, i.e.,  no  false  positives);  but 
sensitivity is moderate (46°/o  false negatives). On the basis of these results,  Zielhuis 
and Verberk (1974) conclude: "If one wants to be certain that all subjects with PbA  > 
0.12 are  selected out of a universe of exposed workers,  PbB  >  40 will  serve this 
objective, however, at the cost of a number of false positives. If, on the other hand, one 
wants  to  select  only  individuals  with  PbA  >  0.12,  then  PbB  >  80 will  serve  this 
objectives, however, with many false negatives.". 
The number of subjects in whom validity has been studied is limited (about 30 cases) 
but it is  likely that even with a larger number of subjects the validity values will be 
similar since air sampling involves many limitations, i.e.: 
- effect of particle size and solubility of particle; 
representation of only a small fraction of total volume of air inhaled; 
- ingestion remains unmeasured; 
- effect of contamination and position of sampling head; 
- effect of the entry of particulates into sampling heads; 
- failure to evaluate individual  differences  in  pharmacokinetics according to age, 
type of respiration, congenital or acquired diseases, etc. (Lyman, 1975). Table I -Mean values and 95% confidence limits of single determinations of lead in blood and 
urine which correspond to two lead-in-air concentrations 
PbA  PbB  PbU 
(mg Pb/m3 )  (JJ.g/1 00 ml)  (JJ.g/1) 
0.20  Mean  70  143 
95% C.l.  48-92  56-230 
015  Mean  60  118 
95% C.L.  38-82  31-205 
Table II -Validity of different PbS and PbU  levels for predicting an unacceptable lead 
exposure (PbAir 0.12mg/m
3
) 
se  Sp  Validity 
PbS  > 40  1.00  0.66  1.66 
JJ.g/100 ml  > 60  0.72  0.80  1.52 
> 80  0.56  1.00  1.56 
PbU  > 60  0.88  0.53  1.41 
IJQ/1  >120  0.56  0.95  1.51 
>160  0.12  0.95  1.07 
Se  =sensitivity,  Sp=specificity,  Sp+Se=validity 
115 
At the 2nd International Workshop on Permissible Limits for Occupational Exposure to 
Lead (Zielhuis,  1977)  the conclusion was reached that a "standard" for  lead  in  air 
based upon the relationship between PbB  and PbA could not be established. Such a 
standard, it was felt, would best be based on PbB alone. 
To conclude this section, it seems appropriate to make the following points: 
a)  Lead in the blood and lead in the urine are indicators of exposure since the levels 
of these parameters are closely influenced by the environmental concentration of 
lead.  · 
b)  Chelatable lead may be considered a "true" indicator-of dose, the levels of which 
reflect the active lead deposit. 
c)  In  currently exposed subjects the indicators of exposure permit prediction of the 
quantity of chela  ted lead. 
d)  In  subjects no longer exposed the indicators of exposure do not permit a reliable 
evaluation to be made of chelatable lead. 
Indicators of Effect in Adult Males 
Biological  tests  which  may  be  used  as  indicators  of  a  biological  lead  effect  are 
separated  according  to  sex  since  in  recent  years  it  has  been  shown  that  some 
indicators of effect behave differently in males and females. 
Erythrocyte delta-aminolevulinic acid dehydratase 
The delta-aminolevulinic acid dehydratase (ALAD) of circulating erythrocytes is highly 
sensitive to inhibition by lead; inhibition of ALAD in  red  blood cells (ABC's) parallels 
inhibition in other tissues, e.g. liver (Sec chi et al., 197  4). 
A  very close negative correlation exists between erythrocyte ALAD and  lead blood 
levels. The enzyme undergoes distinct inhibition in the range of PbB values below 40 
l'g/1 00  ml  (Hernberg  et  al.,  1970;  Haeger-Aronson  et  al.,  1971;  Zielhuis,  1972; 
Lauwerys et al., 1974). There is suggestive evidence that the no-effect level is about 10 
l'g PbB/1 00 ml (Granick et al., 1973). 
Up to 197  4,  studies on the relationship between ALAD and PbB have generally used 
the  method  of  ·Bonsignore  et  al.  (1965)  or  methods  derived  from  this  for  the 
determination  of ALAD.  At present the  European  standardized  method (Berlin  and 
Schaller, 1974) is widely used. Determination of ALAD using the method of Bonsignore 116 
is of little use in monitoring occupationally exposed subjects (see Fig. 5) (Alessio et al., 
1976b).  In  fact, when PbB increases beyond 40 JLg/1 00 ml, the enzymatic activity is 
reduced to a level too low to allow identification of different blood lead levels (de Bruin, 
1968; Basecqz et al., 1971 ; Hernberg et al., 1972; Sec  chi and Alessio, 197  4). However, 
ALAD can have a wider application in  monitoring lead workers when it is  measured 
with the CEC method,.since a marked inhibition of the enzymatic levels occurs only 
when PbB values exceed 50-60 JLg/1 00 ml (see Fig. 5). 
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Figure 5- Correlation between PbB and ALAD determined by two different methods in adult 
males currently exposed to lead 
Validity of ALAD  is  rather moderate for  PbB  levels lower than  40  JLg/1 00 ml  which 
therefore implies a very high percentage of false classifications. Thus when subjects 
with only environmental lead exposure are studied according to Zielhuis (197  4),  "it is 
not possible to base a biological quality guide on individual ALAD  levels''. Validity of 
ALAD  does,  however,  improve  markedly  for  higher  PbB  levels.  For  example,  the 
validity of ALAD (measured with the CEC method) is good at a PbB cut-off ot 60 JLg/1 00 
mi. At this level, at cut-off of 15 m U/ml RBC the enzyme displays a sensitivity of 0.96 
(i.e. 4°/o false negatives) and a specificity of 0.85 (i.e. 15°/o false positives). These data 
indicate that ALAD  may  be  used  as  a  screening  test  for  occupationally  exposed 
subjects (Table Ill). 
After a worker's first exposure to lead, ALAD activity decreases rapidly without any 
appreciable time lag, parallel to the increase in blood lead concentration (Hernberg et 
al., 1972). According to Tala (1972) and Haeger-Aronson et al. (1974), when exposure 
to lead ceases, ALAD activity progressively returns to normal, parallel to PbB.  Thus, 
according to these findings,  ALAD  does not indicate any former lead exposure that 
cannot be detected from an elevation of PbB. 
Table Ill -Validity of ALAD for predicting different PbB  levels. Analysis made on 108 adult 
males currently exposed to lead 
PbB  ALAD 
Se  Sp 
,J.&g/100 ml  mU/ml RBC 
Validity 
;)s40  =s;;;;2o  0.71  0.80  1.51 
~60  ~15  0.96  0.85  1.81 
~70  ~10  0.94  0.92  1.86 
Se =sensitivity.  Sp =specificity,  Validity= Se + Sp 
ALAD determined according to the European standardized method 117 
However,  other studies (Vergnano et  al.,  1969;  Sakurai  et al.,  1974) indicate to  the 
contrary,  that  in  cases  of  severe  past  exposure,  ALAD  remains  inhibited  out  of 
proportion to the current PbS.  It has been conjectured that in this situation enzymatic 
inhibition  is  due  to  an  inhibitor other  than  lead,  probably of  a thermolabile proteic 
nature (Vergnano et al., 1969). 
The significance of erythrocyte ALAD inhibition due to lead in  regard to health is  still 
open to discussion (Zielhuis, 1975a). As  regards ALAD inhibition for the  range of PbS 
up to 40 JLg/1 00 ml "its biological significance is dubious because it is unaccompanied 
by any detectable effects on the biochemical function of man" (NAS, 1972). According 
to  Nordberg  (1979).  an  inhibition  of  ALAD  in  the  cells  of  the  bone  marrow  is  a 
subcritical effect which precedes an  increased level of delta-aminolevulinic in  blood 
and urine and the occurrence of anemia (critical effects). A decrease in ALAD activity 
in blood is an example of an indicator of subcritical effect of lead exposure. 
Until recently, it was not clear whether the inhibition of peripheral erythrocyte ALAD by 
lead was a phenomenon which really occurred in vivo,  or a phenomenon which only 
occurred  in  vitro,  i.e.  a  result  of  membrane-bound  lead  getting  access  to  the 
intracellular enzyme as a result of haemolysis in the test tube required for determining 
ALAD  activity. Roels  et al.  (1974a) have shown that the decrease in  the erythrocyte 
enzyme  is  a true  reflection  of  the  enzyme  activity in  vivo  when  PbB  is  below  120 
JLg/1 00  mi.  ALAD  inhibition  is  highly specific for  increased  lead  absorption:  e.g.  no 
reduction of ALAD  activity has  been  observed in  workers occupationally exposed to 
cadmium  and  mercury  (Lauwerys  et  al.,  1974;  Lauwerys  and  Buchet,  1973).  A 
transitory inihibition of ALAD occurs after acute ingestion of high quantities of alcohol 
(Moore et al.,  1971 ).  In  chronic alcoholism high  PbB values may be  found,  but ALAD 
appears more depressed than  might be  expected from blood  lead  levels,  and  these 
levels  remain  low  for  a  number  of  days  after  suspension  of  alcohol  consumption 
(Krasner et al., 1974; Secchi and Alessio, 1974a). 
In lead-exposed subjects, false negative results of ALAD may be obtained when hyper-
regenerative  erythropoietic  disorders  exist,  e.g.  bleeding  anaemia,  haemolytic 
anaemia (Bonsignore et al., 1970; Battistini et al., 1971 ). 
The European standardized method for determination of ALAD proved to be accurate 
and  with  good  reproducibility.  The  interlaboratory  coefficient  of  variation  in  the 
intercomparison programme sponsored by  the  CEC  in  1974 was  10% (Berlin  et  al., 
1974). 
In the view of Berlin and Schaller (1974), the routine use of ALAD is limited by technical 
problems, particularly the conservation of the blood  s~mple at ooc for a limited time 
interval.  In  our  experience,  when  the  sample  is  stored  at  4  °C,  no  loss  of  enzyme 
occurs after 24 hours (see Table IV). 
Table IV- Erythrocyte ALAD activity (mU/ml) before and after storage at 4 °C 
Samples  Before storage 
After storage 
24 hours  48 hours 
1  38.0  37.6  33.0 
2  21.4  20.8  17.2 
3  19.8  19.9  16.2 
4  16.0  16.0  13.0 
5  9.8  9.7  9.0 
Erythrocyte Protoporphyrin 
Heme synthetase is extremely sensitive to the action of lead and the inhibition of this 
enzymatic activity causes an accumulation of EP in erythrocytes. This is related to the 
fact that the mitochondrial enzyme regulates the incorporation of iron in the porphyrin 
molecule.  In  occupationally exposed subjects,  the  concentration of  this  erythrocyte 
metabolite rises and can reach levels from 1  0 to 50 times higher than the values found 
in subjects not occupationally exposed to lead (Vigliani and Angeleri, 1935; Rubino et 
al., 1958; de Bruin, 1971). 
The methods of erythrocyte protoporphyrin determination are numerous. Some permit 
selective measurement of different porphyrins (Schwartz and Wikoff, 1952; Sassa et 
al., 1973), others measure the total concentration of erythrocyte porphyrins (Piomelli 
et al., 1973). All these methods use extractive techniques. 118 
The discovery that erythrocyte protoporphyrin that rises following an  abnormal lead 
absorption (or following sideropenia) is not "free" but bound to zinc, revolutionized the 
determination methods.  In  fact, zinc protoporphyrin can  be  determined on  capillary 
blood diluted with water or alcohol by direct fluorimetric reading (Lamola, 1974). Since 
1976 instruments have been developed - hematofluorimeters - for the immediate 
determination of  zinc protoporphyrin on undiluted blood (Blumberg et al., 1977). 
Henceforth, protoporphyrin determined with extractive methods will be shown as  EP 
and zinc protoporphyrin as ZPP. 
For greater clarity, EP and ZPP are dealt with separately. 
Erythrocyte protoporphyrin determined with extractive methods 
EP measurement has made considerable advances in paediatrics as a result of studies 
carried out using microanalytical methods (Kammholz et al., 1972; Sassa et al., 1973; 
Piomelli et al., 1973; Chisolm et al., 1974). This test has not been used for monitoring 
occupationally exposed  subjects until  recently.  A highly significant correlation was 
found between EP and PbB in adult males under stable lead exposure. In this situation 
EP is also closely correlated with urinary lead and chelatable lead (Roels et al., 1975; 
Tomokuni et al., 1975; Alessio et al., 1976a). 
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The behaviour of EP  is uniform with respect to the three indicators of dose.  EP first 
undergoes a modest increase with the elevation of the internal load within the normal 
values. Beyond such normal values a net increase occurs, which continues up to an 
asymptotic value which is not further altered by the increase in dose (Alessio et al., 
1976a). 
In adult males the increase in  EP in the 40 to 80 l'g/1 00 ml blood lead range appears 
very  marked,  so  that  the  difference  between  "normal"  subjects,  subjects  with 
"permissible" and subjects with "not permissible" absorption appears more distinct 
than that which can be revealed by blood lead (Fig. 6).  It should be pointed out that at 
PbB levels which do not cause an elevation in EP, a reduction in ALAD levels is already 
in operation. On the other hand, the dose-response relationship calculation has shown 
that in  adult males there is  a no-response PbB  level for an  increase in  EP  of 25-35 
l'g/1 00 ml (Roels et al.,  1975; Zielhuis,  1975a). The no-response PbB  level for ALAD 
appeared to be 15-20 l'g/1 00 ml (Zielhuis, 1975a). 
Moreover,  EP  permits a fairly accurate prediction of the amount of chelatable lead 
(Alessio et al., 1976a). This seems particularly interesting since it is very likely that, as 
an indicator of biological effective internal dose, chelatable lead is more relevant than 
lead in blood. 
EP  can  be  reliably used  as  a screening test for monitoring occupationally exposed 
groups since in the 500-2000 l'g/24 h range for PbB EDTA (see Table V; Alessio et al., 
1976a). 
Table V 
A)  Validity of EP for predicting different PbB levels. Analysis made on 2_01  adult males 
currently exposed to lead 
PbB  EP 
Se  Sp  Validity 
(~oLg/100 ml)  (~oLg/100 ml ABC) 
~40  ~ 50  0.83  0.98  1.81 
~60  ~ 75  0.97  0.99  1.96 
~70  ~100  0.98  0.90  1.88 
B)  Validity of EP for predicting different PbU  EDTA levels. Analysis made on 92 adult males 
currently exposed to lead 
PbU-EDTA  EP 
Se  - Sp  Validity 
(1£Q/24 ore)  (1£Q/100 ml ABC) 
~ 500  ~ 50  0.84  1.00  1.84 
~1000  ~ 75  0.92  1.00  1.92 
~1500  ~100  0.96  0.97  1.93 
~2000  ~150  0.93  0.83  1.78 
Se=sensitivity,  Sp=specificity,  Validity=Se+Sp 
EP determined according to the Schwartz and Wikoff Method 
For example,  at a blood lead  level  of 60 l'g/1 00  ml,  EP  at a cut-off of 75 l'g/1 00 ml 
correctly classified 97°/o of positive subjects and 99°/o of negative subjects. Thus only 
3°/o false negatives and 1  °/o false positives were obtained. 
When  examining recently exposed subjects, account must be taken  of the fact that 
between the beginning of lead absorption and the increase in  EP there is a time lag 
evaluated by Sassa et al. (1973) as 2 months, and by Stuik (197 4) as 2 to 3 weeks. 
Normalization of EP after cessation of exposure is slower than that of PbB, ALAU and 
CP.  In  fact,  in  erythrocytes of subjects who have been  exposed  to  lead  there  is  a 
surplus of EP which persists until the red blood cells are destroyed (Aibahary, 1972). 
However, in severely exposed subjects, EP stays at high levels even for many years 
after cessation  of exposure (Saita  et al.,  1954;  Gajdos,  1957;  Rubino  et al.,  1958). 
Alessio et al. (1976c) recently demonstrated that the correlation existing between EP 
and  PbB  is  decidedly  lower  in  male  subjects  no  longer  exposed  to  lead  than  in 
currently  exposed  subjects,  and  that  for  the  same  PbB  values,  the  EP  levels  are 
markedly higher .in subjects who are no longer exposed. 
EP and chelatable lead are closely correlated both in currently exposed subjects and 
in  subjects with past exposure, and the regression curve in  both groups takes on  an 120 
almost identical profile (see Fig. 7; Alessio et al., 1976c). These data seem to indicate 
that EP  remains at  nigh  levels for a long  period of time due to a direct inhibition of 
heme synthetase by the lead released from the deposits. 
The  erythrocyte  metabolite  can  therefore  be  used  to  detect  the  existence  of  past 
exposure  and  to  determine  whether  a  patient  who  has  had  past  exposure  should 
resume work with lead. 
EP  levels  as  high  as  those  occurring  in  severe  lead  poisoning  might  be  found  in 
erythropoietic protoporphyria, a rare congenital disorder, and  in  thalassemia major. 
Moderate  increases  have  been  found  in  cases  of  iron  deficiency,  serious  liver 
diseases, and tumours (Baloh, 197  4; Sa ita et al., 1966). 
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Zinc protoporphyrin 
Determination  of  zinc  protoporphyrin  with  portable  hematofluorimeters  is  a  very 
practical test which is easier to perform and lower in cost than the extractive methods. 
There is a very close correlation between ZPP and PbB in adult males: The regression 
curve  between  the  indicator of  exposure  and  effect takes  on  the  same  profile  as 
already observed for  EP  (Fig.  7);  in  fact, at PbB  levels below 35-40 JLg/1 00  ml,  ZPP 
undergoes only a moderate increase, but subsequently the  increase is very marked 
(Schaller and Schiele, 1977; Alessio et al., 1978; Fig. 8). 
Without cases having PbB levels above 90 JLg/ml it is not possible to check whether the 
regression curve takes on the asymptotic slope observed for EP determined with the 
Schwartz and Wikoff method. 
Research in progress in our laboratory has shown a high predictive validity of ZPP and 
PbB levels  ~ 60 JLg/1 00 ml : using a cutt-off of ZPP  ~ 80 JLg/1 00 ml validity was 1  .  77, 
with very high sensitivity (0.98), signifying 2% false negatives. The test may therefore 
be  used to advantage in  screening  studies of  occupational exposed subjects.  Such 
studies  are  facilitated by  the  fact that  the  instrument is  portable,  gives  immediate 
results and allows a large number of subjects to be examined in a short time. 
As  the  hematofluorimeter  takes  account  of  the  absorption  spectrum  of 
oxyhemoglobin, the ZPP levels determined on capillary blood are decidely higher than 
those determined on venous blood; whereas they are identical to those determined on 
venous blood after oxygenation (Alessio et al., 1978). 
A  close  correlation  exists  between  ZPP  and  EP;  but  it  should  be  noted  that  while 
Alessio et al. (1978) found that EP  levels, determined according the Piomelli method, 
were higher than ZPP levels, Blumberg et al. (1977) found that ZPP levels were higher 
than EP levels, and Schaller and Schiele (1977) found that ZPP levels were practically 
indetical  to  erythrocyte  protoportphyrin  levels.  A  tentative  explanation  of  the 
discrepancy in results might be the use of a different standard. 
It should moreover be noted that the research in progress in our laboratory has shown 
that by using three hematofluorimeters of different make, significantly different values 
are obtainedA 
It is  hoped that hematofluorimeter manufacturers carry out a joint study as  soon  as 
possible to standardize the calibration of the instrument, so that ZPP values may be 
readily compared in all laboratories. 
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Delta-aminolevulinic acid in urine 
Due to the inhibition of the ALAD of the maturing ABC's by lead, the transformation of 
ALA into prophobilinogen is obstructed, resulting in  an  increase in ALA in  the serum 
and  in  the urine. On  the subject of behaviour of ALA in  the serum, a few studies on 
children  with  acute encephalopathy are  available.  However,  at  present  it does  not 
appear  that  the  test  can  be  used  routinely,  since  detection  of  only  moderately 
increased levels of ALA requires more than 10 ml of plasma (Chisolm, 1975). 
Many  studies  are,  however,  available  on  ALAU.  Researchers  have  found  a  good 
correlation  between  the  urinary  metabolite,  PbB  and  PbU  (Williams  et  al.,  1969; 
Selander and Cramer, 1970; Haeger-Aronsen, 1971; Soliman et al., 1972; Lauwerys et 
al., 1974). The coefficient of correlation between PbB and ALAU is usually between 0.5 
and  0. 7,  and  therefore  is  not  as  close  as  the  correlation  which  generally  exists 
between  PbB  and  the  blood  tests  (ALAD  and  erythrocyte  protophorphyrin).  A 
significant increase in  ALAU  can  be seen at PbB  levels slightly higher than those at 
which there is  an  increase in  erythrocyte protoporphyrin (see  Fig.  1  0;  Alessio et al., 
1976b).  This  phenomenon  is  clearly  seen  from  examination  of  the  dose-response 
relationship.  In  fact, the approximate no-response PbB level for ALAU  is  35-45~'g/1  00 
ml (Roels et al., 1975; Zielhuis, 1975b). 
Erythrocyte protoporphoryn permits better discrimination between exposed workers 
with "permissible" absorption and those with "potentially dangerous" absorption than 
ALAU.  In  fact,  at  a  PbB  concentration  below  the  currently  accepted  TLVs,  the 
progressive elevation of erythrocyte protoporphyrin is more marked than that of ALAU 
(see  Fig. 9).  It  should be  noted, however, that the levels of ALAU,  like the levels of 
CPU,  also  undergo  increasing  elevation  when  PbB  values  exceed  80-90~'g/1 00  ml, 
while erythrocyte protoporphyrin values do  not  undergo any  further  increase. (This 
phenomenon has not yet been verified for ZPP.) Therefore, urinary tests may have an 
important application when  metabolic damage such as  that which can occur in  lead 
intoxication must be evaluated (Alessio et al., 1976b). 
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Figure 9- Relationship between PbS and  indicators of effect in adult males currently exposed 
to lead  • 
The  validity of ALAU  for predicting  PbB  appears to be  distinctly lower than  that of 
erythrocyte protoporphyrin. 
To predict a PbB level  2::  60  ~'g/1 00 ml using a cut-off of ALAU  >  10 mg/1, validity was 
1.67, with sensitivity =  0.75, and specificity =  0.52; the number of false negatives is 
therefore very high (25°/o) (Alessio et al., 1976b). 
In recently exposed subjects, there is a latency period of about two weeks before the 
urinary metabolite increases (Tola et al., 1973; Benson et al., 1976). 
After cessation of lead exposure, the excretion of ALA in the urine becomes "normal" 
relatively quickly.  This  parameter  is  therefore  not  suitable  for  detecting  past  lead 
exposure (Haeger-Aronsen et al., 1974). 
For the determination of ALAU, as for all the other urinary tests, it is difficult to obtain 
24-hour urine samples or urine samples for precise periods of time,  e.g.  4-8  hours. 123 
Generally the determination  is  therefore performed  on  spot  samples.  Owing  to the 
different density of daily samples, widely varying  levels of the metabolite, e.g.  from 
"normal" to "pathologic" can be  obtained from  the same subject.  For an  example, 
see Fig. 10. To overcome this difficulty, the sample is currently corrected according to 
its specific gravity or creatinine. This correction will probably be useful in studies on 
groups of subjects, but in single subjects it does not permit approximation of the value 
expressed in mg/1 or mg/24 h. 
The ALAU reported in the literature for the subjects not occupationally exposed to lead 
are below 6 mg/1 or 4.5 mg/g of creatinine. High values of ALAU can also be found in 
subjects with acu~e  intermittent prophyria. 
Various  chromatographic  and  non-chromatographic  methods  are  available  for  the 
determination of ALAU.  A critical evaluation of some of these  techniques has  been 
made by Roels et al. (1974b}. 
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Coproporphyrin in urine 
In subjects under continuous exposure, there is a good correlation between PbB and 
CPU (Williams et al., 1969; Soliman, 1972; Alessio et al., 1976b). 
An  excretion  of  coproporphyrins  in  the  urine (mainly  isomer  Ill) beyond  the  upper 
normal limits occurs when  the PbB  levels are slightly higher then those at which an 
increase in ALAU values occurs (see Fig.  1  0). This phenomenon is also evident in the 
examination of the dose-response relationship between the two urinary metabolites 
and PbB (Wada, 1976). 
From commencement of exposure to increase in  CPU  there is a time lag of about 2 
weeks  in  recently exposed  subjects (Tala  et  al.,  1973a;  Benson  et  al.,  1976).  With 
cessation  of  exposure,  the  urinary  coproporphyrins  return  to  normal  within  a  few 
weeks and sometimes within a few days (Saita, 1962). 
Urinary coproporphyrin is not a specific test of lead exposure. Increases in the urinary 
metabolite  may  occur also  in  porphyria  cutanea  tarda,  liver  diseases,  haemolytic 
anaemias, malignant blood diseases, infectious diseases, and also after consumption 
of alcohol. However, subjects with severe lead exposure may in some rare cases show 
normal levels of coproporphyrin in the urine (Saita et al., 1966; Lauwerys, 1975). 
The same limitations given for ALAU apply for this test as well. 124 
The  validity of CPU  (determined on  spot samples) to  predict different PbB  levels is 
rather modest, so its use as a screening test is limited (Alessio et al., 1976b). 
Other porphyrins are not as common in urine, although increased uroporphyrin levels 
may occasionally be detected, especially in severe cases of lead poisoning (Stankovic 
et al., 1973). 
Haemoglobin and stippled cells 
These  two  tests  are  only  marginally  important  for  the  routine  monitoring  of  lead 
exposure. Haemoglobin and PbB are generally poorly correlated; a reduction in Hb oc-
curs when the PbB  level exceeds 100-110 JLg/100  ml  (Williams,  1966; Cooper et al., 
1973). 
In the past, stippled cell count was "an early indicator of abnormal lead absorption", 
since the appearance of stippled cells precedes the onset of anaemia (Saita,  1962). 
This test is not used today because it does not accurately reflect the amount of lead 
absorbed and  because the number of stippled cells increases with a much greater 
time lag than the other biological changes discussed above (Lauwerys, 1975). Further-
more, the test is not specific for lead intoxication since stippled cells may be present in 
thalassemia, pernicious anaemia and anaemia due to renal insufficiency (Sa ita, 1962). 
Indicators of effects in adult females 
Because of its relatively recent interest, the number of studies of female exposures is 
rather limited. They generally involve a small sample of subjects with a moderate de-
gree of exposure. 
Erythrocyte delta-aminolevulinic acid dehydrase 
Studies made on groups of subjects not occupationally exposed have shown that adult 
females living in the same place and of the same age as a group of male controls had a 
higher mean  value of erythrocyte ALAD  activity and  a lower mean  value of lead  in 
blood (Haeger-Aronsen et al., 1971; Secchi et al., 1973). 
In the women it was also observed that the reduction in ALAD activity with age is less 
marked than in men (Secchi and Alessio, 197  4b). The difference·  found between the 
two sexes was attributed to a different lead intake with food, wine, and smoking. Tola 
(1973),  who examined  171  women and  1199 men with PbB  levels between 9 and 90 
JLg/100  ml,  found  no  consistent differences between  the  ALAD  values  of  men  and 
women at the same blood levels. Similar results have been obtained in a study of 93 
women  and 95  men  with  PbB  levels  ranging  from  8 to 80  JLg/1 00 ml  (Alessio et al., 
1977). From these data it therefore appears that there are no differences in AlAD level 
between males and females with the same level of internal lead load. 
Erythrocyte protoporhyrin 
Stuik  (197 4)  has  shown  that  increase  in  EP  occurs  in  adult  females  at  a  lower 
concentration of PbB than in adult males (for females at a PbB level of 25 - 35 JLg/1 00 
ml; for males at 35- 45 JLg/1 00 ml), and that the increase in EP was steeper in females 
with the increase in PbB '(alues. 
EP was observed to behave similarly by Roels et al. (1975) in  40 male and 24 female 
adults  with  moderate occupational  exposure  (Pb  50  JLg/1 00  ml).  EP  and  PbB  were 
closely correlated in the the two groups; EP was markedly higher in the women at the 
same internal lead dose, i.e.  PbB.  This phenomenon can also be clearly observed in 
the groups considered in a study by Alessio et al. (1977), see Fig. 12, which consisted 
of subjects with more severe exposure. Similar results are obtained when erythrocyte 
protoporphyrin is determined with hematofluorimeters, like ZPP.  · 
Study. of the dose-response relationship does however show that the no-response PbB 
levels for an increase in EP are 25-35  JLg/1 00 ml for females (Roels et al., 1975). 
In non-occupationally exposed women, the EP levels are higher than in males (Roels et 
al., 1975; Wibowo et al., 1977). 250 
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In occupationally exposed women, ALAU  and  PbB are well correlated. Levels of the 
urinary metabolite in  the women seem slightly higher than  in  men, at the same PbB 
level (Roels et al., 1975). 
Study  of  the  dose-response  relationship  shows  that  the  no-response  levels  for  an 
increase in ALAU are 35 - 45 /Lg/1 00 ml  for males and 30 - 40 /Lg/1 00 ml for females 
(Roels et al., 1975). It does not, however, appear that there is a significant difference 
for ALAU values in non-occupationally exposed subjects in the two sexes. 
Urinary coproporphyrin 
Results by Alessio et al. (1977) show that CPU  and  PbB  are significantly correlated. 
The relationship  between the two parameters does not seem to indicate the existence 
of a difference in behaviour of the urinary metabolite in the two sexes. 
From the available data on adult women, the following conclusions can be drawn: 
in  adult women a significant correlation exists between the indicators of internal 
lead dose and indicators of effect, as had already been confirmed in adult men; 
- the relationship between indicators of dose and indicators of effect, evaluated with 
the regression curve and/or the dose-response curve, shows that in the female, the 
"qualitative" behaviour of the indicators of effect is identical to that observed in 
males. In males the erythrocyte ALAD undergoes a distinct inhibitiqn in the range of 
PbB values below 40 /Lg/1 00 mi. The erythorcyte protoporphyrin initially increases 
rather moderately; then, beyond a PbB level of 40 /Lg/1 00 ml, the increase is very 
marked. ALAU and CPU increase above normal for PbB values higher than those at 
which  an  inc'rease  in  protoporphyrin  occurs.  The  increase  in  the  two  urinary 
metabolites in relation to the increase in  internal lead load is  not as steep as the 
increase in the erythrocyte metabolite. 126 
- There  is  a clear difference in  the  ".qualitative" behaviour of protoporphyrin (and 
perhaps  of  ALAU)  in  the  two  sexes  at  identical  levels  of  internal  dose.  This 
phenomenon appears to be due to a greater susceptibility of haemopoiesis to lead 
in women. The cause of such hypersensitivity might be a relative iron deficiency in 
women,  causing  increased  alterations  in  haemopoiesis  induced  by  lead  (Stuik, 
197  4;  Zielhuis,  1975a).  Synergic action between  sex  hormones  and  lead  on  the 
enzymatic activity of heme synthesis has also been suggested (Roels et al., 1975). 
Conclusions 
A vast number of tests which permit a sufficiently accurate evaluation of the degree of 
exposure,  body  burden  and  toxic affect  are  available  for  monitoring  lead  workers. 
Given the advantages and limitations of each test, the choice of indicator or indicators 
will depend on the type of investigation. 
Two  tests should  be  used  simultaneously for the periodic surveillance of  workers 
exposed to lead concentrations sufficient to cause alterations in biological indicators 
close to the "permissible" limits. One test should be designed to indicate internal dose 
and another to indicate effect. In  monitoring individuals, blood tests are preferable to 
urinary tests, the latter being subject to considerable variation due to differences in 
urine density. Furthermore, elevation beyond the "normal" limit values of the urinary 
indicators  of  effect  (i.e.  delta-aminolevulinic  acid  and  coproporphyrin),  occurs  at 
internal  dose  levels  higher  than  those  at  which  an  alteration  occurs  in  the  blood 
indicators of effect (i.e.  delta-aminolevulinic acid dehydrase activity of erythrocytes 
and erythocyte protoporphyrin). 
In  general, it  is  advisable to use blood lead levels and erythrocyte protoporphyrin for 
periodic monitoring as  these  two tests  integrate well.  This  is  not only because one 
evaluates internal dose and the other the effect but also because blood lead evaluates 
a momentary situation (present  exposure) while  the  erythrocyte metabolite permits 
evaluation of body burden and past exposure. These features are important in relation 
to the fact that industrial levels of exposure are rarely stable, so that PbS alone might 
give only partial information in cases of non-steady-state exposure. On the other hand, 
protoporphyrin does not permit assessment of current absorption. 
A screening test wich is inexpensive, easy to perform, sensitive, specific, precise and 
accurate should be used to identify subjects with the highest exposure from a group. 
The percentage of false negatives should be minimal, but too many false positives may 
give rise to excessive referrals for diagnostic evaluation, cause alarm and overcrowd 
busy outpatients facilities (Chisolm et al.,  197  4).  Both erythrocyte protoporphyrin and 
delta-aminolevulinic acid dehydratase comply on  the whole with these requirements: 
both tests have been shown to possess high predictive validity of the "true situation", 
i.e. internal lead load measured with PbS.  · 
Protoporphyrin  offers  the  following  advantages  over  ALAD:  a)  it  also  permits 
quantification of situations in which an internal lead load has already caused a marked 
inhibition of ALAD;  b)  it can  be  measured  using  capillary blood with  micromethods 
which are rapid to perform. The fluorimetric zinc protoporphyrin technique appears to 
offer a simple, instant and repeatable measurement; c) a higher number of analyses 
can be performed in the course of the day; d) the sample for analysis can be stored 
longer periods of time. 
The  urinary test may be  used for assessment of the environmental conditions of a 
place  of  work  on  a·  group  basis,  although  blood  tests  provide  more  accurate 
information. If urinary tests are used,  it will be appropriate to take the density of the 
samples into account, rejecting those with density lower than 1010, or with creatinine 
concentration below 0.5 g/1. 
For a correct evaluation of a group investigation, it will not be sufficient to express the 
data solely as a mean and standard deviation or range. This procedure can be applied 
only  if the parameter  follows  a  Gaussian  distribution,  and  it  wHI  be  appropriate  to 
consider the percentage distribution of the data as well (Zielhuis, 1974). 
The  choice of biological tests must also be  made  on  the basis of the  availability of 
suitable  equipment  and  trained  technical  staff,  the  possibility  of  easy  and  rapid 
performance, transport and cost. 
The  problem of biological limit values  for workers  exposed  to inorganic  lead  has 
been considered by many authors and has been discussed at numerous meetings of 
experts. Limit values have been proposed or established by national and international 
bodies responsible for the protection of workers health. 127 
In September 1976 a workshop was organized in Amsterdam under the auspices of the 
Permanent Commission and International Association on Occupational Health and the 
World  Health Organization, which  re-examined the  problem of  permissible limits for 
occupational exposure to inorganic lead (Zielhuis, 1977). 
At  the  workshop  the  following  recommended  guidelines  for  PbS  based  on  health 
criteria were  drawn  up:  "for male workers  Individual PbSs  should  not  exceed  60 
l'g/1 00  ml  in  the  light  of present  knowledge  available  to this group". It  is  however 
desirable  to  reduce  individual  exposure  below  this  level,  taking  into  account  the 
effects on the haematopoietic system at concentrations above 45 - 50 l'g/1 00 ml and 
on nerve conduction velocity at concentrations between 50- 60 l'g/1 00 mi. The group 
could not agree on what level should b regarded as a health based permissible level for 
occupational exposure. So far as female workers of child-bearing age are concerned 
the  risk  of  harm  to  the  foetus  at  above  mentioned  PbS  levels  is  not  supported  by 
factual  evidence  but  is  based  on  theoretical  possibility.  Nevertheless,  because  of 
potential  effects  on  the  foetus,  a safe  practice would  be  to  avoid  employment  of 
women of child-bearing age on lead work where blood levels might regularly exceed 40 
l'g/1 00 mi. 
In  1978, recommendations were also made in the U.S.A. by the National Institute for 
Occupational  Safety  and  Health  (N IOSH,  1978),  and  by  the  Italian  Society  of 
Occupational Medicine and Industrial Hygiene (Foa et al., 1978), while in 1980 a report 
of a group of experts was issued by (WHO (WH0-1980). 
In 1982, the Council of Ministers of the European Communities (CEC 1982) adopted a 
directive on  the protection of workers exposed to inorganic lead.  This directive sets 
action levels and limits both for lead in air and for biological indicators (Table VI). The 
exceeding of the limit values may require removal of workers from exposure. 
The  above  limit  values  are  to  be  considered  as  maxima;- Member  states  are 
encouraged to set lower limits. Such  is  the situation already in  some of the  Member 
states. 
Table VI.  CEC biological action levels and limit values for lead exposure at work. 
Action Levels 
a) 
b) 
Limit Values 
PbB >40ug/100 ml 
information of workers 
PbB >sOug/100 ml 
full application of Directive 
a)  PbB  70 ug/100 ml 
b)  PbB between 70 - 80 ug I 100 ml 
- additional biological indicators must be used 
- limit value exceeded if 
ALA >20 ug'/ g creatinine 
or 
ZPP >  20 ug I g haemoglobin 
or 
ALAD<6 E.U. 
Research Needs 
In spite of the fact that lead is the most extensively studied metal from the point of view 
of industrial toxicology, further research is still necessary to establish safe permissible 
limits for exposure. The following are recommendations for further research: 
- Standardization of tests. Standardization of analytical methodology would allow a 
comparison  of  the  studies  being  carried  out  by  the  different laboratories  and 
research workers and would facilitate discussion and application of normal values 
and permissible limits internationally. 
As  a result of the inter-laboratory variability of lead blood levels, the  relationship 
between  these  levels  and  other  biological  indicators  cannot  be  precisely 
determined. 128 
The opinions of the various research workers on the usefulness of correcting the 
results of urinary tests made in spot samples are conflicting. This question should 
be dealt with to verify whether the corrections made for the individual subject allow 
a value  to be  obtained which  is  sufficiently similar to the value  obtained  on  the 
sam·e day on 24 h urine (considering the value expressed as quantity of substance 
per litre and/or quantity of substance per 24 hours). 
Daily variations in the results obtained from the various biological tests should be 
investigates as there are very few references to this in the literature. 
Determination  of  the  relationship  between  external  and  internal  exposure.  More 
extensive studies involving larger groups of subjects and taking particle size and 
solubility into consideration are necessary for this determination. 
Establishment  of  better  indicators  of  internal  lead  dose.  Very  few  studies  are 
available  on  lead  in  plasma although  diffusable plasma  lead  may offer the  best 
approximation  of  the  biologically  effective body  burden.  It  should,  however,  be 
taken into consideration that the plasma fraction is  not a constant fraction of the 
total blood concentration. 
Chelatable  lead  may  provide a more direct measurement of the  rapid  exchange 
pool and it may be used as a rough measure of plasma lead concentrations, since it 
is  normally found  in  plasma  and  not  in  cells.  It  therefore appears  necessary to 
determine  the  dose-effect  relationship  between  chelatable  lead  and  other 
indicators. 
The dose and  rate of administrations of chelating drugs for estimating the mobile 
portion of the body burden should also be standardized. 
- Research on hypersensitivity to lead. The few data available in the literature (Saita 
and  Morea,  1959; Girard et al.,  1967; Albahary,  1972; Saita and  Lussana,  1971 ), 
indicate that  subjects with  genetic alterations (thalassemia,  haemoglobinapathy, 
G6PD deficiency) may be hypersensitive to the action of lead. The high incidence of 
these alterations in some countries of the European Community and the increasing 
transient  population,  e.g.  immigrants  from  Mediterranean  area,  point  to  the 
necessity of a re-examination f the problem. 129 
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Summary 
This  document  reviews  the  metal  manganese  (Mn)  and  manganese(IV)oxide 
(brownstone,  Mn02)  as  related to occupational  exposure and  the possibilities of the 
biological monitoring of exposure. 
Chronic  manganism  has  been  observed  in  workers  exposed  through  inhalation  to 
manganese for periods of more than  two years,  but studies attempting to correlate 
degree and length of exposure with manganese levels in blood, urine, faeces and hair 
show  contradictory  results  and  dose/response  relationships  have  not  been 
established.  Most  authors  assume  that  there  is  not  direct  connection  between 
manganese  concentrations  in  biological  materials  and  the  severity  of  chronic 
manganese  poisoning.  Individual  susceptibility  to  the  disease  is  more  likely  the 
decisive factor. 
Until  further  information  is  available,  the  principle  of  biological  monitoring  can 
therefore only be  recommended with reservation for manganese. An  improvement in 
industrial hygiene measures at workplaces and a regular neurological examination of 
workers  exposed  to  manganese  would  seem  to  be  the  best  currently  available 
methods of preventing chronic manganism. 137 
Manganese 
Chemical and Physical Properties 
Manganese is a very hard, brittle metal, greyish-white in colour. 
Table I -Physical properties of manganese 
Symbol  Mn  -
Atomic weight  54.94 
Melting point  1247 °C 
Boiling point  2030 °C 
Specific gravity  7.2 g/cm
3 
Solubility (Mn and Mn0
2
)  Soluble in diluted acids 
Valency states  From Ill to VII, mostly II, IV and VII 
Pure  manganese  .is  seldom  used  in  industry.  it  is  a  typical  alloying  metal. 
Manganese(IV)oxide (brownstone, Mn02) is the most important manganese compound 
from the viewpoint of occupational medicine. 
The  most  significant organic manganese compounds  are the  antiknock compound, 
methyl  cyclopentadienyl  manganese  tricarbonyl  (MMD.  the  fungicide,  manganese 
ethylene bis-dithiocarbamate and the catalyst and drying agent, manganese stearate. 
The toxicity of these compounds for humans is unknown, and thus organic manganese 
compounds will not be taken into account. 
Although manganese(IV)oxide is the most important manganese compound as far as 
occupational  medicine  is  concerned,  in  many  cases  the  exact  identity  of  the 
manganese  compound  which  causes  a  particular  effect  is  not  reported  in  the 
literature. It has therefore often been necessary to refer to manganese generically in 
this document. 
Effects on Humans 
The significance of manganese as an essential trace element for humans has not been 
proven.  Manganese  deficiencies  in  humans  are  not  known.  The  daily  manganese 
requirement for man is estimated at about 3 mg. In general, this is probably covered by 
food intake. 
There is a possible correlation between exposure to manganese and collagenosis and 
allied diseases (Schroeder et al., 1966). The pathogenic significance of mangenese is 
not known, however. Saric and Hrustic (1975) recently confirmed th.e long-established 
significant  drop  in  systolic  blood  pressure  in  persons  occupationally  exposed  to 
manganese. 
In view of the relatively small quantity of manganese in food, oral manganese intake is 
only very rarely the case of chronic manganese poisoning. Acute intoxication caused 
by potassium permanganate is due less to the manganese content than to the strong 
oxidation potential and the potassium content in the compound. 138 
Manganese poisoning is nearly always due to occupational contact where manganese 
is  mainly absorbed  through  the  lungs.  Inhalation  of manganese fumes  can  lead  to 
acute metal-fume fever. 
Pneumonia  has  also  frequently  been  observed  as  a  result  of  the  effects  of  fine 
manganese dust. This  is  marked by poor response  to antibiotics.  In  other respects 
manganese pneumonia cannot be differentiated from bronchopneumonias from other 
sources.  Permanent damage to the  lungs,  especially pulmonary fibrosis or straight 
pneumoconiosis, does not seem to occur. 
Features  of  chronic  manganese  poisoning  are  disorders  of  the  central  nervous 
system,  the  main  factors being  changes  in  state of  mind and  in  the extrapyramidal 
motor and vegetative nervous system. The clinical picture of 'manganism' is similar in 
many  ways  to  Parkinson's  disease  with  rigor,  tremor  and  akinesia.  In  contrast  to 
Parkinson's syndromes of other genesis, the disease often takes shape suddenly and 
also  affects younger  persons  after generally  more  than  two  years  of  occupational 
exposure. 
In  pathological anatomy, degenerative changes of the ganglion cells in the putamen, 
pallidum, caudate nucleus and thalamus are found. 
Enzyme  inhibition  in  the  metabolism of the biogenic amines is  considered to be  the 
cause of the damage to the central nervous system. Manganese is thought to disturb 
the synthesis of the central transmitter substances, dopamine and serotonin. It is still 
not known, however, why the effect is irreversible. 
When the manganese source is removed the disease generally shows no progression, 
but  also  no  improvement.  In  terms  of  differential  diagnosis,  manganese-induced 
Parkinson's disease must be  considered along with idiopathic, postencephalitic and 
arteriosclerotic types of Parkinson's syndrome. As with other types of parkinsonism, 
improvements were obtained after treatment with L-dopa (Rosenstock et al., 1971 ). 
Mutagenic, teratogenic and carcinogenic effects of manganese in humans have so far 
not been reported. 
Metabolism 
The  main route of occupational exposure is absorption of dust and fumes containing 
manganese  via  the  respiratory  tract.  Cutaneous  absorption  seems  to  be  of  no 
significance. Manganese intake in the case of persons not occupationally exposed is 
mainly oral with food in the form of the water-soluble compounds of manganese. 
Long-term  balance  studies  show  the  gastrointestinal  absorption  of  manganese 
compounds to be slow and slight. Values of between 3 and 12°/o have been calculated. 
The  usual daily intake is  approximately 2-5  mg  Mn/day (Schroeder et  al.,  1966).  Fish 
and  other  forms  of  marine  life  are  relatively  rich  in  manganese.  The  highest 
concentrations were found in tea leaves. 
Drinking water and air intake, approximately 2 p.g and 5-6 p.g  respectively, accounts for 
only a small proportion of the average daily manganese intake. 
There  are  no  reliable  data  available  on  the  extent  of  retention  and  resorption  of 
respirable dust and  fumes  containing  manganese.  Schroeder et  al.  (1966)  maintain 
that  manganese  can  accumulate  in  the  lungs.  It  is  thought  that  manganese  is 
transported  slowly  anq  continuously  from  the  lungs  to  the  blood.  The  content  of 
manganese  in  the  lungs  of  normal  persons,  however,  does  not  appear  to  be  age-
dependent. 
Manganese is transported in blood partially in trivalent form, bound to a betaglobulin, 
transmanganin. The linkage probably takes place in the liver (Rosenstock et al., 1971 ). 
The  manganese content in  red  blood cells  is  about five times the plasma or serum 
manganese  level.  The  individual  organs  are  reported  to have  a  relatively  constant 
manganese  level.  No  correlation  between  organ  concentrations  and  age  has  been 
determined (Schroeder et al., 1966). The highest organ concentrations found are in the 
liver, pituitary gland, small intestine and pancreas. 
About  43%  of  the  total  body  burden  is  contained  in  the  bones.  Manganese  is 
particularly associated with the mitochondrial fraction. 
Manganese is excreted primarily with the faeces. 92°/o of the total excretion is thought 
to  be  via  the  feaces.  It  is  also  thought  that  manganese  elimination  via  the  bile 
contributes  to  elimination  with  the  feaces.  Some  of  the  manganese  probably 
undergoes enterohepatic circulation. 139 
Urinary manganese excretion is low,  amounting to only about 6% of total excretion 
(Schroeder  and  Nason,  1971 ).  Calcium  EDT  A,  on  the  other  hand,  appreciably 
increases urinary excretion and this test might be used to establish elevated exposure 
(Rosenstock et al., 1971 ). 
Based on the figures supplied by Schroeder and Nason (1971) a proportion of the daily 
excretion of about 2°/o can be attributed to perspiration. The deposition of manganese 
in the hair is negligible, about 1 p.g/g. 
Mahany and  Small  (1968)  established  by  intravenous administration  of  54MnCI2  that 
manganese excretion is two phased. They calculated a biological half-life of 4 days for 
the rapid phase aod a half-life of 39 days for the slow phase. 
In  view of the  constant  level  of  manganese  in  the  body  tissues  it  is  assumed  that 
manganese does not accumulate in the body. Long-term balance studies performed by 
Tipton eta. (1969) and by Mcleod and Robinson (1972},  however, do suggest that a 
certain amount of the daily intake of manganese is retained. These studies did not take 
into account all possible pathways of excretion, however, and errors in method cannot 
be ruled out. 
Human manganese metabolism seems to be closely connected with iron metabolism. 
Thomson  et  al.  (1971)  found  increased  manganese absorption  in  patients with  iron 
deficiency  but  no  increased  retention.  Haemochromatosis  due  to  excessive  iron 
absorption is also connected with increased levels of manganese in the liver (Aistatt et 
al.,  1967).  Another  factor,  which  may  influence  manganese  metabolism,  is  lead 
exposure.  Zielhuis  et  al.  (1978)  observed  a  tendency  for  manganese  in  blood  to 
increase with increasing blood-lead levels, but the reason for it is still unclear. 
In general there is probably good autoregulation of the manganese levels in the organs 
and  body (Schroeder et  al.,  1966).  The  same  authors  found  considerably increased 
manganese  levels  in  certain  persons  as  compared  with  controls.  They  therefore 
suggest  a genetically determined disorder of  manganese  metabolism.  The  studies 
performed by  Mena  et  al.  (1969)  also  point  to  individual  differences  in  manganese 
metabolism  and  its  adaptation.  Healthy  manganese  workers  show  a  higher 
metabolism  rate  of  radioactive  54-manganese  than  control  persons  and  persons 
suffering from manganism. The reason for a predisposition to the disease in the latter 
may therefore be a poor adaptation to the increased intake. 
Factors,  which  possibly  influence the  susceptibility to  manganism,  are  alcoholism, 
chronic  infections,  nutritional  deficiencies,  especially  iron  deficiency,  a  high 
nutritional  intake  of  manganese,  and  dysfunction  of  liver  and  kidneys.  The 
mechanisms which may cause an increased susceptibility are strll unknown. 
Biological Indicators 
Methods for Assessing Concentrations in 
Biological Material 
Neutron activation analysis,  atomic absorption with  and  without flame,  colorimetric 
and catalytic processes, X-ray fluorescence and polarography are used to determine 
manganese  levels  in  biological  material.  Neutron  activation  is  a very  sensitive and 
specific technique, but it is impractical due to the time involved and to the requirement 
of a neutron source (d'Amico and Klawans, 1976). 
As  a  reference  method,  however,  neutron  activation  analysis  is  indispensable. 
Colorimetric  methods  require  careful  preparation  of  samples  and  are  neither  very 
sensitive  nor  sufficiently specific.  X-ray  fluorescence  is  not  suitable  for  biological 
material  due  to  its  poor  detection  limit.  Not  enough  work  has  been  done  with 
polarography to determine its potential. 
Atomic absorption, particularly flameless, shows good sensitivity and, given suitable 
sample operation, also high specificity. The material to be analysed can sometimes be 
used  directly and  sample  requirements  are  minimal  (d'Amico and  Klawans,  1976). 
Studies conducted by Smeyers-Verbeke et al. (1976) with the use of flameless atomic 
absorption show that calcium and magnesium, in particular, interfere-with manganese 
determination but only in unphysiologically high concentrations. Suitable temperature 
programmes,  the  use  of  an  addition  process  and  compensation  by  deuterium 
background correction by and large enable matrix effects to be avoided: Conventional 
flame  atomic  absorption  lacks  sensitivity  . in  manganese  determination.  The 
mineralization and extraction procedures required are time-consuming and  samples 
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A comparison  of  normal  blood  and  blood component values  measures by  different 
authors using different methods (Tables  2 and  3),  shows a wide  range  of analytical 
results.  This  is  primarily  due  to  the  methods  employed.  There  is  a  marked  trend 
towards lower values which suggests a lack of specificity in earlier methods. Similar 
drops  in  the  normal  values  of  trace  elements  in  biological  material,  due  purely to 
method, have been  recorded in  recent years for a number of other elements (Mertz, 
1975). 
Concentrations in Blood and Blood Components 
Generally  only  manganese-free  materials  may  be  used  for  collecting  and  storing 
biological  samples  as  indicators for  exposure to manganese.  In  the case  of blood-
samples especially, the venipuncture by steel needles can result in elevations of the 
manganese levels up to 10%. Therefore plastic or nickel needles should be preferred. 
A number of blood and blood-component manganese levels recorded in the literature 
for  normal  subjects  are  summarized  in  Table  2.  Manganese  levels  in  whole  blood 
measured by spectrometry are about ten times higher than the results obtained with 
neutron activation and atomic absorption. 
Table II - Normal manganese levels in blood and blood components 
Country  No.  Test material 
Average  Range 
Method  Author  Year 
11'9/100 ml)  (~g/100 ml) 
U.K  Whole blood  0.24  S.D.± 0.08  Neutron activation  Bowen  1956 
I 
U.S.A  I  16  I  Serum  0 25  0.205 - 0.297  Neutron activation  Papavasiliou  1961 
I 
and Cotzias 
7  ~  Plasma  0 269  0.21  -0.302  Neutron activation  Papavasiliou  1961 
I  I  Whole blood 
and Cotzias 
7  1.160  0.901- 1.45  Neutron activation  Papavasiliou  1961 
I  and Cotzias 
I 
U.S.A.  I 
48  Serum  1 3  Spectrometry  Butt et al.  1964  ! 
47  ·  Whole blood  4.0  S.E. 0.1  Spectrometry  Butt et at.  1964 
USA  12  ! Plasma 
I 
0.43  ±005  Neutron activation  Olehy et at.  1966 
15  Erythrocytes  1.6  ±01  Neutron activatiOn  Olehy et at.  1966 
F R.G. 
:  62  I Serum  1.68  0.05-2.1  Spectrometry  Mertz et at.  1968 
U.S A.  40  Serum  2.4  1 2-3.8  AAS (with flame)  Mahoney et at.  1969 
I 
JAPAN  :  Whole blood  3.47  To 8.85  Spectrometry  Horiuchi et al.  1970 
U.S.A.  I  Plasma  0.83  From 0.25  Colonmetry.  Schroeder  1971 
! 
Spectrometry  and Nasan 
US.A  i  I  Whole blood  3  AAS (with flame)  Smyth et al.  1973 
I 
U.S.A.  19  i  Serum  1.02  0.74- 1 25  AAS (flameless)  d'Amico and  1976 
Klawans 
BELGIUM  I 
20  Whole blood  1.22  S.D. ±~.39  AAS (flameless)  Buchet et al.  1976 
The red blood cells contain abot five times more manganese than plasma or serum. 
The total blood manganese content is approximately 0.14 mg, i.e. one hundreth of the 
entire body burden of 12 to 20 mg (Schroeder and Nason, 1971 ). 
The  analysis results of the various authors differ appreciably. The blood manganese 
levels recorded for control subjects and persons exposed to manganese can therefore 
only be taken as relative values. A certain value is attached to the establishment of the 
blood manganese level in the determination of high exposure levels. Jonderko et al. 
(1971)  consider  the  blood  manganese  level  as  a  parameter  of some  value  in  the 
identification of chronic manganese poisoning. 
Smyth et al. (1973) found no significant correlation between manganese exposure and 
the  blood  manganese  level.  Nor  did  the  blood  manganese  level  differ  appreciably 
between persons exposed to manganese, with an average of 4 p.g/100 ml, and a non-
exposed comparative group, which averaged 3p.g/1 00 mi. 
Mahoney et al. (1969) also found no change in the serum manganese level after daily 
oral intake of 800 mg manganese chloride for three months and 200 mg for four weeks. 
Jonderko et al. (1971) found an increase in the·serum manganese level only in persons 
who had been exposed for more than four years to manganese. They attribute this to 141 
non-occupational  influences  which  could  favour  manganese  retention,  e.g. 
consumption of alcohol. After the  exposure source was  removed  the authors found 
that the serum manganese reverted to normal within 1  0 months. 
Horiuchi et al. (1970) determined by spectrometry the blood manganese level of three 
groups of persons exposed to different degrees of manganese (see also Table 4). The 
most highly exposed group, consisting of 43 workers in  a mangenese mill, showed a 
median of 9.5  ~tg/1 00  ml  (range:  4-5  ~tg/1 00  ml).  The  blood manganese levels of the 
occupationally  exposed  groups  showed  a  statistically  significant  difference  (p  = 
0.0113) in  comparison with the control group with a mean blood manganese level of 
3.47  ~tg/1 00  mi.  Horiuchi  et  al.  (1970)  also  established  a positive correlation  (p  = 
0.097)  between blood  manganese and  neurological findings (see  also Table 5).  This 
significant  relationship  between  blood  manganese  and  neurological  findings  is  not 
confirmed  by  the  studies  of  Smyth  et  al.  (1973),  Jonderko  et  al.  (1971)  and  other 
authors. 
The  studies,  although  partially  contradictory,  do  not  suggest  any  dose/response 
relationship between blood manganese lvels and health disorders. On the other hand, 
the  results,  often  obtained  by  unreliable  methods,  do  not  prove  that  such  dose 
response  relationships do not  in  fact exist. The  relatively short biological  half-life of 
manganese  in  the  human  body  means  that  dose/response  relationships  can  be 
expected at best for the period in which the disease ocyurs, but not after exposure has 
ended. 
In view of the substantial individual difference, assessment of the degree of exposure 
by determination of blood manganese level would seem to be possible on a group but 
not on an individual basis. 
As  things  stand  at  present,  the  proposed  exposure  limit  of  10  ~tg/1 00  ml  blood 
(Department of  Employment  U.K.,  1974) presents  problems both  from  toxicological 
and  analytical  viewpoints.  Considerably  higher as  well  as  considerably  lower blood 
levels are considered to be normal by certain authors. 
Concentrations in Urine 
As the results summarized in Table 3 show, the normal excretion levels of manganese 
in  the urine,  established by  the different authors,  show considerable discrepancies. 
According to the biological criteria of the Department of Employment (U.K.) (1974}, the 
normal  manganese  excretion  in  the  urine  is  less  than  1  0  ~tgll.  50  ~tgll  has  been 
proposed  as  a valu.e  used  for  establishing  a provisional  maximum  exposure  level. 
Urine  excretion  can  be  increased  considerably  by  administering  calcium  EDTA. 
Rosenstock  et  al.  (1971)  see  this  as  a  potentially  valuable  test  for  determining 
manganese  exposure  which  has  occurred  a  considerable  time  back.  Increased 
manganese  excretion  in  the  urine several  years  after exposure  to  manganese  has 
terminated  is  considered  by  Browning  (1961)  to  be  due  to  the  existence  of  lung 
deposits from which manganese is transported to the body. 
The persons examined by Smyth et al. (1973) showed an average urinary manganese 
excretion  rate  three  times  higher  than  non-exposed  control  persons.  Manganese 
excretion  by  the  exposed  group  averaged  19  ~tgll  urine.  Nevertheless,  individual 
results  varied  greatly.  There  was  only  a  slight  correlation  between  the  degree  of 
exposure  measured  by  the  air  concentration  and  the  manganese  excretion  in  the 
urine. Smyth et al. (1973) do not consider urinary manganese excretion to be a suitable 
parameter for manganese exposure due to its low proportion in the total elimination of 
manganese. 
Tanaka  et  al.  (1969)  found  a positive correlation between  manganese  air  level  and 
manganese  excretion  in  the  urine,  but  not  between  manganese  excretion  and 
neutrological  symptoms.  The  authors  assume that  the  manganese  level  in  urine  is 
basically a measure of current exposure. 
Horiuchi  et  al.  (1970),  on  the  other  hand,  found  differences in  urinary  manganese 
excretion  in  the  groups  they examined,  depending  on  the  degree of  exposure.  The 
differences were significant (p  =  0.00049) on  reference to the authors' normal value 
for manganese in  urine with a mean  of 6.3  ~tgll.  In  addition, the authors established 
statistically significant correlations between blood  level and  urinary excretion ( r  = 
0.283) and neurological symptoms (p =  0.097) for blood, and p =  0.001  for urine) for 
all three groups together. The results of the study of Horiuchi et al. (1970) are shown in 
Table 4. The resu_lts of the statistical evaluation are presented in Table 5. 
Confirmation or contradiction of the  results provided by Horiuchi et al. (1970) would 
require further studies. Studies to date do not show any dose/response relationships 
for  urinary  manganese  excretion  and  health  disorders.  The  establishment  of  an 142 
exposure  limit  of  50  p.g/1  currently  presents  problems  from  the  toxicological  and 
analytical  viewpoints.  Nevertheless,  Smyth  et  al.  (1973)  determined  manganese 
excretion levels of more than 45 p.g/1  in four out of five persons exposed to manganese 
who  showed  neutrological  symptoms.  Therefore,  the  proposed  limit  of  50  p.g/1 
(Department of Employment, U.K., 1974) would not appear to be too low. 
Table Ill ·Normal manganese excretion through urine 
Country  No. 
Average  Range 
Method  Author 
(fo'9/l)  (JJg/1) 
U S.A.  1- 10 JJQ/1  AAS (with flame)  AJemian and With  man 
U.S.A.  2  43JJg/d  ± 0.8JJg/d  Spectrometry  Tipton et al. 
53JJg/d  ± 1.6JJg/d 
JAPAN  6.31  to 30 2  Spectrometry  Horiuchi et al. 
U.S.A  300  Colorimetry  Schroeder and Nason 
33  Spectrometry 
U.S.A.  3  4-19JJg/d  AAS (with flame)  Mcleod and  Robinson 
U.S.A.  7  AAS (with flame)  Smyth et al. 
BELGIUM  20  0.65  S.D. ±0.53  AAS (flameless)  Buchet et al. 
Table IV- Manganese in air, in the whole blood and  urine (ranges and medians) for different 
types of work (Horiuchi et al.  1970) 
Type of work  Mn in air  Mn  in blood  Mn in urine 
number of workers  (mg/m3 1  (JJg/100 g)  (JJg/1) 
Manganese mill  2.3. 17.1  4. 54  8. 165 
n =43  8.4  9.5  68.5 
Battery factory  1 5. 21.1  4-20  1 -42 
n =35  4.3  8  6 
Electrode factory  3.1-8.1  4-17  3-19 
n =31  4.9  6  5 
Year 
1969 
1969 
1970 
1971 
1971 
1973 
1976 
Table V  Results of the statistical evaluation from the study of Horiuchi et al.  (1970) (p-values 
by Fisher's direct probability method) 
Groups under examination  Positive neurological findings and Mn in whole blood  Positive neurological findings and Mn in urine 
Manganese mill  0.048 +  0.013+ 
Battery factory  0.520 (n.s.)  0 180 (n.s I 
Electrode factory  0.072 (n.s.)  0.206 (n.s.) 
Total  0.097 (n.s.)  0.001 + 
+=statistically significant,  n.s. =not significant 
Concentrations in Faeces and Hair 
The  manganese content in  the faeces represents both the manganese not resorbed 
into the gastrointestinal tract and the manganese actively eliminated by the body. The 
normal content  in  the faeces of  persons not occupationally exposed  to manganese 
was established as between 1  .6 mg/1 00 g faeces (Jindrichova, 1969) and 4.1  mg/day 
(Horiuchi et al., 1970). Jindrichova (1969) examined 390 persons, some of whom were 
occupationally exposed to considerable quantities of manganese, and found average 
faecal manganese levels of 6.23 mg/1 00 faeces. There was no significant correlation 
between exposure and faecal concentration. The author is of the opinion that values 
over  6  mg  manganese/1 00  g  faeces  are  a  sign  of  occupational  exposure  to 
manganese. However, the manganese content in the faeces differs appreciably from 
individual to individual. For this reason connections between faecal concentration and 
exposure levels can  be applied to groups, but not. to individuals. This study does not 
indicate whether the faecal manganese concentration provides a better parameter for 143 
assessing the hazard than the manganese levels in the blood and urine. There is also a 
lack of data on dose/response relationships which could justify the establishment of a 
toxicologically substantiated limit for manganese excretion through the faeces. 
Studies on  the manganese content -of  hair are  contradictory. Schroeder and  Nason 
(1971) quote a value of approximately 1 p.g/g  whereas Cotzias et al.  (1964) maintain 
that the manganese content of heir depends on its pigment and melanine content. 
Creason et al. (1975) found in New York City iinhabitants an average manganese level 
of 0.56 p.g/g hair in children and 0.95 p.g/g hair in adults. The manganese content in the 
hair  ranged  from  0.05  to  12  p.g/g.  In  persons with both  suspected  and  established 
chronic manganese poisoning, Teisinger et al. (1956) found lower manganese levels in 
the hair of the experimental group than in the control group. 
Rosenstock et al. (1971) detected no manganese in the hair of normal adults by atomic 
absorption spectrometry, while patients with chronic manganese poisoning showed 29 
p.g  Mn/g head hair and 107 p.g  Mn/g chest hair. The authors thought this discrepancy 
was due to different growth rates in the two types of hair. 
The studies on manganese content in hair do not permit any final judgement as to the 
value of this test material as  a measurement of  increased manganese exposure.  It 
would  appear  feasible,  however,  that  the  manganese  content  of  hair  might  allow 
assessment of previous manganese exposure which occurred over a longer period 
than could manganese levels in the body fluids and excreta (Rosenstock et al. 1971 ). 
Biological  Parameters  for  Assessing  Exposure  and  Early  Reversible 
Effects 
Specific  early  biochemical  symptoms  of  manganese  poisoning  in  humans  are  not 
known.  The  effects  of  manganese  of  various  biochemical  and  clinico-chemical 
parameters have been examined by numerous authors. The studies by Rodier (1955), 
in  particular, are of importance. Rodier found a reduction in  urinary excretion of 17-
ketosteroids  in  81 °/o  of  patients  with  chronic  manganese  poisoning.  The  basal 
metabolic rate was higher in 53% of the 84 persons examined. It is not known whether 
these are the symptoms of overexposure or early signs of intoxication (Tanaka et al., 
1969). Jonderko et al. (1971) ran  a widescale clinico-chemical programme and found 
changes indicating liver function disorders in  persons exposed to manganese. After 
exposure ended the parameters tended to revert rapidly to. normal. 
In  addition  to  an  increased  blood  manganese  level,  the  authors  considered  the 
following as early symptoms of chronic manganese poisoning : 
- dysproteinaemia with hypalbuminaemia and hyper-beta globulinaemia 
- increased bilirubin level 
- increased transaminase and asparate aminotransferase activities 
- reduced LDH activities 
- reduced magnesium and increased calcium levels in the serum 
- reduced haemoglobulin and glutathione levels in the erythrocytes. 
The changes most likely do not represent a specific effect of manganese as only slight 
diagnostic  value  can  be  attached  to  the  individual  case.  The  same  probably  also 
applies  to  coproporphyrinuria,  which  is  frequently observed  in  manganese workers 
(Baader, 1960). 
The findings of Rodier (1950) and Jonderko et al. (1971) have so far not been confirmed 
by other authors. Dose/response relationships cannot be established on  the basis of 
the available test material. 
Conclusions 
Most authors assume that there is no direct connection between the rnanganese level 
in the body fluids and faeces and the severity of chronic manganese poisoning. In fact, 
individual  susceptibility to the disease  seems  to be  the decisive factor.  As  far  as 
diagnosis is concerned, detection of the pollutant in biological material shortly after 
the illness has set in gives little more than an indication of the actual exposure. 
The main points of interest for occupational medicine are the manganese levels in the 
blood, faeces and urine. 144 
On  the  basis  of  our  current  knowledge,  biological  monitoring  can  only  be 
recommended with reservation for manganese. 
Further studies should deal with the establishment of dose/response relationships and 
the limit values based on them, as well as with the determination of effects which are 
reversible at an  early stage.  In  particular, the causes of the increased sensitivity of 
some persons must be recognized and suitable examination methods devised to trace 
this group of people. 
Until  then  an  improvement  in  industrial  hygiene  measures  at  worksplaces  and  a 
regular neurological examination of the workers exposed to manganese would seem to 
be the best methods of preventing chronic manganism. 
Research Needs 
The following are recommendations for further research: 
pure  research  and  development of suitable methods to determine the  particular 
predisposition of certain persons to manganism; 
substantiation of other adverse effects and examination of the applicability of the 
principle of biological monitoring; 
establishment  of  toxicologically  justified  exposure  limits  for  manganese  in 
biological material if dose/response relationships are found to exist. 
References 
Ajemian R.S.,  Whitman N.E. (1969).  Determination of manganese in  urine by atomic absorption 
spectrometry. Am. Ind. Hyg. Ass. J. 30, 52 
Alstatt  L.B.,  Pollak  S.,  Feldmann  M.H.,  Reba  R.C.,  Crosby W.H.  (1967).  Liver  manganese  in 
hemochromatosis. Proc. Soc. Exp. Bioi. Med.124, 353 
d'Amico D.J., Klawans H.L. (1976). Direct microdetermination of manganese in normal serum and 
cerebrospinal fluid by flameless atomic absorption spectrophotometry. Anal. Chem. 48, 1469 
Baader  E.W.  (1960).  Klinische  Grundlagen  der  sechsundvierzig  meldepflichtigen 
Berufskrankheiten. MOnchen, Berlin: Urban und Schwarzenberg, 116 
Bowen  H.J.M.  (1956).  The  determination  of  manganese  in  biological  material  by  activation 
analysis with a note on the gamma spectrum of blood. J. Nucl. Energy 3, 18 
Browning E. (1961 ). Toxicity of industrial metals. Ch. 23, Manganese. London: Butterworth, 185 
Buchet J.P.,  Lauwerys R.,  Reels  H.  (1976).  Determination of manganese in  blood and urine by 
flameless atomic absorption spectrophotometry. Clin. Chim. Acta 73,481 
Butt E.M., Nusbaum R.E., Gilmour T.C.,  Didio S.L. (1964). Trace metal levels in human serum and 
blood. Arch. Environ. Health 8, 52 
Cotzias G.C., Papavasiliou P.S., Miller S.T. (1964). Manganese in melanin. Nature 201, 1228 
Creason J.P.,  Hinners T.A.,  Bumgarner J.E.,  Pinkerton C.  (1975). Trace elements in  hair, as 
related to exposure in metropolitan New York. Clin. Chem. 21, 603 
Employment Medical Advisory Service (1974). Biochemical criteria in certain biological media for 
selected toxic substances. Occasional paper 1, Department of Employment, London (U.K.) 
Horiuchi K.,  Horiguchi Sh., Shinagawa K., Utsonomiya T., Tsuyama Y. (1970). On the significance 
of manganese contents in  the whole blood and urine -of  manganese handlers. Osaka City 
Med. J. 16, 29 
Jindrichova  J.  (1969).  Anwendungsmoglichkeiten  der  Mangan-Bestimmung  im  Stuhl  als 
Expositionstest. Int. Arch. Gewerbepath. Gewerbehyg. 25,347 
Jonderko G.,  Kajawaska  A.,  Langauer-Lenowibka  H.  (1971).  Problems of chronic manganese 
poisoning on the basis of investigations of workers at a manganese alloy foundry. Int. Arch. 
Arbeitsmed. 28, 250 
Mcleod B.E.,  Robinson  M.F.  (1971).  Metabolic balance of manganese in  young women.  Br.  J. 
Nutr. 27, 221 
Mahoney J.P.,  Small  W.J.  (1968).  Studies  on  manganese  Ill.  The  biological  half-life  of radio-
manganese. J. Clin./nvest. 47,643 
Mahoney J.P., Sargent K., Greland M., Small W. (1969). Studies on manganese I. Determination in 
serum by atomic absorption spectrophotometry. Clin. Chem. 15, 312 145 
Mena  1.,  Horiuchi  K.,  Burke  K.,  Cotzias G.C.  (1969).  Chronic  manganese poisoning,  individual 
susceptibility and absorption of iron. Neurology 19, 1000 
Mertz D.P., Koschnick R.,  Wilk G., Pfeilsticker A. (1968). Untersuchungen Ober den Stoffwechsel 
von  Spurenelementen beim Menschen.  I.  Serumwerte von  Kobalt,  Nickel, Silber, Cadmium, 
Chrom, Molybdan, Mangan. Z. klin. Chem. klin. Biochem. 6, 171 
Mertz W.  (1975). Trace-element nutrition in  health and disease: Contributions and  problems of 
analysis. Clin. Chem. 21, 468 
Olehy  D.A.,  Schmitt  A.A.,  Bethard  W.F.  (1966).  Neutron  activation  analysis  of  magnesium, 
calcium, strontium, barium, manganese, cobalt, copper, zinc, sodium and potassium in human 
erythrocytes and plasma. J. Nucl. Med. 7, 917 
Papavasiliou  P.S.,  Cotzias  G.C.  (1961 ).  Neutron  activation  analysis:  The  determination  of 
manganese. J. Bioi. Chem., 236, 2365 
Rodier J. (1955). Manganese poisoning in Moroccan miners. Brit. J. Ind. Med. 12, 21 
Rosenstock H.A., Simons D.G., Meyer J.St. (1971) Chronic manganism. Neurology and laboratory 
studies during treatment with levodopa. JAMA 217, 1354 
Saric  M.,  Hrustic  0.  (1976).  Exposure  to  airborne  manganese  and  arterial  blood  pressure. 
Environ. Res. 10, 314 
Schroeder H.A.,  Balassa J.J., Tipton  I.H.  (1969).  Essential trace metals in  man:  manganese. A 
study in homeostasis. J. Chron. Dis., 19, 545 
Schroeder H.A., Nason A.P. (1971 ). Trace-element analysis in clinical chemistry 17, 461 
Smeyers-Verbeke  J.,  Michotte  Y.,  van  den  Winkel  P.,  Massart  D.L.  (1976)  Matrix  effects  in 
determination of copper and manganese in biological material using carbon furnace atomic 
absorption spectrometry. Anal. Chem. 48, 125 
Smyth  L.T.,  Ruhe  R.C.,  Whitman  N.E.,  Dugan  T.  (1973).  Clinical  manganism  and  exposure  to 
manganese in the production and processing of ferromanganese alloy. J. Occ. Med. 15, 101 
Tanaka Sh.,  Lieben J., Harrisburg P. (1969). Manganese poisoning and exposure in Pennsylvania. 
Arch. Environ. Health 19, 674 
Teisinger J., Ykramovski S., Srbova J. (1956). Die chemischen Untersuchungsmethoden fOr das 
biologische Material in  der Gewerbetoxikologie. S.  ZdN.  (Praha),  127, cited by  Jindrochova 
(1969) 
Thomson A.B.A., Olatubosun 0., Valberg  L.S.  (1971 ).  Interrelation of intestinal transport system 
for manganese and iron. Journ. Lab. Clin. Med. 78,642 
Tipton I.H., Stewart P.L.,  Dickson J. (1969). Patterns of elemental excretion in long term balance 
studies. Health Phys. 16,455 
Zielhuis  R.L.,  del  Castilho  P.,  Herber  M.F.A.,  Wibowo  E.A.A.  (1978).  Levels  of  lead  and  other 
metals  in  human  blood:  suggestive  relationships,  determining  factors.  Environ.  Health 
Perspect. 25, 1  03-1 09 Human biological monitoring of
industrial chemicals series
Titanium
H. Valentin. K.H. Schaller149 
Summary 
This document reviews the metal titanium (Ti) and its compounds of industrial interest 
(chlorides and oxides) as related to occupational exposure and the possibilities of the 
biological monitoring of exposure. 
The detailed metabolism of titanium is not known; the lungs, however, accumulate the 
largest quantities as a result of inhalation and are the primary target organ. Titanium 
appears to be a substance with a low resorption rate and one which finds a wide range 
of tolerance in the human body. 
Titanium  has  been  measured  in  blood  and  urine  using  mainly -spark-source  mass 
spectrometry  and  X-ray  fluorescence  analysis.  The  reported  concentrations  vary 
widely and do not appear to be related to exposure. 
It is not recommended that titanium be brought within the scope of human monitoring. 
This is particularly true of titanium dioxide, the titanium compound most widely used in 
industry. It has not yet been determined, however, to what extent human monitoring is 
applicable to other titanium compounds such as organic titanium derivatives. 151 
Titanium 
Chemical and Physical Properties 
Titanium is a grey metal which in the form of powder or dust is extremely inflammable 
and explosive. Its atomic weight is 47.9 and its atomic number is 22. 
Titanium is  found  in  various valencies and  has  metallic and  non-metallic properties. 
The principal valence state is 4 + (titanic), but 3 + (titanous) and 2 + states are also 
known. There are also oxidized compounds such as titanyl chloride (TiOCI2). Titanium 
is  found  in  its metallic state in  compounds such as  titanates, e.g.  calcium, iron and 
potassium titanate. Titanium IV compounds are easily hydrolysed into titanium dioxide 
(Table 1  ). 
In  addition  to  metallic titanium,  titanium  dioxide  and  titanium  tetrachloride  are  the 
main compounds used  in  industry. See Table  2.  In  many cases,  however,  the exact 
identity of the titanium compound which causes a particular effect is not reported in 
the  literature.  Titanium  has  therefore  often  been  referred  to  generically  in  this 
document. 
Table I -Melting points and solubility of titanium and  its principal compounds 
Components  Melting point  Solubility 
Ti  1800  Insoluble in cold water, soluble 
in dilute acids 
Ti0
2  1640  Insoluble in hot and cold water, 
(decomposition)  soluble in sulphuric acid and  , 
alkalis 
TiCI4  30  Soluble in cold water (with) 
hydrochloric acid, alcohol. and 
hot water 
Table II -Some industrial uses of titanium and  its compounds 
Substance  Use 
Titanium  Alloys, Aerospace, 
Ti  Chemical Processing  Industries 
Titanium Dioxide  Pigments, Paints, Lacquers, 
Ti0
2 
Printing Ceramics, Food Additives, Drug and 
Cosmetics Applications 
Titanium Tetrachloride  Polymerization (Ziegler Type)  ~atalyst 
TiCI
4 
Starting Material for Most Organic Compounds 
Titanous Chloride  Polymerization Catalyst 
TiCI3 
Organic Titanium  Cross Linking Agents, 
Compounds  Catalysts 152 
Titanium has a number of organic derivatives. The  principal ones are alkyl  and aryl 
titanates of the general compound type Ti(OR)4. 
Ambient Measurements 
Titanium  uptake  at  the  workplace  is  due  exclusively  to  inhalation.  The  principal 
methods  used  in  analysing  air samples  are  atomic  absorption  spectrometry,  X-ray 
fluorescence  analysis,  neutron  activation  analysis  and,  occasionally,  photometric 
techniques. 
Dittrich  and  Cothern  (1971 ),  using  X-ray  fluorescence  analysis,  examined  dust 
samples from filter papers used a collectors for 25 hours in a high-volume air sampler. 
Similar analyses were carried out by Rhodes et al. (1972) in Texas. The lower detection 
limit  for  titanium  using  X-ray  fluorescence  was  0.011  1Lg/m3.  Dams  et  al.  (1970) 
determined the level of titanium in air samples by neutron activation analysis. 
The  lower detection limits were 0.2 ug  titanium per filter.  In a more recent work this 
group (Dams et  al.,  1972) describes  how  the  titanium concentration on  very clean 
filters  or  impactor  surfaces  was  determined  by  neutron  activation.  Analysis  of  a 
number  of  filters  showed  very  high  levels  of  trace  elements,  a  factor  which 
considerably reduces the analytical sensitivity of the method. 
Atomic absorption spectroscopy was used to analyse a large number of metals in air 
samples after enrichment by  means of suitable filters (Beyer,  1969; Burnham et al., 
1970;  Hwang  1972).  Ranweiler  and  Moyers (1974)  described an  atomic absorption 
spectrometry method for the analysis of dust samples collected on polystyrene filters 
using  high-volume  samplers.  One  of  the  22  metals  found  was  titanium.  The  lower 
detection limit for titanium in practice was 0.07 1Lg/m3. 
Yound  and  White  (1959) developed a colorimetric  method for the  determination of 
airborne titanium. Titanium was found as titanium diocyanate with tri-n-octylphosphine 
in the organic milieu. 
Effects on Humans 
There  is  no  epidemiological  evidence  that  titanium  dust  causes  titanium-induced 
pulmonary fibrosis (Moschinski et al., 1959). No pathological changes were detected in 
clinical and X-ray tests carried out by Vernetti-Biina (1928) on subjects who had been 
exposed for a long period of time to titanium dioxide dust, nor were any such changes 
evident in the blood count. In addition, an autopsy carried out by Schmitz-Moormann et 
al.  (1964) on  a person who had been employed for 15 years on  the  manufacture of 
titanium dioxide pigments revealed no  signs of inflammation or fibrosis in  the lungs. 
These  authors  considered  titanium  dioxide  to  be  an  absolutely  ineri  substance. 
Uragoda  and  Pinto  (1972)  examined  136  workers  in  a  factory  in  Ceylon  in  which 
ilmenite was processed. The  workers were exposed to a large number of minerals, 
principally ilmenite, rutile and zircon ores. These workers showed no greater incidence 
of pulmonary disease than that found in a control group of normal subjects. 
Elo et al. (1972) carried out lung tests on three workers who had been engaged for nine 
years in the manufacture of titanium dioxide pigments. Biopsies showed a significantly 
higher level of titanium than that found in  autopsies on  normal subjects. Deposits in 
the pulmonary interstices were found  in  association with cell destruction and  slight 
fibrosis.  Titanium  dibxide  was  also  found  in  the  lymphatic  system.  The  authors 
concluded  from  this  that  the  lymphatic  system  was  responsible  for  elimination  of 
titanium dioxide from  the  lungs. The  electron microscope revealed  the presence of 
titanium dioxide particles in the lysosomes of the alveolar macrophages. On the basis 
of these findings, Elo et al. (1972) classified industrially manufactured titanium oxide, 
either alone or in conjunction with silicates, as a substance with a slight irritant effect 
on the pulmonary interstices. In a more recent work, the "adverse effects" noted are 
attributed to substances such as  quartz or silicates rather than  to titanium dioxide. 
These  substances  are  present  in  the  manufacture  of  titanium  dioxide  pigments 
(Maatta and Arstila, 1975). 
Heimendinger and  Klotz (1956)  report on  a case of accidental exposure to titanium 
tetrachloride fumes.  Contact with  jets of TiCI4  at  a  temperature of 1  00°C and  the 
inhalation  of fumes  of  titanic  acid and  titanium  oxychloride  resulted  in  superficial 
burns and the formation of scar tissue. There was considerable inflammation of the 
mucous membrane of the pharynx, the vocal cords and the airways, with the formation 
of scar tissue and the later development of laryngostenosis. Histological examination 153 
revealed  phagocytized Ti02  in  the  lungs.  Substantial deposits of dust were  found  in 
association with  localized small  areas of emphysema,  but  no  specific lesions were 
observed. 
No cases are known of damage caused to skin or tissue by titanium (Hygenic Guide 
Series,  1973).  Titanium  compounds  such  as  salicylates,  oxides,  and  titanates  have 
been  used  in  the  treatment of skin  lesions  and  as  aids  in  surgery  (Ereaux,  1955; 
Browning, 1969). 
There is no evidence that titanium or its compounds have any carcinogenic, mutagenic 
or teratogenic effects on man. 
Absorption, Distrubution and Excretion 
Little is known about the absorption of Ti02 in  man. Schroeder et al.  (1963)  report an 
uptake of 300  ~'g Ti  per day in a normal subject. The daily excretion rate is also about 
300  ~tg  Ti  per day.  While  approximately  10  ~'g  are  excreted  in  urine and  290  ~'g  in 
faeces, approximately 0.4 ~'g of titanium are thought to be retained in the lungs. 
Perry and Perry (1959) found a mean level of 10.2  ~'g Till in a pooled sample of normal 
urine. This would mean that approximately 3°/o  of the titanium taken into the body is 
absorbed and excreted via the urine. On the other hand, West and Wyzan {1963) found 
no change in the renal excretion of titanium in five volunteers to whom 5 g of titanium 
dioxide were administered on three consecutive days. The urine was analysed for five 
days after the beginning of the uptake. 
Wide variations were found in the titanium level in different human organs. Generally 
the highest concentration of titanium was  found  in  the  lungs.  Hamilton et  al.  (1972) 
found a titanium concentration of 3. 7 ~tglg wet weight in the lungs _of  subjects from the 
United Kingdom. The  lowest concentration was 0.8  ~tglg and was found  in  the brain. 
Similar results were found by Anspaugh et al. (1971 ). 
Crable et al. (1967, 1968) analysed the metal and dust levels in the lungs of chromium 
workers in West Virginia. The average titanium level in the lungs of 26 miners was 119 
~tglg dry weight. The corresponding figure for titanium levels in normal subjects given 
by  the  same authors  is  19  ~tglg dry weight.  Roething  and  Wehran  (1972) found  that 
titanium also accumulates in the lungs as silicosis progresses. The titanium level in the 
lungs was 4.0- 24.3 mg/kg. Concentrations in the lymph nodes ranged from 12.2- 120 
mg/kg. 
The  mean  level  of  titanium  increased  with  the  seve-rity  of  the  silicosis.  The  lymph 
nodes contained an appreciably higher level of titanium than the lungs. On  the other 
hand, Einbrodt and Lifters (1968) reported that the concentration of titanium dioxide in 
the lymph glands is  less than half of that  in  the  lungs. Only approximately 5% of all 
retained titanium dioxide is transported to the lymph glands. 
Biological  Indicators 
Methods for Assessing Concentrations in  Biological Material 
Information on  titanium  analyses  in  biological  material  is  limited and  the  results  of 
various analyses fluctuate widely; special attention should be paid to these two factors 
when biological material is being analysed for titanium. 
Hamilton et  al.  (1972)  examined  a large  number of  elements  in  human  tissue.  The 
methods of analysis used were spark-source mass spectrometry, X-ray fluorescence 
analysis and various methods of neutron activation analysis. The lower detection limits 
for titanium in human tissue, using spark-source mass spectrometry, were 0.007 ~tglg 
wet weight and with X-ray fluorescence analysis they were 0.3 ~tglg wet weight. Tipton 
et al. (1969) used ARC emission spectroscopy in their examination of faeces and urine. 
Lower detection limits were 9 mg/kg for faeces and 30  ~t91kg for urine, each related to 
ash  weight.  The  comprehensive  studies  by  Schroeder  et  al.  (1963)  employed  the 
technique of Sandell (1959). 
Chromotopic acid used as a reagent gives a sentitivity of approximately 0.25  ~tQig of 
test  material.  McCue (1973) compared various  methods  for  determining titanium  in 
human blood and concluded that the most suitable was a method of Clarks (1970) for 
the determination of titanium  in  ceramic  material.  This  is  a photometric  method  in 
which tiron (4.5-dihydroxy-m-benzenedisulphonic  acid disodium  salt) was  used  as  a 154 
reagent. The  limit detection was 50 JLg/kg.  This method appears to be preferable to 
emission  spectrometry,  atomic  absorption  spectrometry  and  X-ray  fluorescence 
analysis. 
Concentrations in· Blood and Blood Components 
The mean blood titanium level in test material from the United Kingdom was 0.07JLglg 
blood. These tests were carried out by Hamilton et al. (1972) using spark-source mass 
spectrometry. Timakin et al. (1967), on the basis of an examination of 100 healthy men 
and women in the USSR, obtained similar results with an average titanium level of 54.1 
JLg/kg of blood. The blood titanium concentration of 0.03 JLglg  analysed by Maillard and 
Ettori  (1936)  was  within  the  same  range.  Mozhaitseva  (1970)  analysed  the  blood 
titanium  level  of  20  subjects  between  20  and  43  years  of  age.  The  titanium 
concentration varied from 75-159 JLg/1 of blood, the mean reading being 123 ±  5 JLg/1 of 
whole blood. 
According  to the  investigations of  Smyshlyaeva et al.  (1971 ),  the  titanium  level  in 
erythrocytes and in plasma was in the ratio of 2 : 3.  The  ratio lowered slightly as the 
subject's age increased. 
There is some evidence that the level of blood titanium is influenced by a number of 
diseases. Carroll and Tullis (1968), and McCue (1973) found a higher level of titanium in 
the leukocytes of persons suffering leukaemia or Hodgkin's disease than  in  normal 
subjects.  Differences  have  also  been  noted  between  the  blood  titanium  levels  in 
normal subjects and those found in  persons with various forms of cancer or cardiac 
disease. 
No  reference  to  measurements  of  the  titanium  level  in  persons  occupationally 
exposed to titanium was found in the literature. 
Concentrations in Urine 
The  literature provided  little information on  renal  elimination of titanium.  Perry and 
Perry (1959)  found  a  titanium  concentration of  10.2  ~-tg/1  in  normal  urine.  The  high 
figures obtained by Tipton and Cook (1963) are probably affected by the method used. 
Kvirikadze (1967) reported increased renal excretion of titanium in the urine of patients 
with bladder tumors. 
No references to the titanium level in the urine of persons exposed to titanium have 
been found. 
Concentrations in the Lungs 
As stated in the section "Absorption, Distribution and Excretion", the highest titanium 
levels in adults are found in  the lungs (Tipton and Cook, 1963; Hamilton et al.,  1972). 
Schroeder at al.  (1963) examined the relationship between the titanium level  in  the 
lungs and the age of the subject. In  two cases out of five they found no evidence of 
titanium in  the lungs of new-born infants and children. American studies have shown 
that  titanium  accumulates  in  the  lungs  throughout  life.  This  phenomenon  was  not 
observed in test materials such as kidneys, skin or the aorta. Schroeder et al. (1963) 
also  noted  that  regional  differences  in  lung  titanium  levels  should  be  taken  into 
account.  · 
Persons occupationally exposed to titanium show higher titanium levels than normal 
subjects. Crable et al. (1967, 1968) found a mean titanium level of 119 JLglg dry weight 
in  the  lungs  of  26  mine  workers.  Titanium  levels  in  the  lungs  of  subjects  not 
occupationally exposed were 19  ~-tg/g dry weight. Roething and Wehran (1972) were 
able to show that the level of titanium in the lungs of silicosis sufferers increased with 
the severity of the disease. Finnish working parties have also recently noted deposits 
of .titanium dioxide in  the lungs of occupationally exposed persons (Eio et al.  1972; 
Maatta and Arstila, 1975). 155 
Biological  Parameters for Assessing  Exposure and/or Early 
Reversible Effects 
There are many references in the literature concerning human occupational exposure 
to titanium where titanium-bearing ores are smelted and where titanium metals and 
titanium dioxide and carbide are produced. The specific conditions of such exposure 
are described by Mogilavskaya (1972, 1973) and Stokinger (1962). 
On  the  other  hand,  there  is  no  information  in  the  literature  on  dose-response 
relationships at the workplace. In the absence of such information it is not possible at 
present to state occupational tolerance limits for levels in blood, urine or lung tissue. 
Blood and urine analyses have been carried out to determine the presence of titanium 
in  biological  material.  According  to  Schroeder  and  Nason  (1971 ),  titanium 
accumulates in the lungs. The  literature also contains details of titanium analyses of 
lung  tissue obtained by  biopsy or autopsy.  Determination of  the titanium  content of 
these  organs  is,  however,  of  secondary  importance.  The  literature  offers  no 
suggestion for the definition of biochemical parameters. 
Conclusions 
The highest titanium levels in adults are found in the lungs. Uptake at the workplace is 
due exclusively to inhalation. Persons occupationally exposed to titanium show higher 
titanium levels than normal subjects. 
Schaller  and  Valentin  (1976)  recommended that  titanium  not  be  brought within  the 
scope of human monitoring as it is a substance with a low resorption rate which finds a 
wide range of tolerance in the human body. This is particularly true of titanium dioxide 
which is the titanium compound most widely used in industry. 
It has yet to be determined to what extent human monitoring is applicable to certain 
titanium compounds such as organic titanium derivatives. 
Research  Needs 
The following are recommendations for further research : 
- improve  the  methods  of  analysing  titanium  in  biological  material  and  test  their 
reliability criteria; 
- calculate the dose-response effect relationships at cerlain workplaces; 
- test the validity of dose-response relationships for the various compounds. 156 
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Summary 
Absorption of toluene occurs mainly through inhalation of vapours and by skin contact 
with the liquid form. 
Toluene exerts its main toxic action in the central nervous system. 
Toluene gives rises to hippuric acid in vivo and therefore the measurement of hippuric 
acid has some practical application for evaluating current exposure to toluene.  In  a 
group of workers exposed  to  100 ppm  toluene  for 8 hours,  the  mean  hippuric  acid 
concentration in urine at the end of the workshift amounts to about 2.5 g/g creatinine. 
On  an  individual  basis,  this  threshold  has  a good  specificity,  b!Jt  a low sensitivity. 
Currently,  the determination of  0-cresol  in  urine does  not  seem  to  offer additional 
advantages over the analysis of hippuric acid, but further studies are required to test 
the  validity  of  this  test.  During  exposure  to  100 ppm  toluene  at  rest,  the  average 
concentration  of  toluene  in  venous  blood  and  in  air  amounts  approximately  to  40 
/Lg/1 00 ml and 70 mg/m3 respectively. Not enough investigation has been performed to 
evaluate whether analysis of expired air (or blood) collected 16 hours after the end of 
exposure can provide an estimation of the magnitude of previous day intake of toluene. 163 
Toluene 
Chemical and Physical Properties 
- colourless liquid at normal temperature 
- boiling point (760 mm Hg) 11 0.6°C 
- vapour pressure (25°C} 28 mm Hg 
- vapour density : 3.14 
- molecular formula : C6H5CH 3 
- structural formula 
1 ppm  =  3.  75 111{1/m3 
1 mg/m3 =  0.267 ppm 
It is important to keep in mind that if purified toluene contains usually less than 0.01 °/o 
benzene industrial grade may contain up to 25% benzene (NIOSH 1973). 
Chronic effects on humans 
It  is  now recognized that on  the contrary to benzene,  toluene is  not myelotoxic and 
does  not  modify  the  blood  picture  (Browning,  1965;  von  Oettingen  et  al.,  1942). 
Previous  reports  suggesting  that  toluene  has  myelotoxic  properties  resulted  from 
investigations on workers handling toluene contaminated with benzene. 
No specific biological changes have been attributed to toluene which exerts its toxic 
action mainly on  the central nervous system and secondarily on  the liver and  kidney 
(Lauwerys, 1982). 
Metabolism 
Metabolic Pathway 
Absorption of toluene occurs mainly through inhalation of vapours and by skin contact 
with the liquid for~. Skin absorption of toluene vapour is negligible (Piotrowski 1967). 
Although Gerarde (1960) has stated that liquid toluene is poorly absorbed thr.ough the 
intact skin, Dutkiewics and Tyras (1968) have calculated that the rate of absorption of 
liquid toluene through the skin of the hand and forearm of human volunteers ranges 164 
from 14 to 23 mg/cm2/hour. These data·have been confirmed by Guillemin et al (1974). 
Comparing these results with those obtained by Hanke et al. (1961) with benzene it can 
be concluded that the rate of toluene absorption through the skin is 30 to 50 times that 
of liquid benzene and hence skin absorption from contact with liquid toluene should be 
taken into account in the evaluation of toluene exposure. 
Teisinger  and  Srbova  (1955)  have  estimated  at  about  40°/o  the  absorption  rate  of 
inhaled toluene. A fraction (-9- 20°/o) of the absorbed toluene is excreted unchanged in 
the expired air (Srbova and Teisinger 1952). The fraction (-9- 80°/o) of toluene which is 
not eliminated unchanged in the expired air is mainly oxidized by transformation of the 
methyl  radical  into a carboxyl  radical (by  the  microsomal monooxygenase system), 
which is then conjugated with glycine to produce hippuric acid (Fig. 1  ). 
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According to Teisinger and Srbova (1955), about 20°/o of the benzoic acid intermediate 
is  also conjugated with glucuronic acid with formation of benzoylglucuronic acid.  It 
seems,  however,  that  this  alternative  pathway  is  of  much  less  importance  than 
suggested by Teisinger and  occurs only when  heavy toluene absorption takes place 
(Pagnotta and Lieberman, 1967).  · 
Hippuric  acid  is  excreted  in  urine.  Ogata  et  al.  (1970 and  1971) have  found  during 
experiments on  volunteers that 63 to 68°/o  of the toluene absorbed are excreted as 
hippuric  acid  and  Tokunaga  et  al  (1974)  have  estimated  that  around  31 °/o  of  the 
toluene inhaled are excreted as hippuric acid. Its biological half-life is about 3 hours 
and therefore elimination is practically complete in  18 hours (Ogata et al.,  1970; von 
Oettingen et al., 1942). 
On the contrary to benzene, only a very small fraction of toluene (less than 1% of the 
dose) is oxidized on  the aromatic ring with production of ortho-meta- and para-cresol 
(Bakke  and  Scheline, "1970;  Woidowe  et  al.,  1979).  This  difference  in  the  oxidative 
metabolism  of  benzene  and  toluene  probably  explains  the  different  myelotoxic 
properties of both solvents. 
Factors Influencing Metabolism 
Enzyme  inducers (like phenobarbital) can  stimulate the  rate of biotransformation of 
toluene (Ikeda and Ohtsuji, 1971 ). Toluene and trichlorethylene can reciprocally inhibit 
their oxidative degradation (Ikeda 1974). 165 
Biological Indicators 
The biological tests which have been proposed for evaluating toluene exposure are : 
- hippuric acid in urine 
- benzoic acid in urine 
- 0-cresol in urine 
- hippuric acid in blood 
- toluene in blood 
- toluene in expired air. 
It should be noted that like benzene the metabolism of toluene is  rapid and therefore 
the time of biological material sampling is critical. 
The reader should refer to the report on benzene for a critical appraisal of the var1ous 
methods of expressing the results when the analysis is performed on  urine (Lauwerys. 
1979). 
Hippuric Acid in Urine 
All the methods described in the literature for hippuric acid determination 1n urme have 
not  the  same specificity. The  spectrophotometric and  fluorometric techiques which 
are  not  preceded  by  chromatography  lack  of  specificity  because  other  urinary 
metabolites (methylhippuric acid,  uric acid,  etc.) interfere (Pagnotta and  Lieberman. 
1967; Tomokuni and Ogata,  1972; Ellman et  al.,  1961; Kaneko et  al ..  1975). Spectro-
photometric measurement of hippuric acid after its separation from other urine meta-
bolites by paper (Gaffney et al., 1945) or thin layer chromatograph.y (von Kutner et al.. 
1973; Ogata et al.,  1969) is more specific but is too elaborate and time-consuming for 
the routine monitoring of workers exposed to toluene. 
Table I -Concentration of hippuric acid  in urine of subjects not occupationally exposed to toluene 
Subjects  H1ppuric acid in unne  Method  Reference 
Males  X= 1.1  g/1  or 0 8 g/g creatinine  3  Buchet and  Lauwerys 1973 
31  SE  = 0.84 g/1  or 0.45 g/g creatinine 
97th percentile  2.8 g/1 or 1. 7 g/g creatinine 
Males  X=  0 92.g/1  or 0 41  g/g creatinine  2  Von Kutner et al., 1973 
31  SD  = 0.64 or 0 29 g/g creattnine 
Not 1nd 1cated  x  =o.44 911  1  Tomokun1 and Ogata 1972 
SD = 0 20 g/1 
Males  X  =o.53 g/1  (adjusted SG  1016) range0.21 -1 09 g/1  or  1  M1kulsk1 and W1glusz  1970 
21  X=  0 47 g/g creat1n1ne  range= 0.18-0.89 g/g creatinine 
Females  X=  0.52 (adjusted SG  1016) range 0 2- 1 00 g/1  or  1  M1kulsk1 and Wiglusz 1970 
21  X=  0.49 g/g creattnine range= 0.21  - 0.99 g/g creatinine 
Not 1ndicated  X=  0.8 g/1  range= 0.4 to 1.4 g/1  1  Pagnotta and L1eberman  1967 
Male students  geometrtc mean  range  2  Ikeda and Ohtsu)l 1969 (a) 
36  0.3 g/1  (uncorrected)  (0.07 - 1.27) 
0 29 g/1  (SG  1016)  (0.06- 1.39) 
0.23 g/g creatimne  (0.04 -1.17) 
Male workers  0 35 g/1  (uncorrected)  (0.11  -1.08)  2 
36  0 29 g/1  (SG  1016)  (0.09- 0.91) 
0.24 g/g creatinine  (0.08-0.71) 
Female students  0 38 g/1  (uncorrected)  (0.11  -1.43)·  2 
30  0.57 g/1  (SG  1016)  (0.15 -2.13) 
0.45 g/g creatinine  (0.16 -1.24) 
39  X=  0.92 g/1  (SG  1016)  (0.11- 4.3)  3  Engstrom et al., 1976 
traimen  X ..  0.74 g/g creatinine  (0.86- 2.3) 
30  X= 0 79 g/1  (uncorrected) SD = 0.88  4  Angerer 1976 
6  0.4 g/24 hours (uncorrected)  5  Von Oettingen et al., 1942 
46  Median· 0.36 g/g creatinine  6  Gassier et al., 1977 
Methods  Spectrophotometry or colorimetry Without prev1ous chromatography 
Spectrophotometry after chromatography 
3  Gas chromatography 
4  Densitometry after thin layer chromatography 
5  Titration after precipitation 
6  High pressure l1qu1d chromatography 
N.B:  Since methylhippuric acid  is not normally present in ur1ne of non exposed persons, control values for hippuric acid should 
be approximately identical whatever the method used 166 
Quantitative evaluation  of hippuric acjd (and  methylhippuric acid) by densitometric 
analysis of the thin layer plates has also been attempted but is probably less precise 
than gas chromatographic methods (Van Kerckhoven et al., 1974; Angerer 1976). 
Gas chromatographic methods offer the advantage of rapidity, specificity and can also 
permit the simultaneous determination of hippuric and  methylhippuric acid.s (Buchet 
and Lauwerys, 1973). High pressure liquid chromatography has also been used for the 
quantitative determination of hippuric acid in urine (Gessler at al., 1977). 
Hippuric acid is a normal constituent of urine, originating mainly from food containing 
benzoic acid o·r benzoates. Values found in persons non exposed to toluene have been 
summarized in Table 1. 
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Figure 2 -Comparison of postexposure hippuric acid -creatinine ratio with toluene exposure 
(from Pagnotta and Lieberman, 1967) 
The  majority  of  authors  found  that  in  non-occupationally  exposed  workers,  the 
concentrations of hippuric acid in spot urine samples rarely exceed 1.5 g/g creatinine. 
Results of studies which have attempted to correlate hippuric acid excretion in  urine 
with levels of toluene exposure are summarized below. 
In 1942, von Oettingen et al. reported that exposure to concentration of 50 to 800 ppm 
of toluene is associated with and followed by an  increased excretion of hippuric acid 
which is roughly parallel to the intensity of the exposure. 
The results obtained by Pagnotto and Lieberman in 1967 are presented in Fig. 2. 
Each  point on  this figure  represents  the  average  hippuric acid content of samples 
collected at the end of the usual eight-hour work shift from small groups of individuals 
with nearly similar toluene exposure. Pagnotto and Lieberman indicated in their paper 
that in most cases the pl3rcentage of deviation of individual urine values from the mean 
did not exceed 15°/o and even less deviation was found when values were reported as 
a hippuric acid-creatinine ratio. 
According  to their data an  exposure to  100 ppm  toluene (current atmospheric TLV 
proposed by the American Conference of Governmental Industrial Hygienists (ACGIH) 
in 1975 and by NIOSH in 1973) would ~n a group basis produce a urinary hippuric acid 
content of about 2.8 g per liter (adjusted to a S G of 1  016)  or per  g creatinine,  in 
samples  collected  at  the  end  of  the  work  shift.  It  should,  however,  be  noted  that 
Pagt'lotto  and  Lieberman  have  used  a  non  specific spectrophotographic technique 
which  may give higher values  than  chromatographic techniques  if xylene was  also 
present in ambient air. 
The data obtained by Ikeda and Ohtsuji in 1969 (b) are summarized in Fig. 3 taken from 
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Figure 3- Comparison of postexposure hippuric acid excretion with toluene exposure. The 
lines are weighted calculated regression  lines for the means(---) together with 
those for the S.D. ranges(-·-·-) and fiducial ranges (P =  0.05) ( -) 
(from Ikeda and Ohtsuji, 1969 b) 
167 168 
Table II- Hippuric acid  in urine of workers exposed to toluene 
Number of  Toluene  Dur~tion  To tel  Time of urine 
subjects  cone.  exp.  exposure  Concentration hippuric acid  in urine  sampling  Method  Remarks  Ref. 
ppm  (hrs) 
Group (N 'l  50  -¢-8  200  ± 1 5 g/g creatinine 
End of shift 
1  . possible  Pagnotta and Lieberman, 
± 1.46 g/liter (b)  ISG.  1016)  simultaneous  1967 
Group IN?)  100  -¢-a  800  ± 2.5 g/g creatinine  1  exposure 
± 2 66 g/llter  (SG  10161  End of shift  to xylene 
Group (N  ?I  200  .Q.s  1600  ± 5.0 g/g creatinine  1  - quantitative 
± 4.6 g/llter  ISG  1016)  End of shift  determination 
of toluene in 
air (10min. 
samples I 
Geometric mean 
g/liter (a)  g/liter (b)  g/g creatinine 
8  4  -¢-a  32  0.45  0.49  0.43  End of shift  2  Toluene in air  Ikeda and OhtSUJi 
(0.25- 0.79)  (0.28- 0.861  (0.36- 0.53)  measured by  (1969b) 
5  18  -¢-8  144  1.23  0.90  1.23  End of shift 
detector tubes 
(0.97 - 1.56)  (0.6-1.24)  (0.72-2.11) 
10  20  -¢-8  160  1.84  1.18  1.06  End of shift  (1 .22- 2.79)  (0.85- 1.64)  (0.81  -1.40) 
9  50  -Q-8  400  1.92  1.40  1.96  End of shift  (1 .26- 2.93)  (1.03- 1 89)  (1.53- 2.50) 
10  60  -Q-s  480  2.27  1.21  1.14  End of shift  (1 .33- 3.88)  (0.70 -2.10)  (0.75- 1  .72) 
6  65  -¢-a  520  3.29  1.87  1.51  End of shift  (2 83 -384)  (1.62-2.16)  (1.15-1.99) 
8  80  -Q-8  640  3.13  1.87  1.64  End of shift  (2.15- 4.55)  (1.33- 2.63)  (1.05- 2.55) 
8  125  -¢.8  1000  4.73  2.84  3.17  End of shift  (3.45- 649)  (2.28- 3.54)  (2.34- 4.31) 
22  180  -¢.8  1440  4.48  331  4.21  End of shift  (3.23 ° 6.20)  (2.60- 4.22)  (3.42- 5.19) 
20  200  -9-s  1600  5.97  3.66  3.58  End of shift  (4.12- 8.65)  (2.62- 5 11)  (2.28- 5.61) 
12  240  -¢-8  1920  6.48  3.59  5.67  End of shift  (481- 8.34)  (2.82. 4.57)  (4.38- 7.34) 
4or 5  100  7  700  3.09  1 87  Second period  2  Volunt- Ogata et al. 1970 
(  1.69-4.49)  (1  ° 2.75)  of exposure  experiments 
4or 5  200  7  1400  8.19  3.9 
(3.0-13.5)  (2.25- 5.6) 
36  27  -¢.7  189  2.04  End of shift  4  Angerer 1976 
S.D.·  1.37 
a  uncorrected,  b  corrected for a specific gravity of 1016,  Method ·  see Table 1 
According to their results, the average hippuric acid concentration in urine collected at 
the end  of the work shift in  a group of workers exposed to an  atmospheric toluene 
concentration of 100 ppm is estimated at 2.0 gil iter (specific gravity 1.016) or 2.35 g/g 
creatinine. Individual values (5th and 95th percentile) could range from 1.4 to 3.9 g/g 
creatinine  (Imamura  and  Ikeda,  1973).  It  should  be  stressed  that  their  results  on 
toluene  concentration  in  air  (photogravure  printing  industry)  were  obtained  with 
detection  tubes  and  therefore  represent  semi-quantitative  spot  sample 
determinations.  The  authors  recognize  that  fluctuations  of  environmental  toluene 
concentrations  in  the  workshop  surveyed  are  among  the  possible  causes  of  wide 
variation in hippuric acid excretion. 
Tokugana et al. (1974) have found that in  7 workers exposed for 7 hours to 40.2 ppm 
toluene (range : 28.6- 53.7), the excess hippuric acid excreted within 24 hours after 
the  start  of  exposure  (i.e.  after  substrating  the  amount  of  hippuric  acid  normally 
present when the workers were not exposed) amounts to 482 mg (range : 364 - 719). 
Unfortunately they  have  not  indicated the  "normal" level  of  hippuric acid found  in 
these workers. 
Angerer (1976) has  recently reported that in  36 workers exposed to a mean toluene 
concentration of 27  ppm,  the  mean  urinary hippuric acid concentration amounts to 
2.04 g/1 with an SD of 1  .37 g/1. 
Ogata et al. (1970) have exposed 23 male volunteers for 3 hours in the morning and for 
4 hours  in  the afternoon or just for 3 hours  in  the  morning  to toluene vapour. They 
collected the urine for about a day after exposure. They demonstrated that on a group 
basis  there  is  an  excellent  correlation  between  the  total  amount  of  hippuric  acid 
excreted (exposure period  + 18 hours after exposure) and the total exposure (C x T). 
We have reproduced their published figure illustrating this relationship (Fig. 4). cr 
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Figure 4- Relationship between total exposure (ppm x hr) and  total excretion of urinary hip-
puric acid from:  A.  , normal individuals;  e  ,  those exposed 3 hours to toluene 
(for the lowest point mixed with m-xylene); and,  •  , tl:lose exposed 7 hours to 
toluene; and of urinary methylhippuric acid from:  0  , those exposed 3 hours to 
m-xylene;  0  , those exposed 7 hours tom-xylene; and  6  , those exposed 7 hours 
to p-xylene. Means± S.E.M.s are shown (from Ogata et al., 1970) 
They have also studied the correlati9n between intensity of exposure (0,  100 and 200 
ppm) and the concentration of hippuric acid in  urine collected either during the first 
period  of  exposure  or  during  the  second  period  of  exposure  or  during  the  whole 
exposure period. 
The  results obtained when urine are collected during the afternoon are shown on  the 
following figure (Fig. 5) and accompanying table. 
In a group of 5 persons exposed to 100 ppm toluene for 7 hours the average hippuric 
acid concentration in  urine collected during the second period of exposure would be 
about 2.81  g/1 (corrected for S.G. 1.024) or 1.87 g/1 (corrected for S.G. of 1  .016). Ninety 
percent of the values  are  included  in  the  range  1 to  2.75  (corrected for  an  S.G.  of 
1.016). Ogata et al. (1970) have suggested that when the hippuric acid concentration of 
a  worker  exceeds  a  value  corresponding  to  2  standard  deviations  less  than  the 
average quantity excreted  by  subjects  exposed  to  the  permissible  level,  one  must 
conclude that he  may have been exposed to a concentration greater than that level. 
According to their data, the screening (5th percentile) concentration of hippuric acid in 
urine collected during  the  second  period of  a shift during which  the  time-weighted 
average exposure has  been  100 ppm should be  1.00 gil  iter (corrected for a specific 
activity of 1  .016). 
We have seen in a previous table that the upper normal limit for toluene may exceed 1 
g/liter. 
Thus  on  an  individual basis separation  of  the  exposed  from  the  non-exposed  can 
hardly be done regarding single urine analysis for hippuric acid. 170 
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Imamura and Ikeda (1973) and Engstrom et al. (1976) came to the same conclusion. 
On  a  group  basis,  however,  this  test  is  sufficiently  sensitive.  The  results  of  the 
hereabove cited studies have been summarized in Table 2 and in Figs. 6 and 7. 
The excretion rate of hippuric acid at the end of the exposure period is much closely 
related to the time-weighted toluene load than concentrations alone (Veulemans and 
Masschelein, 1979; Veulemans et al.,  1979; Wilczak and Bieniek, 1978). On  a groups 
basis,  a  time-weighted  average  exposure  of  100  ppm  corresponds  to  an  hippuric 
excretion rate of 2.6 mg/min according to Wilczak and Bieniek (1978) and to 4 mg/min 
according  to  Veulemans  et  al.  (1979).  Unfortunately,  for  practical  reasons,  the 
collection of a time-urine sample is frequently impossible. 
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Figure 7- Relationship between hippuric acid concentration (expressed in g/g creatinine) in 
post shift urine sample and toluene exposure. 
Each  point represents the mean value found in a group of workers (see Table 2). 
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Factors Influencing Hippuric Acid Excretion 
Increased  urinary  excretion  of  benzoic  acid  can  also  occur  when  food  containing 
benzoic  acid  precursors  of  benzoic  acid  (mainly  plums,  cranberries,  prunes)  are 
ingested (Pagnotta and Lieberman, 1967). 
Alessio et al. (1981) have found that in non-exposed persons, the mean urinary hippuric 
acid excretion is higher in females than in males. Further investigation is necessary to 
evaluate whether this is due to.a sex-linked difference in hippuric acid production or to 
a difference in the dietary habits of both groups. 
In summary, it appears that in  a group of workers exposed to 100 ppm toluene for 8 
hours, the mean hippuric acid concentration in  urine samples collected at the end of 
the exposure period would amount to around 2.2 g/liter (S.G. 1  016) or 2.5 g/g creatinine 
(Figs. 6 and 7): 
The available data indicate that this test can only be  used to appreciate exposure of 
groups of workers because with the proposed biological threshold, the sensitivity of 
the test is probably limited. A group of experts of the World Health Organization has 
reached the same conclusion (OMS, 1981 ). 
Benzoic Acid In Urine 
Bardodej  (1968)  has  indicated  that  it  is  thoeretically  preferable  to  measure  total 
benzoic  acid  concentration  in  urine  (free  +  conjugated)  because  benzoic  acid 
produced  after  toluene  exposure  is  conjugated  not  only  to  glycine  but  also  to 
glucuronic acid. 
It  has,  however,  been  found  recently  by  Engstrom  et  al.  (1976)  that  there  was  no 
difference between the direct determination of hippuric acid and the determination of 
benzoic acid after alkaline hydrolysis of urine. 172 
0-Cresol in Urine 
Only a minor fraction of inhaled toluene vapour is oxidized at the aromatic ring with the 
production  of  cresols.  Since  0-cresol  is  not  a  major  constituent  of  normal  urine 
(normal  concentration  <  0.3  mg/1),  its  determination  has  been  proposed  as  a 
biological monitoring method (Angerer 1979). Woiwode and Drysch (1 981) exposed 10 
volunteers  to  approximately  200  ppm  toluene  for  4  hours  and  at  the  end  of  the 
exposure period found an average concentration of 1.6 mg 0-cresol per liter of urine 
(S.G.  1  017).  According  to  Pfattli  et  al.  (1979)  a  time-weighted  average  toluene 
exposure of  100 ppm corresponds to a urinary 0-cresol concentration of 1 mg/1 (urine 
collected at  the  end  of  the  workshift).  Further studies are  required  to  compare the 
val1d1ty of this test with that of hippuric acid determination in urine. 
Hippuric Acid in Serum 
Angerer et  al.  (1975) have described a gas chromatographic method for hippuric acid 
determination in serum. They found a low but significant correlation between hippuric 
concentration in serum and in urine (r =  0.37). 
Toluene in Blood 
Engstrom et al. (1976) found a low but statistically significant correlation (r  =  0.64, n 
= 20) between toluene in blood and  in urinary hippuric acid (blood and urine samples 
collected at the end of an 8 hr-working day). On the contrary, Szadkowski et al. (1973) 
found no correlation between toluene concentration in blood and hippuric acid in urine. 
von  Oettingen et al.  (1942) exposed two volunteers to toluene vapour for 8 hours and 
determined the toluene content of venous blood at the end of the exposure. They found 
the following relationship between air and blood toluene concentration. 
Toluene in air  Toluene in blood 
(ppm)  (mg/100 ml) 
200  0.41-0.73 mg/100 ml 
300  >0.60- 0.73 
400  0.87-1.17 
600  >0.66- 0.95 
800  1.82- 2.64 
Szadkowskl et al. (1973) reported that in a control group the normal upper limit of the 
toluene concentration in blood was 15 JA.g  toluene I 100 ml blood (X = 5.3 JA.g/1 00 ml, n 
=  30).  In  an  occupationally  exposed  group  they  found  a  correlation  between  the 
toluene concentration in air and  in blood. The correlation was, however, very low (r = 
0.29). 
On  the  contrary,  Apostoli  et  al.  (1982)  found  an  excellent  correlation  (r  =  0.89) 
between environmental toluene concentration measured with personal samplers and 
toluene level in blood during exposure. In addition these authors were unable to detect 
toluene in blood of non-exposed persons. This data suggest that in workers exposed to 
less  than  50  ppm  toluene  ( <  188  mg/m3)  toluene  concentration  in  blood  during 
exposure is about 3 times higher than in air. A similar ratio was found by Angerer and 
Behling (see below), but on volunteers at rest, the ratio seems closer to 1. 
In six subjects exposed at rest to 100 ppm toluene, Astrand et al (1972) found a mean 
value  for  venous  blood  concentration  during  exposure  of  0.045  mg/1 00  ml  (SE  = 
0.015).  As  expected  this  concentration  increased during  exercise (0.0135  ±  0.013 
mg/1 00 ml  after an  exercise of 50 watts during 20  minutes).  For an  exposure to 200 
ppm, the concentration at rest amounted to 0.064 mg/1 00 ml (SE =  0.01 0). 
Under  steady  state  conditions,  Veulemans  and  Masschelein  (1978)  found  also  a 
constant relation between uptake rate of toluene and toluene concentration in venous 
blood.  During exposure to 50,  100 and  150 ppm toluene at  rest,  the average venous 
blood concentration reaches a plateau value of about 0.02, 0.04 and 0.06 mg/1 00 ml 
respectively.  Under  non-steady state conditions,  however,  no  simple  relation  exists 
between uptake and venous blood concentration of toluene. According to Angerer and 173 
Behling (1981 ),  an  atmospheric concentration of 200  ppm  toluene corresponds to a 
blood concentration higher than 0.26 mg/1 00 mi. Gas chromatographic techniques for 
toluene determination in blood have been described by several authors (Angerer et al., 
1973; Engstrom et al., 1976). 
Toluene In Expired Air 
By exposing volunteers to xylene, Astrand et al. (1972) have shown that the content of 
solvent in alveolar air samples collected during exposure is  related to the intensity of 
exposure. At rest the mean value for alveolar air concentration found during exposure 
to 100 ppm of toluene is 18.1 ppm (SE =  1  :41  ppm; n =  15). 
The corresponding value for an  exposure to approximately 200 ppm at rest was 37.5 
ppm.  The  correlation  between  environmental  exposure  to  toluene  and  its  alveolar 
concentration measured in  workers during the  workshift seems to agree with these 
estimates (Brugnone et al., 1980). 
Astrand et al. (1972) are of the opinion that "neither alveolar air samples (nor venous 
blood samples) taken at given intervals after the conclusion of a period exposure can 
provide sufficiently accurate information on the average amount of solvent in inspired 
air at a working place or on the magnitude of an individual's uptake". 
Conclusion 
Not  enough  investigations  have  been  pe·rformed  to  evaluate  whether  analysis  of 
expired air (or blood) collected 16 hours after the end of exposure (i.e. before the next 
shift) can  provide,  like for benzene,  an  estimation of the  magnitude of previous day 
intake of toluene. 
Analysis of expired air and/or blood during exposure reflects current intake. 
During exposure to 100 ppm  toluene at rest, the average concentration of toluene in 
venous  blood  and  in  air  will  amount  approximately to 40  ~-tg/1 00  ml  and  70  mg/m3 
respectively.  During light physical  exercise, the blood concentration may amount to 
110  ~-tg/1 00 mi. 
Determination of the  average hippuric acid concentration in  urines collected at  the 
end of the workshift is still the most practical method to evaluate whether the overall 
hygiene conditions are satisfactory. A group average below 2 gil iter (S.G.  1  016) or g 
creatinine suggests that the atmosphere was probably contaminated by less than 1  00 
ppm  toluene.  On  an  individual  basis,  one  must  recognize  that  this  threshold  has 
probably a good specificity, but a very low sensitivity. Currently, the determination of 
0-cresol in  urine does not seem  to offer additional advantages over the analysis of 
hippuric acid. 
Research Needs 
The following are recommendations for further research: 
further  investigation  on  the  possibility  of  determining  toluene  concentration  in 
exhaled air and in blood for evaluating the integrated exposure during the previous 
day 
- study factors influencing toluene metabolism and toxicity 
- comparative study of the  validity of  hippuric acid and  o-.cresol  determination  in 
urine. 174 
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EN 
Biological Monitoring is one of the most promising tools for  performing an 
effective program of prevention from  the potentially toxic effects of chemi-
cals  in  occupational  environment;  its  most interesting feature  involves the 
possibility  of  predicting  toxicological. diseases  at  a  very  early  stage  by 
means, of measurement of indicators of dose and effects. 
For  industrial  chemicals  such  as  benzene,  lead,  manganese,  titanium, 
toluene,  alogenated hydrocarbons and cadmium a description of the types 
and characteristics of indicators is given. 
The limitation and difficulties inherent in biological monitoring are analyzed, 
·indicating the goals for further research in this field. 